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Abstract 
Organic light-emitting diodes (OLEDs) are an emerging area in lighting technology, with the 
potential to be cheaper, lighter and more efficient than traditional filament and fluorescent 
lighting sources. Emission in OLED devices is produced by relaxation of excitons, excited states of 
the emissive material formed by the applied electrical current, to the ground state, releasing the 
energy as light. Excitons exist as either singlets or triplets, which can emit light via fluorescence 
and phosphorescence, respectively. While phosphorescence is formally forbidden for simple 
organic molecules, it is allowed for 2nd and 3rd row transition metal complexes due to their strong 
spin-orbit coupling. This maximises the conversion of electrical energy to light when the 
complexes are employed as dopants in OLED devices. Iridium(III) complexes are the most widely 
used, as the emission colour can be tuned easily through relatively simple structural modification, 
although other d6 metal centres have been investigated.  
In this thesis a new family of sulfone containing ligands was synthesised, with the aim of blue-
shifting the emission of the resultant iridium complexes compared to the parent complex, FIrpic. 
Introducing a sulfone group to the 5-position of dfppy (19, 20, 28) resulted in a blue-shift of 10 nm 
compared to FIrpic, due to the lowering of the HOMO with respect to the LUMO. This series of 
complexes was then extended to include complexes 68, 69, 70 and 80, which contain fewer 
aromatic fluorines, as these are known to make the complexes unstable in devices. While a red-
shift is observed when exchanging one fluorine for a methoxy group, complexes 68, 69 and 70 still 
displayed bluer emission than FIrpic. Complex 80 provides a viable fluorine-free alternative to 
FIrpic, with similar emission wavelength, HOMO/LUMO energies and similar orbital distributions, 
as indicated by the computational data. To blue-shift the emission further a new ancillary ligand 
(133) was synthesised and combined with some of the sulfone ligands to produce complexes 140 
and 141 (analogous to complexes 70 and 80). Devices fabricated in the Department of Physics 
retained the blue emission observed in solution and performed comparably with FIrpic. New 
complexes with oxazoline- and oxazole- based ancillary ligands were also synthesised.  
Donor-acceptor chromophoric ligands were also synthesised to investigate the solvent dependent 
dual emission properties of the resultant complexes. The donor and acceptor components were 
varied, producing complexes with differing degrees of dual emission character in solution (90, 
105, 116 and 117), which is tentatively assigned to the prescence of a ligand based CT state. While 
the complexes did not display dual emission properties in the solid state, devices fabricated in the 
Department of Physics showed favourable performances as blue emitters compared to a FIrpic 
device.  
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Chapter 1: Introduction 
Since the first report of electroluminescence from organic molecules in the 1950s,1 there has 
been a considerable amount of research into emissive organic materials. The first Organic Light-
Emitting Diodes (OLEDs), fabricated by Tang and VanSlyke at Eastman Kodak in 1987,2 prompted 
intense study into conducting and emissive materials for display and lighting applications, 
including conductive and emissive polymers, small molecules and transition metal phosphors. 
OLEDs have the potential to be more light-weight, cheaper and more efficient than traditional 
filament and fluorescent lighting sources. OLED devices do not require backlighting, instead 
consisting of layers of thin films, allowing them to be more light weight than current liquid crystal 
display (LCD) technology.3,4 They can also have a wider viewing angle, faster response time and 
consume less energy when displaying dark images.3,4 The absence of backlighting allows OLEDs to 
be deposited onto flexible substrates to form bendable devices.5 In addition, soluble organic 
electroactive materials can be deposited by solution processing, which allows the manufacture of 
devices by inkjet printing techniques, reducing device cost.5,6 Today Active Matrix OLEDs 
(AMOLEDs) are used in the displays of many smart phones, and OLED TVs have been produced by 
Samsung, Sony and LG, although at a high price. In addition, in 2010, Sony debuted a small flexible 
OLED screen prototype, able to roll around a pencil while still displaying images, highlighting the 
unique potential of OLED technology.7 
OLEDs 
OLEDs are devices which emit light in response to an applied electric current. They consist of 
layers of organic semiconducting materials, each of which performs a specific function within the 
device, sandwiched between two electrodes (one of which is optically transparent) and deposited 
onto a substrate such as glass or flexible plastic (Figure 1.1). The cathode and anode serve to 
introduce charges (electrons and holes, respectively) into the device and these pass through the 
layers and combine in the emissive layer to form excitons, excited states of the emissive 
molecules.8 These excited states then collapse back to the ground state, resulting in emission of 
light from the device with a wavelength corresponding to the energy difference between the 
excited and ground states. As electrons and holes have spin ½ the excitons can either be singlets 
(S = 0) or triplets (S = 1) and these are formed in a ratio of 1:3 in devices according to spin 
statistics and experimental observations.8,9 Devices utilising purely fluorescent emitters are 
therefore limited to an internal quantum efficiency (IQE, defined as the ratio of the number of 
internally generated photons to the number of injected electrons) of only 25% as transitions  
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Figure 1.1: Diagram of a typical OLED device. 
between states of differing spin quantum number are formally forbidden by the spin selection 
rules. Materials that can harness the remaining 75% triplet states can theoretically achieve 100% 
IQE. There are a few methods to do this: 1) using heavy metal complexes in which spin-orbit 
coupling (SOC) allows formally forbidden emission from the triplet states,7,10 2) using a form of 
delayed fluorescence, either triplet fusion (TF or P-type delayed fluorescence), which can achieve 
a maximum IQE of 62.5%, or 3) thermally- activated delayed fluorescence (TADF, or E-type 
delayed fluorescence) which can achieve a theoretical 100% IQE.11 
Figure 1.2 shows an example energy level diagram for a typical OLED device. The HOMO and 
LUMO levels of the materials are depicted, and it is evident that it is important for the 
HOMO/LUMO levels of layers to match up to prevent high injection barriers. In addition, charge 
mobilities in adjacent layers must also be matched to neighbouring layers. In order to ensure 
colour purity from a device the excitons must be confined on the emissive molecule; to do this 
charges within the device must be appropriately balanced.  
For this to be achieved electron and hole transport layers (ETLs and HTLs) are inserted next to the 
cathode and anode, respectively, to facilitate the injection of charges by reducing the injection 
barrier.10 Efficient electron transport materials are particularly important, as hole mobility in OLED 
devices is typically 1000 times greater than electron mobility.10 To assist in the balancing of 
charges electron and hole blocking layers (EBLs and HBLs) can be used. These are materials with a 
high LUMO/low HOMO to prevent charge leakage. 
It is necessary to dope most emitters into a host matrix, in order to prevent concentration 
induced quenching.10 This is particularly important for phosphorescent emitters, as triplet-triplet 
annihilation can occur at high concentrations due to the long-lived nature of the excited state.10 
This is a Dexter process wherein two excited triplet states with overlapping wavefunctions collide 
Chapter 1: Introduction 
 
   3 
 
Figure 1.2: Energy level diagram for a typical OLED device. 
to produce one molecule in the singlet ground state and one in an excited singlet state. This 
energy transfer is strongly distance dependent and hence can be reduced by doping a 
phosphorescent material into a matrix. However, the use of a host brings its own difficulties; host 
materials must have a triplet energy (ET) approximately 0.4 eV higher than that of the dopant in 
order for the energy transfer to be efficient.10,12,13 Otherwise, triplet states can remain trapped on 
the host and may undergo quenching. In addition colour purity can also be reduced as the host 
molecules may emit themselves.10,14-17 
While red and green emitters for OLEDs are well known, their blue counterparts continue to 
underperform in devices by comparison. Operational lifetimes (defined here as the time taken for 
the luminance of a device to fall to 50% of its original value) published in 2007 by DuPont for red 
and green phosphors were 46,000 h and 230,000 h, respectively,18 and they recently published a 
solution-processable green material with a lifetime of 1,000,000 h.19 In comparison, the blue 
emitting materials still have a maximum current lifetime of about 40,000 h. 18 The design of 
efficient blue emitting materials is challenging as blue light requires high energy transitions which 
can be difficult to obtain.4,10 In addition the increased energy of the transition can result in an 
increase in radiationless deactivation pathways, such as M-L bond stretching, solvent 
deactivation, vibronic coupling to the ground state and, if the potential energy surface of the T1 
state is shallow enough, direct surface crossing between T1 and S0.
15,20,21 Another challenge is in 
designing hosts and other materials that can be used with these high energy emitters; host 
materials for blue and deep blue materials require large ETs and as a result a wide HOMO-LUMO 
gap Eg,.
10 This can be difficult to obtain as it is normally achieved by decreasing π-conjugation, 
however this reduces the conductance and is detrimental to device efficiency.10,16 It is also 
necessary for the orbital energy levels of the host and emitter to overlap, otherwise efficient 
energy transfer will not occur.12 
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TRANSITION METALS FOR OLEDs 
Luminescent transition metal complexes have attracted great interest in recent years due to their 
wide variety of applications, including sensitisers for f-block emissive complexes,22 bioimaging 
agents,22-25 singlet oxygen sensitisers,26 oxygen and fluoride sensors,27-30 metal ion sensors,31,32 
solar cells,33,34 luminescent sensors of chiral molecules,35 photosensitisers for hydrogen generation 
catalysts,30,36 photodynamic therapy agents,37 and photoredox catalysts.38 Their interesting 
photophysical properties have also found widespread use in the field of optoelectronics, 
particularly in OLEDs or light-emitting electrochemical cells (LEECs). 
 
Figure 1.3: LEFT: Electroluminescent osmium complexes. RIGHT: PtOEP, an electroluminescent platinum complex.  
 
Electroluminescence from a transition metal complex in an OLED device was first reported in 1998 
by Yuguang Ma et. al. from osmium (II) complexes with a chromophoric bipyridine ligand (Figure 
1.3).39 Along with other d6 metal centres (such as Ru
II and IrIII), OsII was identified as a promising 
centre for emissive phosphorescence materials due to its large ligand field splitting and strong 
metal-ligand interactions which allow for highly efficient luminescence.7 In the same year, 
Thompson and Forrest also reported an OLED device with a platinum porphyrazine (PtOEP, Figure 
1.3) complex as the emitter,40 however, both papers reported a quenching of efficiency in devices 
due to triplet-triplet annihilation (TTA) as a result of the materials’ long phosphorescence 
lifetimes. In 1999 Thompson and Forrest utilised fac-Ir(ppy)3 to produce a green OLED device with 
an external quantum efficiency (EQE) of 7.5% at 100 cd/m2 at an operating voltage of 4.3 V.41 
Ir(ppy)3 was identified as promising due to its short phosphorescence lifetime, 2 μs, indicating 
strong spin-orbit coupling and a reduced effect from TTA.41 Since then IrIII complexes have been 
widely studied due to their favourable short phosphorescent lifetimes, strong spin-orbit coupling 
and large ligand-field splitting due to Ir being a 3rd row transition metal.42-44 Although iridium is a 
rare and therefore expensive metal, the quantity required to produce devices is relatively low, as 
they are doped into a host material. In addition, many of the complexes are robust and efficient, 
as a result iridium phosphors remain the industry standard for red and green emitters. 
 
To understand how these complexes perform these functions the nature of the excited state must 
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be considered. In order to do this it is important to understand the different types of excited 
states and electronic transitions that occur, and how they affect the emissive properties of the 
complex, such as colour, photoluminescence quantum yield and lifetime. Armed with this 
understanding, these properties can be tuned through molecular design to produce the features 
desired for specific applications. 
 
Figure 1.4: Generalised molecular orbital diagram for an octahedral complex ML6.  
A general molecular orbital diagram for an octahedral metal complex ML6 is shown in Figure 1.4. 
The energy levels vary depending on the identity of the metal centre M, the oxidation state of the 
metal, and the choice of ligand. Although the orbitals span the entire molecule it is possible to 
identify the orbitals with significant ligand character (L) or metal character (M); once the orbitals 
are labelled as such it is possible to identify four main types of transitions, listed below: 
1) Metal-centred (MC) states 
2) Ligand-centred (LC) states 
3) Metal-to-ligand charge-transfer (MLCT) 
4) Ligand-to-metal charge-transfer (LMCT). 
The lowest energy excited state can be any one of these, or an admixture of two, depending on 
the relative energy levels of the orbitals. 
Metal-centred (MC) states 
These states arise from transitions from metal d orbitals to metal d* orbitals; a transition formally 
forbidden by the Laporte selection rule, however this can be relaxed by spin-orbit coupling (SOC) 
for heavier transition metals.7 As a result d-d* transitions in absorption spectra have lower 
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oscillator strengths and ε values. As population of these states involves population of antibonding 
orbitals, they are often significantly distorted compared to the ground state, as a result they can 
be effective pathways for radiationless deactivation or ligand dissociation.13 For first row 
transition metals these states are often low in energy; however for second/third row transition 
metals they are often higher in energy, as the crystal field splitting parameter increases going 
down a group.7,13 The energy level of these states is still important in the design of high energy 
emissive materials however, as it is important to ensure they are sufficiently high in energy 
otherwise they can provide an efficient quenching mechanism. An energy difference of 0.37 to 
0.50 eV between the emitting and the quenching state is necessary to ensure a sufficiently small 
Boltzmann factor, and thus a small population of the quenching state, at ambient temperature.13 
Ligand-centred (LC) states 
Ligand-centred transitions arise from electron transfer between the π and π* orbitals localised on 
the ligands, and resemble the transitions of the free ligand if the change in its structure upon 
coordination to the metal is minimal.7 As these transitions do not involve the metal centre 
directly, spin-orbit coupling (SOC) does not have much of an effect.7,45 This can be detrimental for 
the emissive properties in OLEDs, as without a relaxation to the selection rules the 3LC → S0 is 
formally forbidden.45 
Metal-to-ligand charge transfer (MLCT) states 
Metal-to-ligand charge transfer states occur on promotion of an electron from the metal d 
orbitals to the ligand π*orbitals, resulting in metal oxidation and ligand reduction.7 Hence the 
energy of the MLCT state can be related to the difference between first oxidation and reduction 
potentials. Due to the change in symmetry between the initial and final states these transitions 
are strongly allowed by the Laporte selection band, resulting in greater extinction coefficients in 
the absorption spectra than seen for d-d* transitions. As these states involve the metal orbitals 
directly, spin-orbit coupling can make the transition between the 1MLCT and 3MLCT, and the 
transition from the 3MLCT to the ground state strongly allowed, resulting in efficient emission.  
Ligand-to-metal charge transfer (LMCT) states 
Ligand-to-metal states occur on promotion of an electron from a ligand π orbital to metal d 
orbitals. These states generally arise from early transition metals in high oxidation states or d10 
metal centres and rarely occur for IrIII complexes.7 
JABLONSKI DIAGRAM 
Another factor to consider is the spin of the excited states; most organic molecules exist as a 
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ground state singlet (S = 0, all electrons are paired); upon excitation of one electron four possible 
states are produced, shown in Figure 1.4. The transition that proceeds with no spin flip results in 
an excited singlet state Sn, and the three transitions where spin flip occurs are described as the 
triplet state Tn. The triplet states are lower in energy than their corresponding singlet states, due 
to the exchange interaction. As a result of quantum mechanics, electrons with the same spin are 
less likely to be found near each other than those with opposite spins, therefore triplet states 
experience less electron-electron repulsion, hence the lower energy. The splitting between the 
excited S and T states (ΔEST) depends on the exchange integral:  
        ⟨ (  ) 
 (  )|
 
   
| (  ) 
 (  )⟩   (Equation 1.1) 
where π/π* = HOMO/LUMO wavefunctions, r1, r2 = electron coordinates and r12= the separation of the two electrons. 
 
Increasing π-conjugation results in a decrease in ΔEST, as does having distinctly localised HOMO 
and LUMOs. This can be prominent in transition metal complexes as the inclusion of the metal 
centre results in increased spatial extension of the wavefunctions and therefore a small gap 
between singlet and triplet states, which increases the inter-system crossing rate and probability.  
 
The relative energy levels of these possible transitions can be shown on a Jablonski diagram 
(Figure 1.5). On absorption of light an electron is promoted to a higher energy orbital, creating an 
excited electronic and vibrational state, typically a singlet state due to the selection rules. From 
here the molecule can relax to a lower vibrational level through vibrational relaxation, or to a 
lower energy electronic state through internal conversion. This occurs due to vibrational overlap 
between the two states and can act as a mechanism to quench emission; however it is not 
normally a favoured transition to the ground state. Both of these processes are non-radiative. 





Figure 1.4: Possible excited states generated on excitation of a molecule. 
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Figure 1.5: Jablonski diagram showing the types of transitions available to a molecule on photoexcitation. 
 
ground state, i.e. fluorescence, which is allowed by the spin selection rules. Another pathway a 
molecule can take is intersystem crossing, the term given to a non-radiative transition between 
two states of differing spin multiplicity. This transition is normally slow for organic molecules, as it 
is forbidden by spin selection rules; however due to spin-orbit coupling it can become more 
favourable for transition metal complexes. For Ru(bpy)3
2+ and Ir(ppy)3, two examples shown later, 
the efficiency of intersystem crossing can be assumed to be unity.46 The molecule can also emit 
from the triplet state to the ground state, a radiative transition referred to as phosphorescence. 
As with other transitions that involve a change in spin multiplicity it is formally forbidden by 
selection rules, meaning for organic molecules ISC to the triplet state can provide a quenching 
route at room temperature, as it is difficult to return to S1 unless the gap is small. The resulting 
triplet states have long lifetimes and so are prone to radiationless deactivation such as collisions 
or quenching with molecular oxygen. Efficient spin-orbit coupling, as can be seen in transition 
metal complexes, can make phosphorescence a strongly allowed transition resulting in efficient 
emission and decreasing the lifetime.13,44 
 
SPIN-ORBIT COUPLING 
Spin-orbit coupling is the coupling of an electron’s spin to its orbital motion, and its magnitude 
(ESO) is given by a matrix element, shown below for zero-order: 
 
     ⟨  |   |  ⟩    ⟨  |       |  ⟩         (Equation 1.2) 
 
where HSO is the spin-orbit coupling operator, ψ1, ψ2 initial and final orbitals involved, ζSO is the spin-orbit coupling  
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The spin-orbit coupling constant ζSO is related to the nuclear charge (Z) an electron experiences 
during its orbit; for atoms it is proportional to Z4, for molecules this is a local effect, hence spin-
orbit coupling is most effective when the electron is located near the heavy atom.48 These 
dependencies explain why transition metal complexes can display efficient spin-orbit coupling, 
and why complexes with localised 3LC states as the lowest energy states have long lifetimes and 
lower quantum yields than complexes with a lowest energy 3MLCT state, or complexes with 
mixing between the LC and MLCT states. Spin-orbit coupling transitions are only possible between 
states of the same symmetry representation, and there are other restrictions on the SOC routes 
related to the orbitals involved in the transitions, as well as whether the integral is one- or two-
centre. Detailed descriptions of the requirements are available.13,49 
 
PHOTOPHYSICAL PARAMETERS 
The efficiency of emission from a molecule can be quantified as the photoluminescence quantum 
yield (PLQY), , defined as the number of photons emitted over the number of photons absorbed. 




      
     (Equation 1.3) 
For molecules that emit via phosphorescence, the triplet state T1 is not normally populated by 
absorption of light, so we have to consider the rate of intersystem crossing from S1 to T1 relative 




    
           
 
  
      
          (Equation 1.4) 
where kISC is the rate of intersystem crossing, kIC is the rate of internal conversion, kf is the rate of fluorescence, and kp is 
the rate of phosphorescence, respectively.  
 
However for most complexes considered here the first term can be ignored, as the rate of 
intersystem crossing is far greater than that of any other pathway. 
 
It is possible to deduce the value of kr and knr from experimentally measureable parameters, as  
can be measured, along with the lifetime τobs, which can be determined from the rate of decay of 
luminescence intensity. Typically the decay is first order: 
 ( )    ( )                   (Equation 1.5) 
and τobs is defined as: 
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              (Equation 1.6) 
From here, we can see that: 
                   (Equation 1.7) 
 
It is clear from these equations that in order to have efficient luminescence from a molecule it is 
important not only to maximise kr, but to minimise knr. kr is proportional to the transition dipole 
moment squared, meaning that factors that influence this such as symmetry, the spin selection 
rule, spin-orbit coupling, nuclear overlap and ΔEST also influence kr.
48 Non-radiative decay is often 
a result of transfer of electronic energy into vibrational energy; hence knr can be increased by 
factors such as a large distortion between the ground and excited states or the presence of higher 
lying states that can be thermally activated and result in bond rupture. 
 
EMISSIVE METAL COMPLEXES 
Ru(bpy)3
2+ 
One of the most widely studied luminescent metal complexes is ruthenium(II) tris(bipyridine), 
Ru(bpy)3
2+, shown in Figure 1.6. First synthesised in 1936 by F.H. Burstall as a comparison with the 
well-known iron analogues,50 its emissive properties were not reported until 1959, by Paris and 
Brandt.51 The emission  of Ru(bpy)3
2+ was initially assigned to an excited singlet MLCT state; it was 
later concluded to be from a triplet MLCT state due to its long luminescence lifetime.52 The 
absorption and emission spectra shown in Figure 1.6 show a strong absorption band (ε ~ 10,000 
M) at ~450 nm, which is responsible for the red colour of the complex. The high extinction 
coefficient indicates that this is not a Laporte forbidden d-d* transition, but the singlet MLCT  








































Figure 1.6: LEFT: Structure of Ru(bpy)3
2+
. RIGHT: Absorption and emission of Ru(bpy)3Cl2 in water. λex = 450 nm.
53
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Figure 1.7: LEFT: Simplified molecular orbital diagram for Ru(L^L)3
2+
 complexes with octahedral geometry. RIGHT: 
Detailed depiction of the MLCT transition in D3 symmetry. 
(1MLCT) band. The triplet MLCT (3MLCT) band can be seen at longer wavelengths, although is far 
less intense due to the forbidden nature of the transition. LC bands are also seen at shorter 
wavelengths, and the molecular orbital diagram showing these transitions is shown in Figure 1.7. 
The emission spectrum is shown in Figure 1.6; the emission at RT in aqueous solution is relatively 
broad and featureless, with a λmax of 625 nm. Juris and Balzani published a detailed review of 
Ru(bpy)3
2+ and its properties in 1988.46 Ru(bpy)3
2+ has been widely studied not only due to its 
photoluminescence properties but also its photostability, and the reversibility and stability of its 
oxidation states. These properties have led to it and its related complexes being investigated for 
solar cells, luminescent photosensitisers, photocatalysts and prompted the investigation into 
transition metal complexes for various photoluminescence applications.  
fac-Ir(ppy)3 
fac-Ir(ppy)3 (hereafter referred to as Ir(ppy)3) is an efficient green emitting complex, shown in  







































Figure 1.8: LEFT: Structure of fac-Ir(ppy)3. RIGHT: Absorption and emission of Ir(ppy)3 in DCM.  λex = 380 nm. 
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Figure 1.8. Initially synthesised in 1985 it was identified as an effective photoreducing agent,54 
prompting investigation into the photophysical properties of it and other triply ortho-metallatedIr 
complexes.55 Its absorption and emission spectra are shown in Figure 1.8. Similar to the 
absorption spectra of Ru(bpy)3 distinct regions can be seen in the absorption spectra for Ir(ppy)3. 
Below 300 nm the intense absorption bands can be assigned to the ligand centred π-π* 
transitions, which are strongly allowed by selection rules. At lower energies (300-400 nm) the 
1MLCT transitions can been seen, followed by the formally forbidden 3MLCT transitions between 
430-450 nm. The emission at room temperature is broad and unstructured, as expected from an 
MLCT state, with λmax of 510 nm. The emission is quenched efficiently by oxygen, indicating the 
triplet character of the emission. Ir(ppy)3 has a short radiative lifetime time of  1.5 – 2 μs in 
deaerated solution, due to the highly efficient spin-orbit coupling between the 3MLCT and higher 
lying singlet states. This efficient SOC results in intersystem crossing times on the order of 100 fs, 
resulting in highly efficient emission.56 A similar molecular orbital diagram to that shown for 
Ru(bpy)3
2+ can be drawn, showing the possible states and transitions (Figure 1.9). As Ir(ppy)3 has 
C3 symmetry in the ground state the t2g orbitals split into two sets, a non-degenerate orbital with 




Figure 1.9: Frontier orbitals, MLCT and LC excitations for Ir(ppy)3 with C3 symmetry. The inner frame shows a simple 




Combined with symmetry-adapted unoccupied π* orbitals from the ppy ligands the simple model 
in the centre of Figure 1.9 is produced.57 Once the electron-electron interactions are taken into 
account the total number of states resulting from these transitions is 36, 12 of which are doubly 
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degenerate under C3 symmetry, although if the complex is doped into a host matrix the symmetry 
can be reduced and these degeneracies split.13 This simple model does not fully describe the 
experimentally observed properties; to obtain a more accurate model higher energy orbitals must 
also be considered (Figure 1.9). This results in a large number of states of comparable energy, 
highlighting the complexity of the system. The triplet excited state of  fac-Ir(ppy)3 has been well 
studied by Yersin,58 and details on the relative levels of the triplet substates can be found therein. 
Use by Forrest and Thompson in an OLED device prompted large scale investigation into Ir(ppy)3 
and other iridium complexes. Devices containing Ir(ppy)3 have been fabricated that approach the 
upper limit for EQE with current device architecture.59-61  
ANATOMY OF AN IRIDIUM COMPLEX 
Phosphorescent iridium(III) complexes for OLEDs are charge neutral species and can be divided 
into two basic categories: homoleptic complexes contain three identical, bidentate monoanionic 
ligands, whereas heteroleptic complexes have non-identical ligands. Both classes contain a 
chromophoric ligand that is responsible for controlling the emission from the complex; these are 
normally cyclometalating ligands that bind to the metal through a carbanion C and a neutral N 
(C^N ligands) to form a 5- or 6-membered metallocycle, although C^C and N^N monoanionic 
ligands are also known.  
 
 
Figure 1.10: Structural isomers of a homoleptic Ir complex with C^N ligands. Dotted lines illustrate the different 
geometries. 
Homoleptic complexes can exist as two isomers, meridional (mer) and facial (fac), shown in Figure 
1.10. The mer isomer is the kinetic product; however it can normally be converted to the 
thermodynamic fac isomer either by photochemical or thermal means.44,62 As a result of the 
different symmetry of the mer isomer compared to the fac the location of the frontier orbitals 
differs, and consequently so do their electrochemical and photophysical properties.62 Studies on a 
selection of mer isomers showed they exhibited broader, red-shifted emission and lower 
luminescence efficiencies compared to their fac counterparts along with lower luminescence 
efficiencies.44,62 In a study on a selection of homoleptic complexes radiative (kr) and non-radiative 
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(knr) decay rate constants were calculated for each isomer and although kr showed little variation 
between isomers, knr was over an order of magnitude larger for the mer isomers, indicating 
effective quenching mechanisms.62 It has been suggested that one pathway for non-radiative 
decay in mer isomers is a bond-dissociation in the excited state, resulting in conversion to the fac 
isomers.62 Ir(ppy)3, described in the previous section, is a classic example of a fac homoleptic 
complex. 
 
As mentioned previously, heteroleptic complexes contain non-identical ligands; typically either 
one or two chromophoric ligands and then the rest of the coordination sphere filled with ancillary 
ligands. Ancillary ligands are generally not involved in the excited state that produces the 
emission,23,63,64 but can influence its properties and modify emission colour indirectly by varying 
the electron density around the metal centre.23 Strong σ-donor or π-acceptor ancillary ligands can 
raise the energy of the deactivating d-d* states that quench emission, thereby increasing the 
luminescence efficiency of the complex. Additional functionality, such as charge carrier transport 
properties and enhanced solubility can also be introduced onto ancillary ligands.10,63,65 Care must 
be taken when choosing ancillary ligands, however, as if the triplet energy of the ancillary ligand is 
lower than that of the chromophoric ligand efficient inter-ligand energy transfer (ILET) can lead to 
significant red-shifts in emission colour.66,67 An example of a typical heteroleptic iridium complex 
is FIrpic (Figure 1.11), the archetypal blue emitter, which will be discussed in more detail in 
Chapter 2. 
 
Figure 1.11: Heteroleptic complex FIrpic. 
In this thesis a variety of iridium complexes for OLED applications will be discussed; in Chapter 2 
sulfone-containing derivatives of FIrpic are synthesised as blue OLED materials and their 
properties are discussed along with their device performance. Chapter 3 is concerned with an 
extension to this family; moving towards fluorine-free blue emitters in an attempt to increase 
complex stability. Their properties and device performance is discussed in comparison to the 
difluoro complexes presented in Chapter 2. In Chapter 4 the synthesis and photophysical 
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properties of a selection of dual-emitting complexes is discussed. Investigation into alternative 
ancillary ligands is conducted in Chapter 5, both for blue emission and efficient emission. In 
Chapter 6 hexadentate ligands are synthesised with the aim of creating ligands to stabilise 
carbene complexes, a class of complexes that exhibit deep blue emission but with limited stability.  
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Chapter 2: Complexes of ligands 
containing difluoro and sulfone 
substituents as blue OLED materials 
FIrpic (1), shown in Figure 2.1, is the archetypal sky blue emitter. With pale-blue emission 
exhibiting CIE coordinates of (0.16, 0.29) it is among the most widely investigated bis-
cyclometalated iridium complexes; this can be attributed to its facile synthesis and desirable 
photophysical and electrochemical properties. First reported in 2001, its emission is considerably 
bluer than that of Ir(ppy)3 due to the presence of the electron withdrawing fluorine substituents 
on the phenyl ring and the picolinate ancillary.1,2 Initial devices were reported with EQEs of 5% but 
recently FIrpic-containing devices have reached 30% EQE, the maximum with current device 
architectures.3 As one of the first blue phosphorescent emissive materials for OLEDs, FIrpic is 
often used as the benchmark for blue phosphors and many derivatives have been synthesised. An 
extensive review of FIrpic and its properties has been published.4 Although FIrpic has excelled in 
many ways there are still some problems, including poor emission colour for RGB display, poor 
solubility in organic solvents and degradation of the material under thermal evaporation and 
during device operation.2,5 The stability of FIrpic and its derivatives will be discussed in Chapter 3; 
in this chapter strategies for blue-shifting the emission of iridium complexes will be discussed 
along with examples, followed by the synthesis, results and discussion of a new series of FIrpic 
analogues. 
 
Figure 2.1: FIrpic. The positions of the phenyl ring are numbered as they are referred to in this work. 
The HOMO/LUMO orbital diagrams for Ir(ppy)3 are shown in Figure 2.2. The HOMO is mostly 
localised on the iridium d-orbitals and the phenyl ring of the ppy ligand, with negligible 
contribution on the pyridyl ring, while the LUMO is mostly localised on the pyridine ring, with a 
small contribution on the 4,6-positions on the phenyl ring.6,7 This is typical for cyclometalated 
iridium complexes based on ppy ligands, and as a result of the distinct HOMO/LUMO distributions  









their energies can be tuned relatively independently, allowing for colour tuning by varying the 
structure of the ligands. Some strategies to tune the emission colour of an iridium complex 
towards the blue region include:9 
 
1) Lowering the HOMO with respect to the LUMO by introducing electron-withdrawing 
groups to positions on the phenyl ring with HOMO localisation 
2) Raising the LUMO by either adding electron donating groups to the pyridine ring or 
replacing the pyridine ring with another heterocycle with higher LUMO energy 
3) Using electron withdrawing ancillary ligands to modulate the electron density about the 
metal centre, thereby affecting the HOMO energy 
4) Using strong σ-donor ligands to increase the crystal field splitting, therefore widening the 
HOMO-LUMO gap and shifting non-emissive d-d* MC states to higher energies. 
 
These strategies can be used in conjunction with each other, and the effects are additive. The 
work in this chapter primarily considers the first strategy. 
 
Due to the success of FIrpic a large number of complexes have been synthesised based on the 
dfppy ligand framework. As can be seen from the HOMO/LUMO localisation of FIrpic (Figure 2.3) 
there is a large density of the HOMO at the 5- position of the difluorophenyl ring, but little  
 








contribution from the LUMO. As a result a common strategy to blue-shift the emission relative to 
FIrpic is to introduce electron withdrawing groups at the 5-position. One example is the 
homoleptic complex FCNIr (Figure 2.4) which displays deep blue emission, with a λmax of 448 nm 
and a vibrational side peak at 476 nm.10 The introduction of the CN substituent results in a blue-
shift of 20 nm compared to fac-Ir(4,6-dfppy)3 due to the lowering of the HOMO with respect to 
the LUMO, giving the complex a band gap of 2.8 eV. Devices incorporating FCNIr as the emitter 
achieved CIE coordinates of (0.15, 0.19) at 5% dopant concentration with an EQE of 4.9% at 300 
cd/m2, significantly bluer than FIrpic devices.10 This dfppy ligand has also been modified to impart 
additional solubility to FIrpic-based complexes; replacing one of the fluorines with an alkoxy 
group results in a slightly bluer emission than FIrpic, as well as an increase in solubility.2 
 
 
Figure 2.4: Structures of a selection of substituted iridium complexes. 
 
Cao et al. synthesised two FIrpic analogues with the SO2Tol and PO(Ph)2 groups at the 5-position 
to blue-shift emission (Figure 2.4).11 Cyclic voltammetry estimations of the HOMO/LUMO levels 
showed a decrease in the HOMO relative to FIrpic, while the LUMO levels remained fairly similar, 
resulting in emission peaks of 460 nm and 489 nm for POFIrpic, and 459 and 486 nm for SOFIrpic 
in DCM solution.11 This represented a blue-shift relative to FIrpic and the devices fabricated 
showed comparable performance to the established material FIr6 (Figure 2.4).11 
 
The highly electron withdrawing CF3 group has also been introduced between the two F atoms 
and some complexes are shown in Figure 2.5.12 The FIrpic analogue showed a blue-shift in 
emission of 11 nm as a result of the addition of the CF3 group, and the HOMO is  significantly 
lowered, based on a 0.24 eV increase in the oxidation potential.12 Exchange of the picolinate 
ancillary ligand for a 3-trifluoromethyl-5-(2-pyridyl)-1,2,4-triazolate system (from 2/3 to 4/5) 
prompted further blue-shift; however the EQEs of devices based on these complexes are low.12 






Figure 2.5: FIrpic analogues containing CF3 groups. 
 
Materials involving ester substituents at the 5-position of dfppy have also been synthesised and 
used as sensors for molecular oxygen (6a/b, Figure 2.6: left).13 Blue emitting sensors are highly 
desirable as they would increase sensor performance in media where there are natural red 
emitters. The ester group was selected as it could allow grafting of the dye to substrates and the 
trifluoromethyl ester was predicted to increase solubility and shift further into the blue region, as 
it has stronger acceptor character.13 However, while use of the CO2CF3 group does result in a blue-
shift in emission relative to FIrpic, it should be noted that presence of the CO2CF3 group results in 
the LUMO being mostly localised there.13 This highlights the need to be aware that introducing 
different groups within the structure can significantly affect locations of the HOMO/LUMO, which 
could result in different emission from what may be expected.13 Related complexes with a 




Figure 2.6: Structures from a selection of substituted iridium complexes. 




2.6: centre, right).14 These complexes displayed bluer emission than FIrpic, with DFT calculations 
and optical measurements indicating band gaps of 2.9 eV and triplet energies of 2.77 eV for the 
pic complexes (7a/b).14 The emission was pushed further to the blue by exchange of the picolinate 
ancillary ligand (7a/b) for a more electron withdrawing trifluoromethylated triazole ligand 
(8a/b).14 Devices fabricated with 7a and 8a showed EQEs of 17.1 and 8.4% and CIE coordinates of 
(0.141, 0.158) and (0.147, 0.116), respectively, which are among some of the highest reported for 
deep blue phosphorescent OLEDs.14 Again, it must be noted that the introduction of these highly 
electron withdrawing perfluorinated carbonyl substituents shifts the LUMO density onto the 




Figure 2.7: A series of homoleptic complexes with substituents at the 5-position. 
 
For another series of homoleptic complexes a variety of substituents were introduced at the 5-
position (Figure 2.7) and the trends in emission colour are as expected, with the EWGs (CHO, CN, 
SCN, SO2Ar) resulting in a blue-shift and the thiol/thioether acting as EDGs and red-shifting 
emission.15 The SCN group blue-shifts the emission only slightly, whereas the other EWGs do so by 
approximately 30 nm, resulting in blue emission without using fluorine substituents.15 These 
complexes were particularly interesting as the synthesis was conducted ‘on complex’, allowing the 
use of groups that could be sensitive to the high reaction temperatures required to synthesise 
homoleptic complexes.15 
A different approach to deeper blue emission is to replace the phenyl ring with a more electron 
deficient group, such as pyridine, as it has been reported that pyridine has a lower HOMO/LUMO 
than other nitrogen containing heterocycles.16 For example, the homoleptic bipyridyl complex 9 
(Figure 2.8) exhibits bright blue emission when irradiated with UV light. Comparison with the 
absorption spectra of FIrpic shows a blue-shift in the LC and 1MLCT/3MLCT transitions.16 The 
intensities of the MLCT transtions also increase, indicating an increase in spin orbit coupling on  






switching to a bipyridyl system.16 Molecular orbital calculations show a lowering of both the 
HOMO and LUMO relative to Ir(ppy)3, however the HOMO is lowered to a greater extent, resulting 
in pure blue, more efficient (PLQY = 0.71) emission with CIE coordinates of (0.14, 0.12).16  
 
It must be noted, however, that there are some disadvantages to lowering the HOMO; for 
example,  if the level drops too low hole injection from the anode is inhibited.16 Consequently, 
simply lowering the HOMO is not the best strategy for producing efficient blue emitting devices, 
other strategies must be employed in conjunction. 
 
While fluorine is considered a withdrawing group, it is a special case, being both strongly 
electronegative, and therefore a good inductive withdrawer, and also a weak mesomeric π-donor. 
The position of the fluorine(s) on the phenyl ring of the iridium complex has a large impact on the 
emission colour; a study on heteroleptic pic complexes revealed that having the fluorines at the 4- 
and 6-positions results in the bluest emission, even bluer than having three fluorines distributed 
at the 3-,4- and 5- positions.17 Another study conducted on homoleptic complexes with ligands 
containing 3 and 4 fluorines at the 3,4,6- and 3,4,5,6- positions noted that the F3ppy complexes 
demonstrated bluer emission than the F4ppy complexes, by approximately 10 nm.
18 This was in 









of the fourth fluorine.18 A theoretical study on the frontier orbitals of some methoxy-substituted  
heteroleptic complexes noted that a large HOMO density is located at the 5-position of the ppy-
based ligand, and suggested that the weak π-donor ability of fluorine was raising the HOMO.19 
Another paper from the DeCola group compared the purely inductive withdrawing CF3 group to 
the mesomeric donor but inductively withdrawing F group in a series of heteroleptic complexes 
(Figure 2.9).20 Introduction of the fluorine substituents at the 4,6-positions (10a) of the phenyl 
ring results in a blue-shift in the emission compared to the unsubstitued complex 10e, whereas 
placing them at the 3,5-positions results in little change in colour (10b).20 On the other hand, 
introducing the CF3 group at the 4,6-positions (10c) results in a red-shift in emission relative to the 
parent complex and a blue-shift when they are introduced at the 3,5-positions (10d). This 
behaviour is rationalised by the donor/acceptor character of F versus the purely inductive 








The effect of fluorine is even unique among the halogens. In 2012 Baranoff et. al. published a 
comparison of FIrpic to its analogues HIrpic, ClIrpic and BrIrpic (Figure 2.10); here FIrpic resulted 
in a blue-shift in emission relative to HIrpic, whereas the blue-shift for ClIrpic and BrIrpic was 
relatively small.21 The oxidation potentials for all the halogenated complexes were similar, ~0.35 V 
greater than that of HIrpic, indicating the stabilisation of the HOMO due to the halogens being 
electron acceptors. However, LUMO energies of ClIrpic and BrIrpic, estimated from the 
electrochemical HOMO level and optical gap, were much lower than that of FIrpic, resulting in the 
red-shift.21 This was correlated with the different values for the Hammett parameters (σm and σp) 
for F versus Cl and Br; Cl and Br exert a stronger electron accepting effect than F in the para 
position, resulting in a lowering of the LUMO as it is localised on the pyridyl ring which is 
ortho/para to the halogens.21 
 
As noted by De Cola et. al. changing the position of substituents can have a large effect on 
emission colour and properties; a substituent may provide a blue-shift at one position and a red-
shift at others.20 In particular, the introduction of strongly withdrawing groups at the 4-position  






seems to result in a red-shift in emission. In one study introducing electron withdrawing groups 
such as -SO2Ar, -PO(Ph)2 and -B(Mes)2 at the 4-position of Ir(ppy)2acac derivatives results in a red-
shift in the emission relative to Ir(ppy)2(acac) (Figure 2.11).
22 For Ir-PO this is due to the strong EW 
effect of P=O lowering the LUMO; however, for Ir-B(mes)2 and Ir-SO2Ar there is a significant 
change in the LUMO location, with less than 50% localised on the pyridyl ring.22 Both complexes 
experience an increase in contribution from the phenyl ring with the mesityl group and boron 
atom also participating in Ir-B and some contribution from the pendant phenyl rings for Ir-SO2Ar.
22 
This highlights the crudeness of the design rule ‘introducing electon withdrawing substituents 
onto the phenyl ring will blue-shift the emission’, as it is important to take into account the 
position of the new substituent and how it impacts the positions ortho-, meta- and para- to it. A 
paper relating the Hammett parameters (σm and σp) to the emission colour accounts for these 
parameters and allows for more effective prediction of molecular properties and design.23 
 
 
RESULTS AND DISCUSSION 
 
Figure 2.12: General target for a bluer FIrpic analogue. 
With the aim of obtaining bluer emission than FIrpic the following general target was designed 
(Figure 2.12); the sulfone moiety was introduced at the 5-position due to its electron withdrawing 
power, both inductively and through resonance. It can be seen from the molecular orbital 
diagram of FIrpic (Figure 2.3) that there is a localisation of the HOMO at this position, but no 
LUMO localisation, which is a strong indication that introducing an EWG at this position should 




result in a selective lowering of the HOMO relative to the LUMO, and therefore a blue-shift in the 
emission colour. Additionally, the sulfone group was chosen as the R group could be exploited to 
enhance solubility and potentially add steric shielding to the aromatic fluorines, which have been 
identified as a source of instability in FIrpic.24 Enhanced solubility would allow fabrication of 
devices via solution processing, a much milder technique than the alternative, vacuum deposition, 
which is routinely used for FIrpic.4 Vacuum deposition requires high temperatures, and a large 
proportion of the doping material is lost; it has been shown to result in the defluorination of 
FIrpic.24 Some examples of sulfone functionalised C^N ligands in the literature include neutral 
complexes,11,15,22,25,26 charged complexes for LEECs,27-29 an example of a sulfone containing N^N 
ligand,30 and even an example of an anionic iridium complex with a disulfinate ligand.31 
 
 
Figure 2.13: Synthesis of target ligands. 
Initial choices of R group were R = p-Tol (synthesised in my MSci project32 and subsequently 
published by Cao),11 and R = Me, due to the commercial availability of the required sodium 
sulfinate salts. The synthetic route to target ligands 15 and 16 is shown in Figure 2.13. The first 
step involves a Suzuki cross coupling of commercially available 2-bromopyridine (11) and 2,4-
difluorophenylboronic acid (12) using Pd(PPh3)4 and Na2CO3 as the catalyst and base, respectively, 
to give dfppy (13) in 84-96% yield. The next step involves an ortho-lithiation using LDA at -78 oC, 
followed by iodination at low temperature to give dfppy-I (14) in 56% yield, a step that is known.12 
The final step in the ligand synthesis is the copper-assisted nucleophilic displacement reaction to 
form 15 and 16, based on reaction conditions to produce diarylsulfones investigated by Suzuki 
and Abe.33 This step was reproducibly low yielding in both cases, 15% and 26% for 15 and 16 
respectively, prompting investigation into improving the synthesis.  
Unreacted and deiodinated starting materials (14 and 13, respectively) account for ca. 50% of the 
missing product, suggesting the sulfinate is not acting as a good nucleophile. In the original 
paper,33 it is noted that aryl halides with electron donating groups, and a hindered example 
(C6Me5I) react in moderate to good yields, suggesting it is not the steric influence of the ortho-
fluorine substituents impeding the reaction.33 Suzuki and Abe noticed improvement in yields of 




the diarylsulfones when the CuI/R-sulfinate sodium salt system was replaced with copper(II) 
bis(arenesulfinate), resulting in yield increases of up to 40% for previously difficult to obtain 
sulfones. The required material was synthesised from copper(II) sulfate and sodium 
methanesulfinic acid in water, and the reaction was repeated. The reaction was left for 24 h, then 
72 h, but showed no improvement, with isolated yields of 17% and 13%, respectively. Alternative 
protocols were attempted; the first, a CuI catalysed coupling reaction using ionic liquids as 
additives,34 however, the product was not obtained. A mixture of sulfone containing products was 
isolated, although none of them could be matched to the pure ligand 15 by NMR characterisation 
and the yield of the mixture was <4%. The second route, a CuI/L- proline catalysed system, was 
conducted in a sealed tube.35 Again, this yielded none of the desired product. Other possible 
conditions were considered, such as a palladium catalysed reaction using Pd2(dba)3, Xantphos, 
Cs2CO3 as the base and 
nBu4NCl as a salt additive. However, these could not be used as they do 
not tolerate ortho- substituents.36 As sufficient quantities of the required products 15 and 16 
could be obtained via the route in Figure 2.13 further variations were not explored. 
Heteroleptic pic complexes 19 and 20, analogues of FIrpic, were synthesised under modified 
Lamansky conditions from the intermediate μ-dichloro-bridged dimers (Figure 2.14).9 Water was 
omitted from the reaction conditions in order to protect the sensitive aromatic fluorines from 
nucleophilic aromatic substitution (SNAr) reactions. Dimer 18 was isolated and characterised 
previously.32 However, attempts to rigorously dry dimer 17 for NMR characterisation failed, as it 
decomposed under ambient conditions over the period of a week. The decomposition products 
were tentatively identified as mononuclear iridium complexes by NMR, although they were not 
fully characterised. Henceforth, all syntheses of the heteroleptic pic- complexes proceeded via a 
one-pot method, unless specified otherwise, to avoid possible decomposition of the intermediate 
dimer.  
Complexes 19 and 20 were synthesised from their respective dimers via the standard method,  
 
 
Figure 2.14: Synthesis of initial complexes. 







H NMR spectrum of complex 19. 
suspended in 2-ethoxyethanol with a large excess of picolinic acid and heated to reflux overnight. 
The complexes were obtained in good yield, 85% and 74%, respectively. It was noted that the p-
Tol complex 20 was more soluble than 19 in common organic solvents. 
The NMR spectra were typical for complexes of this type, and the 1H and 13C spectra of 9 have 
been fully assigned with the aid of 2D experiments (Figure 2.15, 13C assignments presented in 
Chapter 7). Using information from the NOESY experiment the stereochemistry about the metal 
centre could be determined, revealing the trans- nitrogen containing structure shown (Figure 
2.14). This is the expected product from reactions from the μ-dichloro bridged dimer, and was  
 
Figure 2.16: LEFT: X-ray molecular structure of 19. RIGHT: X-ray molecular structure of 20.3CH2Cl2. Thermal ellipsoids 
are drawn at the 50% probability level. Solvent omitted for clarity. 
 




confirmed by the X-ray crystal structure. 
The X-ray molecular structures of 19 and 20 are shown in Figure 2.16. In both complexes the 
expected trans arrangement of the nitrogens of the C^N ligands is observed, with a distorted 
octahedral coordination about the iridium centre. In both complexes the ppy ligand framework is 
almost planar, with small twists of 1.3, 4.0o and 3.0o for complexes 19 and 20, respectively. 
Selected bond distances are shown in Table 2.1. The bond lengths are similar to those reported 
for FIrpic,21 with the exception of the Ir-C bonds, which are shorter. The electrochemical and 
photophysical properties of these complexes will be discussed later. 
 19 20 FIrpic 
a
 
Ir-N(pic) 2.137(3) 2.134(3) 2.135(3) 
Ir-N(ppy-1) 2.046(3) 2.029(3) 2.056(3) 
Ir-N(ppy-2) 2.028(3) 2.048(3) 2.049(3) 
Ir-O(pic) 2.146(2) 2.158(2) 2.158(2) 
Ir-C(ppy-1) 1.991(4) 1.989(3) 2.010(3) 
Ir-C(ppy-2) 1.974(3) 1.985(3) 2.002(3) 
a




Ppy-1 and 2 are defined as the ligands with carbon atoms opposite the pic N/O, 
respectively.   
Table 2.1: Selected bond distances. 
Previous work conducted in our group suggested introduction of a mesityl group at the 4-position 
of the pyridyl ring of dfppy can result in a large increase in the EQE of devices compared to that of 
the parent complex FIrpic, due to the steric shielding it provides.37 This helps to reduce the 
concentration quenching effect in devices, allowing for higher complex loadings and therefore 
brighter devices.  
With this in mind it was desirable to combine mesityl and sulfone substituents to create a bluer 
emitter that is highly efficient under device operation. The initial target was 16, derived from 9, as 
9 was determined to have slightly bluer emission than 10. In addition, the mesityl group was 
predicted to enhance solubility, making the complexes more suitable for solution processing. 
The synthetic route is shown in Figure 2.17, and is analogous to that described for 15 and 16. The 
mesityl-dfppy was constructed as previously described;37 an initial Suzuki coupling between 2-
chloro-4-iodopyridine (21) and 2,4,6-trimethylphenylboronic acid (22) to produce 23. The reaction 
occurs selectively at the 4-position, as the C-I bond is significantly more reactive than the C-Cl 
bond. The base and catalyst used here were K3PO4 and Pd2(dba)3/PCy3 in 1,4-dioxane. The long  





Figure 2.17: Synthesis of mesityl-containing target ligand 26. 
reaction time (3 days) is required due to the steric bulk of the boronic acid. The second step 
involved another Suzuki reaction, with 2,4-difluorophenylboronic acid (12) at the C-Cl bond of 23. 
The reaction was conducted in 1,2-dimethoxyethane, Na2CO3 was used as the base and the 
catalyst was formed in situ from Pd(OAc)2 and PPh3. The reaction was heated to reflux overnight 
to give the product 24 in 85-96% yield. 
The next step involved the ortho-lithiation of 24 between the two fluorines at low temperature (-
78 oC) using LDA, followed by iodination with I2. The reaction proceeds as previously described for 
the synthesis of 14 from 13, however, introduction of the mesityl group into the molecule results 
in a dramatic change in the differences in solubility and properties of 24 and 25 compared to their 
parent compounds. This required them to be separated by reverse phase column chromatography 
on the Biotage® Isolera One ™, and the product 25 was obtained in 43% yield. The final step in the 
ligand synthesis was the copper-assisted nucleophilic displacement reaction to introduce the 
 
Figure 2.18: Synthesis of heteroleptic complex 28. 




sulfone group under the same conditions described for 15 and 16. After purification, 26 was 
isolated in 19% yield and, as in the synthesis of 15, unreacted and deiodinated starting materials 
25 and 24 were also isolated. 
The heteroleptic pic complex 28 was then synthesised via the dichloro-bridged dimer 27 (Figure 
2.18), as with previous iridium complexes, and was obtained in 85% yield. It was noted that the 
solubility of 28 in common organic solvents such as DCM and ethyl acetate was superior to that of 
19, as had been expected. In addition, 28 appeared to retain the blue emission of the parent 
compound by visual inspection, as was the case for the FIrpic analogue.37 The photophysics will be 
discussed later in this chapter. 
The X-ray molecular structure of 28 is shown in Figure 2.19. As can be seen, the C^N ligands adopt 
the expected trans nitrogen arrangement and the coordination around the Ir atom is a distorted 
octahedron. The structure shows disorder in the mesityl and methylsulfone groups of one ligand, 
it is disordered between two orientations in a 0.55:0.45 ratio, with the preferred conformer 
shown here. It can be seen that the methyl groups of the mesityl moiety are sufficient to break 
conjugation between it and the pyridyl ring, with dihedral angles of 86o for the ordered mesityl 
and 82o and 73o for the disordered mesityl. This suggests there should not be a large red-shift in 
emission colour, as the effective conjugation length has not increased. 





 19 20 28 FIrpic 
a
 
Ir-N(pic) 2.137(3) 2.134(3) 2.140(5) 2.135(3) 
Ir-N(ppy-1) 2.046(3) 2.029(3) 2.033(5) 2.056(3) 
Ir-N(ppy-2) 2.028(3) 2.048(3) 2.033(5) 2.049(3) 
Ir-O(pic) 2.146(2) 2.158(2) 2.133(4) 2.158(2) 
Ir-C(ppy-1) 1.991(4) 1.989(3) 2.000(6) 2.010(3) 
Ir-C(ppy-2) 1.974(3) 1.985(3) 1.986(6) 2.002(3) 
a 
Bond lengths taken from 
21 
. Ppy-1 and 2 are defined as the ligands with  
carbon atoms opposite the pic N/O, respectively. 
 
Figure 2.19: LEFT: X-ray molecular structure of 28. Thermal ellipsoids are drawn at the 50% probability level. Solvent 
omitted for clarity. RIGHT: Table 2.2: Selected bond distances. 





Figure 2.20: Synthesis of disulfone ligand 29. 
derivative 29 (Figure 2.20), formed by a nucleophilic aromatic substitution on one of the fluorines. 
Upon synthesis of 15 from a specific batch of 14 it initially seemed that an increased yield of 15, 
approximately 25%, had been isolated. NMR analysis revealed it to be a mixture of two 
compounds, which were then separated by column chromatography, and identified as 15 (15%) 
and 29 (5%). The same batch of 14 was also used to synthesise 16 and in this case an increase in 
yield to 40% from 26% was seen; however, no doubly sulfonated product was identified. This is 
most likely due to the steric demands of a second substitution on the phenyl ring in the p-tolyl 
case. 
Although the 1H NMR spectrum was clean, it was thought that the batch of 14 was contaminated 
with iodine from the reaction mixture, as it had a pink-brown tinge. This theory was tested by 
repeating the reaction with a batch of 14 known to be of the highest purity (as previous reactions 
using this batch had not produced any disulfone 29) and adding a small amount of iodine (3 
mol%). The reaction was worked up as previously to give ligand 15 in 15% yield and 29 in 2% yield, 
suggesting iodine may be involved in the formation of 29. The iodine could coordinate to the 
nitrogen of the pyridine ring, thereby activating the phenyl ring toward nucleophilic aromatic 
substitution by increasing the electron withdrawing power of the pyridyl ring. It is thought that 
the required compound 15 forms first and then, due to its highly electron withdrawing nature, 
undergoes a further nucleophilic aromatic substitution to replace a F atom. It is likely that steric 
hindrance prevents replacement of the final fluorine. 
NMR experiments were conducted to establish which of the fluorines had been replaced. Pure-
shift 1H NMR, a technique that suppresses the homonuclear proton coupling in order to improve 
the resolution and reduce the complexity of the NMR spectra,38 was used to reveal the 
heteronuclear couplings between H and F, which can be obscured in normal 1H spectra by more 
complicated splitting patterns (Figure 2.21). Inspection of the pure shift spectrum of 15 revealed 
that the signal at 8.29 ppm shows two splittings of 8 and 6 Hz, while the signal at 7.19 ppm shows 
only one major splitting of ca. 10 Hz, suggesting that the former is the proton ortho to the pyridyl 
group while the latter is ortho to the fluorine. Comparison with the pure-shift spectrum of 29 





Figure 2.21: Pure shift spectra of 15 and 29. Highlighted in red are the protons on the phenyl ring. 
showed only one coupling remained, with a coupling constant of 6.5 Hz at 8.46 ppm. This value 
suggests it is the fluorine ortho to the pyridyl group that is retained; this is supported by 1H/19F 
heteronuclear NOESY (HOESY) and COSY assignments.  
 In order to compare the effect of a different electron withdrawing group to fluorine at the 4-
position, the heteroleptic pic- complex 30 was synthesised from ligand 29 (Figure 2.22). The 
synthesis was analogous to the complexes previously discussed, and 30 was isolated after column 
chromatography as a bright yellow solid in 84% yield. The NMR spectra of 30 confirmed the 
replacement of the para- fluorine, as the protons at the 3-position appeared as singlets, indicating 
they were not adjacent to a fluorine. 
The X-ray molecular structure of 30 is shown in Figure 2.23. As with other iridium complexes 
formed from the μ-dichloro-bridged dimer, the nitrogens of the pyridyl rings are trans to each 
Figure 2.22: Synthesis of complex 30. 
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Alternative positions of the disordered C^N ligand. Ppy-1 and 2 are defined as  
the ligands with carbon atoms opposite the pic N/O, respectively. 
Figure 2.23: LEFT: X-ray molecular structure of 30.CH3CN. Thermal ellipsoids are drawn at the 50% probability level. 
RIGHT: Table 2.3: Selected bond distances.  
other. The ppy ligand framework is essentially planar, with a twist angle of only 3.1o between the 
pyridyl and phenyl rings. Notably, one of the C^N ligands is disordered between two orientations 
differing by a ca. 10° libration around the Ir atom, with occupancies refined to 0.684(5) and 
0.316(5), respectively. The major conformer is shown in Figure 2.23. 
The synthesis of the homoleptic complexes of ligands 15 and 16 was attemped,32 via a method 
previously used  successfully in our group.39 The route involves synthesis and isolation of the μ-
dichloro bridged dimers 17 and 18, which are then suspended in ethylene glycol with further 
ligand and heated to reflux overnight (Figure 2.24). Purification of the resulting mixture revealed 
complexes 31 and 32 as the major products in 29% and 23% yield, respectively. There was no sign 
of the homoleptic products, and the majority of the material remained at the top of the column as 
intractable brown solid, suggesting decomposition. The formation of 31 and 32 can be explained 
by reaction of the sulfone ligand via nucleophilic aromatic substitution from residual water in the 
solvent, followed by N^O coordination to the iridium. To confirm the instability of the ligands, 16 





















H NMR assignment of 31. 
and at a lower temperature of 160 oC. The NMR spectra of the reaction mixture was complicated, 
and the products were not isolated. However from the mass spectrometry data it can be 
suggested that the ligand undergoes nucleophilic attack by both residual water and the ethylene 
glycol solvent, resulting in the displacement of fluorines. 
Complex 31 was characterised by its 1H NMR spectrum (Figure 2.25), although its poor solubility 
limited the full assignment of the 13C spectrum. The 2D experiments confirmed the orientation 
about the Ir centre. In the 19F NMR spectrum five peaks can be seen indicating one fluorine has 
been replaced. From the COSY spectrum it is clear that the third ligand is not C^N coordinated, as 
two protons are visible on the phenyl ring, suggesting that the fluorine ortho to the pyridyl has 
been replaced by a group that can coordinate to the iridium centre.  
The structure of 32 was unambiguously confirmed by X-ray crystallography, and the X-ray 
molecular structure is shown in Figure 2.26. The nitrogen atoms of the two C^N ligands are trans 
to each other, indicating direct substitution of the chlorides without isomerisation.  The N^O 
bonded ligand experiences a significant twist between the pyridyl and phenyl rings of 37.1o in 
order to bind and form a 6-membered chelate, as opposed to the 5-membered chelate ring 
formed from C^N coordination.  
 
Bidentate ligands that form a 6-membered ring on chelation to Ir are scarce in the literature;40 a 
















Figure 2.26:  LEFT: X-ray molecular structure of 32.2CH2Cl2. Thermal ellipsoids are drawn at the 50% probability level. 
Solvent omitted for clarity. RIGHT: Table 2.4: Selected bond distances. 
few examples include [Ir(C^N)2(N^O)] structures with two ppy C^N ligands and 2-(2’- 
hydroxyphenyl)oxazole,41 or 2-(2’-hydroxyphenyl)oxazoline,42 as the ancillary N^O ligand. To our 
knowledge there are no previous examples of iridium complexes with a 2-(2’-
hydroxyphenyl)pyridine-based ligand in the literature. 
The instability of these ligands (15, 16) under high temperatures and in the presence of 
nucleophiles prompted investigation into alternative ligands that contain fewer fluorines to 
increase stability. This investigation is discussed in Chapter 3. 
 
PHOTOPHYSICAL AND ELECTROCHEMICAL PROPERTIES  
Absorption and emission 
The absorption spectra for complexes 19, 20, 28, 30, 31 and 32 in DCM are shown in Figure 2.27. 
All complexes show strong absorption bands in the 250-300 nm region, assigned to π-π* 
transitions on the ligand based on the calculations of Hay,43 and literature precedent.1 At lower 
energies the complexes display sets of absorption bands with lower oscillator strengths at 350-
420 nm, which are assigned to the 1MLCT transitions, and at even longer wavelengths and smaller 
oscillator strengths the 3MLCT bands can be identified. As the 3MLCT state is a major component 




























Figure 2.27: Absorption spectra of complexes 19, 20, 28, 30, 31, 32 in DCM [<10
-5
 M]. 
of the state responsible for the emission of these complexes the wavelength of this absorption 
band can correlated with the λmax of the emission. For complexes 19, 20 and 28 the bands are all 
at similar wavelengths, 443-445 nm, whereas for FIrpic the band is at 454 nm; this difference is 
reflected in the bluer emission of 19, 20 and 28 compared to FIrpic. For complex 30 the 
absorption extends out to 470 nm and smaller bands are present to ~490 nm, suggesting a much 
lower energy 3MLCT, which is reflected in the greener emission. For the N^O bonded complexes 
31 and 32 the absorption spectra were similar to their pic analogues in the low energy region. 





































Figure 2.28: Excitation spectra of the selected complexes in DCM [<10
-5
 M]. The emission band observed was the 
second emission maximum. 
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Figure 2.29: Emission spectra of selected complexes in deaerated DCM [<10
-5
 M], λex = 380 nm. 
Excitation spectra were recorded (Figure 2.28), revealing as expected that the bands from the 
1MLCT and 3MLCT states are responsible for the emission from the complexes, while the majority 
of the lower energy π-π* transitions are dark. 
The emission spectra of the complexes are shown in Figure 2.29. The emission of 19, 20, 28, 31 
and 32 display a similar profile to that of FIrpic, with an emission maximum, vibronic progression 
and a shoulder at longer wavelengths, indicating the emission originates from a similar excited 
state. The presence of defined features in the emission spectra suggests a mixed LC/MLCT nature 
for the excited state, as broad, featureless emission is associated with CT states, and it has been 
noted that the emission spectrum of FIrpic is similar to that of the protonated ligand dfppyH+.21 
The emission from 19, 20, 28 is blue-shifted by ~10 nm relative to that of FIrpic, indicating the 
sulfone group is efficient at widening the HOMO-LUMO gap. The emission of 30 is significantly 
greener, with λmax of 516 nm with a second band at 536 nm of approximately equal intensity. In 
the case of the N^O bonded complexes 31 and 32 their emission is red-shifted compared to their 
corresponding pic complexes, but with a similar spectral profile, suggesting a similar source for 
the emission. 
The PLQYs, lifetimes (τobs) and calculated radiative and non-radiative decay rates (kr and knr) are 
shown in Table 2.5. The PLQYs for the FIrpic analogues are 0.64–0.68, similar to that of FIrpic, and 
the lifetimes are on the order of 1-2 μs. These are typical values for mono-iridium complexes with 
efficient spin-orbit coupling between the triplet and singlet states. 













































277 (50.1), 301 (34.2), 304 (32.6), 






0.67 1.72 3.90 1.92 
19 
255 (88.6), 282 (67.2), 292 (61.7), 





0.64 2.19 2.92 1.64 
20 
252 (123.7), 286 (90.4), 300 (83.0), 






0.68 2.09 3.25 1.53 
28 
260 (100.4), 283 (76.4), 321 (sh, 






0.68 1.49 4.56 2.15 
30 
261 (89.1), 284 (80.2), 306 (b, 




516, 536 0.48 3.53 1.36 1.47 
31 
264 (95.5), 278 (85.1), 302 (sh, 
58.1), 364 (19.4), 382 (sh, 15.9), 





0.44 2.90 1.52 1.93 
32 
250 (sh, 143.2), 266 (sh, 98.7), 290 
(83.4), 312 (56.5), 368 (19.6), 414 





0.38 2.85 1.33 2.18 
a 




 Data obtained in degassed dichloromethane solution with λex = 
380 nm. 
c 
Observed lowest energy band from excitation spectra. 
d 
Measured relative to Ir(ppy)3 ΦPL = 0.46 in degassed 
dichloromethane at 20 
o
C; estimated error ±10%. 
e 
Estimated error ±5%. 
f
 kr, knr values calculated using Equations 
1.5/1.6.
 
Table 2.5: Photophysical data for selected iridium complexes. 
 
Electrochemistry 
Cyclic voltammetry can be used to provide an estimate of HOMO and LUMO levels of 
cyclometalated iridium complexes which, in turn, can provide a reasonable estimate for the 
energy of the lowest level triplet (T) state. This can help rationalise changes in emission colour 
and can assess the impact of changing substituents on the basic ligand framework. The 
HOMO/LUMO levels can be estimated using the formula below:44 
                 –        
                 (Equation 2.1) 
where E
ons
 = the potential of first onset of the oxidation/reduction peak in question (referenced to Fc/Fc
+
). 




Alternative equations are: 
             –          
45                        (Equation 2.2) 
              –       
46                  (Equation 2.3) 
These equations resulted from plotting the relationship between the oxidation/reduction 
potential and the HOMO/LUMO energy as determined by ultraviolet photoelectron spectroscopy 
(UPS) of thin films. They differ from Equation 2.1 as UPS is conducted on thin films (solid state), 
whereas the electrochemical measurements are conducted in solution in the presence of 
supporting electrolyte, as a result solvent effects and image charge effects must be accounted for. 
These effects are incorporated in the gradient factor. 
Using these estimates it is possible to determine the effect of changing substituents on the 
emission colour and also to evaluate how well the HOMO/LUMO levels will match up with those 
of the host material in devices. For efficient electroluminescence it is important that the triplet 
energy (ET) of the host material is at least as large as that of the emitter, and that they overlap to 
ensure efficient energy transfer from host to dopant. 
Complexes 19, 20, 28, 30, 31 and 32 were investigated by cyclic voltammetry in solution and 
compared to the parent compound FIrpic. The voltammograms are shown in Figure 2.30 and the 
key parameters in Table 2.6. Equation 2.1 is used to calculate the energy of the HOMO.  



































Figure 2.30: Cyclic voltammograms of the iridium complexes. 












1/2  / V 
FIrpic 0.89 - 
19 1.19 - 
20 1.16 - 
28 1.15 - 
30 1.25 - 
31
a
 0.93 (irr) 1.62 (irr) 
32
 a
 0.94 (irr) 1.63 (irr) 
 
a
 (irr) denotes an irreversible oxidation. The values reported are the cathodic peak potentials observed on the first scan. 
All values reported vs Fc/Fc
+
 = 0.00 V. 
Table 2.6: Electrochemistry data of iridium complexes. Measured in MeCN (0.1 M 
n
Bu4NPF6) at 298 K. 
All the pic complexes show a quasireversible oxidation wave, which is assigned to the IrIII/IrIV 
couple. The parent compound FIrpic shows the least positive oxidation potential; this is as 
expected, as it is known that the introduction of electron withdrawing substituents results in a 
lowering of the HOMO, thereby increasing the oxidation potential. There is minimal difference in 
the potentials for 19, 20 and 28, suggesting in the cases studied here the identity of R in –SO2R 
has little impact,as does the introduction of the mesityl group, confirming there is minimal 
conjugation between the mesityl and the pyridyl ring. The EHOMO estimates and E
ox
1/2 values for 
FIrpic and 20 agree with those obtained by Cao et. al.11 Exchange of the para fluorine for a second 
–SO2Me group (19 to 30) results in a further increase in the oxidation potential (by 0.06 V), which 
can be rationalised by –SO2R being a stronger withdrawing group than F. As the emission from 30 
is green rather than blue, it can be concluded that the LUMO of 30 is lowered more than the 
HOMO by the introduction of the sulfone group at this position. This can be rationalised, as the 
HOMO/LUMO molecular orbital plots for FIrpic show a large density of the LUMO at the 4-
position however a relatively small HOMO density, suggesting that introducing an electron 
withdrawing group at this position would lower the LUMO a greater amount than the HOMO and 
thereby resulting in a smaller HOMO-LUMO gap.4 This is supported by a report that introducing 
electron withdrawing groups at the 5-position results in a red-shift in emission relative to the 
parent compound.22 No reduction waves were observed within the solvent window for any of the 
complexes in Table 2.6. 
N^O bonded complexes  31 and 32 show significantly different electrochemical behaviour from 
the pic complexes; an irreversible oxidation occurs at +0.93 V for 31 and +0.94 V for 32, followed 
by a second irrreversible oxidation at +1.62 V and +1.63 V. If the scan is reversed before the 




second oxidation is reached the first oxidation wave is still irreversible. This suggests a chemical 
reaction takes place upon oxidation, and could be attributed to the unusual connectivity around 
the Ir centre. DFT calculations indicate that the HOMO in the N^O complexes is localised over the 
oxygen atom of the N^O ligand, which could explain the irreversibility of the first oxidation wave 
and the similarity of the oxidation values for 31 and 32. 
 
COMPUTATIONAL DATA 
Electronic structure calculations were carried out on iridium complexes 19, 20, 28, 30, 31, 32 by 
Dr Mark Fox (Department of Chemistry) to elucidate the nature of the frontier orbitals and the 
transitions involved in the absorption and emission spectra. The full geometries were optimised at 
the B3LYP/LANL2DZ:3-21G* level and are denoted 19’, 20’, 28’, 30’, 31’, 32’ to distinguish them 
from experimental data. Comparison with optimised and experimental geometries determined 
from the X-ray data for 19, 20, 28, 30, 31, 32 revealed good agreement for the Ir-X bond distances 
(Table 2.7).  






10 2.046(3) 2.028(3) 1.991(4) 1.974(3) 2.146(2) 2.136(3) 
10’ 2.062 2.047 2.013 2.011 2.133 2.162 
11 2.048(3) 2.029(3) 1.989(3) 1.985(3) 2.158(2) 2.134(3) 
11’ 2.061 2.048 2.014 2.011 2.136 2.163 
12 2.033(5) 2.033(5) 2.000(6) 1.986(6) 2.133(4) 2.140(5) 
12’ 2.061 2.048 2.012 2.011 2.135 2.162 
13 2.040(4) 2.042(5) 1.995(4) 1.991(5) 2.148(3) 2.128(4) 
13’ 2.063 2.049 2.01 2.009 2.134 2.165 
15 2.037(4) 2.032(4) 1.989(5) 1.982(5) 2.151(3) 2.161(4) 
15’ 2.065 2.043 2.009 2.008 2.114 2.198 
23 2.042(4) 2.035(4) 1.988(5) 1.985(5) 2.143(4) 2.129(4) 
23’ 2.061 2.048 2.015 2.013 2.14 2.164 
 
 
Table 2.7: Comparison of experimental (10-13, 15, 23) and optimised (10’-13’, 15’, 23’) bond lengths involving the 
iridium atom. 
The frontier orbital energies were computed for all complexes, and the HOMO energies show 
good agreement with the observed oxidation potentials. The HOMO/LUMO distributions of 
selected complexes 19’, 30’, and 31’ are shown in Figure 2.31. The HOMO energies of the sulfone  




  MO Orbital eV Ir Py(Pic) CO2(Pic) Py(ppy) Ph(ppy) 
Firpic 1 138 LUMO -1.87 2 81 10 5 2 
  137 HOMO -5.49 44 2 7 7 41 
19' 178 LUMO -2.23 1 52 7 27 12 
  177 HOMO -6.09 44 2 9 7 39 
20' 218 LUMO -2.15 1 61 8 21 9 
  217 HOMO -5.97 42 2 8 6 41 
28' 242 LUMO -2.15 1 70 9 13 6 
  241 HOMO -6.01 44 2 9 7 39 
30' 210 LUMO -2.46 3 4 1 47 46 
  209 HOMO -6.15 44 2 10 6 37 
31' 215 LUMO -2.2 5 2 2 65 27 
  214 HOMO -5.8 20 8 64 3 5 
32' 275 LUMO -2.04 4 16 6 50 23 
  274 HOMO -5.61 21 6 63 3 7 
 
Table 2.8: HOMO/LUMO energies and % MO contributions for the complexes. 
complexes are all lower than that of FIrpic (1), reflecting the electron withdrawing properties of 
the sulfone moiety. For complexes 19’, 20’, 28’ and 30’ the HOMO is localised on the phenyl rings 
of the cyclometalating ligands and on the iridium d-orbitals, as is the case with FIrpic (Table 2.8). 
The LUMOs for 19’, 20’ and 28’ are distributed across the pyridyl of the picolinate ancillary and 
across the pyridyl ring of the ppy ligands, with a small contribution from the phenyl rings. This is 
slightly different to FIrpic, wherein the LUMO is mostly localised on the pic ancillary ligand (91% 
total). This results in the sulfone complexes having lower LUMO energies than FIrpic 1’, however, 
in the case of 19’, 20’ and 28’ this shift is small compared to the decrease in the HOMO levels. As 
a result complexes 19’, 20’ and 28’ exhibit larger HOMO-LUMO gaps than FIrpic, and their 
emission is predicted to be blue-shifted, which agrees with experimental observation. In the case 
of 30’ the LUMO is almost totally (93%) located on a ppy ligand, with a notable density at the 4- 
position of the phenyl ring, where the additional sulfone is located. The influence of the para 
sulfone results in a lower LUMO energy for 30 than for the other pic complexes, as a result the 
HOMO-LUMO gap is lower, resulting in the green emission.  
Complexes 31’ and 32’ exhibit significantly different HOMO distributions to the pic- complexes; 
the HOMOs are localised on the phenyloxy group of the N^O bonded ligand (Figure 2.31) rather  








. Ir : pic or 
oppy : ppy % orbital contribution ratio listed for each orbital. 
than on the iridium d-orbitals or the phenyl ring of the C^N ppy ligands. As a result, the HOMO 
levels for 31’ and 32’ are higher than those of the pic complexes (19’, 20’, 28’). The unusual 
HOMO distribution is reflected in the oxidation potentials for 31 and 32, which are irreversible 
and at lower oxidation potentials. The LUMOs are also lowered relative to the pic complexes, and 
distributed over C^N ppy ligands, resulting in the smallest HOMO-LUMO gaps for all the 
complexes, including FIrpic.  
 
TD-DFT computations were carried out on the S0 optimized geometries of 19’, 20’, 28’, 30’, 31’ 
and 32’ to predict the emission wavelengths. The initial excitation is assumed to give the lowest 
energy singlet excited state S1 which then undergoes intersystem crossing (ISC) due to the SOC 
induced by the iridium centre to form the triplet excited state T1. Phosphorescence is then 
observed from the S0 ← T1 process. Most of the complexes display small Stokes shifts (30 is the 
exception), suggesting that the T1 geometry is similar to the corresponding S0 geometry. The 









process, with the predicted emission wavelength adjusted to take into account the Stokes shift. 
The predicted and observed emission wavelengths are shown in Table 2.8, and it can be seen that 
there is good agreement for most of the complexes, with the exception of 30’-32’. 
 
Complexes 30-32 exhibit lower PLQYs and longer lifetimes than the rest of the pic complexes, 
suggesting the emission is likely to be from a different excited state. In the case of 30 the large 
Stokes shift suggests substantial rearrangement in the excited state, a suggestion supported by 
the T1 larger vertical energy for 30’ (0.30 eV) compared to 19’ (0.27 eV) and  31’ (0.28 eV).  In the 
case of 31’ and 32’ it is notable that there is a relatively small contribution to the HOMO from the 
metal d-orbitals (20% and 21%, respectively) compared to the rest of the complexes, whereas for 
the HOMO-1 the Ir d orbitals contribute 45% and 38% for 31’ and 32’, respectively. This suggests 
that the S0 ← T1 transition may not be the transition responsible for the emission due to its low 
metal character, which may reduce the rate of intersystem crossing between S1 and T1. This is 
supported by the spin density calculations conducted on the optimised T1 geometries; spin 
densities for 19’, 30’ and 31’ were 0.36, 0.46 and 0.13, respectively. The low spin density value for 
31’ implies that a higher energy triplet state (Tn, n > 1) is responsible for the emission in 31’ and, 
by extension, 32’. Calculations for the emission from the S0 ← T2 transition reveal a better 
agreement with experimental data (474 nm and 472 nm for 31’ and 32’, respectively). 
DEVICE DATA 
OLEDs containing complexes 19, 20 and 28 were fabricated by Dr Hameed Al Atter in the 
Department of Physics at Durham University and compared to a reference device containing 
FIrpic. The hole transporting layer and emissive layer were deposited by solution processing 
techniques, and the electron transporting, electron injection layers and the cathode were then 
fabricated by vacuum deposition. The device structure is as follows: ITO/PEDOT:PSS (45  
 
























FIrpic 1 475 7340 6.2 5.4 12.2 5.1 (0.19, 0.38) 
19 463 776 6.8 3.0 2.0 0.8 (0.19, 0.29) 
20 463 2464 8.0 3.9 8.2 2.9 (0.20, 0.36) 
28 465 2368 8.0 4.0 7.8 2.0 (0.18, 0.30) 
 
a




 Measured at 12 V. 
Table 2.8: Summary of device data.  





























































































































































Figure 2.32: Device data for complexes 19, 20, 28. 
nm)/PVK:OXD-7(30%):Ir complex(15%)(60 nm)/TPBi (30 nm)/LiF/Al. The electroluminescence (EL) 
spectra from the devices are shown in Figure 2.31; for all complexes the EL spectra are similar to 
the photoluminescence (PL) spectra, indicating good exciton confinement to the emissive 
molecule. The EQE and brightness of the devices are shown in Figure 2.31 (panels c and e). As can 
be seen, the devices containing 28 and 20 performed better than the devices of 19, with EQEs of 
4.0% and 3.9%. This can be rationalised by the increased steric shielding due to the mesityl 
substituent in the case of 28, and the p-Tol substituent in the case of 20. These complexes also 
displayed greater solubility than 19, which is beneficial for solution processing. All the complexes 




display lower maximum brightnesses (panel e) than the FIrpic device; however it is notable that 
their electroluminescence is bluer. 
 
CONCLUSION 
New sulfone containing ligands were synthesised with the aim of blue-shifting the emission of the 
resultant iridium complexes compared to the parent complex, FIrpic. Heteroleptic pic complexes 
19, 20, 28 were synthesised, and exhibited bluer emission than FIrpic (~10 nm) while maintaining 
comparable PLQYs and emission lifetimes. Electrochemical study indicated the introduction of the 
sulfone group at the 5- position (19, 20, 28) resulted in a lowering of the HOMO energy, 
suggesting the LUMO energy was not significantly affected. Complex 30, containing disulfone 
ligand 29, highlights the importance of the position of substitution, as it displays green emission 
due to a lowering of the LUMO level. Complexes 31 and 32, heteroleptic complexes with a novel 
ancillary ligand, were also synthesised, bringing to light the instability of these sulfone ligands to 
nucleophilic attack, a feature which will be discussed more extensively in Chapter 3. The 
computed bond lengths and oxidation potentials showed good agreement with the experimental 
data, and the HOMO/LUMO distributions of the pic complexes (19, 20, 28, 30) were comparable 
to parent complex FIrpic. Devices of complexes 19, 20 and 28 were fabricated by solution 
processing in the Department of Physics retain the blue emission obseved in the PL spectra. 
Complexes 20 and 28 were the best performing, with the device of 28 displaying CIE coordinates 
of (0.18, 0.30) at 12 V and a maximum EQE of  4.0%, however all complexes performed less 
favourably than the FIrpic device.   
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Chapter 3: Towards ‘fluorine-free’ 
emission 
While fluorinated ligands are widely used in emissive IrIII complexes there are problems associated 
with their stability. A study of FIrpic devices by HPLC/MS showed that isomerisation occurred 
during device fabrication and it was also noted that degradation of FIrpic with loss of one F 
occurred during the deposition process.1 This is detrimental for the colour purity as the fluorine 
moieties are introduced to blue-shift the emission. In this study the devices were stressed (i.e. 
under operation) for 24 h and the proportion of defluorinated species increased during 
operation.1 Other studies have also shown degradation of FIrpic via loss of the picolinate ancillary 
ligand, or loss of CO2 from the ancillary ligand, followed by reaction with other species.
2,3 The 
instability of fluorinated complexes in LEECs has also been observed, and a correlation drawn 
between increasing the number of fluorines present on the ligands and a decrease in device 
stability.4 
 
Figure 3.1: Defluorination and decyclometalation of ligands upon attempts to split a dichlorobridged dimer. 
Defluorination does not occur solely during device operation; several complexes undergo 
defluorination during synthesis. Attempts to split the Ir-dimer shown in Figure 3.1 with ancillary 
ligands such as acac and dbm (dibenzoylmethane) resulted in the formation of the required 
complex, however defluorinated free ligand was also isolated in increasing yield as the reaction 
temperature was raised.5 In addition, when attempts were made to split the Ir dimer with ppy the 
dimer decomposed to give defluorinated ligand.5 
 
In another example, an attempt to synthesise the homoleptic complex of 2,4-difluoro- 
phenylisoquinoline (Figure 3.2) resulted in mono-defluorination of all three ligands around the Ir 
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Figure 3.2: Defluorination of 2,4-difluoro-phenylisoquinoline ligands. 
 
centre.6 Interestingly, when attempts were made to crack the equivalent non-fluorinated dimer 
with both 2,4-difluoro-phenylisoquinoline and 2,4-difluorophenylpyridine none of the expected 
products were observed.6 Instead, the major products were the homoleptic complexes of the 





Figure 3.3: Partial defluorination and decomposition of an iridium dimer. 
 
Partial defluorination is also observed when reacting the dfppy dimer with NaOCH3, resulting in 
the formation of a heteroleptic complex, shown in Figure 3.3.7 A mechanism is proposed to 
explain this behaviour involving Ir-H and Ir-F intermediates. In another example from our 
laboratory attempts to thermally convert a mer complex of 2-phenyl-γ-carboline ligands (Figure 
3.4) to the fac isomer resulted in regioselective defluorinaton.8 When the mer-isomer was heated 
to 290 oC in glycerol the fluorine ortho to the pyridyl group was replaced on all three ligands and 
the fac-defluorinated product formed. The mer-isomer was successfully converted to the fac-
isomer via UV irradiation.8 The stability of the fluorinated fac-isomer was tested but no 
defluorination was observed when refluxing in glycerol for 48 h, indicating that defluorination 
occurred from the mer-isomer in 58% yield.8 This also confirms that the γ-carboline system 
imparts additional thermal stability to the fac-complex, as comparable treatment of fac-Ir(dfppy)3 
results in decomposition within 2 h.8 It is interesting to note that in all these cases the fluorine 
atom that is replaced is the one that is ortho to the pyridyl substituent; this position is presumably 
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Figure 3.4: Defluorination upon attempted thermal conversion from a mer to fac isomer. 
more activated by the inductive withdrawing effect of the pyridyl ring.8 Attempts to make 
homoleptic complexes of 1-(2-fluorophenyl)isoquinoline and 1-(4-fluorophenyl)isoquinoline 
(Figure 3.5) from their dimers resulted in the isolation of the required product for the latter, while 
the former experienced defluorination on all three ligands, indicating the regioselective nature of 
the defluorination.6 The poor stability of fluorinated Ir complexes has been noted elsewhere, in a 
series of cationic complexes (Figure 3.6). It was observed that the stability of the LEECs they were 
used in decreased as the number of fluorinated ligands increased.9 
These examples highlight the need for care when using fluorinated ligands to synthesise iridium 
complexes for OLED devices, as cleavage of C-F bonds will not only distort the colour of emission 
 
 
Figure 3.5: Regioselective defluorination of fluorinated isoquinoline ligands. 
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Figure 3.6: A selection of cationic complexes for LEECs. 
but also potentially produce reactive species that could interact with other nearby organic 
materials, thereby affecting the device performance. As a result there is an interest both in 
moving away from fluorinated ligands and in finding ways of stabilising them. 
There are a few ways of achieving ‘fluorine-free’ blue emission including: 
1) Modifying existing fluorinated ligands by replacing fluorines with electron donating 
groups 
2) Exchanging the pyridine or phenyl rings in ppy for another heterocycle in order to 
increase the π- π* gap (such as a carbene, imidazole, pyrazole or triazole) 
3) Utilising ancillary ligands that widen the HOMO-LUMO gap and shift quenching d-d* 
states to higher energies, such as carbenes or phosphines. 
This chapter is concerned with the first two methods, although carbene ligands will be discussed 
in more detail in Chapter 6, and there is discussion of ancillary ligands in Chapter 5. 
As was noted in Chapter 2 introducing electron withdrawing groups onto the phenyl ring of ppy 
based ligands is not guaranteed to blue-shift the emission colour; the position and identity of the 
substituent also matters, with fluorine appearing to be a special case among electron withdrawing 
groups. Our paper reported that fluorines can be exchanged for alkoxy groups with a minimal red-
shift in the emission, despite the fact the alkoxy groups are electron donating.10 This observation 
was explained and generalised in a paper by Baranoff which details the correlation between the 
Hammett σm and σp parameters of substituents on ppy ligands and the oxidation and reduction 
potentials of the resultant homoleptic complexes.11 These data allow reasonable predictions of 
emission λmax, provided the localisations of the HOMO and LUMO remain on the phenyl 
ring/iridium d orbitals and pyridyl ring, respectively.11 A series of complexes (35, 36, 38, 39, 42) 
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Figure 3.7 
were then synthesised that replaced the electron withdrawing fluorines with donating methoxy 
and methyl moieties (Figure 3.7). These displayed significant blue-shifts in emission compared to 
the unsubstituted reference compound 33, although they were not as blue as the fluorinated 
analogues (34, 37). The blue-shift induced by fluorine substituents is attributed to it being a 
strong acceptor towards the meta position (σm = 0.34), thereby stabilising the HOMO more than 
the LUMO (σp = 0.06). However, for methoxy/methyl substituents it is their ability to act as strong 
donors towards the para position (σp = -0.17 for Me, σp = -0.27 for OMe), thus destabilising the 
LUMO relative to the HOMO, that is responsible for the blue-shift.11 
A series of complexes with this motif have been synthesised via a route that exploits the 
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heteroleptic complexes containing the 2′,6′-difluoro-2,3′-bipyridine (dfpypy) ligand as the 
chromophore (40, 43a-c) under standard conditions, shown in Figure 3.8.12 However, instead the 
complexes underwent nucleophilic aromatic substitution due to attack at the aromatic fluorines 
by the solvent, methoxyethanol, which produced complexes 44a-d in 33-63% from the μ-dichloro 
bridged dimer.12 Interestingly, when the ligand was subjected to the reaction conditions without 
the presence of iridium the substitution was not observed, indicating that the chelation to the 
Ir(III) centre enhances the susceptibility of the fluorines to nucleophilic attack.12 Complex 41 was 
also synthesised in this study. The two pic complexes 41 and 44a in particular exhibit sky-blue 
emission comparable to FIrpic, with λmax = 454 nm for 44a and λmax = 467 nm for 41, and good 
quantum yields (0.75 and 0.70 in solution, respectively). 
An alternative to exchanging fluorines for donor groups is to exchange the phenyl group in the 
ppy framework for a more electron deficient alternative. Complexes using a pyrimidine instead of 
the phenyl ring were synthesised (Figure 3.9) as an attempt to achieve blue emission without 
fluorinated aromatic ligands (the ancillary ligand contains a CF3 group).
13 Pyrimidine was chosen 
as the ligands were easy to synthesise and the electron deficient nature of the ring would help 
increase the ligand π-π* gap, thereby achieving blue emission.13 For both the 4- and 5-substituted 
pyridyl pyrimidine derivatives the emission colour was shown to be highly dependent on the 
substitution position.13 The complex with 4-substitution 46 displayed green emission (λmax = 535 
nm) while the corresponding 5-substituted complex 45b exhibited sky-blue emission (λmax = 457 
nm) similar to FIrpic.13 The difference was attributed to the ability of the nitrogen atoms in the 4-
substituted ligand to extend the conjugation via a resonance effect, which is not possible in the 5-
substituted isomer, thereby reducing the HOMO-LUMO gap.13 
This approach can be used in conjunction with the use of donors, as in the series of complexes 
shown in Figure 3.10.14,15 Here, donating methoxy groups have been introduced onto 2,3’- 
 
Figure 3.9 
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Figure 3.10 
bipyridine (pypy) and 2-(pyrimidin-5-yl)-pyridine (pmpy) ligands to create aromatic fluorine-free 
complexes (48-50a/b).14 DFT/TD-DFT calculations indicate the electron withdrawing nitrogen 
atoms in the cyclometalating ligand effectively stabilise the ligand π-orbitals, while the donating 
methoxy groups both increase the ligand π* orbitals and lower the electron density of the iridium 
dπ orbitals.14 Emission from all four complexes is in the sky-blue region, with the bluest complex 
being 50a, and they are highly emissive (φ = 0.79-0.93).14 The bluer emission of 50a relative to 49a 
can be rationalised by the greater ligand π-π* gap in the former, however in the case of the 
complexes with the pyrrole-containing ancillary ligand (49b and 50b) the authors note a different 
emission profile for 50b compared to 49b, and do not observe a blue-shift.14 The reasons for this 
are not clear, although it is noted that 50b has significant HOMO distribution on the ancillary 
ligand (31%), whereas the others do not.14 
A water soluble, fluorine-free blue iridium complex has also been synthesised for biological 
applications (Figure 3.11). In this case 1-methyl-3-(2′-pyridyl)pyridinium was used as the C^N 
ligand and substituents on the N^N bipyridine ancillary ligand were varied.16 The resulting 
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Figure 3.12 
withdrawing pyridinium fragment para to the cyclometalating carbon.  
The pyridine fragment can also be replaced with other moieties that increase the ligand π-π* gap; 
one example is carbenes, which will be discussed in Chapter 6. These are strong σ-donors that 
increase the energy of d-d* states as well as the emissive states. Another example is N-aryl/alkyl 
imidazoles, whose increased donor ability compared to pyridine results in a larger shift of the 
LUMO than the HOMO, leading in turn to an increased HOMO-LUMO gap compared to ppy 
ligands.17 A collection of blue emitting N-aryl imidazole complexes is shown in Figure 3.12.18,19 
Here, aryl groups with ortho substituents  have been chosen to avoid extending the conjugation, 
and thereby red-shifting the emission.19 These complexes displayed sky blue emission and two 
exhibited increased thermal stability compared to FIrpic (Td = 429 
oC for 52b, Td = 416 
oC  for 52b , 
and Td = 412 
oC  for 52e compared to Td = 344 
oC for FIrpic 20). All the complexes also showed 
increased device stability compared to FIrpic, with test devices of 52a-d achieving T50 values 
(defined as the time when luminance of a device has dropped to half its initial value) of 4.6-5.8 h, 
whereas T50 = 0.1 h for the comparable FIrpic device.
18,19 
Another fragment that can be used to replace the pyridine group in ppy-based ligands is the 
triazole group; examples of sky-blue triazole complexes are shown in Figure 3.13.21 Due to the 
unsymmetrical substitution on the phenyl rings the ligands display atropisomerism, and upon 
complexation diastereomers are formed which can be separated by column chromatography.21 
The isomers show slight differences in photophysical properties, with small changes in spectral 
width and λmax. The ortho methyl group ensures a break in conjugation between the phenyl and 
triazole ring, which prevents a red-shift in emission.21 
A pyrazole group has also been used, with some complexes shown in Figure 3.14. Although the 
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Figure 3.13: LEFT: Triazole complexes for fluorine-free sky blue emission. RIGHT: Pyrazole complexes for fluorine-free 
sky/deep blue emission. 
pyrazole group is effective at blue-shifting the emission colour it pushes the energy of the 
emissive state close enough to non-radiative states that emission is not observable at room 
temperature for most homoleptic complexes.22 However, complex Ir(flz)3 (54c) is emissive at room 
temperature, due to the extended conjugation of the fluorene unit red-shifting the emission away 
from the non-radiative state.22 
 
RESULTS AND DISCUSSION 
Prompted by the formation of novel complexes 31 and 32 and the interesting product of 
nucleophilic aromatic substitution 29, nucleophilic aromatic substitution (SNAr) on the sulfone 
ligand system was investigated. Due to the withdrawing pyridyl-, fluorine- and sulfone- 
substituents the phenyl ring should be highly activated towards SNAr via an addition-elimination 
reaction at the C-F bonds. Additionally, as identified in the introduction to this chapter, aromatic 
fluorines in particular have been identified as unstable during device operation and fabrication 
resulting in a desire to achieve bluer emission without utilising them.  
 
Figure 3.14: Nucleophilic aromatic substitution on ligand 55. 
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The first attempt was to replicate results from earlier work in our group, wherein hydroxide was 
used to displace one of the fluorines on cyano substituted dfppy 55.10 In that work an aqueous 
solution of KOH (4 M) was added to a solution of ligand 55 in 1,4-dioxane and the mixture heated 
to reflux for 2 h. There was no selectivity as to which fluorine was replaced, resulting in the two 
isomers 56a and 56b (Figure 3.14) which could not be separated by column chromatography. 
Their differing solubility in DCM, which allowed them to be separated by a series of filtrations, 
was ascribed to the ability of 56a to form intramolecular hydrogen bonds, while 56b can only 
form intermolecular hydrogen bonds, which greatly reduced its solubility.10 As CN and SO2R are 





Compound 16 was chosen as the test ligand and the conditions detailed above for 55 were 
replicated; however TLC analysis of the product mixture revealed only a very small conversion of 
the starting material. Increasing the reaction time to 72 h produced no detectable change, 
indicating an increased stability of ligand 16 towards SNAr compared to 55. This is consistent with 
the observation made in Chapter 2, as ligand 16 only underwent a nucleophilic substitution 
reaction when the temperature was significantly greater than 130 oC (160 oC), as no substitution is 
seen during synthesis of the heteroleptic complexes. A higher reaction temperature was needed 
and diglyme (2-methoxyethyl ether) was chosen as the solvent, as it has a high boiling point (162 
oC), is water miscible and non-nucleophilic. The last property is particularly important as ethylene 
glycol was shown to react with 16 at 160 oC. TLC analysis of the reaction in diglyme indicated a 
much greater conversion than was observed for the reaction in dioxane. NMR analysis confirmed 
that the reaction was unselective, with both isomers 57a and 57b being formed (Figure 3.15). 
Attempts to separate 57a and 57b by the method described for the 56a/b failed as there seemed 
to be no difference in their solubility. This was attributed to the presence of the oxygens on the 
sulfone; these are adjacent to the OHs and could therefore hydrogen bond with them, thus 
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removing the solubility difference as no isomer is more prone to intramolecular H-bonding than 
the other. The product mixture was initially obtained in 50% yield (increased to 84% on a second 
attempt, as the work-up was changed) with an approximately 50:50 ratio of the two isomers 
(30:70 for 57a:57b on the second attempt) by 1H NMR analysis. 
The aim was to emulate previous work by alkylating 57a and 57b to produce soluble alkoxy 
derivatives. It was anticipated that the two alkylated derivatives would suffer similar separation 
issues to 57a and 57b, and so we sought a selective alkylation route. The aim was to use a 
sterically hindered base to selectively deprotonate the para hydroxyl group of 57b, and then to 
alkylate the resulting anion. This should result in the formation of the para alkoxy compound 58, 
with the ortho hydroxyl 57a left unreacted; the mixture could then be purified by column 




The base chosen was NaOtBu, and the first alkylating agent investigated was MeI (Figure 3.16); 
this was selected as there is no possibility of an elimination side reaction occurring, which can 
happen with hindered bases and alkyl halides. The mixture of 57a and 57b was dissolved in dry 
THF and NaOtBu and one equivalent of MeI (based on the ratio of the mixture) was added. After 
work up, the 1H NMR characterisation and TLC analysis revealed that, although the methylation of 
the hydroxyl was selective for the isomer desired, the majority of the product and starting 
material were converted into N-methyl pyridinium salts. An attempt was made to convert the 
salts to free pyridines using PPh3,
23 however even with long reaction times and at high 
temperatures (150 OC) the yield was low (29%) and there was concern that longer reaction times 
would result in decomposition. Methyl tosylate was chosen as an alternative alkylating agent, 
however it produced similar results; after work-up and purification by column chromatography 58 
was obtained in 18% yield, with unreacted starting material 57a/b (32%) and (presumed) 
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Figure 3.17. 
pyridinium salts (30%) also isolated. The alkylating agent was then changed to a less reactive alkyl 
bromide, 1-bromooctane, and the reaction was conducted as before. Unreacted starting material 
57a/b (60%) and pyridinium ions were isolated but there was no evidence of any desired product 
formation.  
As the pyridine lone pair was proving problematic an attempt was made to introduce a protecting 
group. An N-oxide was considered; however alkyl halides are known to react with N-oxides to give 
O-alkylated products and it was thought that N-oxides could be difficult to remove without 
reaction at the sulfone. Another option was the use of a borane as a protecting group, as detailed 
by Zajac.24 In this case BH3.SMe2 was used to protect the pyridyl nitrogen in a molecule containing 
an aminopyridine and an alkyl halide, as on treatment with base, if the pyridyl nitrogen is 
unprotected, intramolecular cyclisation occurs.24 This approach could potentially be applied to the 
pyridyl in 57a/57b (Figure 3.17), however, boron is known to coordinate well with oxygen and 
therefore could easily coordinate to the sulfone or the hydroxyl instead, which would inhibit 
reaction with the alkylating agent or prompt unwanted side reactions. A small sample was tested; 
the starting material mixture was dissolved in dry DCM and cooled to -78 oC. Then BH3.SMe2 was 
slowly added, and the solution was stirred at -78 oC for 30 min. After the reaction was worked up 
the product was characterised by 1H and 11B NMR, which indicated the formation of multiple 
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the starting material, which is reported to give a peak at -20.2 ppm in CDCl3.
25 This suggests that 
coordination to other sites in the molecule is occurring, which prevents the use of BH3 as a 
protecting group for this system. 
Due to the small amount of ligand obtained from this route the synthesis was changed. The 
previous work conducted on the ligands derived from 56a/b noted no difference in emission 
colour between the complexes with the methoxy para- or ortho- to the pyridyl group, although 
the para complex displayed a slightly higher PLQY;10 hence we chose the target ligand with a para 
methoxy substituent. The required boronic acid 59 became commercially available, allowing for a 
route analogous to that described for the difluoro-complexes in chapter 2 to be followed. The 
targets 64 and 65, shown in Figure 3.18, were identified as they were analogous to 15 and 16, and 
66 was later synthesised due to solubility concerns with the heteroleptic complexes of 64 and 65.  
 
Figure 3.19: Synthesis of target ligands. 
The first step (Figure 3.19) for all ligands involved a Suzuki coupling between boronic acid 59 and 
the required 2-halopyridine derivative 11, 23, which was high yielding in both cases (91% and 
78%, respectively). The second step introduced iodine by ortho-lithiation; this proceeded in 
comparable yields to the difluoro analogues (58% for 60, 55% for 61) and the products were both 
easily separated from their corresponding starting materials by column chromatography.  
The final step in the synthesis was the copper-assisted nucleophilic displacement to introduce the 
sulfone unit, as used for the difluoro complexes.26 For the previous difluoro-substituted ligands 
15, 16 and 26 the yields were low (26%, 17% and 19%, respectively), and attempts to improve 
them proved unsuccessful. However, in the case of 64 and 65 the yields were significantly higher 
(45% and 53%, respectively). For 64 the unreacted starting material 62 and the de-iodination 
product 60 accounted for 27% and 25% of the missing product, respectively. The improved yields 
could be due to the ability of the methoxy- substituent to better coordinate the copper during the 
C-I insertion step. For 66 the yield was still low, 21%, the reason for which is unclear.  
 
Prompted by the synthetic route for the dimethoxy- ligand 79, which will be discussed later in this  
Chapter 3: Towards ‘fluorine-free’ emission  
 
  64 
 
Figure 3.20 
chapter, an alternative route was tested for ligand 66 (Figure 3.20). Instead of a 
lithiation/iodination protocol to create 63, p-tolyl disulfide was used as the electrophile to yield 
thioether 67 in 21% yield.  
 
The low yield for this reaction is possibly due to the steric demands of the electrophile. 
Compound 67 was then oxidised using mCPBA to give the product 66 in 63% yield. Care must be 
taken at this step to avoid competing oxidation of the pyridine to the N-oxide, as removal of this 
without reducing the sulfone can prove difficult.  
 
Figure 3.21: Synthesis of heteroleptic pic complexes. 
Once the ligands 64-66 were obtained the heteroleptic pic complexes 68, 69 and 70 were 
synthesised under modified Lamansky conditions, as described in chapter 2 (Figure 3.21). Water 
was excluded from the reaction mixture due to the noted sensitivity of fluoroaromatics bearing a 
strong electron-withdrawing group to nucleophilic attack,10,12,27 although this risk should be 
lessened with the exchange of one fluorine for an alkoxy group. The complexes 68, 69 and 70 
were obtained as yellow powders after purification by column chromatography followed by 
trituration with hot ethanol in the case of 68 (54%) and 69 (70%), and recrystallisation from 
ethanol in the case of 70 (83%). The fact that a recrystallisation rather than trituration can be 
carried out for 70 indicates its increased solubility, a property favourable for device applications.  
The NMR spectra of the complexes were as expected for heteroleptic pic complexes, and the 1H  
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H NMR spectrum of complex 68. 
and 13C spectra of 68 have been fully assigned with the aid of 2D experiments (Figure 3.22, 13C 
assignment present in the experimental section). As with 19 and 31 the stereochemistry about 
the metal centre was determined using the NOESY, revealing the expected trans orientation of 
the C^N ligand’s nitrogens about the iridium centre, which was confirmed by the crystal structure.  
The X-ray crystal structures of 68 and 69 are shown in Figure 3.23, although it should be noted 
that the crystals of 69 diffracted poorly, giving only a low resolution structure. Both complexes 
show the expected orientation of ligands around the metal centre for complexes synthesised from 
the dichloro-bridged dimer; the nitrogens of the chromophoric ligands are trans to each other. In  
 
 19 28 68 69 
Ir-N(pic) 2.137(3) 2.140(5) 2.129(4) 2.147(7) 
Ir-N(ppy-1) 2.046(3) 2.033(5) 2.041(4) 2.008(7) 
Ir-N(ppy-2) 2.028(3) 2.033(5) 2.035(4) 2.014(9) 
Ir-O(pic) 2.146(2) 2.133(4) 2.142(3) 2.134(12) 
Ir-C(ppy-1) 1.991(4) 2.000(6) 1.990(4) 2.006(8) 
Ir-C(ppy-2)
 b
 1.974(3) 1.986(6) 1.987(4) 1.973(7) 
Ppy-1 and 2 are defined as the ligands with carbon atoms opposite the pic N/O, respectively. 
Table 3.1: Selected bond distances. 
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Figure 3.23: LEFT: Molecular structure of 68.CH2Cl2, thermal ellipsoids set at 50%, solvent omitted for clarity. RIGHT: 
Molecular structure of 69. 
the case of 69 the twist between the phenyl and pyridyl rings is 0.6-3.4o, whereas for 68 it is much 
larger (12.7° and 14.7°). The structure for 69 shows significant disorder of the mesityl ring, 
possibly due to difficulties in cooling the crystal and the presence of disordered solvent in the 
structure. The dihedral angles between the mesityl and pyridyl rings for 69 were 73.4 and 91.0o, 
highlighting again the effectiveness of the ortho methyl substituents at restricting the conjugation 
with the pyridyl ring. Selected bond lengths are shown in Table 3.1 and compared to those of 
FIrpic and the relevant difluoro analogues. The photophysics and electrochemistry of these 
complexes will be discussed later. 
To further extend the ‘fluorine-free’ idea an analogue of 28 and 69 was designed, namely the 
dimethoxy-ligand complex 80, which contains no fluorines. An attempt was made to synthesise 
ligand 79 via a route analogous to that of the difluoro- (15, 16, 28) and 2-fluoro-4-methoxy- (64-
66) ligands (Figure 3.24). The first step was a Suzuki coupling between 23 and 71 to give 72 in 68% 
yield. However, attempted iodination to give 73 failed. It was anticipated that it would not be 
possible to deprotonate 72 with LDA, as the electron-donating ability of the methoxy substituents 
reduces the acidity of the proton between them, and, as all the starting material 72 was  
 
Figure 3.24 
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H NMR spectra of ligand precursors 24, 61 and 72 with protons on the phenyl ring highlighted. 
recovered, this was assumed to be the case. Stronger bases such as n-butyllithium were 
considered; however, pyridyl groups are known to undergo nucleophilic substitution with 
alkyllithium reagents.28-30 The change in acidity of the phenyl ring protons upon exchange of each 
fluorine for a methoxy group can be seen from the 1H NMR spectra (Figure 3.25). Protons 1, 2 and 
3 are increasingly shielded with each replacement of fluorine, with the proton nearest to the 
introduced methoxy group showing the largest shift.  
 
A new route (Figure 3.26) was therefore devised where a methylsulfide substituent was 
introduced. The first step involves introduction of the methyl sulfide group via ortho-lithiation of 
1,3-dimethyoxybenzene 74 to give literature compound 75 in 81% yield.31 Compound 75 is highly 
activated towards electrophilic aromatic substitution due to the three electron donating 
substituents, hence monobromination of 75 to give 76 was achieved, using one equivalent of 
bromine to avoid oversubstitution, in quantitative yield, as described in the literature.31 The novel 
boronic acid 77 was then synthesised by lithium-halogen exchange, followed by reaction with 
B(OMe)3/B(O
iPr)3 and aqueous workup (51% yield). It was noted that 77 is relatively unstable; it 
deborylates upon storage under ambient conditions over a period of weeks. 
Boronic acid 77 was then coupled to 23 via a Suzuki reaction using Pd(OAc)2/PPh3 as the catalytic 
system to give 78 in 60% yield, followed by oxidation of the sulfide 78 using m-  
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Figure 3.26: Synthesis of target ligand 79. 
chloroperoxybenzoic acid to give the sulfone 79 in 83% yield);. During the oxidation a significant 
amount of material appeared to stick at the top of the column; this was removed with highly polar 
solvents (water/MeOH) and identified as the pyridine N-oxide by NMR and mass spectroscopy 
analysis. This was observed even when only two equivalents of mCPBA were used, and it proved 
difficult to selectively reduce this N-oxide without also reducing the sulfone.  
During the course of this work it was discovered that the pyridine nitrogen could be ‘protected’ as 
the pyridinium HCl salt 78a, which minimised N-oxide formation. After oxidation the reaction 
mixture was treated with a basic workup to deprotonate the HCl salts, and 79 was isolated after 
column chromatography in 83% yield. The sulfide group was not oxidised prior to the Suzuki 
coupling due to concerns that a sulfone group may interfere with the lithiation steps.   
Initial attempts to synthesise complex 80 from IrCl3.H2O and 79 proved unsuccessful; the dimer 
did not appear to form, as a result when picolinic acid was added to the mixture the major 
product was Ir(pic)3.  Difficulties inducing cyclometalation of ligands containing methoxy  
 
Figure 3.27: Protection of the pyridine nitrogen. 
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Figure 3.28 
substituents have been reported previously, and in that case the alternative iridium source 
[Ir(COD)Cl]2 was used to synthesise the dimers with great success.
11 [Ir(COD)Cl]2 typically reacts 
with cyclometalating ligands via oxidative addition, due to the low oxidation state of the metal, 
whereas IrCl3 cyclometalates via electrophlic aromatic substitution.
32 The [Ir(COD)Cl]2 was 
prepared by refluxing IrCl3.3H2O with 1,5-cyclooctadiene in isopropanol/water overnight, and 
upon repeating the reaction the intermediate dimer now appeared to form. This was reacted in 
situ with a minimum amount of picolinic acid in an attempt to suppress ligand exchange. The 
product 80 was isolated after column chromatography as an off-yellow solid in 40% yield (Figure 
3.28).  
 
PHOTOPHYSICAL AND ELECTROCHEMICAL PROPERTIES 
Absorption and emission 
The absorption spectra for complexes 68-70 and 80 in DCM are shown in Figure 3.29. As with the 























Figure 3.29: Absorption spectra of listed complexes in DCM [<10
-5
 M]. 
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Figure 3.30: Excitation spectra of the complexes in DCM [<10
-5
 M]. The emission band observed was the second 
emission maximum. 
assigned to π-π* transitions on the ligand based on the calculations of Hay,33 and literature 
precedent.34 At lower energies the complexes display sets of absorption bands with lower 
oscillator strengths at 350-420 nm, assigned to the 1MLCT transitions, and at even longer 
wavelengths and smaller oscillator strengths the 3MLCT bands can be identified. As with the 
difluoro complexes the 3MLCT state is a major component of emissive state of these complexes, 
and the wavelength of this absorption band correlates with the λmax of the emission. For 
complexes 68, 69 and 70 the bands are all at similar wavelengths, 449-450 nm, indicating that the 
R group in the -SO2R substituent and the addition of the mesityl group both have little effect.  































Figure 3.31: Emission spectra of the complexes in deaerated DCM [<10
-5
 M], λex = 380 nm. 
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There is approximately 5 nm of red-shift compared to their difluoro analogues (19, 20 and 28), 
indicating that the donating methoxy substituent results in a small decrease in the ΔEHOMO-LUMO. 
Importantly, this is still a blue-shift compared to FIrpic, which has a λmax at 454 nm. The 
3MLCT 
band for the dimethoxy- complex 80 has a λmax at 456 nm, suggesting that the emission colour of 
the two complexes should be similar, provided the bandwidth of the spectra are comparable. 
Excitation spectra for all complexes were recorded (Figure 3.30), revealing that the bands from 
the 1MLCT and 3MLCT states are responsible for the emission from the complexes, as expected, 
while the majority of the lower energy π-π* transitions are dark. 
 
The emission spectra of the complexes are shown in Figure 3.31. The spectra of 68, 69, 70 and 80 
also exhibit a similar profile to that of FIrpic, with an emission maximum, vibronic progression and 
a shoulder at longer wavelengths, indicating that the emission originates from a similar excited 
state. As with the of difluoro complexes the emission is consistent with a mixed LC/MLCT state, 
due to the vibronic nature of the emission. The emission from 68, 69 and 70 is blue-shifted by 6-8  
Complex λmax
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277 (50.1), 301 (34.2), 304 (32.6), 






0.67 1.72 3.90 1.92 
68 
253 (89.0), 264 (97.7), 290 (87.0), 
319 (sh, 35.6), 372 (10.2), 406 (s 
sh, 4.5), 449 (0.6) 
460, 489, 
522 (sh) 
0.63 2.67 2.36 1.39 
69 
255 (99.0), 269 (118.1), 291 
(110.6), 336 (s sh, 27.6), 376 
(15.9), 402 (sh, 6.8), 450 (0.9) 
461, 489, 
523 (sh) 
0.67 1.79 3.74 1.84 
70 
258 (s sh, 108.5), 271 (128.6), 297 
(123.4), 307 (sh, 112.5), 339 (s sh, 
29.2), 379 (15.7), 450 (1.0) 
462, 490, 
524 (sh) 
0.67 1.78 3.76 1.85 
80 
275 (104.4), 291 (101.9), 324 (sh, 




0.58 2.13 2.72 1.97 
a 




 Data obtained in degassed dichloromethane solution with λex = 
380 nm. 
c 
Energy difference between lowest energy excitation maxima and highest energy excitation maxima. 
d 
Measured relative to Ir(ppy)3 ΦPL = 0.46 in degassed dichloromethane at 20 
o





 kr, knr values calculated using Equations 1.5/1.6.
 
Table 3.2: Photophysical data for selected iridium complexes 
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nm relative to that of FIrpic, a red-shift of only ~2 nm compared to the analogous difluoro-
complexes 19 and 20. This indicates that the methoxy group is less effective than fluorine at blue-
shifting the emission, although the change is small when only one fluorine is exchanged. 
The PLQYs, lifetimes (τobs) and calculated radiative and non-radiative decay rates (kr and knr) are 
shown in Table 3.2. The PLQYs for complexes 68, 69, 70 and 80 are all comparable with their 
analogous difluoro complexes (19, 20, 28). The lifetimes are on the order of 1-3 μs. These are 
typical values for mono-iridium complexes with efficient spin-orbit coupling between the triplet 
and singlet states.35 
 
Electrochemistry 
The electrochemical behaviour of complexes 68-70 and 80 was investigated using cyclic 
voltammetry and compared to the parent compound FIrpic and their difluoro analogues (19, 20, 
28). The voltammograms are shown in Figure 3.32 and the key parameters in Table 3.3. Formula 
2.1 is used to calculate the energy of the HOMO.  
Complex Eox1/2  / V HOMO / eV 
FIrpic 0.89 -5.69 
68 1.02 -5.82 
69 1.02 -5.82 
70 1.01 -5.81 
80 0.89 -5.69 
 
All values reported vs Fc/Fc
+
 = 0.00 V. 
Table 3.3: Electrochemistry data of iridium complexes. Measured in MeCN (0.1 M 
n
Bu4NPF6) at 298 K. 
The complexes all show a quasireversible oxidation wave which was assigned to the IrIII/IrIV 
couple. Compared to the difluoro complexes (19, 20, 28), all the mono-fluoro complexes (68-70) 
display less positive oxidation potentials, with a difference of 0.13-0.17 V. This is expected, as the 
HOMO is localised on the phenyl rings of the C^N ligand, and an electron withdrawing fluorine has 
been exchanged for an electron donating methoxy group which will raise the orbital energies. The 
oxidation potentials are  still more positive than that of FIrpic, suggesting that if the LUMO 
remains at a similar energy the HOMO-LUMO gap for the mono fluoro complexes (68’, 69’, 70’) 
will be larger, and the emission bluer, than that of FIrpic. This is supported by experimental 
observation. As with the difluoro complexes there is little variation upon changing the identity of 
R in –SO2R, or upon addition of the mesityl group. The dimethoxy complex 80 has a similar 
oxidation potential to FIrpic, and as the emission colour is similar it suggests that the HOMO-  
Chapter 3: Towards ‘fluorine-free’ emission  
 
  73 




































Figure 3.32: Cyclic voltammograms of 68, 69, 70 and 80. 
LUMO gap is similar, creating a ‘fluorine-free’ alternative. No reduction waves were observed 
within the solvent window.  
 
COMPUTATIONAL DATA 
Electronic structure calculations were carried out on iridium complexes 68-70 and 80 by Dr Mark 
Fox (Department of Chemistry) to elucidate the nature of the frontier orbitals and the transitions 
involved in the absorption and emission spectra. The full geometries were optimised at the 
B3LYP/LANL2DZ:3-21G* level of theory and are denoted 68’, 69’, 70’, 80’ to distinguish them from 
experimental data. Comparison with optimised and experimental geometries determined from 
the X-ray data for 68 revealed good agreement for the Ir-X bond distances (Table 3.4). The orbital 
energies were computed for 68’, 69’, 70’, 80’ and show good agreements with the observed  
 
 68 68’ 
Ir-N(ppy) 2.042(4) 2.061 
Ir-N(ppy) 2.035(4) 2.048 
Ir-C trans N 1.988(5) 2.015 
Ir-C trans O 1.985(5) 2.013 
Ir-O 2.143(4) 2.140 
Ir-N(pic) 2.129(4) 2.164 
 
Table 3.4: Comparison of the experimental (68) and optimised (68’) bond lengths involving the iridium atom. 
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Complex HOMO / eV 
Calc HOMO / 
eV 




FIrpic 1 -5.69 -5.49 -1.87 3.62 
68 -5.82 -5.82 -2.06 3.76 
69 -5.82 -5.74 -2.00 3.74 
70 -5.81 -5.64 -1.94 3.70 
80 -5.69 -5.53 -1.89 3.64 
 
Table 3.5: Comparison between experimental HOMO energies (estimated from observed oxidation potentials) and 
the calculated HOMO/LUMO energies. 
oxidation potentials (Table 3.5). As expected, the exchange of a fluorine for a methoxy (19’ to 68’, 
28’ to 69’ then 80’) results in an increase of the HOMO level relative to the LUMO, resulting in a 
decrease in the HOMO-LUMO gap, which correlated well with the observed emission λmax. This 
reflects the greater donor ability of the methoxy group compared to fluorine. The frontier orbital 
distributions for 68’, 69’, 70’, 80’ are similar to FIrpic, with the HOMO largely localised on the 
metal d orbitals (39-41%) and the phenyl ring (42-45%) and the LUMO localised mostly on 
thepyridine of the pic ligand (78-82%). Notably the orbital distribution and energies of 80’ and 
FIrpic are very similar, suggesting 80 should be a good replacement for FIrpic in devices. 
 
TD-DFT computations were carried out on the S0 optimised geometries of 68’, 69’, 70’ and 80’ to 
predict emission wavelengths of these iridium complexes. The initial excitation is assumed to give 
the lowest energy singlet excited state S1 which then undergoes intersystem crossing (ISC) due to 
the SOC induced by the iridium centre to form the triplet excited state T1. Phosphorescence is 
then observed from the S0 ← T1 process. Complexes 68’, 69’, 70’ and 80’ display small Stokes 
shifts, suggesting that the T1 geometry is similar to the corresponding S0 geometry. The reverse  
Complex 










1’ 471 1 471 
68’ 463 68 460 
69’ 467 69 461 
70’ 467 70 464 
80’ 473 80 474 
 
a
 Values from TD-DFT data on S0 optimized geometries with scaling energy factor of 0.945 based on dichloromethane at 
298 K. 
b 
Observed highest energy band from emission spectra. 
Table 3.6: Comparison between calculated and observed emission wavlengths. 
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process S0 ← T1 is therefore considered to have the same nature as the computed S0 → T1process, 
with the predicted emission wavelength adjusted to take into account the Stokes shift. The 
predicted and observed emission wavelengths are shown in Table 3.6, it can be seen that there is 
good agreement for all complexes. 
 
DEVICE DATA 
OLEDs containing complexes 68, 69, 70 and 80 were fabricated by Dr Hameed Al Attar in the 
Department of Physics at Durham University and compared to a reference device containing  
















































































































































































Figure 3.34: Device data for complexes 68, 69, 70, 80 
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FIrpic. The hole transporting layer and emissive layer were deposited by spin-coating and the 
electron transporting, electron injection layers and the cathode were then fabricated by vacuum 
deposition. The device structure is as follows: ITO/PEDOT:PSS (45 nm)/PVK:OXD(30%):Ir 
complex(15%)(60 nm)/TPBi (30 nm)/LiF/Al. The electroluminescence (EL) spectra from the devices 
are shown in Figure 3.35, panel a; for all complexes the EL spectra are similar to the 
photoluminescence (PL) spectra, indicating good exciton confinement on the emissive molecule. 
Complexes 69 and 70 containing the mesityl substituent were the best performing of the 
complexes synthesised in this chapter, with maximum EQEs of 3.9% and 3.4%, respectively (panel 
c). Complexes 68 and 80 gave less efficient devices; in the case of 68 this can be rationalised by 
the lack of the mesityl substituent, however, the reason for the poor performance of 80 is 
unclear. Compared to FIrpic, all complexes gave lower EQEs (panel c), lower efficiencies (panel d) 
and lower maximum brightnesses (panel e), although the mono-fluorinated complexes (68, 69, 
70) display bluer electroluminescene than FIrpic (panel a), which could be partially responsible for 
their lower performance. The device of 69, however, exhibits a lower turn on voltage than the 
FIrpic device, and comparable brightness when operated at less than 7 V (panel e). 
























FIrpic 1 475 7340 6.2 5.4 12.2 5.1 (0.19, 0.38) 
68 469 1772 8.1 3.0 5.9 2.1 (0.17, 0.33) 
69 469 2851 6.0 3.9 7.6 3.3 (0.17, 0.32) 
70 470 2072 8.5 3.5 6.1 1.9 (0.16, 0.30) 
80 478 516 8.5 1.2 2.6 0.9 (0.22, 0.40) 
 
a




 Measured at 12 V. 
Table 3.7: Summary of device data.  
 
CONCLUSION 
The family of sulfone-containing complexes introduced in Chapter 2 has been extended by the 
synthesis of complexes 68, 69, 70 and 80, which contained fewer aromatic fluorines. The 
photophysical and electrochemical properties were compared to the parent complex FIrpic, and 
the difluorinated sulfone containing complexes 19, 20, 28. While a small red-shift is observed on 
exchanging one fluorine for a methoxy group, complexes 68, 69, 70 still displayed bluer emission 
than FIrpic, as well as comparable quantum yields and lifetimes. Complex 80 provides a viable 
fluorine-free alternative to FIrpic, with similar emission wavelength, HOMO/LUMO energies and 
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similar orbital distributions, as indicated by the computational data.  Devices of all complexes 
fabricated in the Department of Physics retain the blue emission obseved in the PL spectra, and 
the best two complexes, 69 and 70, performed comparably to the best of the difluoro complexes 
of Chapter 2, 28. Devices were fabricated by solution processing, and the solubility has been 
enhanced compared to FIrpic by the sulfone and mesityl groups.  
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Chapter 4: Dual emissive phosphorescent 
materials 
Compounds that display broad emission spectra are of great interest for lighting applications, 
including white OLEDs (WOLEDs).1,2 One origin of broad spectral emission is dual emission, 
wherein emission occurs approximately simultaneously from two distinct excited states of the 
same compound. For iridium complexes one method of accomplishing this is to incorporate them 
into polymer chains containing other emissive materials of different colours, details of which can 
be found in the following reviews: Farinola et. al.,2 Xiao et. al.,3 and Ulbricht et. al.4 The other 
alternative involves emission from two distinct excited states of a single iridium complex; reports 
of this in the literature are rare, and among the reported examples there are a variety of 
mechanisms responsible for the dual emission character.  
 
In the case of complex 81b (Figure 4.1), a neutral mer- homoleptic complex, the two main 
emission features are vibronic bands in the blue region (P1 400-500 nm) and a broad, featureless 
band in the red region (P2 550 nm).
5 On lowering the temperature the intensity of the P1 increases 
dramatically, along with an increase in the lifetime (4.9 ns at 298 K to 236 ns at 218 K).5 
Experimental observations and TD-DFT calculations ascribed the dual phosphorescence character 
to the existence of two triplet states: an intra-ligand charge transfer (ILCT) state of pyrazolate → 
pyridine character, with a small MLCT contribution (10%), and a second localised ligand to ligand 
charge transfer (LLCT) state of pyrazolate → pyridine character, with a greater MLCT contribution 
(20%).5 Although the LLCT state is predicted to have higher energy than the ILCT state by TD-DFT, 
due to the increased MLCT character of the LLCT state the Ir-L bond lengths are predicted to be 
lengthened, resulting in a lowering of the LLCT state. The P1 band is therefore assigned to the  
 
 
Figure 4.1: Structures of dual emitting complexes. 
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Figure 4.2: LEFT: Selected temperature dependent luminescent spectra of 81b in Ar saturated DCM. Inset: the 
intensity changes of the P1 and P2 emission bands with temperature. RIGHT: The proposed mechanism of dual 
emission in 94b. Adapted from reference 
5
. 
ILCT state, and the P2 band to the LLCT state. The proposed mechanism of the dual emission of 
81b is shown in Figure 4.2.  
An example of a neutral heteroleptic complex that exhibits dual emission is shown in Figure 4.3.6  
Complex 82a shows broad green emission in aerated and non-aerated DCM, but blue-shifted 
emission that displays fine structure in acetonitrile. The emission profile in 2-methyl THF and 1:1 
MeOH:EtOH is somewhat intermediate (Figure 4.4).6 By comparison, the emission profile for the 
related complex 82b shows only unstructured emission with a λmax of 602 nm with only minor 
solvatochromic effects.6 The absorption spectrum of 82a was invariant to changes in the solvent, 
and the excitation spectra obtained in MeCN for various emission wavelengths showed little 
variation and matched well with the absorption spectra, indicating that the complicated features 
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Figure 4.4: LEFT: Emission spectra of 82a in various solvents, at 298K. The dotted lines represent aerated and the 




experiments showed no evidence of direct solvent interactions, although solvent interactions in 
the excited state cannot be completely excluded.6 The influence of oxygen (3O2) on the emission 
was also investigated, with higher energy bands (480 nm and 505 nm) showing a much greater 
oxygen sensitivity than the lower energy band (600 nm).6 As was the case with complex 81b, the 
higher energy emission was assigned to a 3LC state with low metal character while the lower 
energy emission was assigned to a 3CT state with significant metal character (Figure 4.4).6 The 
relative energy of the 3CT state is thought to be solvent dependent based on the emission spectra, 
although it was noted that the exact nature of the CT state was difficult to determine 
computationally based on the electronic distribution of the frontier molecular orbitals.6 
Examples of dual emitting iridium complexes have been employed as biological sensors; a family 




Figure 4.5: Dual emissive complexes with biologically active groups. 
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Figure 4.6: LEFT: Normalised emission spectra of 83a in deaerated DCM (line), CH3CN (dash) and phosphate buffer 




biologically active groups (biotin 83b and estradiol 83c), as well as a long, hydrophobic C18H37 
chain (83d).7 Parent compound 83a exhibits dual emission in organic solvents at room 
temperature, with a structured high energy band at ~500 nm (τo = 1.1 – 2.5 μs) and a broad, lower 
energy band at ~593 – 619 nm (τo = 0.1 – 0.3 μs).
7 As solvent polarity is increased (from DCM to 
MeCN/MeOH) the intensity of the lower energy band decreases until, in the case of the aqueous 
deareated phosphate buffer, the emission becomes completely dominated by the higher energy 
band (Figure 4.6).7 The intensity of both bands decreases in aerated solutions, with the higher 
energy band being more strongly affected.7 The emission bands of 83a were assigned to an intra-
ligand (3IL/LC) excited state for the higher energy band, and a mixed 3MLCT/3LLCT excited state.7 
Complexes 83b and 83c display similar dual-emissive properties to 83a in organic solvents and 
aqueous buffer, with the high energy band being dominant in aqueous aerated buffer solutions. 
On addition of the appropriate proteins (avidin and estrogen receptor α (ERα), respectively) the  
 
Figure 4.7: LEFT: Emission of 83c in aerated phosphate buffer at 298 K on addition of ERα. RIGHT: Emission of 83d in 
aerated phosphate buffer at 298 K on addition of HSA. Reproduced from reference 
7
. 
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biologically active groups bind with the protein, causing an increase in the intensity of the lower 
energy band, and a decrease in the intensity of the higher energy band (Figures 4.6 and 4.7). This 
was attributed to the increased hydrophobic character of the local environment of the complexes 
upon binding with the protein. In the case of complex 83d, the long hydrophobic C18H37 chain is 
thought to ‘wrap around’ the complex in aqueous buffer solutions, resulting in emission 
dominated by the lower energy band. Upon interaction with either human serum albumin (HSA, a 
protein known to bind lipids) or β-cyclodextrin (known to bind aliphatic chains) to aerated buffer 
solutions the intensity of the higher energy band increases relative to the lower energy band, 
resulting in a blue-shift of the emission colour (Figure 4.7). It is proposed that the binding of the 
aliphatic chains results in the iridium core being exposed to the hydrophilic buffer solution, 
enhancing the higher energy band. A mechanism for the dual emission of these complexes is not 
proposed, although it is noted that the parent complex, which lacks the amine groups on the ppy 
ligands, does not show dual emission. 
 
 
Figure 4.8: Dual emitting complexes for metal sensing. 
Other examples of dual emitting iridium complexes used for biological sensors are shown in 
Figure 4.8; complex 84a is a selective sensor for Cu(II) ions,8 while complex 84b is a sensor for 
Zn(II),9 although it is less selective. In both cases dual emission is observed from the complexes in 
solution when no metal ions are present; for 84a this is attributed to emissive states originating 
from both the ppy (475-550 nm) and the 2-(2’-benzo[b]thienyl)pyridine (btp) ligands (575-700 
nm),8 for 84b the higher energy band (461, 491 nm) is associated with the dfppy ligand and the 
lower energy band is associated with emission from the phenanthroline (phen) ligand (528 nm), 
although it is noted that this emission exhibits a large degree of charge transfer character.9 When 
84a is exposed to Cu2+ ions the emission from the btp ligand is quenched while the ppy emission  
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Figure 4.9: LEFT: Reversible change in the phosphorescence spectrum of 84a in response to CuCl2 (red line, Cu(II)-free 
state; green line, in the presence of CuCl2 (1 equiv); blue line, after subsequent addition of Na2EDTA (100 equiv) to 
the mixture). The inset depicts the corresponding change in phosphorescence intensity ratio of green vs red bands. 
Adapted from reference 
8
. RIGHT: Change in phosphorescence spectrum of 84b with increasing total zinc 
concentration. Adapted from reference 
9
. 
remains intense (Figure 4.9). This results in a colour change on binding of copper, and is selective 
even in the presence of other metal ions, such as Na+, K+, Mg2+, Ca2+, Zn2+, Fe2+, Ni2+, Cr2+ and Co2+.8 
In the case of 84b, the emission intensity of the free complex is poor at RT, with a PLQY of 0.02; 
on binding of Zn2+ an enhancement in the intensity of the lower energy band is observed, 
increasing the PLQY to 0.58.9 Compound 84b selectively binds Zn2+ in the presence of Na+, Mg2+, 
K+, Ca2+, and Mn2+, although paramagnetic ions Fe2+, Co2+, Ni2+ and Cu2+ bind more strongly with 
the complex, however their binding also quenches the emission.9 
An example of a white-light emitting iridium complex with a very simple structure is shown in 
Figure 4.10.10 When excited within the ligand π-π* and MLCT absorption bands 85 displays broad, 
relatively featureless emission covering almost the whole visible region, from 440 nm to 800 nm, 
that is independent of the excitation wavelength.10 The emission spectra were independent of 
concentration (over a range of 10-3 to 10-7 M) showing that the emission was not due to excimer 
formation.10 TD-DFT calculations indicated that the LUMO, LUMO+1 (which are based over the 
cyclometalating ligands) and LUMO+2 (which possesses mainly acac character) are close in 
energy, resulting in several excited states that are close in energy (<0.1 eV).10 The authors note 
that they have no evidence for dual emission from 85, rather that the emission results from an 
excited state of mixed character, as suggested by the calculations.10 The authors propose that 
vibronic coupling between bright (such as the imidazole-based transition) and dark states (such as 
the acac-based transition) may be the cause of the spectral broadening observed in 85. The PLQY  
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Figure 4.10: LEFT: Complex 85. RIGHT: Absorption and emission spectra (λex = 355 nm) of 95 in DCM. 
of 85 has been measured in solution, in a PMMA matrix, and a thin film emulating the emissive 
layer of an OLED, and it is low in all cases (0.015, 0.07 and 0.05, respectively).  
 
RESULTS AND DISCUSSION 
A series of complexes synthesised by previous members of the group is shown in Figure 4.11. The 
emission spectra of complexes 86, 87, 88, 89, 90 are shown in Figure 4.12; with the exception of 
complex 90 the emission spectra is typical of mono iridium complexes, the vibronic structure is  
 
Figure 4.11: Iridium complexes synthesised by previous members in our group. 
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Figure 4.12: Emission spectra of the complexes in degassed solvent at 298 K.  
indicative of a mixed LC/MLCT state and little variation in emission profile is seen upon changing 
solvents, indicating that the charge transfer character is low. In the case of 90, however, a lower 
energy band (λmax = 570 nm) develops on increasing the solvent polarity, which results in 
broadened emission. We were interested in investigating 90 for white OLEDs, and in developing 
design rules for the synthesis of further dual emitting iridium complexes. 
The analogous complex 89 does not exhibit dual emission, despite containing the same dialkoxy 
substituted carbazole moiety (a strong electron donor), and neither did complex 87, which 
contains the 2,4-difluoro-3-pyridyl group (a strong electron acceptor). This observation, and the 
fact that the second band grows in at lower energy, is consistent with the emission originating 
from a charge-transfer interaction between the donor and acceptor moieties in 90. Hence we 
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have now varied the identity of the donor/acceptor units to determine whether other strong 
donors/acceptors would produce the same effect. Initially the 2,4-difluoro-3-cyanophenyl group 
was chosen to allow comparison with existing complex 88. Additional quantities of complex 90 
were synthesised for further study. 
The route to target ligands 101 and 102 is shown in Figure 4.13. The first section of the synthesis 
involves construction of 2,7-dimethoxycarbazole (95). The first step involved synthesis of the 
boronic acid 92, via a Grignard reaction in 90% yield. This was followed by a Suzuki coupling 
reaction with 1-bromo-2-nitro-4-methyoxybenzene 93 to form the required biphenyl derivative 94 
in 92% yield.  
 
The ring closure reaction was then achieved using P(OEt)3, which was freshly distilled prior to use. 
The carbazole 95 (formed in 85% yield) was then coupled with 2-chloro-4-iodopyridine 21 in an 
Ullman-type reaction to give 96 (96% yield). The methoxy ethers were then deprotected with BBr3 
to give the phenol 97 (72%) and hexyl chains were added to improve the solubility of the resulting  
 
 
Figure 4.13: Synthesis of target ligands. 
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complexes, via a Williamson ether synthesis to give 98 (79%). 
The next step was to perform Suzuki coupling reactions with the desired MIDA boronates; 99 was 
available in our laboratory, and 100 was synthesised via the route shown in Figure 4.14. 
 
 
Figure 4.14: Synthesis of the required MIDA-boronic ester. 
First ortho lithiation of 103 with LDA was used to introduce the boronic acid group into the 
required position (72%), then the MIDA ester 100 was synthesised via a condensation reaction 
between 104 and MIDA. The reaction was conducted in a Dean-Stark apparatus to remove the 
water produced and the product was obtained in good yield (72%). The MIDA esters were used 
due to the instability of the parent boronic acids under the reaction conditions. Longer reaction 
times, as required for coupling reactions with the less active 2-chloropyridine derivatives, suffer 
from competing deborylation, particularly for highly electron-deficient boronic acids.11,12 
 
The Suzuki couplings between boronic esters 99/100 and 98 followed the protocol described by 
Burke et al.11 The initial synthesis of 101, conducted in refluxing dioxane, resulted in a poor yield 
(<10%), and no unreacted MIDA boronic ester was isolated, suggesting decomposition. The MIDA 
esters are thought to operate by releasing the active boronic acid species in the presence of base, 
and the rate of this release can be controlled via choice of base and reaction temperature. Hence 
the reaction temperature was lowered to 60 oC, which resulted in an improved yield (87%) of 101. 
The reaction conditions were repeated with 100 and the ligand (102) was isolated in 83% yield. 
The target heteroleptic pic complexes 90 and 105 were then synthesised (Figure 4.15). Reaction of 
the ligands (101, 102) with IrCl3.3H2O gave yellow precipitates presumed to be the intermediate 
μ-dichloro-bridged dimers, which were not isolated. Picolinic acid was then added and the 
solution heated to reflux. TLC analysis revealed a large number of yellow spots, suggesting the 
formation of many iridium complexes. The desired complexes 90 and 105 were isolated in low 
yields (9% and 13%); and in the case of complex 90 each additional spot was isolated by column 
chromatography. From the mass spectra it could be seen that each spot corresponded to the  
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Figure: 4.27: Synthesis of heteroleptic complexes. 
replacement of one fluorine with an ethoxyethanol group (Figure 4.16). The 1H NMR spectra of 
the spots are complex, which can be attributed to a lack of selectivity in the fluorine replacement, 
resulting in a mixture of isomers all with a similar polarity. This instability of aromatic fluorines 
towards nucleophilic attack has been discussed in Chapters 2 and 3, although for the complexes 
synthesised in this thesis so far this instability has not been observed at temperatures below 160 
oC, indicating the increased electron withdrawing nature of the pyridine nitrogen in 90 compared 
to the sulfone moiety described in Chapters 2 and 3. As detailed in Chapter 2, the instability of the 
2,4-difluoro-2’,3-bipyridine ligand under the standard reaction conditions has been observed 
before, wherein the methoxyethanol solvent attacks the ligands and the tetra alkoxylated 
heteroleptic complex is isolated as the major product in good yield (Figure 3.8).13 As a result, the 
temperature of the reaction was dropped to 120 oC, and the yields improved to 33% and 54% for 
90 and 105, respectively. The photophysics of the complexes, along with the device performance  
 
 
Figure 4.16: Mass spectra of two products isolated from the reaction of 101 with IrCl.3H2O and picolinic acid in 
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will be discussed later. 
Due to the noted instability of complexes 90 and 105, there was interest in removing some of the 
fluorines from the acceptor portion of the molecules. As a result complex 116 was designed, 
which exchanges the carbazole moiety for a more strongly donating dialkoxy-phenothiazine unit 
to compensate for the weakening in acceptor strength from removing the fluorine. The synthesis 
of target ligand 113 is shown in Figure 4.17, and is analogous to that of 101 and 102. First, amine 
107 was constructed via a Buchwald-Hartwig type reaction between 91 and 106, which proceeded 
in 62% yield, and then the ring was closed using elemental sulfur and iodine to give the 
phenothiazine 108 in 30% yield.14 An Ullmann type reaction was then used to couple 108 with 2-
chloro-4-iodopyridine to give 109 (52%), followed by deprotection of the ethers with BBr3 to give 
110 (95%) and then a Williamson ether reaction with hexyl bromide to give 111 (76%). 
The final step in the ligand synthesis was a Suzuki coupling with the MIDA ester, 112. This was 
conducted under the conditions previously described for 101 and 102; however no product was 
 
 
Figure 4.17: Synthesis of target ligand 113. 
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obtained. The catalytic system was therefore changed to Pd(OAc)2/PPh3 in dimethoxyethane 
(DME) with Na2CO3 to give the product 113 in 81% yield. 
The required MIDA boronic ester was synthesised in the manner previously described for 100 
(Figure 4.18). The intermediate boronic acid 115 was synthesised via lithiation ortho to the 
fluorine of 114 (crude yield 92%), followed by a condensation reaction with MIDA to form MIDA 
boronate 112 in 55% yield (51% over the two steps). 
 
Figure 4.18: Synthesis of required MIDA-boronic ester. 
The synthesis of complex 116 is shown in Figure 4.19. The reaction was conducted in toluene at 
115 oC in an attempt to prevent the degradation of the material, as observed with 90 and 105, 
however, no product was observed. TLC showed a small amount of free ligand 113 remained, and 
analysis of the 1H NMR spectrum indicated that the dimer had formed, however it had not spilt to 
form the complex 116. The crude reaction mixture was redissolved in 2-ethoxyethanol, further 
picolinic acid was added and the reaction was repeated. Upon purification the desired product 
116 was isolated in low yield (9%). Repeating the reaction in the non-nucleophilic solvent diglyme 
gave 116 in a higher yield (26%). 
 
 
Figure 4.19: Synthesis of complex 116. 
The photophysics, device performance and electrochemistry of complexes 90, 105 and 116 will be 
discussed later, however it is noted that while the complexes exhibited dual emission properties 
in solution state with increasing solvent polarity this emission could not be replicated in solid 
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Figure 4.20: Synthesis of complex 117. 
state films or devices. As a polar medium stabilised the lower energy emission band it was 
considered that a charged analogue may exhibit a broad spectrum emission in a light-emitting 
electrochemical cell (LEEC). With this in mind complex 117 was synthesised (Figure 4.20); the first 
step was to form the intermediate μ-dichloro bridged dimer from ligand 102 (dry diglyme, 130 oC), 
followed by reaction with bipyridine, NH4PF6 and AgPF6 according to the procedure described by 
Bünzli et. al.15 The final complex 117 was isolated as an off yellow solid in 22% yield. 
 
PHOTOPHYSICAL AND ELECTROCHEMICAL PROPERTIES 
Absorption and emission 
The absorption spectra of complexes 86-90, 105, 116 and 117 in toluene are shown in Figure 4.21. 
The complexes possessing extended aromatic systems, namely carbazole and phenothiazine show 



























Figure 4.21: UV-Vis absorption spectra of the complexes in toluene [10
-5
 M]. 
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Figure 4.22: Absorption and emission (λex = 310 nm) of ligand 102 in toluene [<10
-5
 M]. 
325 nm are assigned to π-π* transitions on the ligand based on the calculations of Hay16 and the 
absorption spectra of ligand 102 (Figure 4.22). The intense bands at 350-425 nm are assigned to 
the 1MLCT bands, as they are not present in the ligand spectrum, and at much lower oscillator 
strengths (0.8-1.8 x 103 dm3/mol cm) the 3MLCT bands can be seen.  
Excitation spectra for all complexes (Figure 4.23), reveal, as expected, that the bands from the 
1MLCT states are responsible for the emission from the complexes, while the majority of the 
higher energy π-π* transitions are dark. 























Figure 4.23: Excitation spectra for complexes 90, 105 and 117 in chlorobenzene [<10
-5
 M]. The emission band 
observed was the second emission maximum. An excitation spectra for 116 could not be measured. 
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The emission spectra of complexes 90, 105, 116 and 117 in various solvents are shown in Figure 
4.24. It can be seen that that complexes 90, 105 and 116 exhibit dual emission on increasing the 
solvent polarity (from methyl cyclohexane, to chlorobenzene, to chloroform). Emission from 
complex 117 shows some variation on moving to different solvents, however, there is no sign of a 
broad feature, suggesting a lack of charge transfer. Compared to 90, the effect of solvent polarity 
on the emission of 105 is weaker, as the ratio between the phosphorescence band assigned to the 
LC/MLCT state and the charge transfer band is greater. In the case of 116, the additional peak is 
present even in non-polar methyl cyclohexane (MCH), and it shifts to a longer wavelength in more 
polar solvents, such as chlorobenzene and chloroform. Complex 117 could not be dissolved in 
MCH, and the emission spectra were recorded in chlorobenzene, chloroform and ethanol. 































































































































Figure 4.24: Emission spectra of complexes 90, 105, 116 and 117. The emission spectra for complex 116 were 
smoothed. 
The emission spectrum of ligand 102 is shown in Figure 4.22; it is broad and featureless with a λmax 
= 488 nm, and shows a large Stokes shift, indicating distortion in the excited state. Based on the 
structure of the ligand, with a strong donor and strong acceptor component, the emission could 
be due to intramolecular charge transfer. The emission is quenched slightly by oxygen (Figure 
4.22), and the emission band has a lifetime of 0.98 μs in deaerated toluene solution, and 0.64 μs 
in aerated toluene solution. The lifetime data also indicated the presence of a short decay 
component (<60 ns), although this could not be measured on the experimental set up, suggesting,  
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Figure 4.25: Emission spectra of complex 105 in a chlorobenzene, chloroform and ethanol [<10
-5
] showing the relative 
intensity of the emission bands. 
along with the lifetime measurements, the possibility of a delayed emission mechanism. 
The PLQYs and lifetimes of complexes 90, 105, 116 and 117 are shown in Table 4.1. For complex 
105 the PLQY was measured in chlorobenzene, chloroform and ethanol, to determine the effect 
of the solvent polarity on the efficiency of the emission. Unfortunately the PLQY could not be 
measured in methyl cyclohexane, as the solubility of 105 was so low that the absorbance could 
not be detected. Upon  increasing the solvent polarity a decrease in the PLQY is observed, in 
conjunction with an increase in the intensity of the lower energy band (Figure 4.25). A plot of the 
relative solvent polarity against the PLQY is shown in Figure 4.26. As the solvent polarity increases  
 
Figure 4.26: Plot of relative solvent polarity against PLQY measured in degassed solvent. The values for relative 
polarity are normalized from measurements of solvent shifts of absorption spectra and were taken from reference 
17
. 
y = -0.2744x + 0.188 















Relative solvent polarity 
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the intensity of the CT band relative to the LC/MLCT band increases dramatically, although the 
PLQY falls sharply. This effect has been documented previously, both for charge transfer 
complexes,18,19 and for compounds, such as porphyrins, that possess intramolecular charge 
transfer (ICT) states or undergo photoinduced electron transfer (PET).20-22 In these cases the use 
of more polar solvents increases the efficiency of the ICT/CT/PET processes, however the 
quantum yields of the compounds decrease. This is attributed to non-radiative solvent 
dissociation or, in the case of the CT complexes, solvent stabilised ionic separation. This 
observation therefore supports the assignment of the lower energy band to a state with strong CT 
character. For complexes 94, 116 and 117 the PLQYs were measured in chlorobenzene, as the 
complexes could not be dissolved in methyl cyclohexane. The PLQYs of 116 and 117 are 
significantly lower than those of 90 and 105. In the case of 116 this can be partially explained by 
the significant red-shift in emission colour compared to 90 and 105; lower energy excited states 


























306 (55.9), 313 (53.0), 
365 (33.8), 382 (38.7), 
445 (0.9) 
MCH 456, 482 - - 
CBZ 





CHCl3 456, 486, 526 - - 
105 
296 (64.5), 308 (62.3), 
372 (31.0), 389 (33.8), 
454 (1.7) 
MCH 462, 490 - - 
CBZ 
469, 499, 550 
(sh) 
0.13 
0.52 (470)  
0.49 (550) 
CHCl3 464, 496, 550 0.12 - 
EtOH 600 0.008 - 
116 
304 (34.5), 325 (30.8), 
360 (23.0), 382 (16.5), 
445 (1.2) 
MCH 459, 501, 570 - 
- CBZ 459, 493, 654 0.01 
CHCl3 456, 486, 655 - 
117 
301 (100.8), 316 (85.3), 
368 (45.4), 385 (51.9) 
CBZ 475, 504 0.005 0.45 (475) 
CHCl3 494, 523 (sh) - 0.57 (495) 
EtOH 481, 507 - 
0.2 (495) 
0.23 (505) 








 Data obtained in degassed solvent, with λex = 365 nm. MCH = 
methylcyclohexane, CBZ = chlorobenzene, Tol = toluene. 
c 
Measured in degassed solvent, relative to quinine sulfate ΦPL 
= 0.546 in 0.5 M H2SO4 at 20 
o
C; estimated error ±5%. 
d 
Estimated error ±5%, measured in deaerated solvent. The 
number within ( ) refers to the wavelength corresponding to the lifetime. [ ] refers to a lifetime in aerated solvent.
 
Table 4.1: Photophysical data for selected compounds. 
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Figure 4.27: The decay profile of complex 90 in chlorobenzene (λex = 355 nm). 
cause is the apparent increase in charge transfer character (suggested by the fact that the broad 
emission feature is present even in non-polar solvents), resulting in more efficient quenching via 
radiationless deactivation in solution. 
For complexes 90, 105 and 117 the lifetimes of the two bands were measured, and are shown in 
Table 4.1. The values for the two features are the same within experimental error. This is 
highlighted by the decay profile of complex 90 (Figure 4.27), which shows no significant change in 
spectral features during the decay, suggesting that the decays come from states similar in origin. 
 
 

























Figure 4.28: The emission profile of 90 in chlorobenzene at varying temperatures. 
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The effect of temperature on the emission spectra of complex 90 was also investigated (Figure 
4.28). On decreasing the temperature from room temperature to 230 K the ratio between 
emission bands changes, with an increase in the intensity of the lower energy feature relative to 
the higher energy feature. This can be rationalised by the difference in the degree of CT character 
between the two bands; the PLQY of the complexes and the intensity of the lower energy band 
show a strong dependence on solvent polarity, suggesting the stabilisation of a state with 
increased dipole moment (CT state) on moving to more polar solvents. Upon cooling the 
chlorobenzene solution (m.pt. = 228 K) the viscosity of the solution increases, decreasing the rate 
with which solvent molecules that support the CT state can dissociate, resulting in an 
enhancement of the 550 nm emission. The higher energy feature, assigned to a mixed LC/MLCT 
state, is not as substantially affected, as it has less CT character that requires solvent stabilisation.   
 
Electrochemistry 
Complexes 90, 105, 116 and 117 were investigated by cyclic voltammetry, and the cyclic 
voltammograms are shown in Figure 4.29. Complexes 90, 105 and 117, which contain the 2,7- 
dialkoxycarbazole moiety, show a change in the voltammogram profile on increasing the number 































































































Figure 4.29: Cyclic voltammograms of complexes 90, 105, 116 and 117. 
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of cycles. On the first scan all the complexes initially show two oxidation waves, which can be 
assigned to the Ir3+/Ir4+ couple, and the oxidation of the carbazole moiety. On the reverse scan, 
the oxidations of the carbazoles are quasireversible; however, another reduction wave emerges. 
On additional forward scans a new oxidation is seen to grow in before the oxidation assigned to 
the iridium oxidation. It is known that upon oxidation of carbazole units a radical cation is formed, 
and is localised at the 3- and 6-positions of the carbazole subunit. From here, due to the close 
proximity of the molecules on the surface of the electrode, two radical cations can dimerise. This 
gives rise to the additional reduction on the first back-scan. The additional oxidation peak 
observed in the subsequent scans is assigned to the oxidation of dimer species formed.23 It is 
noted that if the 3- and 6- position are blocked this behaviour is not observed. Complex 116 does 
not contain the carbazole subunit and instead shows two quasireversible oxidations, assigned to 


















1/2  dimer 
/ V 
HOMO / eV 
FIrpic 0.89 - - -5.69 
90 0.40 0.52 0.27 -5.20 
105 0.55 0.64 0.40 -5.35 
116 0.52 0.58 - -5.32 
117 0.75 0.82 0.57 -5.55 
a
 Values for this oxidation are the aniodic peak potential. [Het] refers to the heterocycle, either carbazole of 
phenothiazine. All values reported vs Fc/Fc
+
 = 0.00 V. 
Table 4.1: Electrochemical data for selected complexes. Measured in DCM (0.1 M 
n
Bu4NPF6) at 298 K. 
 
DEVICE DATA 
To our knowledge, no devices have been reported that use complexes that display dual emissive 
properties in solution as the emissive material. Complexes containing ligands with donor and 
acceptor groups, both on the same ligand,24 and on different ligands,25 that do not show dual 
emission properties in solution have been used in OLED devices, and display favourable 
performances due to their charge transport properties. OLEDs using complexes 86-90, 105, 116 
and 117 as the emitters were fabricated by Dr Gareth Griffiths in the Department of Physics at 
Durham University and compared to a reference device containing FIrpic. The hole transporting 
layer and emissive layer were deposited by solution processing techniques, and the electron 
transporting, electron injection layers and the cathode were then fabricated by vacuum 
deposition. The device structure is as follows: ITO/PEDOT:PSS (50 nm)/PVK:OXD:Ir complex 
[100:50:8] (75 nm)/TPBi (25 nm)/LiF (1 nm)/Al. The electroluminescence (EL) spectra from the  
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  Figure 4.30: Device data for complexes 86-90, 105 and 116. 
devices are shown in Figure 4.30, panel a; for complexes 90, 105 and 116 the EL spectra show no 
sign of the dual emissive properties present in the PL spectra.  Thin films of complexes also only 
display emission from the LC/MLCT band; this is not unexpected as in a solid, non-polar 
environment the conformations required for population of, and emission from, the CT state may 
not be accessible. Complexes 90 and 116 are less efficient than FIrpic, with lower EQEs (panel d), 


























FIrpic 1 473 2179 7.2 2.14 4.63 1.36 (0.17, 0.37) 
90 472-491 1657 9.3 1.46 3.44 0.91 (0.22, 0.38) 
105 476 2988 8.0 2.09 4.73 1.09 (0.19, 0.38) 









 Measured at 12 V. 
Table 4.2: Summary of device data. 
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comparably with the FIrpic device, with a maximium EQE of 2.09% and higher maximum 
brightness (2988 cd/m2), although 105 requires higher driving voltages to achieve comparable 
brightnesses to the FIrpic device. Due to the loss of the dual emission feature the EL spectra of the 




Complexes 105, 116 and 117 were synthesised to probe the origin of the dual emission properties 
seen in 90, and to establish design rules for synthesising new dual-emitting complexes. The 
photophysical and electrochemical properties were investigated, and compared to FIrpic,  as well 
as other related complexes (86-89) synthesised by previous members of our group. Taking into 
account the structural motifs that are present in the complexes that display dual emission 
(namely, the presence of strong donor and acceptor components), the response of the new 
spectral features to solvent polarity, and consideration of the free ligand spectra, the origin of the 
dual emissive character is tentatively assigned to the presence of a ligand based CT state. 
Unfortunately, the complexes did not display dual emission properties in the solid state, although 
it is noted that no solid state or OLED device data has been reported for the dual emissive 
complexes detailed in the introduction. Nevertheless, devices fabricated in the Department of 
Physics showed favourable performances as blue emitters compared to the FIrpic device. It 
remains a challenge to exploit the properties of dual emissive compounds for WOELDs. 
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Chapter 5: New ancillary ligands  
As discussed in Chapter 1, emissive heteroleptic complexes consist of one or two chromophoric 
ligands, with the rest of the coordination sphere occupied by so called ‘ancillary’ ligands.  These 
ligands are typically not directly involved in the excited state that produces the emission,1-3 but 
can influence its properties and modify emission colour indirectly. They can also be used to 
introduce additional functionality to the complex, such as electron or hole transporting groups,2,4 
or increased steric shielding to reduce triplet-triplet annihilation.5 Functionalised ancillary ligands 
have been used in iridium complexes for sensitisation of lanthanide ions, which are important for 
biological imaging applications.5 Complexes with β-diketonate ancillary ligands have been 
synthesised that display enhanced phosphorescence emission in the solid state (EPESS), a 
phenomenon that could be exploited in bioimaging.3 Addition of promesogenic groups onto the 
ancillary ligand of charged iridium complexes, results in complexes that undergo reversible colour 
tuning in response to surface stress or heating, promising properties for device applications.6 
Ancillary ligands can also be used to incorporate iridium complexes into polymers without 
interfering with their photophysical properties; polymers containing iridium complexes have a 
variety of uses, for example as single molecule white light emitters, as described in Chapter 4.7 
 
Ancillary ligands with singlet and triplet energies significantly higher than those of the other 
ligands are referred to as non-chromophoric, and emission from the excited state predominantly 
arises from the(C^N)2Ir fragment.
8-10 Here, while the ancillary ligand is not directly involved in the 
excited state, it can still influence the emission of the complex by modifying the electron density 
at the iridium centre.3,8,9,11,12 Electron withdrawing ancillary ligands stabilise metal d-orbitals, and 
as the HOMO for emissive iridium complexes is partially localised on the Ir centre this results in a 
lowering of the HOMO relative to the LUMO, thereby blue-shifting the emission.8 For complexes  
 
Figure 5.1: Illustrative energy level diagrams showing the effect of raising the 
1
MLCT energy on the emission energy. 
Adapted from reference 
8
. 
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with ppy based ligands the excited state is typically of mixed 3LC/3MLCT character, as the HOMO is 
of Ir d-orbital and cyclometalating ligand character, while the LUMO is mainly on the 
cyclometalating ligand. Lowering the HOMO level by using ancillary ligands therefore increases 
the separation between the 1/3MLCT and 3LC states by raising the energy of the MLCT states, thus 
resulting in an increase in emission energy, as shown in Figure 5.1.8 Care must be taken with this 
approach, however, as the contribution from states involving the iridium atom (i.e. the MLCT 
states) is required to allow the spin orbit coupling; increased 3LC emission character is associated 





Figure 5.2: A selection of iridium complexes with blue-shifting ancillary ligands. 
 
A selection of complexes that illustrate this approach is shown in Figure 5.2. Here, replacing the 
pic ligand of FIrpic with a triazole (118a, FIrtaz) or tetrazole (118b, FIrN4) results in a blue-shift in 
emission λmax of ~ 10 nm.
13 Typically, azole ligands act as strong σ-donors and weak π-acceptors 
due to the electron-rich nature of the triazole ring.14 Devices using 118b as the dopant emitter 
were compared to a reference device containing FIrpic; the 118b devices retained the blue 
emission present in the PL spectrum, and the CIE coordinates of (0.15, 0.24) were bluer compared 
to those reported for the FIrpic device- (0.15, 0.28), although the electroluminescence efficiencies 
and EQEs were lower.14 
 
A series of complexes containing pyrazolyl based ancillary ligands (Figure 5.3, 119a-e and 119h) 
also demonstrate this effect, as the electron withdrawing nature of the ancillary ligand is 
increased (from 119a<119b<119e) a blue-shift in the emission colour is observed.12 Cyclic 
voltammetry data confirmed that the reduction potentials were largely unaffected by the change 
of ancillary ligand, with the potentials for all complexes remaining in a narrow range (-2.62 – -2.68 
V), while the oxidation potentials increase with increasing withdrawing capability of the ancillary 
ligand.12 These complexes are of additional interest, as the pyrazole ancillary ligands of 119e could  
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be used to coordinate other metal centres.12 A further study extended the series to include the  
ancillary ligands (119f, g to 119i-n) and a larger series of cationic complexes; in both series 
increasing the electron withdrawing potential of the ancillary ligand resulted in a blue-shift in 
emission. However, this was coupled with the expected decrease in radiative decay rates 
associated with a decrease in MLCT character in the excited state.8 The PLQYs of the complexes 
vary with the choice of ancillary ligand, however the non-radiative decay values (knr) appear to 
follow the energy gap law, implying that any decrease in PLQY with increasing emission energy is 
due to the decrease of MLCT character in the excited state rather than an increase in non-
radiative decay pathways.8 
 
The substituent on the triazole ancillary ligand can effect the emission properties of the 
complexes; those shown in Figure 5.4 possess phenyl rings substituted with either electron 
donating or electron withdrawing substituents at the 3-position of the triazole ring display 
emission colours ranging from blue-green to near UV.14 The complexes with electron donating  
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Figure 5.4 
groups (120c, d) exhibit greener emission, due to a tail into the green region of the spectra, 
attributed to either the presence of a ligand-to-ligand charge transfer (LLCT) or an aggregation-
induced effect.14 The bluest emission is from complex 120h, and it is observed that an increase in 
the twist angle between the triazole and the substitued phenyl ring (120g, 120h vs 120e, 120f) 
results in a blue-shift in emission, and a switch from a pyridyl-triazole based MLCT state to an 
MLCT state based on the cyclometalating dfppy ligands.14 
 
A variation on this strategy is to use strong field ancillary ligands, either strong σ-donors or π-
acceptors, to increase the ligand field splitting, thereby lowering the energy of the metal d-
orbitals and resulting in an increase in the emission energy. Strong field ligands also increase the 
energy of the d* antibonding orbitals, thereby increasing the energy of deactivating d-d* states 
and improving the efficiency of the complex.15-17 Additionally, the lack of extended conjugation in  
the bidentate phosphine ligands reduces the participation of the ancillary ligand in the frontier 
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conjugated bidentate phosphine ligands are shown in Figure 5.5. Complexes 121a and 121b, 
containing a non-conjugated (P^N)H ligand, display blue emission, with λmax of 455 nm, 
representing a significant blue-shift compared to FIrpic, and PLQYs of > 0.70.16 On exchanging the 
dfppy based ligand for a phenylpyrazole cyclometalating ligand in 121c the emission profile 
changes, three emission maxima are now observed at 431, 458, and 482 nm, resulting in true-blue 
emission insolution. The PLQY of complex 121c was low in solution (0.02), but improved in the 
solid state when measured into a host material (0.25-0.35).16 Devices of 121b and 121c displayed 
blue and deep blue emission, respectively, with CIE coordinates of (0.154, 0.215) and (0.163, 
0.145), respectively.16 The device of complex 121b showed a peak EQE and luminance efficiency 
of 12.6% and 20.3 cd A-1, while the device of complex 121c gave a peak EQE and luminance 





A comparable phosphine ancillary ligand was used in a series of cationic complexes 122a-c (Figure 
5.6).18 Complex 122b, an analogue of FIrpic, displayed blue emission with λmax of 452 and 481 nm 
and, although the solution PLQY was very low (0.013 in DCM, 0.002 in ethanol), it improved to 
0.18 when doped into a PMMA film. 
 
Complexes containing charged ancillary ligands possessing a neutral phosphine and a 
cyclometalating phenyl ring have also been synthesised; complexes 123a-c show first λmax of 456-
469 nm, with 123a and 123b, containing the fluorinated phosphine ligand, showing a significant 
blue-shift compared to FIrpic (λmax = 470 nm).
19 The complexes show moderate (0.19 and 0.06 for 
123a and 123c, respectively) to high (0.67 for 123b) PLQYs, and a device containing 123b 
displayed CIE coordinates of (0.156, 0.199) at 100 cd/m2, a blue-shift compared to complexes such 
as FIrpic and FIrtaz (118a).19 This work was later extended to include complexes 124a and 124b,  
analogues of 123c and 123a, respectively, with a pyridyl-pyrazole chromophoric ligand (Figure 
5.7).15 The complexes displayed deep-blue emission in solution, with λmax of 430, 458 nm and 428,  
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455 nm for 124b and 124c respectively, although the solution PLQYs were low (<0.01).15 The 
PLQYs of the complexes improved dramatically when doped into films of host materials UGH2 and 
CzSi, presumably due to the restriction of intramolecular twisting and/or torsional motions. 
Devices using 124b and 124c as the dopants with UGH2 and CzSi as host materials, and displayed 
CIE coordinates of (0.152, 0.110) and (0.155, 0.106), respectively, close to the ideal coordinates of 




More exotic ancillary phosphine ligands can be seen in Figure 5.8; here the tridentate P^C2 
chelate was designed to offer long term stability to the complexes in devices and its saturated 
nature enables facile fine tuning of the emission by varying the substituent on the triazole 
ligand.20 There is little variation in the emission colour on varying the monodenate phosphine 
ligands, although it does have a profound effect on the efficiency of emission; on increasing the 
donating ability of the phosphine the radiative rates increase due to the increase in energy of the 
deactivating MC state relative to the emissive state and an increase in MLCT participation in the 
emissive state.20 The complexes performed well in devices, with a device of complex 125g 
exhibiting CIE coordinates of (0.169, 0.247) and an EQE of 8.5% at a brightness of 100 cd/m2.20 
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The phosphine moiety has also been combined with a o-carborane to create a strong field 
ancillary ligand; the phosphine acts as a strong σ-donor/π-acceptor and o-carborane can act as a 
good σ-donor, resulting in a ligand that forms stable metal-ligand bonds.21 Additionally, due to the 
electron deficiency and lack of π-orbitals, the o-carborane fragment was predicted to have little 
involvement in the HOMO and therefore also in the electronic transitions.21 Complexes 126a and 
126b (Figure 5.9) displayed blue/blue-green emission in solution, with 126b being significantly 
bluer than FIrpic.21 The quantum yields of the complexes in solution were low, however they were 
enhanced in doped films; this effect was attributed to potential twisting and/or torsional motions 
of the carborane in solution.21 The electrochemical properties of the complexes showed an 
increase in oxidation potential relative to FIrpic and mer-(dfppy)3, highlighting the strong field 
character of the ancillary ligand.21 
 
In addition to chelating ancillary ligands strong field monodentate ligands can also be used to 
blue-shift emission, including phosphines,22,23 cyanide,22,24 iso-cyanide and thiocyanate.23 
Complexes of the form Ir(F2Meppy)(PPhMe2)2(H)(X), where X = Cl (127a), NCMe (127b) and CN 
(127c) (Figure 5.10) all exhibit blue emission with λmax of 439-446 nm in solution, although the 
PLQYs are low (<0.07).22 As the field strength of the ancillary ligand increases (Cl < NCMe < CN) the 
emission is blue-shifted, and the (calculated) HOMO level drops significantly (0.29 eV), as 
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cyanide and isocyanate ancillary ligands serve to blue-shift the emission  due to their strong 
electron-withdrawing ability, resulting in complexes that all exhibit bluer emission than FIrpic (λmax 
= 469 nm), although the choice of R group in RNC had little effect on the emissive properties.24 
Additionally, the strong field nature of the ligands can also shift the  deactivating MC d-d* states 
to higher energies, resulting in efficient emission at room temperature (PLQYs > 0.60).24 
 
‘Chromophoric’ ancillary ligands, i.e. those that participate in the excited state provide another 
mechanism for tuning the emission colour.25 When the triplet state of the ancillary ligand is lower 
than that of the 3MLCT transition centred on the chromophoric ligand an interligand energy 
transfer (ILET) process can occur, resulting in subsequent emission from the lower energy 3LC 
state, red-shifting the emission.25,26 Ancillary ligands can also participate in the excited state via 
LLCT mechanisms, wherein either the HOMO or, more commonly, the LUMO is localised on the 
ancillary ligand, while the other frontier orbital is located on the cyclometalating ligand. The ILET 
effect can be seen in the family of complexes shown in Figure 5.11; the complexes all contain 
dfppy as the cyclometalating ligand while the ancillary ligands are all related to picolinic acid.9,25 
 
Figure 5.11 
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Figure 5.12 
FIrpic and 129a displayed blue/green emission, with vibronic features characteristic of emission 
from a mixed 3LC/3MLCT state localised on the dfppy ligand, while the remaining complexes 
(129b-g) display featureless, red-shifted emission.9,25 Electrochemical analysis indicated that the 
HOMO levels of the complexes were all similar in energy, while the LUMO levels decrease across 
the series.9,25 Based on the DFT calculations and the experimental data it was concluded that the 
cyclometalating ligands are preferentially excited, the energy is then rapidly transferred to the 
ancillary ligand, followed by ancillary ligand centred phosphorescence.9,25 Similar complexes were 
described by Zhou (Figure 5.12); here the complexes are divided into two series, a FIrpic based 
series (130a,b, FIrpic) and a FIrqui based series(130c-f), which displayed ILET emission.27 The 
substitution of the pyridine ring in the FIrpic series had no impact on the colour of the emission, 
as was to be expected, as the ancillary ligand is not directly involved in the excited state, however 
the intensity of the emission does vary.27 In the case of the ILET series the introduction of 
substituents onto the quinoline ring affects both the emission colour and the intensity, as the 
ancillary ligand is directly involved in the excited state.27 
 
Figure 5.13: Initial mechanism proposed for the ILET process. Adapted from reference 
28
. 
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Figure 5.14: LEFT: complexes 131a,b. RIGHT: Proposed energy level diagrams of complexes 131a,b and mechanism of 
emission. IC = internal conversion, ISC = intersystem crossing, VR = vibrational relaxation. Adapted from reference 
28
. 
There is a debate in the literature around the exact mechanism of the ‘ILET’ process. The initial 
suggestion involved a nanosecond ILET process between the triplet state of the C^N 
chromophoric ligand (3C^N) and the triplet state of the ancillary ligand (3L^X), followed by 
phosphorescence from this state on a microsecond timescale (Figure 5.13), when the 3L^X state is 
lower in energy than the 3C^N state.29 However, a later study on complexes 131a and 131b 
(Figure 5.14) revealed no sign of a nanosecond timescale process; the complexes were studied by 
time-correlated single photon counting (TCSPC), revealing a single exponential decay to a 
resolution of 300 ps.28 Femto-picosecond transient absorption spectroscopy revealed an ultrafast 
(<1 ps) intersystem crossing process (S1→Tn), followed by a rapid (<10 ps) internal 
conversion/vibrational relaxation process (Tn→T1) to populate the lowest energy triplet state, 
which then decays by phosphorescence (μs), with no evidence of a nanosecond process.28 
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the conjugation in the ancillary ligand commonly results in activation of an ILET/ILCT-type 
process.26 Some further examples of this are shown in Figure 5.15; on increasing the conjugation 
in the ancillary ligand across the series (132a to 132b) the emission is red-shifted, and 
electrochemical and computational data support a shift in the LUMO from the cyclometalating 
ligand to the ancillary ligand, resulting in a decrease in the HOMO-LUMO gap.26 
 
NEW ANCILLARY LIGANDS FOR BLUE IRIDIUM COMPLEXES – RESULTS AND DISCUSSION  
Due to the success of the sulfone ligands discussed in Chapters 2 and 3 there was interest in 
devising new ancillary ligands to further blue-shift the emission, in particular to be paired with the 
mono-fluoro and ‘fluorine-free’ ligands 66 and 79 synthesised in Chapter 3. Pyrazolepyridine 
ligands (and the related triazolepyridines) have been used as blue-shifting ancillary ligands due to 
their high acidity, reducing the electron density around the metal centre and thereby reducing the 
HOMO level relative to the LUMO.8,12,11 They are also used as the chromophoric ligands in N-
heterocyclic carbene complexes,30 and in conjunction with a variety of other ligands, such as 
difluorophenylpyridine ligands and chelating phosphine ligands.17,31,32 Ligand 133 was chosen as 
the initial target, as the CF3 group is strongly electron withdrawing,
33,34 and our group has shown 
that a mesityl substituent can increase the PLQY and efficiency of complexes in devices.35 The 
route to ligand 133 is shown in Figure 5.16, and can be generalised to other ligands of the same 
type. 




Figure 5.16: Synthesis of target ligand 133. 
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choice of R1 and R2 groups can be introduced to create a variety of ancillary ligands. The synthesis 
of 137 started with a reaction between 4-nitro-α-picoline N-oxide 134 and acetyl chloride.36 The 
nitro group is replaced by a chloride and the reagent generated (thought to be acetyl nitrite) 
attacks the ortho-methyl group to produce an oxime intermediate, which results in the desired 
nitrile 135.36,37 This reaction has been documented in 2-methylpyridine, 2-methylquinoline and 2-
methyl pyridazine N-oxides.37,38 Although the yield is low (23%), 2-cyano-4-chloropyridine 135 was 
produced in sufficient quantity to continue, and the starting material 134 was inexpensive, 
compared to the high cost of 136 and 137. The next step was to remove the N-oxide using PCl3, 
which produced 136 in good yield (73%). Then a reaction with methyl magnesium chloride 
resulted in the formation of the ketone 137 upon acidic workup.  
From 137 it would be possible to synthesis a wide variety of ligands; however for the target 
molecule 133 the next step was a Suzuki coupling with mesitylboronic acid (22) to give 138, 
followed by a crossed Claisen condensation type reaction with ethyl trifluoroacetate to give a 
diketone intermediate 139. The crude material was used in the next step directly, and reacted 
with hydrazine hydrate to give 133 via a ring closing condensation reaction.39 
 
Figure 5.17 
Once ligand 133 was obtained, it remained to synthesise the desired complexes. Ligands 66 and 
79, the synthesises of which are described in Chapter 3, were chosen as the chromophoric ligands 
due to the promising performance of complex 70  derived from 66, and the desire to create a 
bluer fluorine-free complex than 80 (derived from 79). The complexes 140 and 141 were 
synthesised as shown in Figure 5.17. The routes were analogous to those used for the 
corresponding pic complexes 70 and 80, with complex 140 being obtained in 70% yield from 
ligands 66 and 133 using IrCl3.3H2O, and complex 141 being obtained in 27% yield from ligands 79 
and 133 using [Ir(COD)Cl]2. 
 
PHOTOPHYSICAL AND ELECTROCHEMICAL PROPERTIES 
Absorption and emission 
The absorption spectra of complexes 140 and 141, analogous pic complexes 70 and 80 and FIrpic  
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Figure 5.18: UV absorption spectra of the complexes in DCM [<10
-5
 M]. 
are shown in Figure 5.18. As with complexes 70 and 80, 140 and 141 show strong absorption 
bands (with oscillator strengths of >100 x 103 dm3/mol cm) in the 250-325 nm region, assigned to 
the π-π* transitions on the ligands, based on the calculations of Hay,40 and literature precedent.41 
At lower energies and oscillator strengths the complexes display another set of absorption bands, 
assigned to the 1MLCT transitions. Here, we see differences between the pic complexes 70 and 80 
and 140 and 141; the 1MLCT bands appear to have moved to higher energies on replacing the pic 
ligands with ligand 133, suggesting 133 has indeed decreased the energy of the metal d-orbitals. 
At very low oscillator strengths (>1x103 dm3/mol cm) the 3MLCT bands can be seen between 450-
456 nm. 
The excitation spectra of complexes FIrpic, 70, 80, 140 and 141 are shown in Figure 5.19, revealing 
as expected that the bands from the 1MLCT and 3MLCT states are responsible for the emission 
































Figure 5.19: Excitation spectra of the complexes in DCM [<10
-5
 M]. The emission band observed was the second 
emission maximum.  
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Figure 5.20: Emission spectra of selected complexes in deaerated DCM, λex = 380 nm. 
from the complexes, while the majority of the lower energy π-π* transitions are dark. 
The emission spectra of the complexes are shown in Figure 5.20. The spectra of 140 and 141 
display a similar profile to that of FIrpic and the analogous pic complexes 70 and 80, with an 









































277 (50.1), 301 (34.2), 304 (32.6), 
337 (13.8, sh), 357 (8.9, sh), 400 
(6.2), 454 (0.8) 
468, 496, 
531 (sh) 
0.67 1.72 3.90 1.92 
70 
258 (s sh, 108.5), 271 (128.6), 297 
(123.4), 307 (sh, 112.5), 339 (s sh, 
29.2), 379 (15.7), 450 (1.0) 
462, 490, 
524 (sh) 
0.67 1.78 3.76 1.85 
140 
274 (144.4), 293 (136.7),  370 
(19.4), 419 (sh,2.7), 447 (0.7) 
457, 486, 
521 (sh) 
0.62 2.30 2.70 1.65 
80 
275 (104.4), 291 (101.9), 324 (sh, 




0.58 2.13 2.72 1.97 
141 
255 (sh, 100.4), 277 (125.8), 292 
(133.5), 321 (59.6) (sh), 375 (16.3), 
406 (sh, 5.1), 454 (0.8) 
466, 494, 
531 (sh) 
0.52 3.13 1.66 1.53 
a 




 Data obtained in degassed dichloromethane solution with λex = 
380 nm. 
c 
Energy difference between lowest energy excitation maxima and highest energy excitation maxima. 
d 
Measured relative to Ir(ppy)3 ΦPL = 0.46 in degassed dichloromethane at 20 
o





 kr, knr values calculated using Equations 1.5/1.6.
 
Table 5.1: Photophysical data for selected iridium complexes. 
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emission originates from a similar excited state. This is consistent with a mixed LC/MLCT state, 
due to the vibronic nature of the emission. The emission λmax for 140 and 141 is blue-shifted by 5 
nm and 4 nm relative to their analogous pic complexes, respectively. This represents blue-shift of 
11 nm and 3 nm relative to that of FIrpic, indicating the new ancillary ligand is effective at blue-
shifting the emission. 
The PLQYs, lifetimes (τobs) and calculated radiative and non-radiative decay rates (kr and knr) are 
shown in Table 5.1. The PLQYs for complexes 140 and 141 are comparable to their pic analogues, 
70 and 80, although the lifetimes of 140 and 141 are slightly longer. 
Electrochemistry 
The electrochemical behaviour of complexes 140 and 141 was investigated using cyclic 
voltammetry and compared FIrpic and their pic analogues 70 and 80. The voltammograms are 
shown in Figure 5.21, panel a, and the key parameters in Table 5.2. Formula 2.1 is used to 
calculate the energy of the HOMO. 








































Figure 5.21: Cyclic voltammograms of the iridium complexes. Panel a: full oxidation scan. Panel b: scan reversed after 
first oxidation. 
Whereas the pic complexes 70 and 80 show a single quasireversible oxidation wave, complexes 
140 and 141 show an initial oxidation that appears irreversible, followed by a second reversible 
oxidation at higher potentials. If the scan is reversed before the second oxidation is reached the 
oxidation wave is quasireversible (Figure 5.21, panel b). As both complexes (140 and 141) contain 
the same ancillary ligand it is assumed the second oxidation occurs either on this ligand or is due 
to an interaction this ligand has with the metal. Notably, in both cases exchanging the pic ancillary 
ligand for ligand 133 (70 to 140, 80 to 141) results in an increase in the oxidation potential of the 
Ir3+/Ir4+couple, suggesting that ligand 133 is effective at lowering the energy of the HOMO. No  
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1/2  / V 
HOMO / 
eV 
FIrpic 0.89 - -5.69 
70 1.01 - -5.81 
80 0.89 - -5.69 
140 1.02 (1.07) 1.28 -5.82 
141 0.91 (0.95) 1.17 -5.71 
 
Values in ( ) denote the cathodic peak potential observed on the first scan. All values reported vs Fc/Fc
+
 = 0.00 V. 
Table 5.2: Electrochemistry data of iridium complexes. 
reduction waves were observed within the solvent window [to  2.0 – -2.5 V]. 
 
DEVICE DATA 
OLEDs containing complexes 140 and 141 were fabricated by Dr Hameed Al Attar in the 
Department of Physics at Durham University and compared to a reference device containing 
FIrpic, and devices containing related complexes 70 and 80.The hole transporting layer and 
emissive layer were deposited by solution processing techniques, and the electron transporting, 
electron injection layers and the cathode were then fabricated by vacuum deposition. The device 
structure is as follows: ITO/PEDOT:PSS (45 nm)/PVK:OXD(30%):Ir complex(15%)(60 nm)/TPBi (30 
nm)/LiF/Al. 
The electroluminescence (EL) spectra from the devices are shown in Figure 5.22, panel a; for all 
complexes the EL spectra are similar to the photoluminescence (PL) spectra, indicating good 
exciton confinement on the emissive molecule. Complex 140 was less efficient than the 


























FIrpic 1 475 7340 6.2 5.4 12.2 5.1 (0.19, 0.38) 
70 470 2072 8.5 3.5 6.1 1.9 (0.16, 0.30) 
80 478 516 8.5 1.2 2.6 0.9 (0.22, 0.40) 
140 464 1066 9.5 2.3 4.1 1.2 (0.17, 0.28) 
141 473 456 7.9 1.7 3.9 1.4 (0.23, 0.40) 
 
a 




 Measured at 12 V. 
Table 5.3: Summary of device data. 
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Figure 5.22: Device data for complexes 70, 80, 140, 141. 
current and power efficiencies (panels d and f), although it is noted that the emission is 
significantly bluer (6 nm) and, based on the electrochemical data, the HOMO is lower in energy, 
which could be partially responsible for the reduced performance. Complex 141, however, 
performed slightly better than 80, with comparable brightness and turn on voltage (panel e), but 
superior EQEs, current and power efficiencies. The electroluminescent λmax of 141 is also blue-
shifted relative to 80, making 141 a very promising aromatic fluorine-free blue emitter. Key device 
parameters are summarised in Table 5.3. 
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CONCLUSION 
A new ancillary ligand 133 was devised with the aim of blue-shifting emission, and was paired 
with ligands 66 and 79, the syntheses of which are described in Chapter 3, to create complexes 
140 and 141, analogous to 70 and 80. The photophysical and electrochemical properties were 
compared to FIrpic and their parent complexes; ligand 133 successfully blue-shifted the emission 
of 140 and 141 relative to the pic complexes, and quantum yields were comparable. Devices of 
complexes 140 and 141 were fabricated in the Department of Physics, and retain the blue 
emission observed in the PL spectra. Future work would involve expanding this ancillary ligand 
family, with the aim of optimising device performance. 
 
INVESTIGATING A NEW FAMILY OF ANCILLARY LIGANDS – RESULTS AND DISCUSSION  
In 2013 complexes 142a and 142b (Figure 5.23) were published by Zhu, Bryce et.al. featuring 
novel oxazoline/thiazoline containing ancillary ligands.42 Complexes 142a and 142b showed 
promising device performance, with low turn on voltages (3.5-3.7 V), high maximum brightnesses 
of 61,560 cd/m2 (at 16 V) and 21,350 cd/m2 (at 14.5 V), and maximum EQEs of 17.1% and 8.5%, 
respectively.42 The exchange of the oxazoline (142a) for the thiazoline (142b) results in a 
broadening of the emission spectra, giving rise to a change in the emission colour from green to 
yellow/orange.42 Also of interest is the unusual localisation of the frontier orbitals in these 
complexes; the LUMO is located on the pyridyl ring of the cyclometalating ligand, as expected, 
while the HOMO is localised on the Ir d-orbitals and the phenoxylate of the ‘ancillary’ ligand.42 
 
Figure 5.23: Iridium complexes containing oxazoline/thiazoline ancillary ligands. 
Other similar complexes have been synthesised, such as those shown in Figure  5.24; here 
enantiomerically pure chiral oxazoline ancillary ligands are used to separate the Δ/Λ isomers of 
the complexes 143a-d.43 The diastereomers each have similar photophysical properties, and were 
considered in future applications as luminescent sensors of chiral molecules.43 A similar series 
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Figure 5.24 
shown in Figure 5.25 has an oxazole (rather than oxazoline) based ancillary ligand, and the 
conjugation length of this ligand was increased (144a to 144c).44 In this case the HOMO is 
localised on the Ir d-orbitals and the phenolate ring of the ancillary ligand, while the LUMO is 
located mostly on the cyclometalating ligands, although as the conjugation length of the ancillary 
ligand increases a greater portion is localised on the oxazole ring.44 DFT calculations reveal 
participation from higher lying unoccupied orbitals (LUMO+1, LUMO+2) in the lowest energy 
triplet state of the complexes, resulting in emission dominated by the ‘ancillary’ ligand.44 
Oxazoline, oxazole and benzoxazole ligands have also been used as the chromophoric ligand for 
iridium complexes for use as photosensitisers for water splitting.45 
 
Figure 5.25 
As the oxazoline/oxazole ligands described above have produced complexes with interesting 
properties it was of interest to expand the family of complexes to further probe the effect of 
substituents, both on the chromophoric and ancillary ligands. This work was conducted in 
collaboration with Prof. Dongxia Zhu of Northeast Normal University, Changchun, China. The 
initial aim was to retain the good device performance, and the narrow emission bandwidth of 
142a, while blue-shifting the emission by choice of chromophoric cyclometalating ligand. Complex 
142a displays an unusual HOMO-LUMO distribution, with the LUMO based on the pyridine ring of 
the ppy ligand, while the HOMO is localised on the iridium atom, and the  
Chapter 5: New ancillary ligands 
 
  123 
 
Figure 5.26: Initial target complexes. 
phenolate ring of the ‘ancillary’ ligand. As a result the two initial target complexes are shown in 
Figure 5.26, 145 and 146. Compound 145 was chosen as the fluorines are known to result in a 
blue-shift in emission compared to typical ppy-based complexes. However in this system it was 
thought they may not be as effective, as the HOMO is not localised on the phenyl ring. Utilising a 
dfppy (13) cyclometalating ligand could still affect the emission colour by withdrawing electron 
density from the metal d-orbitals, where the HOMO is partially located. Complex 146 was chosen 
in an attempt to raise the energy of the LUMO relative to the HOMO by virtue of the strongly 
electron-donating carbazole unit. 
 
 
Figure 5.27: Synthesis of ligand 151 
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The synthesis of dfppy 13 is shown in Figure 2.13, and the synthesis of ligand 151 is shown in 
Figure 5.27. Ligand 13 was synthesised from a Suzuki reaction between commercially available 
boronic acid 12 and 2-bromopyridine 11, as described in Chapter 2. For ligand 151, the first step 
involved synthesis of the 3,6-(bistertbutyl)carbazole 148 from carbazole 147 via a Friedel-Crafts 
type alkylation (19% yield). The next step was an Ulmann-type reaction between 148 and 21 to 
give 149 (79%), followed by the final Suzuki coupling between 149 and phenylboronic acid 150 
using Pd(PPh3)4 as the catalyst and Na2CO3 as the base. Compound 151 was obtained in 
quantitative yield. 
 
Figure 5.28: Synthesis of ancillary ligand 152. 
The synthesis of ancillary ligand 152 is shown in Figure 5.28, and proceeded as described.42 First, 
commercially available ester 153 was refluxed with amine 154 to produce 155 in 82% yield. Then, 
the reaction of 155 with thionyl chloride gave the product 152 in 94% yield. 
Complexes 145 and 146 were synthesised via the standard one-pot method (Figure 5.32); the 
ligands 13 and 151 were each reacted with IrCl3.3H2O in 2-ethoxyethanol to produce precipitates 
presumed to be the intermediate dichloro-bridged dimers. Ancillary ligand 152 and Na2CO3 were 
then added, and after purification complexes 145 and 146 were isolated as yellow and orange 
powders, in 79% and 19% yield, respectively. 
The low yield of complex 146 was attributed to difficulties in the purification; the complex 
appeared unstable on silica. It is possible the stability is due to reaction with the chlorinated  
 
Figure 5.29 
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solvent when exposed to acidic media, such as silica, however the expected dichloro dimer did 
not contaminate the samples of 146.46 This mechanism of instability will be discussed in further 
detail later, with complexes 163 and 164, as they were more strongly affected. The photophysics, 
electrochemistry and device performance of these complexes is discussed later. 
Crystals of 145 suitable for X-ray crystallographic analysis were grown by Guangfu Li (Northeast 
Normal University) and the structure (solved by Dr Baiqiao Song at Northeast Normal University) 
is shown in Figure 5.30. As expected for a complex synthesised via the dichloro-bridged dimer the 
nitrogen atoms of the cyclometalating ligands are trans oriented about the iridium centre. Both 
the cyclometalating ppy ligands show relatively small twist angles between the pyridyl and phenyl 
rings, with values of 0.2o and 5.7o, respectively. The ancillary ligand, on the other hand, 
experiences a larger twist angle of 8.3o to accommodate the 6-membered chelate.  Notably, this 
deformation is far smaller than that experienced by 31, highlighting the difference in angles 
required by a coordinating 5-membered heterocycle (oxazoline) and 6-membered heterocycle 
(pyridine). Selected bond lengths are shown in Table 5.4 and compared to those of parent 







Ir-N(1) 2.124(3) 2.119 (3) 
Ir-N(2) 2.035(3) 2.031(4) 
Ir-N(3) 2.046(3) 2.043(4) 
Ir-O(1) 2.146(3) 2.133(3) 
Ir-C(10) 1.988(5) 1.982(4) 
Ir-C(21) 2.006(5) 2.000(5) 
a Values for  complex 114a taken from reference 42 
 
Figure 5.30: Crystal structure of complex 145.MeOH, solvent omitted for clarity. Table 5.4: Selected bond lengths.  
It was also of interest to synthesise the oxazole analogue 156 of ancillary ligand 152 to determine 
the effect of additional heteroaromaticity on the properties of the resultant complex. The initial 
route to ligand 156 was to oxidise ligand 152 using MnO2, however the yield was low (28%) 
despite a large excess (>18 molar equivalents) of oxidising agent. As a result, a new route was 
devised, shown in Figure 5.31. The first step is analogous to the first step in the synthesis of 152, 
namely a condensation reaction between ester 157 and an amine 158, containing an aldehyde  
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Figure 5.31: Synthesis of ancillary ligand precursors 160 and 161. 
masked as a dimethylacetal moiety, to give the amide 159 in 40% yield. 
Oxazole 160 is then synthesised by a ring closure reaction; amide 159 was treated with Eaton’s 
reagent (made in house by mixing methanesulfonic acid and P4O10) as described for a similar 
compound.47 Upon work up of the reaction mixture TLC analysis revealed the presence of two 
spots, neither of which corresponded to starting material 159. The products were identified as 
160 and 161, and isolated in 19% and 18% yield, respectively. Compound 161 is the result of the 
reaction between product 160 and the methanesulfonic acid used to form Eaton’s reagent; on 
reviewing the literature alkyl sulfonic acids have been observed to react with aryl rings in the 
presence of phosphorus reagents.48 The sulfone moiety in 161 is introduced para to the o/p-
directing methoxy group. 
 
Once 160 and 161 were obtained the final step was to deprotect the ethers to leave the final 
phenol products, 156 and 162. The initial conditions used were those described previously, using 
conc. HBr (48% aq.).47 However, the unreacted starting materials were recovered in 100% yield. 
As a result, the deprotection was performed with BBr3 to give the two phenols, 156 and 162, in 
68% and 39% yield, respectively (Figure 5.32). As the HOMO for parent complex 142a and 
complex 145 (DFT calculations discussed later) is located on the phenoxylate section of the 
ancillary ligand it was thought that the complex of side-product 162 could be of interest, as it may 
provide colour tuning by shifting the HOMO. 
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Figure 5.33 
Complexes 164 and 165 were synthesised using standard conditions, shown in Figure 5.33, 
analogous to the synthesis of complexes 145 and 146. The complexes were synthesised via a one-
pot method; ppy 163 was reacted with IrCl3.3H2O in 2-ethoxyethanol to produce precipitates 
presumed to be the intermediate dichloro-bridged dimers. Addition of the required ancillary 
ligand 156 or 162 and Na2CO3 followed, and after work up attempts were made to purify the 
complexes by column chromatography. Here, problems were encountered; complexes 164 and 
165 were highly insoluble in solvents other than DCM, however, with a mixture containing DCM 
as the column solvent the isolated product was contaminated with traces of the intermediate 
dichloro-bridged dimer, which could be easily identified by 1H NMR. This trace impurity persisted 
through multiple columns, despite a clear separation between complex 164 and 165 and the 





H NMR spectrum of complex 164. 
Chapter 5: New ancillary ligands 
 
  128 
chloride source the N^O and O^O ligands, such as pic and acac, of heteroleptic complexes can be 
cleaved, and the intermediate dichloro-bridged dimer is reformed.46 With this knowledge it was 
assumed that the use of DCM as a column solvent and the acidic silica provided a source of 
chloride ions and acid, respectively, resulting in the generation of dichloro dimer impurities during 
the column chromatography. As a result the purification of 164 and 165 was repeated, this time 
utilising neutral alumina as the stationary phase and treating the eluent DCM with K2CO3 to 
remove any acid impurities before it was used. Complexes 164 and 165 were thereby obtained in 
high purity as bright yellow powders in 35% and 57% yield. 
The 1H and 13C NMR spectra of complex 164 have been fully assigned with the aid of 2D 
experiments (Figure 5.34, 13C assignment is in the experimental section). As with complexes 19, 31 
and 68, described in previous chapters, the stereochemistry about the metal centre was 
determined using the NOESY experiment, revealing the expected trans orientation of the C^N 
ligands nitrogens about the iridium centre. 
Crystals of complex 165 were grown that were suitable X-ray crystallography analysis, and the 
molecular structure is shown in Figure 5.35. As expected for a complex synthesised via the 
dichloro- bridged dimer the nitrogen atoms of the cyclometalating ligands are trans oriented 
about the iridium centre, and the ligands are arranged in a distorted octahedral geometry. The 
twist angles between the phenyl and pyridyl rings of the cyclometalating ligands are small, 0.7o 
and4.8o, and a similar twist angle is observed for the ancillary ligand, 4.5o.  Selected bond lengths 
are shown in Table 5.5 and compared to those of parent complex 142a. Notably, the Ir-N1 bond 
length (the bond to the N of the oxazole/oxazoline) is longer for 165 than for complexes 142a and 










Ir-N(2) 2.035(3) 2.031(4) 2.0349(10) 
Ir-N(3) 2.046(3) 2.043(4) 2.0418(10) 
Ir-O(1) 2.146(3) 2.133(3) 2.1452(8) 
Ir-C(10/1) 1.988(5) 1.982(4) 1.9894(11) 
Ir-C(21/2) 2.006(5) 2.000(5) 2.0003(12) 
 
Figure 5.35: Crystal structure of complex 165.2THF, solvent omitted for clarity. Table 5.5: Selected bond lengths. 
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PHOTOPHYSICAL AND ELECTROCHEMICAL PROPERTIES 
Absorption and emission 

























Figure 5.36: Absorption spectra of complexes 145, 146, 164 and 165 in DCM [<10
5
]. 
The absorption spectra of complexes 145, 146, 164 and 165 are shown in Figure 5.36. The strong 
bands between 250-320 nm are assigned to π-π* transitions on the ligand based on the 
calculations of Hay,40 and literature precedent. The intense bands at 350-400 nm are assigned to 
the 1MLCT bands, and at much lower oscillator strengths (1.1-5.2 x 103 dm3/mol cm) the 3MLCT 
bands can be seen. The extinction coefficients and absorption profiles of complexes 145, 164 and 
165 are similar, as they all possess similar cyclometalating and ancillary ligands. The extinction 
coefficients for complex 146 are significantly higher; this is consistent with the introduction of 
large, conjugated groups such as carbazoles into the molecular structure. 
Excitation spectra for all complexes were recorded (Figure 5.37), revealing as expected that the 
bands from the 1MLCT states are responsible for the emission from the complexes, while the 
majority of the higher energy π-π* transitions are dark. 
The emission spectra of the complexes are shown in Figure 5.38. All four complexes display a 
similar emission profile to that of parent complex 142a, the emission is broad and largely 
featureless, indicating a strong MLCT contribution to the emission. Introducing the fluorine atoms 
onto the phenyl ring of the ppy ligands (from 142a to 145) results in a blue-shift of 21 nm, this is 
expected due to the electron-withdrawing ability of the fluorine groups. Even though the 
computational work (discussed in a later section) indicates phenyl ring contribution to the HOMO 
is small, the introduction of fluorines here can still lower the HOMO energy by decreasing the  
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Figure 5.37: Excitation spectra of complexes 145, 146, 164 and 165 in DCM [<10
5
 M]. 
energy of the metal d orbitals by coordination. Introducing the carbazole moiety onto the pyridyl 
ring of the ppy ligand (from 142a to 146) results in a red-shift of 12 nm; it was thought that 
introducing an electron donating group to the pyridyl ring would shift the LUMO to higher 
energies, resulting in a blue-shift in emission. In this case, while the HOMO level does not seem to 
have been affected according to the electrochemical data, the complex displays a red-shift in 
emission. This suggests the LUMO has been lowered, rather than raised, by the introduction of 
the carbazole unit. A reason for this may be an increase in conjugation, or a change in LUMO 
distribution. 



























Figure 5.38: Emission spectra of complexes 145, 146, 164 and 165 in degassed DCM [<10
5
 M], λex = 355 nm. 
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Exchanging the oxazoline fragment for the more conjugated oxazole moiety (from 142a to 163) 
results in a small blue-shift of 6 nm, this could be due to the increased electron-withdrawing 
capability of the oxazole fragment, compared to the oxazoline, as a result of the extended 
conjugation. The introduction of the sulfone moiety onto the phenoxylate ring of the ‘ancillary’ 
ligand results in a further blue-shift of 13 nm. As the HOMO in the oxazoline complexes (142a, 
145) is localised on the phenoxylate ring, and literature precedent suggests that this is likely to be 
true for the oxazole complexes (164 and 165) 44 it is expected that introduction of an electron 
withdrawing SO2Me group would result in a blue-shift in emission.  
The PLQYs, lifetimes (τobs) and calculated radiative and non-radiative decay rates (kr and knr) are 
shown in Table 5.6. The PLQYs for complexes all complexes are comparable to the literature (0.42-
0.65 vs 0.55 for 142a), with complex 145 having the highest PLQY, 0.65. The lifetimes for all four 
complexes are between 0.85-1.8 μs, typical values for an iridium complex.  
Complex λmax
abs 





































 249, 340 (sh), 377 (sh), 443 (sh) 527 0.55 0.34 1.61 1.32 
145 
252 (104.8), 275 (sh, 74.2), 334 
(18.7), 374 (16.0), 390 (14.7), 438 
(3.9), 464 (1.8) 
506 0.65 1.52 4.28 2.30 
146 
260 (166.5), 288 (129.8), 330 (sh, 
60.1), 346 (77.3), 368 (78.3), 418 
(28.4), 464 (10.4), 499 (5.2) 
539 0.52 0.87 5.98 5.52 
164 
255 (119.3), 280 (sh, 79.3), 303 (sh, 
43.3), 386 (20.8), 402 (18.5), 456 
(5.2), 488 (2.0) 
521 0.45 1.71 2.63 3.22 
165 
253 (111.0), 279 (83.2), 297 (64.1), 
339 (18.9), 365 (18.3), 380 (17.3), 
401 (13.4), 451 (4.5), 483 (1.2) 
508 0.42 1.80 2.33 3.22 
a 




 Data obtained in degassed dichloromethane solution with λex = 
380 nm. 
c 
Measured in degassed DCM relative to  quinine sulfate ΦPL= 0.546 in 0.5 M H2SO4 at 20 
o
C; estimated error 
±5%. 
d 
Estimated error ±5%. 
e
 kr, knr values calculated using Equations 1.5/1.6. 
f 




Table 5.6: Photophysical data for selected iridium complexes. 
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It was observed in the synthesis of complexes 145, 146, 164, 165 that the complexes were 
unstable in the presence of chlorinated solvents and acid; while attempting to obtain the 
photophysical measurements decomposition was observed in three of the complexes, 146, 164 
and 165. A peak was observed to grow in at 460 nm. The intensity of this peak varied in the 
complexes, and also varied with the batches of DCM used. As the 1H NMR spectra showed no 
degradation, the emission spectra of complex 146 was recorded in toluene, which showed no sign 
of decomposition, indicating the decomposition had occurred in the DCM solution. Fresh 
solutions in DCM were prepared, and exhibited no sign of decomposition. As the complexes have 
been known to degrade in chlorinated solvents due to acidic impurities, it is possible that this is 
the cause of the decomposition, with each complex possessing a different rate of decomposition. 
Complex 146 was observed to be particularly unstable, which could explain the shorter lifetime 
(0.87 μs) and high non-radiative decay rate. Spectra of the complexes after 72 h of exposure to 
ambient conditions are shown in Figure 5.39. In all cases, the emission λmax shifts (a blue-shift for 
145 and 146, red-shifts for 164 and 165) and the intensity of the emission drops.  An additional 
peak is observed for all four complexes, at 445–460 nm. It is proposed that over time the acidic 
impurities in the DCM solvent attack the complexes, resulting in the formation of their precursor 
dichloro dimers, resulting in the release of the ancillary ligands 152, 156, 162, which emit in the 
blue region. With additional time, the rate of decomposition could be probed with NMR 
spectroscopy. 
 



























Figure 5.39: Emission spectra of solutions of complexes 145, 146, 164 and 165 in degassed DCM after exposure to 
ambient conditions for 72 h. [<10
5
 M], λex = 355 nm. 
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Electrochemistry 
The electrochemical behaviour of complexes 145, 146, 164 and 165 were investigated using cyclic 
voltammetry and compared to the parent compound 142a. The voltammograms are shown in 
Figure 5.39 and the key parameters in Table 5.7. Formula 2.1 is used to calculate the energy of the 
HOMO.  


































Figure 5.39: Cyclic voltammograms of complexes 145, 146, 164 and 165. Measured in DCM (0.1 M 
n
Bu4NPF6) at 298 K. 
Complexes 145, 146, 164 and 165 all show an electrochemically quasi/irreversible oxidation at 
0.08-0.37 V vs Fc/Fc+, similar to that of the parent complex 142a (Figure 5.39). Complex 142a 
shows an oxidation potential of 0.08 V, with no reductions observed in the solvent window. 
Exchanging the ppy ligand for dfppy (142a to 145) results in an increase of 0.29 V in the oxidation 
potential, indicating the HOMO level has been shifted to lower energies, as desired. For complex 
146 the oxidation potential is 0.08 V, similar to that of parent complex 142a; this is as expected, 
as there is no localisation of the HOMO on the pyridyl ring of the cyclometalating ligand, therefore  
Complex E
ox
1/2  / V a HOMO / eV 
142a 0.08 -4.88 
145 0.37 -5.17 
146 0.08 -4.88 
164 0.18 -4.98 
165 0.30 -5.10 
All values reported vs Fc/Fc
+
 = 0.00 V. 
Table 5.7: Electrochemistry data of iridium complexes. Measured in DCM (0.1 M 
n
Bu4NPF6) at 298 K. 
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the oxidation potential is not expected to vary significantly on introduction of substituents here. 
Upon replacing the oxazoline fragment with an oxazole (142a to 164) the oxidation potential 
increases by 0.1 V. As the HOMO for 142a is localised on the iridium d-orbitals and across the 
phenoxylate ring it is possible that switching from an oxazoline to an oxazole results in a lowering 
of the HOMO energy due to the increased electron withdrawing ability of the oxazole compared 
to the oxazoline. Introducing the sulfone group (165 vs 164) results in an increase in the oxidation 
potential of 0.12 V; if the HOMO of 164 is still localised on the phenoxylate ring of the ancillary 
ligand introducing an electron withdrawing group such as a sulfone should lower the HOMO level. 
In the voltammograms of both 142a and 164 a reduction appears on the reverse sweep. When 
the cyclic voltammogram of 142a was obtained at -78 oC (achieved by cooling the DCM solution 
with a dry ice/acetone bath), the reduction features disappeared, suggesting they result from 
decomposition of the complex. Complex 164 began to precipitate out of solution on lowering the 
temperature, hence a voltammogram at -78 oC could not be measured. The trends in oxidation 
potentials are consistent with the observed photophysical properties; introducing electron 
withdrawing groups onto the cyclometalating or the ancillary ligand results in a lowering of the 
HOMO energy, and a widening of the HOMO-LUMO gap. Introducing the electron donating 
carbazole group (146) results in no change in the oxidation potential, and a red-shift in the 
emission relative to 142a, suggesting the shift is due to a lowering of the LUMO. No reduction 
features were observed within the solvent window (-1.5 V vs Fc/Fc+). 
 
COMPUTATIONAL DATA 
Electronic structure calculations were carried out on iridium complex 145 by Dr Yun Geng 
(Northeast Normal University) to elucidate the nature of the frontier orbitals and the transitions 
involved in the excitation spectra. The full geometry was optimised at the B3LYP/LANL2DZ:6-21G* 
level and is denoted 145’ to distinguish it from experimental data. The computed orbital energies 










 / eV 
452.33 nm HOMO→LUMO LCLACT+ MLACT 
3.35 439.30 nm HOMO→LUMO+1 LCLBCT+MLBCT+LCLACT 
376 nm HOMO→LUMO+2 LCLACT+LCLBCT+MLACT+MLBCT 
a
 Excitation energies calculated for the excited states. 
b 
Ligand notation: A, B =2-(2,4-difluorophenyl)pyridine; C =2 -(2’-
hydroxyphenyl)-2-oxazoline  
Table 5.8: TD-DFT calculation results for complex 145’ 
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Figure 5.40: The contour plots of the HOMOs and LUMOs of complex 145’. 
145’ is localised mainly across the central iridium atom and the phenoxylate ring of the ancillary 
ligand, with a small contribution from the oxazole ring. The LUMO is localised on a ppy ligand, 
across the pyridine and phenyl rings. The frontier orbitals are shown in Figure 5.40. The first three 
transition energies are shown in Table 5.8; the lowest energy transition (HOMO → LUMO) is of 
LLCT/MLCT character, with an energy gap of 3.35 eV. This represents an increase in energy 
compared to parent complex 142a, for which an energy gap of 3.22 eV was calculated. 
 
DEVICE DATA 
Devices of complexes 145 and 164 were fabricated by Prof. Yu Liu (Jilin University). The device 
structure is as follows: ITO/NPB (40 nm)/CBP:Ir complex(5 or 10%) (30 nm)/TPBI (25 nm)/LiF/Al. 
The layers were deposited by vacuum disposition. Complexes 146 and 165 would not sublime, 
and so devices were not fabricated.  The electroluminescence (EL) spectra from the devices are 
shown in Figure 5.41, panel a; for all complexes the EL spectra are similar to the 
photoluminescence (PL) spectra, indicating good exciton confinement on the emissive molecule. 






 (-1.567 eV) 
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 (-1.480 eV) 
LUMO+2 
 (-1.054 eV) 
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Figure 5.41: Device data for complexes 142a, 145 and 164. Data for complex 142a taken from reference 
42
. X% refers 
to the weight % of complex in the emissive layer. 
(5% or 10%) in the CBP host in the devices, suggesting no significant aggregation of the complex. 
The increase in complex loading results in an increase in performance for both complexes, 
although the effect is more significant for 145. Notably, the devices of complex 163 achieved high 
brightness at lower voltages than those required for the devices of 142a and 145 (panel e). 
Complex 145 was less efficient in devices than both complexes 142a and 164; this can be 
rationalised by the fact that 145 exhibits bluer emission (panel a). The two complexes achieved 
good EQEs (14.0% and 14.2% for 145 and 164, respectively, panel c), comparable to the literature 
compound 142a.42 
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Values reported are the maximum values above a brightness of 10 cd/m
2
, while 
the values in brackets report the overall maximum values.  
Table 5.9: Summary of device data. 
 
CONCLUSION 
A family of four complexes, 145, 146, 164 and 165, related to the known complex 142a were 
synthesised. Exchanging a ppy ligand for a dfppy ligand (from 142a to 145) resulted in a blue-shift 
of 21 nm, indicating that the introduction of the fluorine atoms was effective at widening the 
HOMO-LUMO gap. Replacing an oxazoline with an oxazole ring on the ancillary ligand (from 142a 
to 164) resulted in a small blue-shift in the emission colour. Addition of the sulfone moiety onto 
the phenyl ring of oxazole ancillary ligand 156 resulted in an additional blue-shift of 13 nm, as the 
HOMO in these complexes is located on the ancillary ligand. As introducing electron withdrawing 
groups on to both the cyclometalating ligand and the ancillary ligand resulted in a blue-shift in 
emission, these two approaches could be combined in the future to produce bluer complexes. All 
complexes displayed good PLQYs (0.42-0.65) in solution. Devices of complexes 145 and 164, 
fabricated by vacuum deposition, retained the emission observed in the PL spectra, and 
performed favourably compared to the literature compound 142a. Further work to be conducted 
would be to investigate the properties of complex 146 and 165 in devices, fabricated by solution 
processing.  
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Chapter 6: ‘Hemicage Ir complexes’ for 
enhanced stability 
In the search for deep-blue emitters focus has shifted from phenylpyridine-based ligands to 
ligands containing alternative heterocycles, such as pyrazoles, or carbenes. Pyrazoles raise the 
energy of the LUMO, thus widening the HOMO-LUMO gap and blue-shifting the emission.1 
Carbenes, as strong σ-donor ligands, firstly destabilise the LUMO, and secondly, increase the 
energy of non-radiative MC states as a result of the strong metal-ligand bonds formed.1,2 This 
results in deep-blue to near-UV emission from carbene complexes at room temperature, with 
some complexes even displaying solution PLQYs of up to 0.40.3,4 Carbene ancillary ligands can also 
be used to blue-shift the emission and increase PLQYs by shifting deactivating states to higher 
energies.5,6 Some examples of carbene-Ir complexes are shown in Figure 6.1.  
Figure 6.1: Carbene complexes 166a-d taken from reference 
7
. Complexes 167a, b taken from reference 
3
. Complexes 




However, despite the favourable emission properties of carbene complexes there are still some 
disadvantages; some carbene complexes have been reported to have long excited state lifetimes 
(>20 μs), resulting in increased triplet-triplet annihilation at high brightnesses.9,10 Carbene 
complexes are known to be unstable in OLEDs for long periods of device operation,11 and it is 
thought that one mechanism for radiationless deactivation is cleavage of the iridium-carbene 
bond to form a five-coordinate intermediate.12 Once bond rupture occurs, the ligand cannot 
recoordinate, resulting in decomposition. Methods of preventing this include increasing the 
rigidity of the ligands to restrict the complex from achieving the required structural conformation 
for bond dissociation, or utilising tripodal or hexadentate type chelates to form hemicage 
structures around the iridium centre. Advantages of hemicage complexes include a decrease in 
Chapter 6: Hemicage Ir complexes for enhanced stability 
 
   141 
reactivity, as the reactive metal centre is effectively encapsulated within the ligand structure.13 
Quenching of the luminescence by agents such as molecular oxygen, or solvent can therefore be 
inhibited, which can result in increased quantum yields in solution.14 Formation of cage or 
hemicage complexes can also lead to a decrease in the non-radiative decay rate, as non-radiative 




Figure 6.2: Complexes 169a/b taken from reference 
15





Few examples of iridium cage/hemicage complexes have been reported in the literature, however 
several ruthenium(II) complexes have been reported.15,17-19 Some examples of caged and 
hemicaged ruthenium complexes are shown in Figure 6.2; in particular, complexes 169c and 169d 
showed increased photostability, with the photodecomposition rate of 169d estimated to be at 
least 104 times smaller than that of [Ru(bpy)3][PF6]2.
17 Complexes 169a and 169b also show 
significantly enhanced (1-7 times) quantum yields compared to their parent compounds.15  
The first iridium hemicage complex was reported by Schaffner-Hamann et. al. in 2004, complex 
170 (Figure 6.3).20 Building on their previous work with ruthenium(II) and iron(II) complexes,21 an 
enantiomerically pure ligand containing pinene units was complexed to produce a single isomer, 
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Figure 6.3 
chiral complex 170, which exists as the Λ-fac isomer.20 In terms of photophysical properties, 170 
displays similar absorption and emission spectra to the parent complexes, with a slightly lower 
PLQY (0.51 vs 0.64). The stability of 170 relative to the parent complexes was not investigated.  
The first iridium complex with a caged structure was synthesised in 2010 by Ruggi et. al. and is 
shown in Figure 6.4.14 Hemicage complex 172 was synthesised by reacting tripodal ligand 171 with 
IrCl3/CF3CO2Ag, and the ester moieties were then reacted with another equivalent of the tris(2-
aminoethyl)amine cap to give the caged complex 173.14 The photophysical properties of 
complexes 172 and 173, such as quantum yield, excited state lifetime and emission wavelength 
are similar.14 The effect of shielding on the oxygen sensitivity of complexes 172 and 173 was 
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Ir(ppy)3; it was found that the hemicage and cage complexes 172 and 173 showed a dramatic  
decrease in the quenching constant (40% and 80%, respectively) compared to Ir(ppy)3, 
highlighting the effectiveness of the cage structure at protecting the iridium centre.14 These 
complexes therefore have potential for application in biological systems, as these environments 
are often oxygen rich.14 
 
The final examples of iridium hemicage complexes are shown in Figure 6.5, reported by St-Pierre 
et. al.13 Complexes 174a and 174b are related to Ir(ppy)3, with the tethers connected on the 
pyridine ring for 174a, and on the phenyl ring for 174b.13 The photophysical properties of 174a 
and 174b are similar, with 174b exhibiting stronger solvatochromism; this is attributed to the 
difference in the orientation of the dipole moments within the molecule.13 The two complexes 
exhibit high quantum yields in polar aprotic solvents, such as acetonitrile or butylnitrile, 76% and 
79% for 174a and 174b, respectively.13 This is comparable to the value obtained for Ir(ppy)3 in the 




RESULTS AND DISCUSSION 
Inspired by these iridium and ruthenium hemicage complexes, the aim was to synthesise a 
tripodal, hexadentate ligand containing carbenes, with the goal of creating complexes that are 
more photochemically and thermodynamically stable, in the hope that they would exhibit 
superior performance under device operation. In addition, the cage effect has been shown on 
several occasions to enhance the PLQYs of emissive complexes; switching to tridentate carbene 
ligands produced complexes that displayed near-UV emission with PLQYs of over 0.40.3 The 
synthesis of the initial target 180 is shown in Figure 6.6; the choice of tether unit was inspired by a 
paper by McDaniel et. al concerning the synthesis of Cr(III) complexes.22 The first step involved  
the reaction of triethanolamine 175 with thionyl chloride to produce the trichloroammonium salt 
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176 in 95% yield.23 Next was a triple nucleophilic substitution reaction using the sodium salt of 4-
bromophenol as the nucleophile to give 177 in 49% yield after purification.24 Also isolated was the 
disubstituted intermediate, in 24% yield. A small excess of NaOH base was used to account for the 
fact the starting material was an HCl salt. Once 177 was obtained the next step was to introduce 
the imidazole fragment, via three Ullman coupling reactions, using CuI/1,10-phenanthroline as the 
catalyst system, and Cs2CO3 as the base. Product 178 was isolated after recrystallisation in 46% 
yield. The final step was to create the carbene precursor, imidazolium salt 179. This was 
attempted by treating a solution of 178 with three equivalents of CH3I. A solid was isolated that 
was later identified as the methylated ammonium salt of the desired product 179 (50%), 
indicating the alkylation was not selective.  
 
Figure 6.6: Attempted synthesis of target complex 180. 
It was decided to attempt to synthesise an iridium complex from the ammonium salt 179CH3I, as 
it may be possible to remove the methyl group later. The ligand 179CH3I was combined with 
IrCl3.3H2O and Ag2O in 2-ethoxyethanol, shielded from light, and the reaction was heated to reflux 
overnight, as described in the literature for analogues.1 After work up the reaction mixture was 
subjected to column chromatography, and although many fractions were obtained, none 
appeared to contain the desired complex [180CH3]
+I-. Analysis of the 1H NMR spectrum suggested 
extensive decomposition of the ligand had occurred. It was not clear whether this was due to (i) 
strain within the ligand structure due to the short connection between the ligand fragment and 
the amine tether; (ii) the choice of iridium starting material or (iii) issues with the carbene 
formation. As a result, it was decided that the analogous ppy ligand 183 should be synthesised, to 
identify if the problem was ligand specific or not. 
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Initially the aim was to use intermediate 177 to synthesise the ligand 183, and a variety of 
coupling procedures were attempted, as shown in Figure 6.7. A nickel catalysed Kumada coupling 
was attempted, as was a Negishi coupling on 4-bromophenol, however, NMR spectra revealed no 
sign of product 182. Due to the known difficulties preparing 2-pyridyl Grignard reagents and 2-
pyridyl boronic acids,25,26 and the commercial availability of boronic acid 181 the synthesis was 
revised (Figure 6.8). For the new route the first step involved synthesis of 182 from 2-
bromopyridine 11 and commercially available boronic acid 181 to give the product in 84% yield, as 
described in the literature.27 There then followed a nucleophilic substitution reaction of 182 with 
176 to give the desired product 183 in 40% yield after purification by reverse phase column 
chromatography. An advantage of this route over the previously outlined route for 179 is that it 
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To form the desired iridium complex 184 it was thought that the use of IrCl3.3H2O may be an issue 
as this requires the reaction to proceed via the intermediate dichloro dimer, which involves a 
trans arrangement of the nitrogen atoms of the cyclometalating ligands about the iridium centre. 
This is the incorrect stereochemistry for the fac-isomer, and due to the tether it is possible that 
the third arm of the ligand would not be able to reach the iridium centre. Therefore, Ir(acac)3 was 
used instead, as the arms of the tripod can sequentially coordinate with the correct 
stereochemisty. The first set of conditions tried involved heating to reflux a mixture of Ir(acac)3 
and ligand 183 in tridecane, a high boiling solvent, overnight. TLC analysis revealed no sign of 
reaction; both 183 and the Ir(acac)3 were reclaimed after column chromatography. When the 
solvent was switched to glycerol, another solvent frequently used to synthesise fac-iridium 
complexes, and the reaction was reattempted. This time, the Ir(acac)3 and ligand were consumed 
and a new, fluorescent spot appeared on TLC. The spot did not move off the baseline unless 
extremely polar solvent mixtures were used (DCM, 0-100% ethanol), and once obtained the NMR 
spectrum was complicated, and no product could be identified. It was considered that the ligand 
might have reacted with the iridium source to form a network structure rather than a 
mononuclear cage complex, possibly due to the length of the linker. It was therefore decided to 
extend the linker by two ethylene glycol units, as this is comparable to complex 170 synthesised 





The initial route is shown in Figure 6.9, and the first step involved a one pot in situ Finkelstein 
reaction and nucleophilic substitution to attach a diethylene glycol unit to the phenolpyridine 182. 
The desired product (185) was isolated in 87% yield. The next step involved making the sodium 
salt of 185 and using it as a nucleophile to attack 176. This was attempted first using NaH as the 
base, then by using sodium to generate the sodium salt directly (Figure 6.11). In both cases, while 
it appeared the sodium salt had formed, only a trace amount (<1%) of product could be isolated 
despite heating the reaction to reflux overnight. The chloride 176 was transformed to the iodide 
free base 187 via a Finkelstein reaction, and the reaction was repeated with 185 and 187. 
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However, again, only a small amount of product was isolated. In all three cases, 185 was isolated 
as the major component from the reaction. The poor yields of these reaction may reflect the poor 
stability of the central amine unit. 
 
Figure 6.10 
The next tactic was to exchange the nature of the reaction sites, as shown in Figure 6.10. Here, 
triethanol amine 175 was used as the nucleophile and reacted with 188, which was synthesised 
via an Appel reaction from 185 (Figure 6.7, 82% yield). Triethanolamine 175 was then treated with 
NaOH, and 188 was added, and the mixture was heated to reflux overnight. However, no product 
186 was isolated, instead, unreacted 188 was identified, along with species displaying doublets of 
doublets in the 4.5-6.8 ppm region, suggesting formation of the elimination product 189 (Figure 
6.10). 
 
Due to the synthetic difficulties described above, a new route shown in Figure 6.11 was devised, 
analogous to the synthesis of complex 170 by Schaffner-Hamann et.al.20  Following the literature 
route THP-protected diethylene glycol unit 191; the reaction was conducted as described in the 
literature and 191 was obtained in 93% yield.20 Next, 191 was converted to the sodium salt, which 
was then reacted with 176 to give 192 in 63% yield. The next step was to remove the THP 
protecting group, typically achieved using a catalytic amount of acid. In this case the crude NMR 
revealed no sign of product 193, instead indicating cleavage of one of the ether linkages to give 
triethanolamine 175. 
 
Therefore, the synthesis was redesigned to avoid any protecting groups that require removal with 
acid. Patent literature reports the synthesis of 193 directly from diethylene glycol 190 and the 
free base of 176, N(CH2CH2Cl)3, prepared by washing 176 with an aqueous Na2CO3 solution and 
extracting.28 The mono-sodium salt of 190 was synthesised by adding sodium into stirred 
diethylene glycol 190; when the sodium had completely dissolved N(CH2CH2Cl)3 was added and 
the solution heated to reflux overnight. The residual diethylene glycol was removed via distillation  
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to give the desired product 193 in 99% yield. 
 
The next step was to replace the alcohol moieties with halides to allow an analogous synthesis 
with that of 183. Initially an Appel reaction with CCl4/PPh3 was attempted (Figure 6.12), however 
analysis of the crude MS data indicated the presence of product 194, starting material 193, as well 
as mono and disubstituted compounds. This route was then abandoned in favour of that 
proposed in the paper (Figure 6.12);20 the alcohol moieties of 193 were transformed to mesylates, 
by a combination of mesyl chloride and base (NEt3) to give a mixture containing 195 and 
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material (193) obtained in the previous step it is possible that the product 195 decomposed 
during the reaction or the purification. The crude mixture was then reacted with NaI to give a 
mixture of 196 and bis(2-iodoethyl) ether. The yield of the reaction appeared to be low, and the 
impurity was not removed due to concerns about the stability of compound 196. 
 
To synthesise the ligand 186, a nucleophilic substitution of the iodides of 196 with the sodium salt 
of 182 was attempted (Figure 6.12); the initial conditions utilised NaOH as the base, and the 
reaction was conducted in MeOH. After work up the crude reaction mixture was subjected to 
reverse phase column chromatography, both phenol 182 and phenolate salt of 182 were isolated, 
along with the product of the nucleophilic substitution of bis(2-iodoethyl) ether, however none of 
the desired product 186 was isolated. Due to the synthetic difficulties and the apparent instability 






Due to the success of complex 170, the amine core was exchanged for a phenyl ring and a new 
target (203) was designed. The synthesis of key intermediate 203 is shown in Figure 6.13, and the 
initial steps follow those described by Schaffner-Hamann et.al.20 First, 1,3,5-tricarboxylate 197 
was reduced to the trialcohol 198 using LiAlH4 (in quantative yield), then the alcohols were 
transformed into bromines using PBr3 to give 199 in 74% yield after purification. The next step 
was to introduce the glycol chains, achieved by reacting the sodium salt of the THP-protected 
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glycol 191 with 199 to produce 200 in 30% yield. The THP protecting groups were then removed 
by catalytic conc. HCl to give 201 in 75% yield. 
 
A small amount of diethylene glycol was observed in the NMR spectrum, despite being carefully 
removed in the previous step. This was thought to be due, again, to cleavage of one of the ether 
linkages, as seen for 192 (Figure 6.11). Hence a route analogous to the synthesis of 193 directly 
from 190 was attempted to avoid the use of the protecting group, and is shown in Figure 6.13. As 
with the synthesis of 193, the sodium salt of 190 was formed by adding sodium to diethylene 
glycol, followed by the addition of 199. Some residual diethylene glycol sodium salts remained, 
however, as both the product and impurity were readily soluble in water these could not be 
extracted. Due to the high polarity of the product it was not suitable for normal phase column 
chromatography, and little separation between these salts and the product 201 was observed on 
utilising reverse phase chromatography. As a result the impurity was left for removal at a later 
stage.   
 
The alcohol groups of 201 were then transformed to mesylates, as described for 193, to give 202, 
along with the mesylate diethylene glycol impurity. 202 was then subjected to Finkelstein 
conditions to replace the mesylates with iodides. At this stage the bis(2-iodoethyl) ether could be 
easily removed by distillation (b.pt. 110-120 oC at 0.66 mbar 29) to give 203 in 54% yield over the 





From here it remained to attach the appropriate phenols, shown in Figure 6.14, to create the final 
ligands. Phenols 182 and 204 have already been identified as targets, with the synthesis of 182 
described previously.  At this point, two other targets were identified, 205 and 206. Compound 
205 was chosen to expand the family to include an orange/red emitter, as fac-Ir(thpy)3 [thpy = 2-
(2-thienyl)pyridine] is well known.30 Compound 206 was chosen as it was noted by Yeh et. al. that 
the fac- isomer of 81b had not been synthesised, but computational work suggested that it would  
Chapter 6: Hemicage Ir complexes for enhanced stability 
 
   151 
 
Figure 6.15 
be a true-blue emitter, without the dual emissive properties that are observed in the mer-isomer 
81b.31 The hexadentate ligand structure would ensure the formation of the fac geometry, as the 
tethers prevent the approach of the third ligand once the first two have assumed the trans 
nitrogen arrangement required for the mer geometry. 
 
The initial attempt at the synthesis of 204 (Figure 6.15) followed the literature procedure 
described by Zhu et. al.:32 an Ullmann reaction using CuI as the catalyst, and Cs2CO3 as the base. 
Unfortunately, the product was obtained in only 14% yield, and additional precautions, such as 
thoroughly dried reagents and degassed solvent, did not result in any improvement. As the 
coupling between 177 and imidazole had previously proceeded in good yield (46% for a threefold 
reaction) it was thought that the issue may be interference from the free -OH group of 207. As a 
result, the phenol 207 was protected using the THP group (Figure 6.15), which is base resistant 
and easily removed with acid. The protected phenol 208 was isolated in 37% yield. The Ullmann 
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previously proved successful, using CuI/1,10-phen as the catalytic system and Cs2CO3 as the base. 
The product 209 was isolated in 69% yield, and the THP group was removed with conc. HCl to give 
the desired phenol 204 in quantitative yield. 
 
Phenol 205 was synthesised in 69% yield via a Suzuki coupling between 210 and 211 using 





The first route attempted to synthesise 206 was a Suzuki coupling between boronic ester 212 and 
commercially available bromide 210 (Figure 6.17). The boronic ester 212 was synthesised 
according to the literature procedure, shown in Figure 6.18, and was isolated in 73% yield.33 
Compounds 210 and 212 were subjected to Suzuki conditions, with Pd(PPh3)4 and Na2CO3 as the 
catalyst and base, respectively. Upon purification starting material 210 and deborylated pyrazole 
213 were isolated, with no sign of desired product 206. As 210 had been shown to perform well 
under Suzuki conditions with boronic acid 211, it was decided that the free NH of the pyrazole 212 
should be protected. Therefore, THP derivative 214 was synthesised in 24% yield. The order of  
 
Figure 6.18 
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reactions was also reversed, with pyrazole 213 protected with THP to give 215 in 95% yield, 
followed by lithiation and introduction of the Bpin group to give 214 in 41% yield. Boronic ester 
214 was then subjected to Suzuki conditions (Figure 6.19) that had been utilised previously in our 
group for coupling a variety of N-substituted 3-trifluoromethylpyrazole boronic esters to both 
electron rich and electron poor haloarenes.34 These conditions had been shown to reduce both 
the incidence of homo-coupling of the boronic ester and the rate of protodeboronation.34 In our 
case, after work up of the crude reaction mixture 1H NMR peaks corresponding to the product 
could be found, and a large amount of starting material 210 remained. 
 
As a result, this route was abandoned in favour of a route analogous to the synthesis of ligand 
144, which involves constructing the pyrazole ring from a diketone intermediate. The proposed 
route is shown in Figure 6.20, and starts from the low-cost, commercially available amine 217. The 
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literature method.28 Product 218 was obtained in quantitative yield. The alcohol substituent of 
218 was then protected as methoxy derivative 219, which was then isolated in 23% yield. The 
cyano group was then transformed into an acetyl via reaction of 219 with MeMgBr followed by 
acid work up to give 220 in 56% yield. It remained to form the diketone intermediate 221 via a 
crossed Claisen condensation with ethyl trifluoroacetate, followed by a ring closing condensation 
with hydrazine hydrate to give pyrazole 222. The final step would be to deprotect the methyl 
group with BBr3 to give the desired phenol 206. Unfortunately, this synthesis was not completed 
due to lack of time during the course of this work. 
 
 
Figure 6.21: Synthesis of tripodal ligands 223 and 224. 
 
 
With the alcohol derivatives 182, 204 and 205 in hand the next step was to synthesise the final 
ligands. NaOH was added to solutions of 182 and 204 in THF, and the mixtures were heated to 
reflux until all the base had reacted (Figures 6.21 and 6.22). Then the tri-iodo core reagent 203 
was added, and the solution heated to reflux overnight. The solvent was removed and the 
residues were purified by reverse phase column chromatography to give 223 in 66% yield. In the 
case of 205, the major product isolated was the doubly substituted product 225, in 84% yield. The 
reaction was repeated, and again, 225 was the major product. It is unclear why the reaction 
appears to stop at this stage. When the reaction was repeated, this time adding 225, instead of 
the iodo centre 203, the desired product 226 was isolated in 50% yield. 
 
In the case of 204, the reaction was attempted in THF; however, on deprotonation of 204 the 
sodium salt began to precipitate out. Nonetheless, reagent 203 was added anyway; however no 
product was isolated. With dioxane as the solvent no increase in solubility was observed. DMF 
was also tried, and the sodium salt of 204 proved soluble. Reagent 203 was then added, however 
after attempted purification by column chromatography a residual unidentified impurity was  
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Figure 6.22 
 
observed by NMR. This impurity appears to contain alkyl chains and some aromatic protons. One 
suspected product is the result of an elimination reaction on the iodo centre to leave an alkene 
fragment; this is supported by the appearance of two doublets of doublets at 6.50 ppm in the 1H 
NMR spectrum. The reaction was repeated at a lower temperature of 50oC, in an attempt to 
suppress the formation of this side-product, however no improvement was observed. An attempt 
was made to continue through to the final carbene precursor, 227 (Figure 6.23), by reacting the 
crude 224 with three equivalents of MeI, however the NMR spectrum of the crude material 
revealed the presence of two species. Attempted resolution of these species both with reverse 
phase column chromatography and with normal phase chromatography in highly polar solvent 




Figure 6.23: Synthesis of target complex. 
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1 160 4.7 0 
2 reflux 2.3 32 
3 reflux 0.9 0 
4 reflux 3 0 
5 reflux 1.9 23 
 
Table 6.1: Reaction conditions for synthesis of complex 228.  
 
promise in separating the precursor 224 and the impurity; however, there was not sufficient time 
to conduct this on a preparative scale during the course of this work.  
 
Using ligands 223 and 226 the final step was to synthesise the desired complexes 228 and 229. 
Based on the procedures outlined by 170 for the synthesis of Schaffner-Hamann et.al.,20 and 
previous related work conducted by Beeston et. al. on ruthenium cage complexes,15 the reactions 
were conducted under high dilution (approx. 2-3 ml per mg of ligand) in an attempt to ensure 
formation of the desired cage species, as opposed to polymeric species. 
 
Ligand 223 was suspended in ethylene glycol and Ir(acac)3 was added. The solution was heated to 
reflux for 24 h, with vigorous stirring. The reaction was attempted five times, at a variety of 
temperatures and concentrations, as shown in Table 6.1. At the lower temperature of 160 oC no 
formation of product was observed, and both the unreacted ligand 223 and the Ir(acac)3 were 
isolated (reaction 1). The temperature was increased to reflux (b.pt. 197 oC), and the volume 
reduced, and this time product 228 was isolated in 32% and 23% yields (reactions 2 and 5). Due to 
the difficulties associated with removing the large volume of ethylene glycol in the work up the 




Figure 6.24: Synthesis of complex 229. 
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by Ruggi et. al. in the synthesis of 172,14 and St-Pierre et. al. in the synthesis of 174a/b.13 In the 
case of 228, no complex was isolated, instead a large quantity of emissive material that proved 
difficult to move on TLC except in the most polar solvent mixtures, suggesting formation of 
polynuclear species. This is contrary to that observed by Ruggi et. al. and St-Pierre et. al., who 
reported yields of 20% for 172 and 33-37% for 174a and 174b, respectively. However, this can be 
explained by the fact the tethers to the core in the case of 228 are much longer, allowing more 
freedom of movement and possibly reducing the rate of complex formation, allowing the 
separate arms more opportunities to come into contact with other metal centres than if the 
chains were shorter. 
 
On one occasion (reaction 4), under similar conditions to the two successful reactions, the 
reaction failed, with Ir(acac)3 and ligand 223 being identified on TLC. It is not clear the reason for 
this, but it could be due to the difficulties ensuring adequate heating, stirring and degassing 
across such a large volume of solvent. Ideally, another iridium source would be used as Ir(acac)3 is 
known to produce lower yields than reagents such as IrCl3.3H2O, or the μ-dichloro dimers, and is 
also more costly.35,36 
 
For complex 229 the synthesis was analogous to that of 228; ligand 226 and Ir(acac)3 were 








H NMR spectrum of complex 228 in CD2Cl2. 
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H NMR spectrum of complex 229 in CD2Cl2. 
 
(Figure 6.24). The reaction was worked up as described for 228, by distillation of the ethylene 
glycol solvent, followed by purification by column chromatography to give 229 as an orange 
powder in 8% yield. A significant quantity of black, intractable solid remained at the top of the 
column, a possible explanation for the low yield of this reaction compared to the synthesis of 229. 
 
The 1H NMR spectra of complexes 228 and 229 have been fully assigned with the aid of 2D 
experiments, and are shown in Figure 6.25 and Figure 6.26, respectively. The fac- geometry of the 
complexes is clear from the relative simplicity of the NMR spectra, highlighting the C3 symmetry of 
the complexes in solution. It is also notable that the closest methylene protons to the phenyl core 
(protons H5a and H5b for complex 228 and 229) appear as two signals with a coupling constant of 
12.2 Hz and the signals are roofed. This is due to the reduced flexibility of the chains close to the 
core, as a result of the geometry required for the cage coordination. This results in the geminal 
protons becoming diastereotopic due to the inherent chirality of the Ir(ppy)3 unit.
14 There is also a 




Photophysical and electrochemical properties 
Absorption and emission 
The absorption spectra of complexes 228 and 229 are shown in Figure 6.28. The strong bands  
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Figure 6.27: Parent and related complexes. 
between 250-320 nm are assigned to π-π* transitions on the ligand based on the calculations of 
Hay,37 and literature precedent. The intense bands at 350-400 nm are assigned to the 1MLCT 
bands.  
 
The lower energy 3MLCT bands could not be easily distinguished. The absorption spectrum of  
complex 228 bares a strong resemblance to that of parent complex 230,38 shown in Figure 6.20, 
indicating that the addition of the tether unit has had little effect on the absorption of the 
complex. The parent complex of 229 is not known (231); however, the absorption spectrum of 
229 does resemble that of related complex 232 (Figure 6.27).30 
 
Excitation spectra for all complexes were recorded (Figure 6.29), revealing as expected that the 


















Figure 6.28: Absorption spectra of complexes 228 and 229 in DCM [<10
5
 M]. 
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Figure 6.29: Excitation spectra of 228 and 229 in dearated DCM [<10
5
 M]. The emission band observed was in the 500-
560 nm range. 
majority of the higher energy π-π* transitions are dark. 
The emission spectra of the complexes are shown in Figure 6.30. The spectrum of 228 is similar to 
that of parent complex 230, broad, featureless emission indicative of a large MLCT contribution to 
the excited state. The emission of complex 229 displays a similar profile to that of complex 232, 
with the presence of strong vibronic features. Emission from the fac thienylpyridine (thpy)-based 
iridium complexes is known to display significant LC character.30,39  In both cases, this suggests 
 




























Figure 6.30: Emission spectra of selected complexes in deaerated DCM [<10
5
 M], λex = 355 nm. 
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Complex λmax
abs 

































287 (78.3), 303 (76.6), 362 
(27.0), 402 (12.3, sh), 446 
(3.3), 477 (0.6) 
503, 519 0.92 1.87 4.92 0.43 
229 
279 (54.6), 305 (70.1), 344 




0.43 7.20 0.60 0.79 
230
f




300 (35.5), 343 (15.9), 398 
(11.9, sh)  
548, 592, 
643 
0.40 7.10 0.56 0.85 
a 




 Data obtained in degassed dichloromethane solution with λex = 
380 nm.  
c 
Measured in degassed DCM relative to  quinine sulfate ΦPL= 0.546 in 0.5 M H2SO4 at 20 
o
C; estimated error 
±5%. 
d 
Estimated error ±5%. 
e
 kr, knr values calculated using Equations 1.5/1.6.
 f 









Table 6.2: Photophysical data for selected iridium complexes 
that the introduction of a tethering unit has not significantly impacted the nature of the excited 
state.  
The PLQYs, lifetimes (τobs) and calculated radiative and non-radiative decay rates (kr and knr) for 
complexes 228 and 229 are shown in Table 6.2, and compared to literature data for complexes 
230 and 232. The phosphorescent lifetime of 228 is comparable to that measured for parent 
complex 230, but the PLQY is higher (0.92 vs 0.65). This could indicate an increased stability 
towards quenching mechanisms, whether via vibrations or solvent quenching, for the hemicage 
complex 228. This is in line with previously reported hemicage/cage iridium complexes.  In the 
case of complex 229 the PLQY and the lifetime are both comparable to the related complex 232. 
Other complexes containing substituted thpy ligands also display long phosphorescent lifetimes, 
this is consistent with a reduced MLCT contribution to the excited state, as the spin-orbit coupling 
is less allowed. For both 228 and 229 the complexes appear to show reduced knr values relative to 




The electrochemical behaviour of complexes 228 and 229 was investigated using cyclic 
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voltammetry and compared to the literature data for parent compound 230. Literature data could 
not be found for related complex 232. The voltammograms are shown in Figure 6.31 and the key 
parameters in Table 6.3. Formula 2.1 is used to calculate the energy of the HOMO.  
 
Complex Eox1/2  / V HOMO / eV 
228 0.17 -4.97 
229 0.13 -4.93 
230 0.30 -5.10 
All values reported vs Fc/Fc
+
 = 0.00 V. 
Table 6.3: Electrochemistry data of iridium complexes. Measured in DCM (0.1 M 
n
Bu4NPF6) at 298 K. 
 
The complexes both show a reversible oxidation wave which was assigned to the IrIII/IrIV couple. 
Introduction of the tethering unit results in a small (0.1 V) decrease in the oxidation potential of 
228 compared to 230, which is reflected in the red-shift in emission (8 nm) spectra. Complex 229 
exhibited a less positive oxidation potential compared to 228, consistent with the red-shift in the 
































Figure 6.31: Cyclic voltammograms of 228 and 229. 
 
CONCLUSION 
Two tripodal ligands, 223 and 226, and their respective iridium complexes, 228 and 229, were 
synthesised. The complexes displayed comparable or superior PLQYs and lifetimes to the 
parent/related complexes, and the 1H NMR data suggested some limited motion in solution. It 
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remains to complete the synthesis of the other target ligands derived from alcohols 204 and 206, 
and their iridium complexes. The performance of the complexes in devices remains to be 
investigated. The complexes could also be tested as sensors for metal cations, as the cavity 
created between the phenyl-centre and the complex could be large enough to house a metal ion, 
and the PEG chains provide a coordinating environment. It’s anticipated that coordination of a 
metal ion may induce changes in the photophysical properties, such as the PLQY, lifetime, or even 
the λmax of the emission.  
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Chapter 7: Conclusions 
During the course of this work a variety of ligands were synthesised with the aim of tuning the 
emissive properties of the resultant iridium complexes. The distinct localisations of the HOMO 
and LUMO in iridium(III) complexes with phenylpyridine-based ligands allows for the facile tuning 
of the emission colour by introduction of substituents with electron-withdrawing/donating 
properties onto positions with high HOMO or LUMO density. This manipulation of orbital energies 
was used in the design of the sulfone-containing ligands of Chapters 2 and 3. Here, electron-
withdrawing sulfone moieties were introduced at the 5-position of the phenyl ring, a position with 
a large HOMO localisation, in order to blue-shift the emission relative to that of the parent 
complex, FIrpic. Complexes 19, 20 and 28, containing a sulfone and two fluorine substituents, 
were synthesised and exhibited bluer emission than FIrpic (~10 nm) while maintaining 
comparable PLQYs and emission lifetimes. Investigation of their electrochemical properties 
indicated that the introduction of the sulfone group resulted in a lowering of the HOMO energy, 
as predicted. As fluorine substituents are known to be unstable during device operation there was 
interest in synthesising ligands with fewer fluorines, while still retaining blue emission. Complexes 
68, 69 and 70, containing one fluorine, one methoxy and one sulfone substituent on the phenyl 
ring, displayed similar emission  to their difluoro analogues, with only a small red-shift of 2-3 nm 
being observed. Complex 80, a fluorine-free analogue containing two methoxy groups and one 
sulfone unit, displayed a similar emission wavelength and oxidation potential to FIrpic, suggesting 
it could be a viable fluorine-free alternative. 
 
Figure 7.1: FIrpic analogues containing  
The emissive properties of iridium(III) complexes can also be tuned by the choice of ancillary 
ligand; electron-deficient ancillary ligands can indirectly affect the emission of iridium complexes 
by lowering the energy of the d-orbitals, thereby lowering the energy of the HOMO. In Chapter 5 
a new ancillary ligand 133 was devised with the aim of blue-shifting emission while also increasing 
complex solubility and steric shielding of the Ir core. Exchanging the pic ancillary ligand in 70 and  
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Figure 7.1: Analogues to complexes 70 and 80, containing new ancillary ligand 133. 
80 for the new ancillary ligand 133 produced complexes 140 and 141, which exhibited a 3-5 nm 
blue-shift in emission relative to their parent complexes.  
Attention must be paid to the relative energy levels of the ligands in heteroleptic complexes, for a 
ligand to be truly ancillary it should play no part in the excited state, requiring a deeper HOMO 
and a higher LUMO than that of the cyclometalating ligand. In the case of complexes 145, 146, 
164 and 165 (Chapter 5) and their literature analogue 142a, the HOMO resides on the phenolate 
ring of the ‘ancillary’ ligand, rather than on the cyclometalating ligand, while the LUMO still 
resides on the pyridyl ring of the phenylpyridine-based ligand. The emission colour of these 
systems could still be tuned, with the exchange of a ppy ligand for a dfppy ligand (from 142a to 
145) resulting in a blue-shift of 21 nm, indicating that the introduction of the fluorine atoms was 
effective at widening the HOMO-LUMO gap, despite the phenyl ring of dfppy not being involved in 
the HOMO. Addition of the sulfone moiety onto the phenyl ring of oxazole ancillary ligand 156 
resulted in an additional blue-shift of 13 nm (from 164 to 165), as the HOMO in these complexes 





Figure 7.3: Complexes containing oxazoline/oxazole ancillary ligands. 
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Figure 7.4: Proposed structures for further blue-shifting the emission relative to literature complex 142a. 
cyclometalating ligand (145) and the ancillary ligand (165) resulted in a blue-shift in emission, 
these two approaches could be combined in future work to produce bluer complexes. Some 
proposed structures are shown in Figure 7.4.  
 
Figure 7.5:  Complexes containing ligands with donor-acceptor character. 
Combinations of substituents have also been shown to produce some interesting photophysical 
effects. Complexes 90, 105 and 116 (Chapter 4), containing ligands with strong donor and 
acceptor components, displayed solvent dependant dual-emission properties.  The origin of this 
dual emissive character was tentatively assigned to the presence of a ligand based CT state.  
It is also possible to affect other emissive properties, such as the PLQY and emission lifetime, of a 
complex through structural modification. Two hexadenate tripodal ligands 223 and 226 were 
synthesised derived from known cyclometalating ligands, and the tripodal complexes 228 and 229  
 
 
Figure 7.6: Tripodal complexes synthesised in this work, and proposed future complexes.  
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Figure 7.7: Proposed potential coordination of metal ions within the cage structure of complex 128. 
were synthesised with the aim that using a single hexadentate, ligand as opposed to three 
bidentate ligands would increase complex stability and reduce quenching. Complexes 228 and 229 
displayed comparable or superior PLQYs and lifetimes to the parent/related complexes, and the 
1H NMR data suggested some limited motion in solution. Further derivatives remain to be 
synthesised, and their properties investigated in devices. Additionally, these complexes have the 
potential to be used in the sensing of metal ions, as the cavity created between the phenyl-centre 
and the complex could be large enough to house a metal ion, and the PEG chains provide a 
coordinating environment, as shown in Figure 7.7.  
To conclude, the emissive properties, such as emission colour, efficiency and lifetime, of 
cyclometalated iridium(III) complexes have been modified by the choice of substituents on the 
ligands. The emissive properties of heteroleptic complexes have also been modified by the choice 
of the ‘ancillary’ ligand. It is important to consider not only the nature of the substituent 
(electron-withdrawing/donating ability) but also their position on the ligands; for example, 
introducing a sulfone group at the 5-position results in a blue-shift in emission, while introducing 
it at the 4-position results in a dramatic red-shift in emission. Care must also be taken when using 
the molecular orbital distributions to decide which substituents to introduce and where; once a 
substituent is introduced the orbital distributions can change significantly, meaning the effect of a 
substituent on the emissive properties is not always predictable.  
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Chapter 8: Experimental Data  
General procedures 
All commercially available chemicals were used without further purification unless stated 
otherwise. Reactions requiring an inert atmosphere were performed under a blanket of argon gas, 
which was dried over a phosphorus pentoxide column. Anhydrous solvents were dried through an 
HPLC column on an Innovative Technology Inc. solvent purification system.  Column 
chromatography was performed using 40-60 μm mesh silica gel. Analytical TLC was performed on 
plates pre-coated with silica gel (Merck, silica gel 60F254) and visualised using UV light (254, 315, 
365 nm). NMR spectra were recorded on Bruker Avance 400 MHz, Varian Mercury 200, and 400 
MHz, Varian Inova 500 MHz or Varian VNMRS 600 and 700 MHz spectrometers. Chemical shifts 
are referenced to tetramethylsilane [TMS, Si(CH3)4] at 0.00 ppm. Melting points were determined 
in open ended capillaries using a Stuart Scientific SMP3 melting point apparatus at a ramping rate 
of 1 oC/min. They are recorded to the nearest 0.1 oC. ESI and MALDI mass spectra were recorded 
on a Thermo-Finnigan LTQ FT (7.0 T magnet) spectrometer. ASAP mass spectra were recorded on 
a Waters Xevo QTOF spectrometer. GCMS spectra were recorded on a Thermo-Finnigan Trace 
GCMS (EI and CI ion sources). Elemental analyses were obtained on an Exeter Analytical Inc. CE-
440 elemental analyser. Where solvent mixtures are mentioned any percentage/ratio is by 
volume. 
Electrochemistry 
Cyclic voltammetry experiments were recorded using a BAS CV50W electrochemical analyser 
fitted with a three-electrode system consisting of a Pt disk (Ø = 1.8 mm) as the working electrode, 
a Pt wire as an auxiliary electrode and either an Ag/AgNO3 (0.1 M[NEt4][ClO4] in CH3CN) system or 
an additional platinum wire as the reference electrode. Solvents and supporting electrolytes will 
be specified in each chapter. Experiments were conducted at a scan rate of 100 mV/s, unless 
otherwise specified. 
Chapters 2, 3 and 5i: Cyclic voltammetry experiments were conducted in dry acetonitrile solution 
with nBu4NPF6 (0.1 M) as the supporting electrolyte. The reference electrode was an Ag/AgNO3 
(0.1 M[NEt4][ClO4] in CH3CN) system; this was assumed to be stable and was referenced externally 
to ferrocene and decamethylferrocene, which displayed potentials (E1/2) of -0.41 V and +0.10 V 
versus Ag/AgNO3 under these condtions. It was not possible to use ferrocene as an internal 
reference as upon addition (of both Fc and Me10Fc) some form of interaction was observed, 
resulting in the distortion of the complexes redox waves. 
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Chapters 4, 5ii and 6: Cyclic voltammetry experiments were conducted in dry DCM solution with 
nBuNPF6 (0.1 M) as the supporting electrolyte. The reference electrode was a platinum wire, and 
the complexes were internally referenced to ferrocene (Fc/Fc+) for chapter 4, and 
decamethylferrocene for chapters 5ii and 6. 
Solution photophysics 
Solution state photophysical data were obtained using freshly prepared solutions of the 
complexes in the solvent specified. Emission and lifetime measurements were taken using 
thoroughly degassed solutions achieved by three freeze−pump−thaw cycles, and obtained using a 
quartz cuvette with a path length of 1 cm. The solutions had absorbance below 0.10 to minimise 
inner filter effects. All UV-vis absorption measurements were recorded using a Unicam UV2-100 
spectrometer operated with the Unicam Vision(ver. 3.50) software. Baseline correction was 
achieved by reference to pure solvent in the same cuvette. Absorption measurements were 
obtained using quartz cuvettes with a path length of 2 cm. 
Solution PLQYs were recorded in degassed solvent, and determined using the relative method, 
with either quinine sulfate (ΦPL = 0.546 in 0.5 M H2SO4) or Ir(ppy)3 (ΦPL = 0.46 in degassed 
dichloromethane) as the reference. The PLQYs are computed according to the following equation: 
        
     
       
 (
  




where subscripts ‘x’ and ‘ref’ denote the material being measured and the reference, respectively. Φ represents the 
PLQY, Grad is the gradient of the gradient from the plot of integrated fluorescence intensity vs absorbance, and η is the 
refractive index of the solvent. 
 
There is considerable debate in the literature surrounding the PLQY value of Ir(ppy)3, with the 
originally reported value of 0.40 suggested to be inaccurate; values reported vary from 0.40 to 
1.00 in a variety of solvents.1-3 The value used in this thesis was determined by measuring the 
PLQY of Ir(ppy)3 using quinine sulfate as the reference (ΦPL = 0.546 in 0.5 M H2SO4). Fifteen 
solutions of Ir(ppy)3 were measured, and the data was fitted using OLS linear regression, resulting 
in an R2 value of 0.99, and a standard error of 2%, a satisfactory level of accuracy for this 
measurement.   
 
The data for the solutions of Ir(ppy)3 used as a reference were also plotted and fitted using OLS 
linear regression to give an R2 value of 0.99 and a standard error of 2%. This indicates that the 
PLQY for Ir(ppy)3 was consistent across several measurements within the level of accuracy of the  
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Absorption (A.U.)   
Adj. R2 0.99349 
  
Adj. R2 0.98916 
   Value Standard Error 
 
  Value Standard Error 
Intercept 0 -- 
 
Intercept 0 -- 
Slope 1.87E+10 4.05E+08 
 
Slope 2.94E+10 6.88E+08 
 
Figure 7.1: LEFT: Plot of absorbance vs. integrated emission intensity used to determine the PLQY of Ir(ppy)3. RIGHT: 
Plot  of absorbance vs. integrated emission intensity for the reference solutions of Ir(ppy)3 used to determine the 
PLQYs of the complexes described in chapters 2, 3 and 5i. Below each graph are the tables describing the linear fit 
and standard error.  
experiment. 
Chapters 2, 3 and 5i: Excitation and emission spectra were recorded on a Jobin−Yvon−Horiba 
SpexFluoromax 3 Spectrometer. Quantum yields were determined in degassed DCM in 
comparison with a standard [Ir(ppy)3 = 0.46]. Solutions of the complexes in degassed DCM [<10
-5 
M] were used for decay measurements. Samples were excited with a pulsed Nitrogen laser 
emitting at 337.1 nm. Emission was focused onto a spectrograph and detected on a sensitive 
gated iCCD camera (Stanford Computer Optics) with sub-nano-second resolution.  
Chapter 4: Emission spectra for complex 105 were recorded using a custom spectrometer.  The 
sample was excited by the output of a UV-LED (356 nm) and the luminescence collected at 90o 
and imaged onto the entrance slit of a CCD-spectrograph (Ocean Optics MayaPro spectrometer 
equipped with a 100μm entrance slit and a HA1 grating) and controlled by the manufacturer's 
software (SpectraSuite). Spectra were typically acquired using a 1 second integration time and 
averaged over 1-16 spectra and dark signals were subtracted. Emission spectra for the remaining 
complexes were recorded on a Jobin−Yvon−Horiba SpexFluoromax 3 Spectrometer or a Horiba 
Jobin Yvon SPEX Fluorolog 3-22 spectrofluorometer. Quantum yields were determined in 
degassed solvent in comparison with a standard [quinine sulfate = 0.546 in 0.5 M H2SO4]. 
Solutions of the complexes in degassed solvent [<10-5 M] were used for decay measurements. The 
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sample was excited by the output of a pulse laser diode which produced a 1 kHz train of pulses of 
20 ns duration at 405 nm.  The luminescence was collected at 90° and focused onto the entrance 
slit of a monochromator (Bethan TM 300V).  The emission was detected by a photon counting 
PMT and the arrival times of photons at the detector were determined using a multichannel 
scaler.   
Chapters 5ii and 6: Excitation and emission photoluminescence spectra were recorded on a 
Horiba Jobin Yvon SPEX Fluorolog 3-22 spectrofluorometer. Quantum yields were determined in 
degassed DCM in comparison with a standard [quinine sulfate = 0.546 in 0.5 M H2SO4]. Solutions 
of the complexes in degassed DCM [<10-5 M] were used for decay measurements, using the set up 
described for Chapter 4. 
X-ray crystallography 
The X-ray crystal structures for 19, 20, 28, 30, 32 and 165 were solved by Dr Andrei Batsanov 
(Durham University). The X-ray crystal structures for 68, 69 were solved by Dr Dmitry S. Yufit 
(Durham University). The X-ray crystal structure of 145 was solved by Dr Baiqiao Song (Northeast 
Normal University, Jilin, China). 
 
General synthetic procedures 
General procedure for ortho lithiation followed by iodination: 
Procedure A: The substrate (1 eq.) was dissolved in THF (dry) under argon, and the solution was 
cooled to -78 oC. LDA (1.2 eq.) was added dropwise with stirring over 20 min. The solution was 
stirred for 1 h at -78 oC. A solution of I2 (1.1 eq.) in dry THF (30 ml) was added to the flask 
dropwise. The solution was stirred for 90 min then allowed to warm to RT overnight. Once 
warmed, the solution was quenched with an aqueous solution of NaS2O3 to remove unreacted 
LDA and I2. The solution was then extracted with DCM (3 x 75 ml), and the organic phases 
combined, dried over MgSO4, filtered and the solvent was reduced in vacuo. The residue was 
passed through a silica plug (eluent: DCM/ethyl acetate) to remove baseline impurities revealed 
by TLC. The solvent was removed and the crude product was either triturated with cold hexane, 
or purified by column chromatography, to remove any unreacted starting material. The purified 
product was then dried on a high vacuum line to leave pure product. 
Procedure B: nBuLi (1.2 eq.) was added to a stirred solution of DIPA (1.3 eq.) in THF (dry) at 0 oC 
and the solution was stirred for 30 min. The temperature was then lowered to -78 oC and a 
solution of the substrate (1 eq.) in THF (dry) was added in portions via cannula and the mixture 
was stirred for a further 1 h. A solution of I2 (1.1-1.3 eq.) in THF (dry) was added to the flask 
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dropwise. The solution was stirred at -78 oC and allowed to warm to RT overnight. The reaction 
was then worked up as described in procedure A to give the pure product. 
General procedure for sulfone synthesis: 
The iodo compound (1 eq.), the required sodium sulfinate derivative (1.6 eq.) and CuI (1.5 eq.) 
were dissolved in DMF (dry) and stirred under argon. The mixture was heated at 110 oC overnight. 
The mixture was cooled to RT and water (20 ml) and DCM (20 ml) were added. The solid was 
filtered off and washed with more DCM. The organic layer was separated, dried over MgSO4 and 
the solvent was removed in vacuo. The product was then purified by column chromatography to 
give pure product, unless otherwise specified. This is in accordance with the method described in 
the literature.4 
General procedure for synthesis of Iridium pic complexes: 
Method A: IrCl3.3H2O (1 eq.) was added to a stirred solution of the cyclometalating ligand (2.1-2.2 
eq.) in 2-ethoxyethanol. The mixture was heated to reflux at 130 oC under an atmosphere of 
argon overnight. The mixture was then left to cool and the solvent was removed in vacuo. The 
yellow solid, presumed to be the intermediate bis(μ-Cl)dimer complex, was washed with cold 
hexane to remove any free ligand and dried. Where possible, the intermediate bis (μ-Cl) dimer 
was characterised. The dimer was then suspended in 2-ethoxyethanol and picolinic acid (<3 eq.) 
was added. The mixture was stirred and heated to reflux (130 oC) under an atmosphere of argon 
overnight. The mixture was allowed to cool to room temperature and the solvent was removed. 
The product was then purified by column chromatography to give pure product, unless otherwise 
specified. 
Method B: The reaction was conducted via a one-pot method, as a result the intermediate bis(μ-
Cl) dimer was not isolated. Otherwise, the reaction was conducted as described in Method A. 
 
Experimental details for chapter 2: complexes of ligands containing difluoro and sulfone 
substituents as blue OLED materials 
2-(2,4-Difluorophenyl)pyridine 13 
A solution of 2-bromopyridine 11 (15.60 g, 98.7 mmol) and 2,4-
difluorophenylboronic acid 12 (16.50 g, 104.5 mmol) in 1,4-dioxane (200 ml) was 
degassed with argon for 30 min. Separately a 2 M solution of Na2CO3 (12.72 g in 60 
ml water) was degassed with argon for 20 min. The solutions were combined and 
Pd(PPh3)4 (0.51 g, 0.44 mmol) was added. The mixture was refluxed and stirred 
vigorously at 90 oC for 20 h. Once cooled the reaction mixture was poured into distilled water (ca. 
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100 ml) and the aqueous layer was extracted with DCM (3 x 150 ml). The organic phase was dried 
over MgSO4 and concentrated in vacuo. The product 13 was separated from the crude reaction 
mixture via vacuum distillation (bpt. 125-130 oC, 20 mbar), leaving a pale yellow oil (18.35 g, 96%); 
δH (400 MHz; CDCl3; Me4Si) 8.71 (1H, dt, J 4.0 1.4), 8.00 (1H, td, J 8.8 6.6), 7.72-7.80 (2H, m), 7.23-
7.30 (1H, m), 7.01 (1H, dddd, J 8.8 7.8 2.6 1.0), 6.92 (1H, ddd, J 11.3 8.8 2.5); δF (400 MHz, CDCl3, 
Me4Si) -109.30 (1F, p, J 7.8), -112.97 (1F, q, J 9.5). NMR data are consistent with the literature 
data.5 
2-(2,4-Difluoro-3-iodophenyl)pyridine 14 
Method 1: The reaction was conducted using the general procedure A for lithiation 
followed by iodination. The following reagents were used in the stated quantities: 2-
(2,4-difluorophenyl)pyridine 13 (5.00 g, 26.15 mmol), LDA (15.7 ml, 2 M in THF), I2 
(7.30 g, 28.77 mmol) and THF (70 ml, dry). The reaction was worked up as described 
in the general procedure, and the product was purified by trituration with cold 
hexane to remove any unreacted starting material. The purified product was then dried on the 
high vacuum line to leave a pale pink tinged solid, 2-(2,4-difluoro-3-iodophenyl)pyridine 14 (5.59 
g, 67%); δH (400 MHz, CDCl3, Me4Si)  8.70 (1H, ddd, J 4.8 1.8 1.0), 7.98 (1H, td, J 8.7 6.5), 7.70-7.80 
(2H, m), 7.29 (1H, td, J 4.9 2.4), 7.03 (1H, ddd, J 8.7 6.9 1.5); δF (400 MHz, CDCl3, Me4Si) -91.08 (1F, 
q, J 5.6), -98.94 (1F, d, J 8.0). NMR data are consistent with the literature data.6 
Method 2: The reaction was conducted using the general procedure B for lithiation followed by 
iodination. The following reagents were used in the stated quantities: nBuLi (7.06 ml, 2.5 M), DIPA 
(2.67 ml, 19.05 mmol) in THF (35 ml, dry), 2-(2,4-difluorophenyl)pyridine 13 (2.81 g, 14.7 mmol) in 
THF (dry, 20 ml), I2 (4.66 g, 18.36 mmol) in THF (10 ml, dry). The reaction was worked up as 
described in the general procedure, and purified as described above to give 14 (2.67 g, 65%). 
2-(2,4-Difluoro-3-[methanesulfonyl]phenyl)pyridine 15 
Method 1: The reaction was conducted using the general procedure for sulfone 
synthesis. The following reagents were used in the stated quantities: 2-(2,4-
difluoro-3-iodophenyl)pyridine 14 (1.00 g, 3.15 mmol), sodium methanesulfinate 
(0.515 g, 5.05 mmol), copper iodide (0.90 g, 4.73 mmol), DMF (3 ml, dry). The 
reaction was worked up as described in the general procedure, and purified by 
column chromatography (4% EtOAc in DCM, increased to 20% EtOAc in DCM). The product was 
then recrystallised from a mixture of hexane and DCM to give 15 as a white solid (0.133, 15%); 
m.pt. 95.2-97.0 oC; δH (400 MHz; CDCl3; Me4Si) 8.72 (1H, dt, J 4.8 1.4), 8.27 (1H, td, 8.6 6.0), 7.71-
7.87 (2H, m), 7.32 (1H, ddd, J 6.7 4.8 2.1), 7.18 (1H, td, 9.2 1.6), 3.34 (3H, s); δF (376 MHz, CDCl3, 
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Me4Si) -106.14 (1F, dd, J 9.3 6.2), -111.50 (1F, d, J 8.3); δC (101 MHz, CDCl3, Me4Si) 159.86 (dd, J 
262.6 4.0), 157.50 (dd, J 262.6 3.9), 150.89, 150.18, 137.32 (dd, J 10.9 5.8), 136.90, 125.80 (dd, J 
13.7 4.1), 124.63 (d, J 9.5), 123.42, 118.55 (dd, J 17.3 15.5), 113.80 (dd, J 23.1 4.0), 45.88 (t, J 2.4); 
HRMS (FTMS+ESI): calcd for [C12H9F2NO2S+H]
+: 270.03948. Found: 270.03938. 
Method 2: i) Copper(II) sulphate (0.38 g, 2.37 mmol) was dissolved in water (10 ml). Sodium 
methanesulfinate (0.48 g, 4.73 mmol) was added. The solution changed from blue to green and a 
white precipitate formed. The solution was filtered and the water evaporated to leave an orange-
brown solid. The solid was washed with DCM and dried on the high vacuum line for 3 h. It was 
then dried in the oven overnight at 50 oC and dried on the vacuum line for a further 4 h to give an 
orange-brown solid, presumed to be copper(II) bis(methanesulfinate). 
ii) 2-(2,4-difluoro-3-iodophenyl)pyridine 14 (1.00 g, 3.15 mmol) and the orange-brown solid were 
dissolved in DMF (3 ml, dry) and stirred under argon, and the mixture was heated at 110 oC 
overnight. The mixture was cooled to RT and water (20 ml) and DCM (20 ml) were added. The 
solid was filtered off and washed with more DCM. The organic layer was separated, dried over 
MgSO4 and the solvent was removed in vacuo. The crude product mixture was separated by 
column chromatography (1:2 EtOAc in DCM, increased to 1:1). Unreacted starting material was 
recovered, and 15 was obtained as a white crystalline solid (0.150 g, 17%). The NMR data was 
consistent with that obtained previously. 
The reaction was repeated using copper(II) sulphate pentahydrate (0.59 g, 2.36 mmol), sodium 
methanesulfinate (0.48 g, 4.73 mmol) and 2-(2,4-difluoro-3-iodophenyl)pyridine 14 (1.00 g, 3.15 
mmol). The copper compound which formed was dried for 72 h in the oven and the reaction was 
heated at 110 oC for 72 h. The reaction was worked up as before and the product was obtained, 2-
(2,4-difluoro-3-[methanesulfonyl]phenyl)pyridine 15 (109 mg, 13%). The NMR data was consistent 
with that obtained previously. 
2-(2,4-Difluoro-3-[methanesulfonyl]phenyl)pyridine 15 and 2-(2-fluoro-3,4-
di[methanesulfonyl]phenyl)pyridine 29 
The reaction was conducted using the general procedure for sulfone synthesis. The 
following reagents were used in the stated quantities: 2-(2,4-difluoro-3-
iodophenyl)pyridine 141 (1.00 g, 3.15 mmol), sodium methanesulfinate (0.515 g, 
5.05 mmol), CuI (0.90 g, 4.73 mmol), DMF (3 ml, dry). The reaction was worked up 
as described in the general procedure, and the crude product mixture was 
subjected to column chromatography (1:2 EtOAc in DCM, increased to 1:1 to elute final fraction). 
                                                          
1 The 2-(2,4-difluoro-3-iodophenyl)pyridine 14 used for this experiment was from a batch containing trace iodine. 
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Upon NMR analysis a mixture of products was revealed. The mixture was columned for a second 
time (10% EtOAc in DCM) to give two white solid products, 2-(2,4-difluoro-3-
[methanesulfonyl]phenyl)pyridine 15 (125 mg, 15%) and 2-(2-fluoro-3,4-
di[methanesulfonyl]phenyl)pyridine 29 (56 mg, 5%); m.pt. 194.0-198.1 oC; δH (400 MHz; CDCl3; 
Me4Si) 8.78 (1H, d, J 4.7), 8.46 (1H, dd, J 8.4 6.9), 8.28 (1H, dd, J 8.3 1.1), 7.83 – 7.91 (2H, m), 7.81 
– 7.76 (m, 1H), 7.35 – 7.44 (1H, m), 3.58 (3H, s), 3.49 (3H, s); δF (376 MHz, CDCl3, Me4Si) -106.57 
(1F, d, J 6.9); δc (101 MHz, CDCl3, Me4Si) 159.10 (d, J 265.4), 150.49, 150.13 (d, J 1.8), 143.03, 
137.01, 136.64 (d, J 5.2), 135.16 (d, J 15.3), 129.59 (d, J 14.7), 128.15 (d, J 3.5), 125.20 (d, J 9.8), 
124.34, 46.27, 45.28; HRMS (FTMS+ESI): calcd for [C13H12FNO4S2+H]
+: 330.0270. Found: 330.0273. 
As the starting material 14 appeared to be contaminated with iodine the reaction was repeated 
using rigorously purified 14 (1.00 g, 3.15 mmol), sodium methanesulfinate (0.515 g, 5.05 mmol), 
CuI (0.90 g, 4.73 mmol) and additional iodine (27 mg, 0.10 mmol, 3 mole %). The reaction was 
worked up as before to give 2-(2,4-difluoro-3-[methanesulfonyl]phenyl)pyridine 15  (124 mg, 
15%) and 2-(2-fluoro-3,4-di[methanesulfonyl]phenyl)pyridine 29 (24 mg, 2%). 
 
2-(2,4-Difluoro-3-[(4-methylbenzene)sulfonyl]phenyl)pyridine 16 
The reaction was conducted using the general procedure for sulfone synthesis. 
The following reagents were used in the stated quantities: 2-(2,4-difluoro-3-
iodophenyl)pyridine 14 (2.67 g, 8.42 mmol), sodium p-toluenesulfinate (2.40 g,  
13.47 mmol), CuI (2.40 g, 12.60 mmol), DMF (15 ml, dry). The reaction was worked 
up as described in the general procedure, and the product was purified by column 
chromatography (EtOAc (0-5%) in DCM), followed by recrystallisation from a hexane/DCM 
mixture to give 16 as white crystals (550 mg, 20%); m.pt. 99.5-100.9 oC; δH (400 MHz; CDCl3; 
Me4Si) 8.64 (1H, d, J 5.2), 8.15 (1H, td, J 8.6, 6.0), 7.95 (2H, d, J 8.0), 7.70-7.81 (2H, m), 7.30 (2H, d, 
J 8.1) 7.23-7.27 (1H, m), 7.07 (1H, td, J 9.2, 1.6), 2.38 (3H, s); δF (376 MHz; CDCl3; Me4Si) -105.24 
(1F, t, J 7.5), -110.44 (1F, d, J 8.1); HRMS (FTMS+ESI): calcd for [C18H13F2NO3S+H]
+: 346.0713. 
Found: 346.0692. NMR data is consistent with the literature data.7 
 
2-(2,4-Difluoro-3-[(4-methylbenzene)sulfonyl]phenyl)pyridine 16 
The reaction was conducted using the general procedure for sulfone synthesis. The following 
reagents were used in the stated quantities: 2-(2,4-difluoro-3-iodophenyl)pyridine 142  (3.00 g, 
9.46 mmol), sodium p-toluenesulfinate (2.70 g, 15.14 mmol) and CuI (2.70 g, 14.19 mmol). The 
reaction was worked up as described in the general procedure, and the product was purified by 
                                                          
2
 The 2-(2,4-difluoro-3-iodophenyl)pyridine 14 used for this experiment was from a batch containing trace iodine. 
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column chromatography (EtOAc (0-5%) in DCM) and the product was recrystallised from a 
hexane/DCM mixture to give 16 as white crystals (1.32 g, 40%). The NMR data was consistent with 
that obtained previously. 
 
Iridium complex 19 
The reaction was conducted as described in the general 
procedure for synthesis of iridium pic complexes, 
Method A. The following reagents were used in the 
stated quantities: IrCl3.3H2O (107 mg, 0.30 mmol), 2-(2,4-
difluoro-3-[methanesulfonyl]phenyl)pyridine 15 (180 mg, 
0.67 mmol), picolinic acid (154 mg, 1.25 mmol) and 2-
ethoxyethanol (10 ml). Attempted purification of a small 
portion of the intermediate μ-dichloro dimer resulted in 
rapid decomposition under ambient conditions, so no characterization data were obtained. The 
reaction was worked up according to the general procedure, and purified by column 
chromatography (DCM:acetone, 1:1) to leave 19 as a yellow solid (190 mg, 85%); Anal. Calc. for 
C30H20F4IrN3O6S2: C, 42.35; H, 2.37; N, 4.94. Found: C, 42.17; H, 2.23; N, 4.88; δH (700 MHz; CDCl3; 
Me4Si) 8.75 (1H, dt, J 5.8, 1.3, HD6), 8.39 (1H, d, J 8.4, HB3), 8.35 (1H, d, J 7.8, HA3), 8.34 (1H, d, J 8.8, 
HD3), 8.04 (1H, td, J 7.8, 1.6, HA4), 7.93 (1H, td, J 6.4, 1.6, HB4), 7.91 (1H, td, J 6.4, 1.7, HD4), 7.75 (1H, 
dt, J 5.1, 1.4, HA6), 7.54 (1H, ddd, J 7.8, 5.4, 1.5, HA5), 7.45 (1H, dd, J 5.7, 1.4, HB6), 7.35 (1H, ddd, J 
7.3, 5.8, 1.4, HD5), 7.14 (1H, ddd, J 7.4, 5.8, 1.4, HB5), 5.97 (1H, d, J 10.0, HE6), 5.73 (1H, d, J 10.1, 
HC6), 3.27 (3H, s, HE7), 3.21 (3H, s, HC7); δF (376 MHz, CDCl3, Me4Si) -105.12 (1F, d, 9.8), -106.30 (1F, 
d, 10.0), -109.57 (1F, s), -110.28 (1F, s); δC (176 MHz; CDCl3; Me4Si) 172.36 (s, CA7), 164.19 (d, J 
6.8,CB2), 162.97 (d, J 6.4, CD2), 161.34 (d, J 8.1, CC2), 160.60 (d, J 8.5, CE2), 159.66 (dd, J 268.2, 2.82, 
CE5),  159.19 (dd, J 266.4, 3.0, CC5), 157.54 (dd, J 271.1, 3.50, CE3), 157.33 (dd, J 270.0, 4.5, CC3), 
151.11 (s, CA2), 148.89 (s, CD6), 148.41 (s, CB6), 148.32 (s, CA6), 139.58 (s, CB/D4), 139.57 (s, CB/D4), 
139.46 (s, CA4), 130.10 (m, CC1), 129.92 (m, CE1), 129.18 (s, CA3/5), 129.11 (s, CA3/5), 124.49 (d, J 21.8, 
CB3), 124.21 (s, CD5), 124.14 (s, CB5), 124.00 (d, J 20.6, CD3), 116.64 (d, J 19.3, CE6), 116.45 (d, J 19.1, 
CC6),111.83 (t, J 16.6, CC4), 111.22 (t, J 16.5, CE4), 45.94 (s, CC7/E7), 45.90 (s, CC7/E7); HRMS 
(FTMS+ESI): calcd for [C30H20F4N3O6S2
191Ir+H]+: 850.0414. Found: 850.0439. 
 
Iridium complex 20 
The reaction was conducted as described in the general procedure for synthesis of iridium pic 
complexes, Method A. The following reagents were used in the stated quantities:  IrCl3.3H2O (278 
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mg, 0.79 mmol), 2-(2,4-difluoro-3-[(4-
methylbenzene)sulfonyl]phenyl)pyridine 16 (600 mg, 1.78 
mmol), 2-ethoxyethanol (20 ml) to give the intermediate μ-
dichloro dimer as a yellow solid (700 mg, 96%); δH (400 MHz; 
CDCl3; Me4Si) 8.91 (4H, dd, J  6.2, 1.4), 8.35 (4H, d, J  8.5), 
7.88-7.94 (4H, m), 7.83 (8H, d, J  8.1), 7.24 (8H, d, J  8.5), 6.87 
(4H, ddd, J  7.4, 5.8, 1.4), 5.24 (4H, d, J  10.6), 2.36 (12H, s); δF (376 MHz; CDCl3; Me4Si) -105.27 
(4F, d, J  10.4), -109.88 (4F, s); HRMS (FTMS+ESI): calcd for [C72H48Cl2F8
191Ir2N4O8S4+Na2]
2+: 
939.0320. Found: 939.0303. 
The reaction was continued as described in the general Method A. The following reagents were 
used in the stated quantities: Ir dimer (500 mg, 0.27 mmol), picolinic acid (336 mg, 2.73 mmol), 2-
ethoxyethanol (10 ml). The reaction was worked up as previously described, and the product was 
purified by column chromatography (THF/DCM, 3:7 v/v), followed by recrystallisation from 
DCM/hexane to leave 20 as a yellow solid (421 mg, 77%). Anal. Calc. for C42H28F4IrN3O6S2: C 50.29; 
H 2.81; N 4.19. Found: C 50.03; H 2.96; N 4.01; δH (400 MHz; acetone-d6, Me4Si) 8.65 (1H, dt, J  
5.7, 1.1), 8.37 (2H, t, J  8.3), 8.19–8.07 (4H, m), 7.94 (1H, d, J  5.2), 7.87 (4H, t, J  7.6), 7.80 (1H, d, J  
5.8), 7.62 (1H, ddd, J  6.6, 5.4, 2.6), 7.55 (1H, ddd, J  7.4, 5.8, 1.4), 7.43-7.34 (5H, m), 6.01 (1H, d, J  
10.7), 5.70 (1H, d, J  10.6), 2.41 (3H, s), 2.40 (3H, s); δF (376 MHz; acetone-d6; Me4Si) -107.87 (1F, 
dd, J  10.7, 4.1), -108.61 (1F, dd, J  10.6, 3.6), -110.89 (1F, s), -111.59 (1F, s); HRMS (FTMS+ESI): 
calcd for [C42H28O6N3F4
191IrS2+Na]
+: 1026.0883. Found: 1026.0870. Crystals for X-ray analysis were 
grown by slow evaporation of a DCM/hexane solution of 20.  
 
2-Chloro-4-(2,4,6-trimethylphenyl)pyridine 23 
A solution of 2-chloro-4-iodo-pyridine 21 (5.00 g, 20.88 mmol) and 2,4,6-
trimethylphenylboronic acid 22 (3.46 g, 21.09 mmol) in 1,4-dioxane (50 ml) 
was degassed for 20 min. Separately, a solution of K3PO4 (5.63 g, 26.52 mmol 
in 15 ml) was degassed for 15 min. The solutions were combined, PCy3 (117 
mg, 0.42 mmol) and Pd2(dba)3 (191 mg, 0.21 mmol) was added. The mixture was degassed for a 
further 5 min and then heated to reflux under an atmosphere of argon for 3 days with stirring. 
The mixture was allowed to cool and the solution volume was halved in vacuo, followed by 
addition of DCM (50 ml). The layers were separated, and the organic layer was washed with water 
(2 x 30 ml) then dried over MgSO4. The residue was purified by column chromatography 
(hexane:EtOAc 1:4). The product containing fractions were combined and the solvent removed. 
Any residual 2-chloro-4-iodo-pyridine 21 was distilled using a Kugelrohr apparatus to leave 2-
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chloro-4-(2,4,6-trimethylphenyl)pyridine 23 as a clear oil (2.68 g, 6.90 mmol, 69%); δH (400 MHz; 
CDCl3; Me4Si) 8.78 (1H, dd, J 5.0 0.9), 8.10 (1H, td, J 8.8 6.7), 7.61 (1H, dt, J 2.3 1.1), 7.11 (1H, dd, J 
4.9 1.5), 7.05 (1H, dddd, J 8.8 7.8 2.6 1.0), 7.00 (2H, s), 6.93 (1H, ddd, J 11.3 8.8 2.5), 2.37 (3H, s), 
2.07 (6H, s); δF (376 MHz, CDCl3, Me4Si) -109.16 (1F, m), -112.69 (1F, q, J 9.4). NMR data were 
consistent with the literature.8 
 
2-(2,4-Difluorophenyl)-4-(2,4,6-trimethylphenyl)pyridine 24 
A solution of 2-chloro-4-(2,4,6-trimethylphenyl)pyridine 23 (1.88 g, 8.11 
mmol), 2,4-difluorophenylboronic acid  12 (1.92 g, 12.2 mmol), Pd(OAc)2 (111 
mg, 0.49 mmol) and triphenylphosphine (551 mg, 2.10 mmol) in 1,2-
dimethoxyethane (70 ml) was degassed with argon for 25 min. Separately a 2 
M aqueous solution of Na2CO3 (3.51 g, 33.11 mmol in 17 ml) was degassed for 
15 min. The solutions were combined and the mixture was heated to reflux 
under argon atmosphere for 24 h. The reaction mixture was then cooled to room temperature 
and DCM (50 ml) was added, followed by brine (50 ml). The organic layer was separated and dried 
over MgSO4. The solvent was removed in vacuo and the residue was purified by column 
chromatography (EtOAc:hexane 1:6 v:v) to give 24 as a yellow-tinged liquid (2.38 g, 95%); δH (400 
MHz; CDCl3; Me4Si) 8.78 (1H, dd, J 5.0 0.9), 8.10 (1H, td, J 8.8 6.7), 7.61 (1H, dt, J 2.3 1.1), 7.11 (1H, 
dd, J 4.9 1.5), 7.05 (1H, dddd, J 8.8 7.8 2.6 1.0), 7.00 (2H, s), 6.93 (1H, ddd, J 11.3 8.8 2.5), 2.37 
(3H, s), 2.07 (6H, s); δF (376 MHz, CDCl3, Me4Si) -109.16 (1F, m), -112.69 (1F, q, J 9.4). NMR data 
were consistent with the literature.8  
 
2-(2,4-Difluoro-3-iodophenyl)-4-(2,4,6-trimethylphenyl)pyridine 25 
Method 1: The reaction was conducted using the general procedure A for 
lithiation followed by iodination. The following reagents were used in the 
stated quantities: 2-(2,4-difluorophenyl)-4-(2,4,6-trimethylphenyl)pyridine 24 
(800 mg, 2.59 mmol), LDA (1.55 ml, 2M in THF), I2 (689 mg, 2.71 mmol in 5 ml 
THF, dry) and THF (20 ml). The reaction was worked up as described in the 
general procedure, and the product was purified by column chromatography 
(EtOAc (0-2%) in DCM) and impure fractions were further purified by using the Biotage® Isolera 
One ™ purification system to leave 25 as a white semi-solid (360 mg, 32%); δH (400 MHz, CDCl3, 
Me4Si); 8.77 (1H, dd, J 5.0 0.9), 8.07 (1H, td, J 8.7 6.4), 7.59 (1H, dt, J 2.4 1.3), 7.12 (1H, dd, J 4.9 
1.5), 7.05 (1H, ddd, J 8.6 6.9 1.5), 6.98 (2H, s), 2.35 (3H, s), 2.06 (6H, s); δF (376 MHz, CDCl3, Me4Si) 
-90.98 (1F, q, J 5.7), -93.59 – -93.67 (1F, m); δC (101 MHz, CDCl3, Me4Si) δC (101 MHz, CDCl3, Me4Si) 
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161.85 (dd, J 249.4 5.4), 158.83 (dd, J 250.2 5.9), 152.15 (d, J 3.4), 150.31, 150.07, 137.75, 136.13, 
135.20, 132.31 (dd, J 9.2, 4.2), 128.50, 125.50 (d, J 9.4), 124.46 (dd, J 14.4, 3.7), 123.96, 111.94 (d, 
J 3.7), 111.71 (d, J 3.7), 72.01 (dd, J 30.9, 29.3), 21.16, 20.71; HRMS (FTMS+ESI): calcd for 
[C20H16NF2I+H]
+: 436.0374. Found: 436.0378. 
Method 2: The reaction was conducted using the general procedure B for lithiation followed by 
iodination. The following reagents were used in the stated quantities: nBuLi (3.69 ml, 2.5 M), DIPA 
(1.40 ml, 9.99 mmol), 2-(2,4-difluorophenyl)-4-(2,4,6-trimethylphenyl)pyridine 24 (2.38 g, 7.68 
mmol), I2 (2.14 g, 8.43 mmol) and THF (45 ml, dry). The reaction was worked up as described in 
the general procedure, and purified using the Biotage® Isolera One ™ purification system to leave 
25 as a white semi-solid (2.50 g, 75%). 
 
2-(2,4-Difluoro-3-[methanesulfonyl]phenyl)-4-(2,4,6-trimethylphenyl)pyridine 26 
The reaction was conducted using the general procedure for sulfone 
synthesis. The following reagents were used in the stated quantities: 2-(2,4-
difluoro-3-iodophenyl)-4-(2,4,6-trimethylphenyl)pyridine 25 (657 mg, 1.51 
mmol), sodium methanesulfinate (247 mg, 2.42 mmol), CuI (431 mg, 2.26 
mmol) and DMF (3 ml, dry). The reaction was worked up as described in the 
general procedure, and the product was purified by column chromatography 
(2.5% EtOAc in DCM, increased to 10% v/v) to give 26 as an off-white solid  (130 mg, 22%); m.pt. 
74.6-77.5 oC; δH (400 MHz; CDCl3; Me4Si) 8.77 (1H, d, J 5.0), 8.36 (1H, td, J 8.6 6.0), 7.58-7.64 (1H, 
m), 7.21 (1H, td, J 9.0, 1.5), 7.13-7.17 (1H, m), 6.96 (2H, d, J 1.1), 3.33 (3H, s), 2.33 (3H, s), 2.03 
(6H, s); δF (376 MHz, CDCl3, Me4Si) -106.14 (1F, dd, J 10.2, 8.6), -111.40 (1F, d, J 11.0); δC (101 
MHz, CDCl3, Me4Si) 159.81 (dd, J 262.6, 4.0), 157.46 (dd, J 262.0, 4.0), 156.18 (d, J 3.9), 151.00 (d, J 
2.1), 150.59, 150.25, 137.83, 137.31 (dd, J 10.8, 5.7), 135.79, 135.03, 128.47, 125.96 – 125.56 (m), 
124.43, 118.54 (dd, J 17.6, 15.5), 113.77 (dd, J 23.1, 3.9), 45.79 (t, J 2.4), 21.09, 20.64; HRMS 
(FTMS+ESI): calcd for [C21H19F2NO2S +H]
+: 388.1183. Found: 388.1170. 
Ir complex 28 
The reaction was conducted as described in the general 
procedure for synthesis of Iridium pic complexes, Method A. 
The following reagents were used in the stated quantities:  
IrCl3.3H2O (40 mg, 0.11 mmol), 2-(2,4-difluoro-3-[(4-
methylbenzene)sulfonyl]phenyl)pyridine 26 (90 mg, 0.232 
mmol), 2-ethoxyethanol (6 ml) to give the intermediate μ-
dichloro dimer 27 as a yellow solid. A small sample was set 
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aside for purification, and the NMR spectra of the product was consistent with the intermediate 
bis(μ-Cl)dimer complex: δH (400 MHz; CDCl3; Me4Si) 9.52 (4H, d, J 5.9), 8.23 (4H, s), 6.97-7.05 
(12H, m), 5.34 (4H, d, J 10.8), 3.18 (3H, s), 2.40 (3H, s), 2.11 (3H, s), 2.07 (3H, s); δF (376 MHz, 
CDCl3, Me4Si) -105.73 (4F, d, J 12.0), -110.17 (4F, s). 
The reaction was continued as described in the general Method A. The following reagents were 
used in the stated quantities: Ir dimer, picolinic acid (90 mg, 0.731 mmol) and 2-ethoxyethanol (6 
ml). The reaction was worked up as previously described, and the product was purified by column 
chromatography (30% EtOAc in DCM) to leave Ir complex 28 as a yellow solid (105 mg, 85%); Anal. 
Calc. for C48H40F4IrN3O6S2.0.5CH2Cl2: C, 51.57; H, 3.66; N, 3.72. Found: C, 51.32; H, 3.62; N, 3.69; δH 
(400 MHz; CDCl3; Me4Si) 8.82 (1H, dd, J 6.0 0.7), 8.40 – 8.48 (1H, m), 8.21 (1H, t, J 1.7), 8.15  (1H, t, 
J 1.7), 8.09 (td, J 7.8 1.6), 7.89 (1H, ddd, J 5.4 1.6 0.8), 7.60 (1H, ddd, J 7.8 5.3 1.5), 7.50 (1H, dd, J 
6.0 0.7), 7.21 (1H, dd, J 5.9 1.7), 6.95 – 7.04 (5H, m), 5.94 (1H, d, J 10.3), 5.73 (1H, d, J 10.4), 3.25 
(3H, s), 3.20 (3H, s), 2.35 (6H, s), 2.12 (3H, s), 2.09 (3H, s), 1.96 (3H, s); δF (376 MHz, CDCl3, Me4Si) -
105.58 (1F, dd, J 10.9 3.5), -106.77 (1F, dd, J 11.4 3.3), -109.82 (1F, d, J 4.1), -110.61; HRMS 
(FTMS+ESI): calcd for [C48H40F4N3O6S2
191Ir + H]+: 1086.1979. Found: 1086.1978.   
Iridium complex 30 
The reaction was conducted as described in the general 
procedure for synthesis of Iridium pic complexes, Method A. 
The following reagents were used in the stated quantities: 
IrCl3.3H2O (94 mg, 0.27 mmol), 2-(2-fluoro-3,4-
bis(methylsulfonyl)phenyl)pyridine 29 (194 mg, 0.59 mmol), 
and 2-ethoxyethanol (8 ml) to give an orange-yellow solid 
presumed to be the bis(μ-Cl)dimer, which was used without further purification. Due to its very 
poor solubility NMR data could not be obtained.  
The reaction was continued as described in the general Method A. The following reagents were 
used in the stated quantities: Ir dimer, picolinic acid (245 mg, 1.99 mmol), 2-ethoxyethanol (8 ml). 
The reaction was worked up as described in the general procedure, and the product was purified 
by column chromatography (DCM:Acetone 1:1 v/v) to give 30 as a yellow solid (208 mg, 80%); 
Anal. Calc. for C32H26F2IrN3O10S4: C, 39.58; H, 2.70; N, 4.33. Found: C, 39.42; H, 2.61; N, 4.42; δH 
(400 MHz; CDCl3; Me4Si); 8.85 (1H, d, J 5.2), 8.52 (1H, d, J 8.6), 8.48 (1H, d, J 8.6), 8.36 (1H, d, J 
7.5), 7.97-8.10 (3H, m), 7.70 (1H, d, J 5.2), 7.62 (1H, d, J 6.0), 7.57 (1H, t, J 6.4), 7.49 (1H, t, J 6.4), 
7.29 (1H, t, J 6.6), 7.14 (1H, s), 6.83 (1H, s), 3.43 (3H, s), 3.41 (3H, s), 3.37 (3H, s), 3.36 (3H, s); δF 
(376 MHz, CDCl3, Me4Si) -105.51 (1F, s), -106.32 (1F, s); HRMS (FTMS+ESI): calcd for 
[C32H26F2N3O10S4
191Ir+H]+: 970.0153. Found: 970.0177. Crystals for X-ray analysis were grown by 
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slow evapouration of a DCM/acetonitrile mixture of 30. 
 
Iridium complex 31 
IrCl3.3H2O (69 mg, 0.20 mmol) was added to a stirred 
solution of 2-(2,4-difluoro-3-
[methanesulfonyl]phenyl)pyridine 15 (116 mg, 0.67 
mmol) in 2-ethoxyethanol (8 ml). The mixture was 
heated to reflux at 130 oC under an atmosphere of 
argon overnight. The mixture was then left to cool and 
the solvent was removed in vacuo to leave a yellow 
solid, presumed to be the bis(μ-Cl)dimer, which was 
used without further purification. The dimer was dissolved in ethylene glycol (8 ml) and the 2-
(2,4-difluoro-3-[methanesulfonyl]phenyl)pyridine 15 (58 mg, 0.22 mmol), NEt3 (0.1 ml) and 
acetylacetone (0.1 ml) were added. The mixture was stirred under argon and heated to reflux at 
190 oC overnight. The mixture was then left to cool. DCM (25 ml) and water (25 ml) were added 
and the organic layer was separated and washed with water (2 x 60 ml) to remove the majority of 
the ethylene glycol. The solvent was removed in vacuo to leave a brown liquid residue. This was 
washed with water (5 ml) to remove any residual ethylene glycol. The residue was then purified 
by column chromatography (DCM/Methanol 29:1 followed by DCM/EtOAc 80:20) to give iridium 
complex 31 as a yellow solid (56 mg, 29%); δH (700 MHz; CD2Cl2; Me4Si) 9.03 (1H, ddd, J 5.7, 1.7, 
0.8, HA6), 8.49 (1H, d, J 8.5, HA3), 8.27 (1H, d, J 8.5, HC3), 8.10 (1H, ddd, J 5.7, 1.7, 0.8, HC6), 8.00 (1H, 
td, J 8.0, 7.4, 1.6, HA4), 7.85 (1H, ddd, J 8.2, 7.4, 1.7, HE4), 7.82 (1H, ddd, J 8.4, 7.6, 1.6, HC4), 7.73 
(1H, dd, J 8.0, 1.1, HE3), 7.52 (1H, dd, J 8.8, 6.0, HF3), 7.47 (1H, ddd, J 5.7, 1.7, 0.8, HE6), 7.35 (1H, 
ddd, J 7.3, 5.7, 1.4, HA5), 6.98 (1H, ddd, J 7.4, 5.8, 1.4, HC5), 6.96 (1H, ddd, J 7.4, 5.8, 1.4, HE5), 6.33 
(1H, dd, J 10.6, 8.8, HF4), 5.93 (1H, d, J 10.5, HB6), 5.71 (1H, d, J 10.5, HD6), 3.20 (3H, s, HB/D7), 3.19 
(3H, s, HB/D7), 2.74 (3H, s, HF7); δF (376 MHz, CDCl3, Me4Si) -105.39 (1F, dd, J 10.1, 6.2), -105.70 (1F, 
dd, J 10.1, 2.8), -106.70 (1F, dd, J 9.9, 2.6), -109.10 (1F, s), -109.94 (1F, s); δC (176 MHz, CDCl3, 
Me4Si) 167.68 (CF1), 163.85 (CC2), 162.72 (CA2), 162.45 (CF5), 159.03 (CB5, J 262.5), 158.33 (CD5, J 
272.9), 155.38 (CE2), 150.91 (CC6), 150.41 (CE6), 149.08 (CA6), 139.94 (CA4), 139.68 (CC4), 139. 53 
(CE4), 136.07 (CF3), 131.78 (CD1), 130.56 (CB1), 125.92 (CE3), 125.71 (CF2), 124.98 (C A3), 124.51 (CC3), 
124.26 (CA5), 123.82 (CE5), 123.19 (CC5), 120.95 (CF6), 117.23 (CB6, d, J 18.1), 116.46 (CD6, d, J 17.8), 
104.60 (CF4, d, J 24.1), 46.33 (CB+D7), 45.49 (CF7); HRMS (FTMS+ESI): calcd for 
[C36H25F5N3O7S3
191Ir+H]+: 994.0459. Found: 994.0478. 
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Iridium complex 32 
IrCl3.3H2O (136 mg, 0.39 mmol) was added to a stirred 
solution of 2-(2,4-difluoro-3-[(4-
methylbenzene)sulfonyl]phenyl)pyridine 16 (293 mg, 0.85 
mmol) in 2-ethoxyethanol (10 ml). The mixture was heated 
to reflux at 130 OC under an atmosphere of argon 
overnight. The mixture was then left to cool and the 
solvent was removed in vacuo to leave a yellow solid, presumed to be the bis(μ-Cl)dimer, which 
was used without further purification. The dimer was dissolved in ethylene glycol (8 ml) and the 2-
(2,4-difluoro-3-[(4-methylbenzene)sulfonyl]phenyl)pyridine 16 (130 mg, 0.38 mmol), NEt3 (0.1 ml) 
and acetylacetone (0.1 ml) were added. The mixture was stirred under argon and heated to reflux 
at 190 OC overnight. The mixture was then left to cool. DCM (25 ml) and water (25 ml) were added 
and the organic layer was separated and washed with water (2 x 60 ml) to remove the majority of 
the ethylene glycol. The solvent was removed in vacuo to leave a brown liquid residue. The 
residue was then purified by column chromatography (DCM/Methanol 29:1 followed by 
DCM/EtOAc 80:20) to give iridium complex 32 as a yellow solid (110 mg, 23%); Anal. Calc. for 
C54H35F5IrN3O7S3: C, 53.11; H, 2.89; N, 3.44. Found: C, 52.64; H, 2.89; N, 3.37; δH (400 MHz; CDCl3; 
Me4Si) 8.36 (1H, d, J 8.5), 8.25 (1H, d, J 8.5), 7.93 (3H, dd, J 6.3, 1.8), 7.89 – 7.78 (4H, m), 7.71 (2H, 
tdd, J 8.1, 6.2, 1.7), 7.62 – 7.55 (1H, m), 7.42 (1H, dd, J 8.9, 6.0), 7.36 – 7.26 (3H, m), 7.15 – 7.05 
(2H, m), 6.99 – 6.91 (2H, m), 6.91 – 6.76 (5H, m), 6.28 (1H, dd, J 10.4, 8.8), 5.92 (1H, d, J 10.3), 
5.40 (1H, d, J 10.6), 2.41 (3H, s), 2.37 (3H, s), 2.19 (3H, s); δF (376 MHz; CDCl3; Me4Si) -105.11 – -
105.21 (2F, m), -108.21 (1F, dd, J 10.7, 3.1), -108.35 (1F, d, J 4.3), -108.90 – -108.97 (1F, m); HRMS 
(FTMS+ESI): calcd for [C54H35F5N3O7S3
191Ir+H]+: 1222.13925. Found: 1222.13928. Crystals for X-ray 
analysis were grown from slow evaporation of a solution of 32 in DCM/hexane/MeOH (1:2:1) at 
RT.  
 
Experimental details for chapter 3: Toward ‘fluorine-free’ emission 
3-Fluoro-6-(pyridin-2-yl)-2-tosylphenol 57a and 3-fluoro-4-(pyridin-2-yl)-2-tosylphenol 57b 
Attempt 1: An aqueous solution of potassium hydroxide [4M KOH 
(214 mg, 3.85 mmol) in water (1 ml)] was added to a solution of 2-
(2,4-difluoro-3-[(4-methylbenzene)sulfonyl]phenyl)pyridine 16 
(400 mg, 1.15 mmol) in 1,4-dioxane (7 ml). The mixture was 
heated to reflux (90 oC) for 2 h and then evaporated to a volume of 
ca. 1 ml. Water (20 ml) was added, upon which a yellow-white precipitate formed.  Aqueous 
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acetic acid (conc. AcOH (2 ml) in H2O (8 ml)) was added, which led to precipitate formation. The 
precipitate was collected, washed with water, and dried under vacuum. TLC analysis indicated a 
majority of the starting material remained unconverted. The reaction was set up again and left for 
72 h, however this produced little change.  
Attempt 2: The reaction mixture was dissolved in diglyme (6 ml) and an aqueous solution of KOH 
(334 mg, in 1.5 ml). The solution was heated to 160 oC overnight, allowed to cool and water (20 
ml) was added, followed by a solution of aqueous acetic acid (2 ml glacial in 8 ml water). A 
precipitate formed which was filtered and washed with water and diethyl ether to remove the 
digylme. The reaction mixture was then heated under reflux in DCM (20 ml) for 10 min, allowed to 
cool to room temperature, and filtered; this operation was repeated another two times. Upon 
filtration a white solid was collected (216 mg), which proved to be insoluble in organic solvents. 
The combined filtrates were evaporated to dryness and the residue was purified by column 
chromatography (EtOAc (10%) in DCM) to give a yellow solid. NMR analysis suggested a mixture 
of 2 compounds, with MS data suggesting formation of the require compound(s), 57a and 57b, 
(combined weight 192 mg, 48%) in a 1:1 ratio by 1H NMR analysis. 
Attempt 3: The above reaction was repeated using 2-(2,4-difluoro-3-[(4-
methylbenzene)sulfonyl]phenyl)pyridine 16 (400 mg, 1.16 mmol) in diglyme (6 ml), KOH (214 mg, 
3.85 mmol) in water (1 ml). The mixture was purified by column chromatography (10% EtOAc in 
DCM) to yield a mixture of the 57a and 57b (342 mg, 86%). A ratio of 57a:57b of 30:70 was 
revealed by NMR analysis. 
 
2-(2-Fluoro-4-methoxy-3-tosylphenyl)pyridine 58 
The product mixture 57a:57b (50:50, 50 mg, 0.15 mmol) was dissolved in THF 
(dry, 2.5 ml) and NaOtBu (10 mg, 0.10 mmol) was added. The mixture was stirred 
for 40 min. CH3I (22 mg, 0.01 ml, 0.16 mmol) was then added rapidly and the 
mixture was heated to reflux under argon overnight. The mixture was allowed to 
cool and then DCM (20 ml) and water (20 ml) were added. The mixture was 
separated and the aqueous layer was extracted with DCM (4 x 20 ml). The fractions were 
combined and the solvent was removed in vacuo. The mixture was then purified by column 
chromatography (10% MeOH in DCM, increased to 100% MeOH to elute baseline material) to give 
2-(2-fluoro-4-methoxy-3-tosylphenyl)pyridine 58 (20 mg,  39%); δH (400 MHz; CDCl3; Me4Si) 8.67 
(1H, d, J 4.6), 8.14 (1H, t, J 8.6), 7.92 (2H, d, J 8.40), 7.71-7.80 (2H, m), 7.29 (2H, d, 8.40), 7.23-7.27 
(1H, m , 6.84 (1H, dd, J 9.0 1.3), 3.84 (3H, s), 2.41 (3H, s); δF (376 MHz, CDCl3, Me4Si) -112.61 (1F, 
d, J 7.9); δc (101 MHz, CDCl3, Me4Si) 158.46 (d, J 263.41), 159.08 (d, J 3.4), 152.01, 149.82, 144.30, 
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140.03, 136.74, 136.71, 136.67, 129.36, 127.93, 124.67 (d, J 9.7), 122.67, 121.85, 121.70, 118.69 
(d, J 13.1), 108.72 (d, J 3.6), 56.87, 29.82; HRMS (FTMS+ESI): calcd for [C19H16FNO3S + H]
+: 
358.0913. Found: 358.0889. 
Also obtained was a mixture of N-methylated pyridinium salts (104 mg), isolated when the 
column was flushed with 100% MeOH. 
Demethylation of N-methylpyridiunium salts 9 
The mixture of pyridinium salts obtained from the above reaction (104 mg, 0.214 mmol) was 
dissolved in DMF (dry, 6 ml) and the solution was stirred. Then PPh3 was added (73 mg, 0.28 
mmol) and the solution was heated to reflux (150 oC). The reaction was monitored by TLC. After 6 
h TLC showed little change, extra PPh3 (32 mg, 0.12 mmol) was added. After 20 h the reaction was 
cooled and DCM (25 ml) and water (25 ml) were added. The layers were separated and the 
aqueous layer was washed with DCM (2 x 25 ml). The solvent was removed and the residue was 
purified by column chromatography (10% EtOAc in DCM), changed to DCM:MeOH:NH3(aq) 15:4:1 
to elute the pyridinium ions), resulting in recovered 57a:57b (21 mg, 29%). 
Methyl 4-methylbenzenesulfonate 
K2CO3 (1.45 g, 7.79 mmol) was added to stirred methanol (10 ml). Then tosyl 
chloride (2.00 g, 10.49 mmol) was added (with caution) to the suspension, 
which was then stirred overnight at RT. Water (20 ml) was added and the 
majority of the methanol was removed in vacuo. Then DCM (35 ml) was added and the layers 
were separated. The aqueous layer was then extracted further (2 x 25ml DCM). The solvent was 
removed in vacuo to yield a crystalline semi solid, methyl 4-methylbenzenesulfonate TsOMe (1.60 
g, 82%); δH (400 MHz; CDCl3; Me4Si) 7.80 (2H, d, J 8.3), 7.36 (2H, d, J 7.9), 3.74 (3H, s), 2.46 (3H, s). 
The NMR data were consistent with the literature data.10 
2-(2-Fluoro-4-methoxy-3-tosylphenyl)pyridine 58 
The product mixture 57a:57b (28:70, 342 mg, 0.99 mmol) was dissolved in THF (15 ml) and 
NaOtBu (86 mg, 0.89 mmol) was added. The mixture was stirred at RT for 1.5 h. Then TsOMe (145 
mg, 0.78 mmol) was added and the solution was heated to 70 OC. The reaction was stirred 
overnight, then allowed to cool. The volume of THF was reduced to 5 ml then water (50 ml) and 
DCM (100 ml) were added. An emulsion formed, so dilute HCl (7%, 15 ml) was added. The 
aqueous layer was then separated and the organic layer was concentrated in vacuo. The residue 
was purified by column chromatography (10% EtOAc in DCM, changed to NH3(aq):MeOH:DCM 
(1:4:15, increased to 1:2:14) to elute the pyridinium ions). The product was 58 (65 mg, 18%); NMR 
data was consistent with that obtained previously.  
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Also isolated: Starting material mixture 57a:57b (110 mg, 32%), pyridinium ions (110 mg, 30%). 
 
2-(2-Fluoro-4-methoxyphenyl)-pyridine) 60 
A solution of 2-fluoro-4-methoxyphenylboronic acid 59 (1.00 g, 5.88 mmol) and 2-
bromopyridine 11 (0.62 ml, 6.46 mmol) in dioxane (30 ml)  was degassed by bubbling 
argon for 30 min. An aqueous solution of  Na2CO3 (0.79 g, 7.44 mmol in 4 ml) was 
added, followed by Pd(PPh3)4 (70 mg, 0.06 mmol). The mixture was heated to 95 
oC 
overnight under argon then allowed to cool and the solvent was removed in vacuo. 
Water and DCM were added and the organic layer was separated, dried over MgSO4 and the 
solvent was removed in vacuo. The crude oil was purified by distillation using a Kuglerohr 
apparatus. Residual 2-bromopyridine was distilled first (70-80 oC, 0.75 mbar), followed at 115 oC, 
0.75 mbar by 2-(2-fluoro-4-methoxyphenyl)-pyridine) 60 as a pale yellow oil (1.09 g, 91%); δH (400 
MHz; CDCl3; Me4Si) 8.68 (1H, ddd, J 4.8, 1.8, 1.0), 7.95 (1H, t, J 9.0), 7.67-7.77 (2H, m), 7.18 (1H, 
ddd, J 7.0, 4.9, 1.5), 6.81 (1H, ddd, J 8.8, 2.5, 0.7), 6.69 (1H, dd, J 13.2, 2.5), 3.83 (3H,s); δF (376 
MHz, CDCl3, Me4Si) -114.74 (1F, t, J 12.3); δC (101 MHz; CDCl3; Me4Si) 161.47 (d, J 11.2), 161.32 (d, 
J 249.5), 153.43 (d, J 2.8), 149.68, 136.40, 131.63 (d, J 4.9), 124.03 (d, 9.8), 121.85, 120.01 (d, J 
11.9), 110.65 (d, J 2.9), 102.00 (d, J 27.0), 55.72; HRMS (FTMS+ESI): calcd for [C12H10NFO+H]
+: 
204.0825. Found: 204.0817.  
2-(2-Fluoro-3-iodo-4-methoxyphenyl)-pyridine) 62 
The reaction was conducted using the general procedure B for lithiation followed by 
iodination. The following reagents were used in the stated quantities: nBuLi (1.94 ml, 
2.5 M), DIPA (0.75 ml, 5.34 mmol), 2-(2-fluoro-4-methoxyphenyl)-pyridine) 60 (790 
mg, 3.89 mmol), I2 (1.38 g, 5.44 mmol) and THF (35 ml, dry). The reaction was 
worked up as described in the general method, and the product was then purified by 
column chromatography (hexane:EtOAc 3:2 v/v) to give 2-(2-fluoro-3-iodo-4-methoxyphenyl)-
pyridine) 62 (746 mg, 58%) as an off-white solid; m.pt. 107.2-109.7 oC; δH (400 MHz; CDCl3 Me4Si) 
8.69 (1H, dt, J 4.8, 1.5), 7.98 (1H, t, J 8.8), 7.71-7.78 (2H, m), 7.19-7.28 (1H, m), 6.76 (1H, dd, J 8.8, 
1.2), 3.96 (3H, s); δF (376 MHz; CDCl3; Me4Si) -93.14 (d, J 10.7); δC (101 MHz; CDCl3 Me4Si) 160.09 
(d, J 248.0), 160.33 (d, J 6.1), 152.82 (d, J 3.3), 149.79, 136.62, 131.84 (d, J 4.8), 124.23 (d, J 9.6), 
122.33, 121.25 (d, J 14.9), 106.97 (d, J 2.9), 75.06 (d, J 28.96), 57.02; HRMS (FTMS+ESI): calcd for 
[C12H9NFOI+H]
+: 329.9791. Found: 329.9787. 
 
2-(2-Fluoro-4-methoxy-3-(methylsulfonyl)phenyl)pyridine 64 
The reaction was conducted using the general procedure for sulfone synthesis. The following 
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reagents were used in the stated quantities: 2-(2-fluoro-3-iodo-4-
methoxyphenyl)-pyridine) 62 (1.02 g, 3.11 mmol), CuI (0.89 g, 4.67 mmol), 
MeSO2Na (0.51 g, 4.98 mmol) were added to a stirred solution of in DMF (2.5 ml, 
dry). The reaction was worked up as described in the general procedure, and the 
product was purified by column chromatography (DCM:EtOAc 1:1) to give 2-(2-
fluoro-4-methoxy-3-(methylsulfonyl)phenyl)pyridine 64 (390 mg, 45%); δH (400 MHz; CDCl3; 
Me4Si) 8.70 (1H, dt, J 4.8, 1.4), 8.23 (1H, dd, J 9.0, 8.3), 7.72-7.82 (2H, m), 7.26-7.30 (1H, m), 6.98 
(1H, dd, J 8.9, 1.3), 4.03 (3H, s), 3.34 (3H, s); δF (376 MHz; CDCl3; Me4Si) -113.56 (d, J 9.3); δC (176 
MHz; CDCl3; Me4Si) 159.07 (d, J 3.4), 158.4 (d, J 263.2), 151.87 (d, J 1.7), 149.96, 136.87 (d, J 6.1), 
136.72, 124.60 (d, J 9.8), 122.80, 122.20 (d, J 14.3), 118.01 (d, J 13.6), 108.66 (d, J 3.5), 57.28, 
45.61; HRMS (FTMS+ESI): calcd for [C13H12NFO3S+H]
+: 282.0600. Found: 282.0615. 
Ir complex 68 
The reaction was conducted as described in the 
general procedure for synthesis of Iridium pic 
complexes, Method B. The following reagents were 
used in the stated quantities: IrCl3.3H2O (233 mg, 0.66 
mmol), 2-(2-fluoro-4-methoxy-3-
(methylsulfonyl)phenyl)pyridine 64 (390 mg, 1.39 
mmol), picolinic acid (284 mg, 2.31 mmol), 2-
ethoxyethanol (12 ml). The reaction was worked up as 
described in the general procedure and the residue was purified by column chromatography (5% 
MeOH in DCM). The yellow solid obtained was then suspended in ethanol and heated to reflux. 
The solution was filtered to afford complex 68 as a yellow solid (310 mg, 54%); Anal. Calc. for 
C32H26N3F2O8S2Ir: C, 43.93; H, 3.00; N, 4.80. Found: C, 44.02; H, 3.26; N, 4.97; δH (700 MHz; CDCl3; 
Me4Si) 8.78 (1H, ddd, J 5.8, 1.7, 0.8, HA6), 8.37 (1H, ddd, J 7.8, 1.5, 0.8, HE3), 8.34 (1H, d, J 8.5, HB3),  
8.27 (1H, d, J 8.5, HA3), 8.02 (1H, td, J 7.8, 1.6, HE4), 7.84 (1H, td, HB4) 7.82 (1H, td, J, HA4), 7.79 (1H, 
ddd, J, HE6), 7.52 (1H, ddd, J 7.7, 5.4, 1.5, HE5), 7.46 (1H, ddd, J 5.9, 1.6, 0.8, HB6), 7.23 (1H, ddd, J 
7.3, 5.8, 1.4, HA5), 7.03 (1H, ddd, J 7.4, 5.8, 1.4, HB5), 5.73 (1H, s, HC6), 5.57 (1H, s, HD6), 3.56 (3H, s, 
HC8), 3.51 (3H, s, HD8), 3.25 (3H, s, HC7), 3.20 (3H, s, HD7); δF (376 MHz; CDCl3; Me4Si) -112.10 (1F, s), 
-112.58 (1F, s); δC (176 MHz; CDCl3; Me4Si) 172.31 (s, CE7), 165.37 (d, J 6.2, CB2), 164.21 (d, J 6.2, 
CA2), 161.38 (CC/D2), 160.56 (CC/D2), 158.69 (d, J 3.0, CC5), 158.40 (d, J 284.0, CC3), 158.30 (d, J 284.0, 
CD3), 158.18 (d, J 2.6, CD5), 151.18 (s, CE2), 148.64 (s, CA6), 148.26 (s, CE6), 148.00 (s, CB6), 138.90(s, 
CE4), 138.73 (s, CA/B4), 138.70 (s, CA/B4), 128.81 (s, CE3), 128.78 (s, CE5), 126.12 (d, J,CC1), 125.81 (d, 
CD1), 123.53 (d, J, CB3), 122.96 (d, J, CA3), 122.41 (s, CB5), 122.35 (s, CA5), 111.28 (d, J 11.4, CD4), 
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111.01 (CD6), 110.93 (d, J 11.5, CC4), 110.73 (CC6), 56.09 (s, CC8), 55.97 (s, CD8), 45.29 (s, CC/D7), 45.28 
(s, CC/D7); HRMS (FTMS+ESI): calcd for [C32H26N3F2O8S2
191Ir+H]+: 874.0814. Found: 874.0786. 
Crystals for X-ray analysis were grown by slow vapour diffusion of pentane into a solution of 68 in 
DCM. 
2-(2-Fluoro-4-methoxyphenyl)-4-mesitylpyridine 61 
A solution of 2-chloro-4-(2,4,6-trimethylphenyl)pyridine 23 (1.23 g, 5.31 
mmol), 2-fluoro-4-methoxyphenylboronic acid 59 (1.00 g, 5.88 mmol), 
Pd(OAc)2 (73 mg, 0.36 mmol) and PPh3 (363 mg, 1.52 mmol) in 1,2-
dimethoxyethane (60 ml) was degassed with argon for 30 min. Separately a 2 
M aqueous solution of sodium carbonate (11 ml, 2.31 g, 24.01 mmol) was 
degassed for 25 min. The solutions were combined and the mixture was 
heated to reflux under argon atmosphere for 24 h. The reaction mixture was 
then cooled to room temperature and the DME was removed in vacuo. DCM (50 ml) was then 
added, followed by brine (50 ml). The organic layer was separated and dried over MgSO4. The 
solvent was removed in vacuo and the residue was purified by column chromatography 
(EtOAc:hexane 1:5 v/v) to give 2-(2-fluoro-4-methoxyphenyl)-4-mesitylpyridine 61 as a yellow oil 
(1.35g, 78%); δH (400 MHz; CDCl3; Me4Si) 8.73 (1H, dd, J 4.9, 0.9), 8.02 (1H, t, J 9.0), 7.55-7.61 (1H, 
m), 7.03 (1H, dd, J 5.0, 1.5), 6.94-6.99 (2H, m), 6.84 (1H, ddd, J 8.8, 2.5, 0.7), 6.69 (1H, dd, J 13.1, 
2.5), 3.85 (3H, s), 2.34 (3H, s), 2.05 (6H, s); δF (376 MHz, CDCl3, Me4Si) -114.38 (1F, t, J 13.2); δC 
(101 MHz; CDCl3; Me4Si ) 161.28 (d, J 250.1), 161.41 (d, J 11.4), 153.50 (d, J 2.8), 149.79, 149.69, 
137.48, 136.51, 135.28, 131.59 (d, J 4.8), 128.33, 125.00 (d, J 9.8), 122.86, 119.95 (d, J 11.6), 
110.58 (d, J 3.0), 101.93 (d, J 27.2), 55.67, 21.05, 20.62; HRMS (FTMS+ESI): calcd for 
[C21H20FNO+H]
+: 322.1607. Found: 322.1608. 
2-(2-Fluoro-3-iodo-4-methoxyphenyl)-4-mesitylpyridine 63 
The reaction was conducted using the general procedure B for lithiation 
followed by iodination. The following reagents were used in the stated 
quantities: nBuLi (2.1 ml, 2.5 M), DIPA (0.81 ml, 5.78 mmol), 2-(2-fluoro-4-
methoxyphenyl)-4-mesitylpyridine 61 (1.35 g, 4.20 mmol), I2 (1.49 g, 8.09 
mmol) and THF (30 ml, dry). The reaction was worked up as described in the 
general method, and the product was then purified by column 
chromatography (hexane:EtOAc 2:1) to give an off-white solid, 2-(2-fluoro-3-iodo-4-
methoxyphenyl)-4-mestitylpyridine) 63 (1.03 g, 55%); m.pt. 167.4-168.5 oC; δH (400 MHz; CDCl3; 
Me4Si) 8.73 (1H, dd, J 5.0, 0.9), 8.05 (1H, t, J 8.8), 7.54-7.61 (1H, m), 7.06 (1H, dd, J 5.0, 1.5), 6.96 
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(2H, s), 6.78 (1H, dd, J 8.8, 1.1), 3.97 (3H, s), 2.34 (3H, s), 2.05 (6H, s); δF (376 MHz, CDCl3, Me4Si) -
92.81 (d, J 12.6); δC (101 MHz; CDCl3; Me4Si)  159.98 (d, J 248.3), 160.21 (d, J 6.1), 152.81 (d, J 3.3), 
150.05, 149.76, 137.55, 136.27, 135.17, 131.73 (d, J 4.9), 128.34, 125.21 (d, J 9.7), 123.27, 121.17 
(d, J 14.5), 106.83 (d, J 2.9), 74.96, 56.88, 21.05, 20.62; HRMS (FTMS+ESI): calcd for 
[C21H19NFOI+H]+: 448.0574. Found: 448.0565. 
2-(2-Fluoro-4-methoxy-3-(methylsulfonyl)phenyl)-4-mesitylpyridine 65 
The reaction was conducted using the general procedure for sulfone 
synthesis. The following reagents were used in the stated quantities: 2-(2-
fluoro-3-iodo-4-methoxyphenyl)-4-mestitylpyridine) 63 (1.00 g, 2.24 mmol), 
CuI (0.68 g, 3.58 mmol) and MeSO2Na (0.34 g, 3.35 mmol) and DMF (3.5 ml, 
dry). The reaction was worked up as described in the general procedure, and 
the product was purified by column chromatography (DCM:EtOAc 1:1) to 
give 2-(2-fluoro-4-methoxy-3-(methylsulfonyl)phenyl)-4-mesitylpyridine 65 (470 mg, 53%); m.pt. 
169.2 -170.8 oC; (400 MHz; CDCl3; Me4Si) 8.74 (1H, d, J 5.0), 8.30 (1H, t, J 8.6), 7.57-7.63 (1H, m), 
7.10 (1H, dd, J 5.0, 1.5), 7.00 (1H, dd, J 9.0, 1.2), 6.92-6.97 (2H, m), 4.05 (3H, s), 3.32 (3H, s), 2.33 
(3H, s), 2.03 (6H, s); δF (376 MHz; CDCl3; Me4Si) -113.44 (d, J 9.5); δC (176 MHz; CDCl3; Me4Si) 
159.09 (d, J 3.3), 158.49 (d, J 263.0), 152.00, 150.46, 150.07, 137.77, 136.91 (d, J 5.9), 136.11, 
135.17, 128.49, 125.72 (d, J 8.9), 123.89, 122.24 (d, J 14.0), 118.06 (d, J 13.3), 108.68 (d, J 3.4), 
57.29, 45.61, 21.18, 20.74; HRMS (FTMS+ESI): calcd for [C22H22NFO3S+H]
+: 400.1383. Found: 
400.1379. 
Iridium complex 69 
The reaction was conducted as described in the general 
procedure for synthesis of Iridium pic complexes, Method B. 
The following reagents were used in the stated quantities: 
IrCl3.3H2O (189 mg, 0.54 mmol), 2-(2-fluoro-4-methoxy-3-
(methylsulfonyl)phenyl)-4-mesitylpyridine 65 (450 mg, 1.13 
mmol), picolinic acid (231 mg, 1.88 mmol) and 2-
ethoxyethanol (20 ml). The reaction was worked up as 
described in the general procedure and the residue was purified by column chromatography (5% 
MeOH in DCM). The yellow solid was suspended in ethanol and heated to reflux. The solution was 
filtered hot to leave pure Ir complex 69 as a yellow solid (420 mg, 70%); Anal. Calc. for 
C50H46N3F2O8S2Ir.CH2Cl2: C, 51.21; H, 4.04; N, 3.51. Found: C, 51.34; H, 3.99; N, 3.55; δH (400 MHz; 
CDCl3; Me4Si) 8.80-8.87 (m, 1H), 8.44 (1H, dt, J 7.8, 0.9), 8.19 (1H, s), 8.12 (1H, s), 8.07 (1H, td, J 
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7.7, 1.5), 7.88 (1H, dt, J 5.1, 1.3), 7.57 (1H, ddd, J 7.6, 5.3, 1.5), 7.45 (1H, d, J 5.9), 7.09 (1H, dd, J 
5.9, 1.8), 6.93-7.02 (4H, m), 6.87 (1H, dd, J 5.9, 1.8), 5.83 (1H, s), 5.77 (1H, s), 3.61 (3H, s), 3.58 
(3H, s), 3.23 (3H, s), 3.19 (3H, s), 2.34 (6H, s), 2.09 (3H, s), 2.05 (3H, s), 2.00 (3H, s), 1.95 (3H, s); δF 
(376 MHz; CDCl3; Me4Si) -111.68 (1F, s), -112.28 (1F, s);  HRMS (FTMS+ESI): calcd for 
[C50H46N3F2O8S2
191Ir+H]+: 1110.2379. Found: 1110.2393. 
2-(2-Fluoro-4-methoxy-3-tosylphenyl)-4-mesitylpyridine 66 
The reaction was conducted using the general procedure for sulfone 
synthesis. The following reagents were used in the stated quantities: 2-(2-
fluoro-3-iodo-4-methoxyphenyl)-4-mesitylpyridine 61 (0.81 g, 1.81 mmol), 
sodium p-tolylsulfinate (0.52 g, 2.90 mmol), CuI (0.52 g, 2.71 mmol) and DMF 
(3 ml, dry). The reaction was worked up as described in the general 
procedure and the product mixture was purified by column chromatography 
(5% EtOAc in DCM, increased to 20%) to give 2-(2-fluoro-4-methoxy-3-
tosylphenyl)-4-mesitylpyridine 66 as an off white solid (0.17 g, 21%); δH (400 
MHz; CDCl3; Me4Si)  8.73 (1H, dd, J 5.0, 0.9), 8.22 (1H, dd, J 8.9, 8.2), 7.88-7.98 (2H, m), 7.56-7.66 
(1H, m), 7.26-7.33 (2H, m), 7.08 (1H, dd, J 5.0, 1.5), 6.94-6.99 (2H, m), 6.87 (1H, dd, J 9.0, 1.2), 3.85 
(3H, s), 2.41 (3H,s), 2.34 (3H, s) 2.04 (6H, s); δF (376 MHz; CDCl3; Me4Si) -112.69 (1F, d, J 10.9); δC 
(101 MHz; CDCl3; Me4Si) 158.40 (d, J 263.0), 158.98 (d, J 3.3), 152.10 (d, J 1.8), 150.26, 149.88, 
144.17, 139.92, 137.63, 136.68 (d, J 6.1), 136.05, 135.10, 129.26, 128.36, 127.82, 125.62 (d, J 9.9), 
123.64, 121.78 (d, J 14.2), 118.64 (d, J 13.4), 108.61 (d, J 3.6), 56.77, 21.65, 21.07, 20.64; HRMS 
(FTMS+ESI): calcd for [C28H26NFO3S+H]
+: 476.1696. Found: 476.1718. 
p-Tolyl disulfide 
DDQ (0.91 g, 4.01 mmol) was added cautiously to a stirred solution 
of 4-methylbenzene thiol (1.00 g, 8.05 mmol) in DCM (50 ml) which 
was cooled by an ice bath. The solution was stirred for 30 min 
before the solvent was removed. The residue was purified by column chromatography (hexane) to 
give the product, p-tolyl disulfide (0.90 g, 91%); δH (400 MHz; CDCl3; Me4Si) 7.41 – 7.33 (2H, m), 
7.18 – 7.07 (2H, m), 2.32 (3H, s); NMR data are consistent with the literature data.11 
2-(2-Fluoro-4-methoxy-3-(p-tolylthio)phenyl)pyridine 67  
nBuLi (1.35 ml, 2.5 M in hexanes) was added dropwise to a stirred solution of DIPA (0.52 ml,  3.71 
mmol) in THF (10 ml, dry) at 0 oC under argon. The solution was stirred at 0 oC  for 30 min before 
the temperature was lowered to -78 oC. A solution of 2-(2-fluoro-4-methoxyphenyl)-4-
mesitylpyridine 61 (0.90 g, 2.81 mmol) in THF (20 ml, dry) was added dropwise via cannula and 
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the mixture was stirred at -78 oC for 1 h. A solution of p-Tolyl disulfide 
(0.90 g, 3.65 mmol) in THF (20 ml, dry) was slowly added, and the reaction 
mixture was stirred at -78 oC for 1 h before being left to warm to RT 
overnight. The reaction was quenched with water, DCM was added, and 
the organic layer separated. The aqueous layer was washed with further 
DCM (3 x 50 ml), the extracts combined and the solvent removed. The 
crude oil was purified by column chromatograpy (5% EtOAc in DCM) to give a mixture of 
unreacted 61 and the desired product, 67, (22% by NMR) which could not be separated. The 
residue was used for the next step without further purification.  
2-(2-Fluoro-4-methoxy-3-tosylphenyl)-4-mesitylpyridine 66 
m-Chloroperoxybenzoic acid (234 mg, 1.36 mmol) was added to a stirred solution of the crude 
mixture of 67 and 61 from the reaction described above in DCM (50 ml). The solution was stirred 
at RT overnight. The reaction was quenched with aqueous sodium bisulfite and the organic layer 
was separated. The aqueous layer was extracted with further DCM. The solvent was removed in 
vacuo and the residue was purified by column chromatography (DCM: EtOAc 4:1) to give a white 
solid, 2-(2,4-dimethoxy-3-(methylsulfonyl)phenyl)-4-mesitylpyridine 66 (184 mg, 63%). The NMR 
data was consistent with that obtained previously. 
Also isolated was 2-(2-fluoro-4-methoxyphenyl)-4-mesitylpyridine  61 (590 mg), which remained 
from the previous step. 
 
Iridium complex 70 
The reaction was conducted as described in the general 
procedure for synthesis of iridium pic complexes, Method B. 
The following reagents were used in the stated quantities:  
IrCl3.3H2O (72 mg, 0.20 mmol), 2-(2-fluoro-4-methoxy-3-
tosylphenyl)-4-mesitylpyridine 66 (184 mg, 0.42 mmol), 
picolinic acid (37 mg, 0.30 mmol) and 2-ethoxyethanol (5 ml). 
The reaction was worked up as described in the general 
procedure and the residue was purified by column chromatography (EtOAc in DCM 1:4, increased 
to 1:3) to give a yellow solid. This was purified further by recrystallisation from ethanol  to give 
complex 70 (210 mg, 83%); Anal. Calc. for C62H54N3F2O8S2Ir: C, 58.94; H, 4.31; N, 3.33. Found: C, 
58.60; H, 4.26; N, 3.27; δH (400 MHz; CDCl3; Me4Si) 8.74 (1H, d, J 5.8), 8.39 (1H, d, J 7.8), 8.15 (1H, 
s), 8.08 (1H, s), 8.04 (1H, td, J 7.7, 1.6), 7.85-7.90 (2H, m) 7.77-7.85 (3H, m), 7.56 (1H, ddd, J 7.4, 
5.3, 1.1), 7.40 (1H, d, J 5.9), 7.30 – 7.20 (4H, m), 7.03 – 6.92 (5H, m), 6.81 (1H, dd, J 5.9, 1.8), 5.71 
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(1H, s), 5.63 (1H, s), 3.43 (3H, s), 3.37 (3H, s), 2.38 (6H, s), 2.34 (6H, s), 2.08 (3H, s), 2.00 (3H, s), 
1.96 (3H, s), 1.94 (3H, s); δF (376 MHz; CDCl3; Me4Si)  -110.60 (1F, s), -111.33 (1F, s);  HRMS 
(FTMS+ESI): calcd for [C62H54N3F2O8S2
191Ir+H]+: 1262.3005. Found: 1262.3020.   
2-(2,4-Dimethoxyphenyl)-4-mesitylpyridine 72 
2-Chloro-4-mesitylpyridine 23 (1.16 g, 5.01 mmol), 2,4,6-
trimethylphenylboronic acid 71 (1.00 g, 5.50 mmol) and PPh3 (340 mg, 1.30 
mmol) were dissolved in DME (70 ml) and the solution was degased for 20 
min by bubbling with argon. Separately, an aqueous solution of Na2CO3 (2.16 
g, 20.38 mmol) was degassed for 20 min. The solutions were combined and 
Pd(OAc)2 (68 mg, 0.30 mmol) was added. The mixture was heated to reflux 
overnight before being cooled. The solvent was removed under reduced pressure and DCM and 
water were added. The organic layer was separated, and the aqueous layer was extracted with 
further DCM. The extracts were combined and the solvent removed. The residue was purified by 
column chromatography (DCM:EtOAc 1:1) to give a white solid, 2-(2,4-dimethoxyphenyl)-4-
mesitylpyridine 72 (1.13 g, 68%); m.pt. 143.5-145.3 oC; δH (400 MHz; CDCl3; Me4Si) 8.70 (1H, dd, J 
5.0, 0.9), 7.86 (1H, d, J 8.5), 7.65 (1H, dd, J 1.6, 0.9), 6.93-7.00 (3H, m), 6.64 (1H, dd, J 8.6, 2.4), 
6.54 (1H, d, J 2.4), 3.86 (3H, s), 3.79 (3H, s), 2.34 (3H, s), 2.07 (6H, s); δc (101 MHz; CDCl3; Me4Si) 
161.35, 158.16, 155.89, 149.33, 148.68, 137.30, 136.96, 135.44, 132.01, 128.29, 125.89, 122.14, 




The reaction was conducted as described in the literature method. nBuLi (18.8 ml, 
2.5 M) was added to a stirred solution of TMEDA (6.50 ml, 43.46 mmol) in hexane 
(30 ml, dry) at 0 oC and the solution was stirred for 30 min. A solution of 1,3-
dimethoxybenzene 74 (5.00 g, 36.19 mmol) in hexane (20 ml, dry) was added in portions via 
cannula and the mixture was stirred for a further 1 h. A solution of dimethyl disulfide (4.18 ml, 
47.03 mmol) in hexane (20 ml, dry) was added to the flask dropwise. The solution was stirred at 0 
oC and allowed to warm to RT overnight. The reaction mixture was poured into water (300 ml) 
and acidified with conc. H2SO4 (CAUTION, MeSH produced). The precipitate was filtered off, and 
the filtrate was extracted with DCM (100 ml).  The solvent was removed and the solids combined 
and recrystallized from hot methanol to give white crystals, 2,6-dimethoxythioanisole 75 (5.14 g, 
77%); δH (400 MHz; CDCl3; Me4Si) 7.24 (1H, t, J 8.3), 6.58 (2H, d, J 8.4), 3.90 (6H, s), 2.37 (3H,s). 
NMR data are consistent with the literature data.12 
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3-Bromo-2,6-dimethoxythioanisole 76 
The reaction was conducted as described in the literature method. A solution of 
Br2 (0.79 ml, 15.41 mmol) in DCM (20 ml) was added dropwise to a stirred 
solution of 2,6-dimethoxythioanisole 75 (2.89 g, 15.68 mmol) in DCM (50 ml) 
cooled by an ice bath. The solution was stirred at 0 oC for appox. 30 min, by which 
time the solution was a pale yellow colour. The solvent was removed under reduced pressure 
(care, may evolve HBr) and the product was distilled using the Kugelrohr apparatus (~150 oC at 0.6 
mbar) to leave a clear oil, 3-bromo-2,6-dimethoxythioanisole 76 (4.07 g, 98%); δH (400 MHz; 
CDCl3; Me4Si) 7.43 (1H, d, J 8.9), 6.59 (1H, J 8.9), 3.90 (3H, s), 3.89 (3H, s) 2.42 (3H, s). NMR data 
are consistent with the literature data.12 
 
(2,4-Dimethoxy-3-(methylthio)phenyl)boronic acid 77 
nBuLi (11.25 ml, 2.5 M in hexanes) was added dropwise to a stirred solution of 3-
bromo-2,6-dimethoxythioanisole 76 (6.17 g, 23.45 mmol) in THF (15 ml, dry)  at 
-78 oC. The mixture was stirred at -78 oC for 1 h. Triisopropyl borate (8.11 ml, 
35.15 mmol) was slowly added, and the reaction mixture was stirred at -78 oC 
for 1 h before being left to warm to RT overnight. Dilute HCl was added and the solution was 
extracted with EtOAc. The solvent was removed in vacuo to leave a sticky brown solid which was 
redissolved in EtOAc and was extracted with aqueous KOH (150 ml). The aqueous layer was 
acidified to pH 5 with dilute HCl and extracted with EtOAc. The solvent was removed in vacuo to 
give a beige solid, (2,4-dimethoxy-3-(methylthio)phenyl)boronic acid 77 (2.80 g, 52%); δH (400 
MHz; CDCl3; Me4Si) 7.80 (1H, d, J 8.4), 6.79 (1H, d, J 8.4), 5.88 (2H, br s), 3.98 (3H, s), 3.97 (3H, s), 
2.42 (3H, s); δB (128 MHz; CDCl3; Me4Si) 28.66 (1B, br s); HRMS (FTMS+ESI): calcd for 
[C9H13O4S
10B+H]+: 228.0742. Found: 228.0732. 
2-(2,4-Dimethoxy-3-(methylthio)phenyl)-4-mesitylpyridine 78 
2-Chloro-4-mesitylpyridine 23 (0.72 g, 3.11 mmol), (2,4-dimethoxy-3-
(methylthio)phenyl)boronic acid 77 (0.85 g, 3.73 mmol) and PPh3 (211 mg, 
0.80 mmol) were dissolved in DME (50 ml) and the solution was degased for 
20 min by bubbling with argon. Separately, an aqueous solution of Na2CO3 
(1.34 g, 12.64 mmol in 10 ml) was degassed for 20 min. The solutions were 
combined and Pd(OAc)2 (43 mg, 0.19 mmol) was added. The mixture was 
heated to reflux for 24 h before being cooled. The solvent was removed under reduced pressure 
and DCM and water were added. The organic layer was separated, and the aqueous layer was 
extracted with further DCM. The extracts were combined and the solvent removed. The residue 
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was purified by column chromatography (DCM:EtOAc 1:1 v/v) to give a white solid, 2-(2,4-
dimethoxy-3-(methylthio)phenyl)-4-mesitylpyridine 78 (0.70 g, 60%); m.pt. 133.4-136.2; δH (400 
MHz; CD3OD; Me4Si) 8.65 (1H, dd, J 5.1, 0.9), 7.62 (1H, d, J 8.6), 7.58 – 7.52 (1H, m), 7.16 (1H, dd, J 
5.1, 1.6), 6.97 (2H, s), 6.97 (1H, d, J 8.7), 3.94 (3 H, s), 3.57 (3 H, s), 2.39 (3H, s), 2.31 (3H, s), 2.05 
(6H, s); δC
13C NMR (101 MHz, CD3OD; Me4Si) 161.38, 159.22, 156.10, 150.69, 148.72, 137.40, 
136.03, 134.50, 130.81, 127.99, 126.57, 126.07, 123.18, 119.02, 107.31, 99.99, 19.73 , 19.34, 
16.60; HRMS (FTMS+ESI): calcd for [C23H25NFO2S+H]
+: 380.1684. Found:  380.1666. 
 
2-(2,4-Dimethoxy-3-(methylthio)phenyl)-4-mesitylpyridinium chloride 78a  
HCl (0.05 ml, 12 M) was added to a stirred solution of 2-(2,4-
dimethoxy-3-(methylthio)phenyl)-4-mesitylpyridine 78 (236 mg, 0.62 
mmol) in DCM/MeOH (40 ml, 1:1), and the mixture was stirred at RT 
overnight. The solvent was removed in vacuo to leave the product as a 
white solid, 2-(2,4-dimethoxy-3-(methylthio)phenyl)-4-
mesitylpyridinium chloride 78a (259 mg, 100%); m.pt. 177.3-180.2 oC; 
δH (400 MHz; CD3OD; Me4Si) 8.84 (1H, d, J 6.1), 8.18 – 8.12 (m, 1H), 7.87 (1H, dd, J 6.1, 1.9), 7.74 
(1H, dd, J 8.8, 0.9), 7.12 (1H, d, J 8.8), 7.09-7.08 (2H, m), 4.03 (s, 3H), 3.75 (s, 3H), 2.47 (s, 3H), 2.37 
(s, 3H), 2.14 (s, 6H); δC (176 MHz, CD3OD; Me4Si) 164.17, 160.76, 159.45, 150.20, 140.89, 139.28, 
134.22, 133.75, 130.94, 128.91, 128.51, 126.27, 120.38, 117.78, 109.99, 108.05, 99.79, 60.89, 
55.66, 22.77, 19.71, 19.16, 16.28. 
 
2-(2,4-Dimethoxy-3-(methylsulfonyl)phenyl)-4-mesitylpyridine 79 
m-Chloroperoxybenzoic acid (436 mg,  2.68 mmol) was added to a stirred 
solution of 2-(2,4-dimethoxy-3-(methylthio)phenyl)-4-mesitylpyridinium 
chloride 78a (510 mg,  1.22 mmol) in DCM (20 ml). The solution was stirred at 
RT overnight. The reaction was quenched with aqueous NaHSO3 and the 
organic layer was separated. The aqueous layer was extracted with additional 
DCM. The organic layers were then washed with aq. NaOH before the solvent 
was removed in vacuo and the residue was purified by reverse phase column chromatography 
(water/MeOH) to give a white solid, 2-(2,4-dimethoxy-3-(methylsulfonyl)phenyl)-4-
mesitylpyridine 79 (420 mg, 83%); m.pt. 155.8-160.8 oC, started to discolour at 148.7 oC; δH (400 
MHz; CDCl3; Me4Si) 8.75 (1H, dd, J 5.0, 0.9), 8.05 (1H, d, J 8.9), 7.70 (1H, dd, J 1.6, 0.9), 7.09 (1H, 
dd, J 5.0, 1.6), 6.98 (1H, d, J 8.9), 6.96 (2 H, s), 4.00 (3 H, s), 3.61 (3 H, s), 3.33 (3 H, s), 2.33 (3 H, s), 
2.03 (6 H, s); δC (101 MHz, CDCl3, Me4Si) 158.95, 158.44, 154.71, 150.38, 149.99, 137.74, 137.21, 
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136.22, 135.07, 128.45, 128.14, 125.69, 123.55, 123.44, 109.10, 63.42, 56.97, 46.25, 21.16, 20.74; 
HRMS (FTMS+ESI): calcd for [C23H25NFO4S+H]
+: 412.1583. Found:  412.1564. 
Iridium complex 80 
[Ir(COD)Cl]2 (51 mg, 0.19 mmol) was added to a stirred 
solution of 2-(2,4-dimethoxy-3-(methylsulfonyl)phenyl)-4-
mesitylpyridine 30 (130 mg, 0.32 mmol) in 2-ethoxyethanol 
(5 ml). The solution was heated to 130 oC under an argon 
atmosphere overnight, Picolinic acid (26 mg, 0.21 mmol) was 
added and the solution was heated at 130 oC for 6 h under an 
argon atmosphere. The solution was cooled and the solvent 
was removed in vacuo. The residue was purified by column chromatography (DCM/CH3CN 2:1 v/v) 
to give a yellow solid, iridium complex 80 (70 mg, 40%); Anal. Calc. for C52H52IrN3O10S2.1.5CH2Cl2: 
C, 50.89; H, 4.39; N, 3.33. Found: C, 50.43; H, 3.97; N, 3.08 δH (400 MHz; CDCl3; Me4Si) 8.84 (1H, d, 
J), 8.50 (1H, dd, J 1.8, 0.7 Hz), 8.45 (1H, d, J 7.7), 8.37 (1H, dd, J 1.8, 0.7), 8.04 (1H, td, J 7.8, 1.6), 
7.84 (1H, d, J 5.3), 7.53 (1H, ddd, J 7.4, 5.4, 1.5),  7.45 (1H, d, J 5.9), 7.05 (1H, dd, J  5.9, 1.9), 7.04 – 
6.96 (4H, m), 6.81 (1H, dd, J 5.9, 1.9), 5.83 (1H, s), 5.78 (1H, s), 3.92 (3H, s), 3.89 (3H, s), 3.55 (3H, 
s), 3.54 (3H, s), 3.49 (3H, s), 3.25 (3H, s), 3.20 (3H, s), 2.35 (6H, s), 2.11 (3H, s), 2.05 (3H, s), 2.00 
(3H, s), 1.96 (3H, s); HRMS (FTMS+ESI): calcd for [C52H52N3O10S2
191Ir+H]+: 1134.2778. Found: 
1134.2792.  
 
Experimental details for chapter 4: Dual emissive phosphorescent materials for white 
light  
(4-Methoxyphenyl)boronic acid 9213 
The reaction was conducted according to the literature method. Bromoanisole 91 
(10.00 g, 53.5 mmol) was dissolved in dry THF (40 ml) and added dropwise to a 
stirring mixture of magnesium turnings (1.56 g, 64.2 mmol) in THF (25 ml, dry). A 
catalytic amount of iodine was added to initiate the reaction. Once addition was 
completer the mixture was heated to reflux for 3 h. The Grignard reagent was then diluted with 
THF (20 ml, dry) and added by cannula to a stirred solution of  trimethyl borate (9.6 ml, 85.6 mmol 
in 20 ml of dry THF) at -10oC, resulting in the formation of a white precipitate. The reaction 
mixture was stirred at 0 oC for 3 h and allowed to warm to room temperature overnight. The 
mixture was acidified to pH 1 with HCl (10 %) and extracted twice with EtOAc. The organic layers 
were dried over MgSO4 and  the solvent was removed in vacuo. The crude boronic acid was 
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washed with hexane to give a white solid, (4-methoxyphenyl)boronic acid 92 (8.12 g, 90%); δH 
(400s MHz; CDCl3; Me4Si) 8.13-8.21 (2H, m), 6.96-7.06 (2H, m), 3.90 (3H, s). NMR data are 
consistent with the literature data.13 
4,4'-Dimethoxy-2-nitro-1,1'-biphenyl 94 
A solution of (4-methoxyphenyl)boronic acid 92 (3.60 g, 23.69 
mmol) and 4-bromo-3-nitroanisole 93 (5.00 g, 21.55 mmol) in 
1,4-dioxane (100 ml) was degassed with argon for 25 mins. An 
aqueous solution of Na2CO3 (2.97 g, 28.02 mmol in 14 ml) was degassed for 20 mins. The solutions 
were combined, degassed for a further 5 mins before Pd(PPh3)4 (498 mg, 0.43 mmol) was added. 
The mixture was heated to reflux under argon for 72 h before being cooled to RT. The volume of 
the solution was reduced by 75% before DCM (100 ml) and water (100 ml) were added. The layers 
were separated and the aqueous layer was futher washed with DCM (2 x 50 ml). The organic 
layers were combined, dried over MgSO4 and the solvent removed in vacuo. The crude product 
was purified by trituration/recrystallisation from ethanol to give 4,4'-dimethoxy-2-nitro-1,1'-
biphenyl 94 as a yellow-green crystalline solid (5.17 g, 92%); δH (400 MHz; CDCl3; Me4Si) 7.29-7.36 
(2H, m), 7.18-7.24 (2H, m), 7.13 (1H, dd, J 8.6, 2.7), 6.90-6.97 (2H, m), 3.89 (3H, s), 3.84 (3H, s). 
NMR data are consistent with the literature data.14 
2,7-Dimethoxycarbazole 95 15 
The reaction was conducted as described in the literature. 4,4'-
dimethoxy-2-nitro-1,1'-biphenyl 94 (5.17 g, 19.9 mmol) and 
triethylphosphite (25 ml) were heated to 160 oC overnight under 
an atmosphere of argon (the yellow solution turned cloudy  due to the formation of white 
crystals). The mixture was allowed to cool to RT and methanol was added (10 ml). The solution 
was left in an ice bath for 2 h before the solution was filtered and washed with cold MeOH to give 
a white crystalline material, 2,7-dimethoxycarbazole 95 (3.86 g, 85%); δH (400 MHz; CDCl3; Me4Si) 
10.96 (1H, s), 7.83 (2H, d, J 8.5), 6.93 (2H, d, J 2.2), 6.72 (2H, dd, J 8.5, 2.2), 3.81 (6H, s). NMR data 
are consistent with the literature data.15 
9-(2-Chloropyridin-4-yl)-2,7-dimethoxy-9H-carbazole 96 
2,7-Dimethoxycarbazole  95 (3.16 g, 13.90 mmol) and 4-iodo-2-chloropyridine 21 (3.61 g, 13.91 
mmol) were dissolved in 10 ml of dry DMF. Then, the reaction mixture was degassed by bubbling 
argon for 15 mins, following by an addition of CuI (0.77 g, 4.04 mmol), 1,10-phenanthroline (1.43 
g, 7.93 mmol) and K2CO3 (3.84 g, 27.83 mmol). The reaction mixture was heat at 120 
oC over the 
weekend. The solution was cooled and water was added. The precipitate was collected, dried and 
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purified by column chromatography (DCM) to give 9-(2-chloropyridin-4-
yl)-2,7-dimethoxy-9H-carbazole  96 (4.51 g, 96%) as a white solid; m.pt. 
109.3-110.9 oC; δH (400 MHz; CDCl3; Me4Si) 8.62 (1H, dd, J 5.4, 0.6), 7.88 
(2H, dd, J 8.6, 0.5), 7.63 (1H, dd, J 1.9, 0.6), 7.52 (1H, dd, J 5.4, 1.9), 6.98 
(2H, d, J 2.2), 6.93 (2H, dd, J 8.5, 2.2), 3.87 (6H, s); δC (101 MHz; DMSO-d6; 
Me4Si) 158.65, 158.00, 152.43, 152.28, 147.51, 140.59, 121.04, 120.45, 
117.89, 110.03, 95.23, 55.97; MS (ASAP+): m/z 338.1 (M+, 100%). 
9-(2-Chloropyridin-4-yl)-9H-carbazole-2,7-diol 97 
9-(2-Chloropyridin-4-yl)-2,7-dimethoxy-9H-carbazole  96 (4.51 g, 13.31 
mmol) was dissolved in DCM (150 ml, dry) and the solution was cooled to 0 
oC under an argon atmosphere. BBr3 (20.01 g, 79.87 mmol) was slowly 
added over 10 mins. After 1 hour, the reaction was stopped by an addition 
of water (40 ml). The precipitate was collected, dried and recrystallised 
from ethanol to give 97 as a white solid (3.00 g, 72%); m.pt. 289.0-290.5 oC; 
δH (400 MHz; DMSO-d6; Me4Si) 9.53 (2H, br s), 8.65 (1H, d, J 5.4), 7.85 (1H, d, J 1.7), 7.83 (2H, d, J 
8.4), 7.74 (1H, dd, J 5.4, 1.9), 6.89 (2H, d, J 2.0), 6.73 (2H, dd, J 8.4, 2.1); δC (151 MHz; DMSO-d6; 
Me4Si) 156.33, 152.23, 152.11, 147.81, 140.42, 120.65, 120.61, 120.06, 117.03, 110.80, 96.48; MS 
(ASAP+): m/z 310.1 (M+, 100%). 
9-(2-Chloropyridin-4-yl)-2,7-bis(hexyloxy)-9H-carbazole 98 
9-(2-Chloropyridin-4-yl)-9H-carbazole-2,7-diol 97 (2.46 g, 7.9 mmol) and 
K2CO3 (3.28 g, 23.7 mmol) was dissolved in DMSO (80 ml) and the 
solution was stirred at RT for 2 h. 1-bromohexane (3.32 ml, 23.7 mmol) 
was slowly added over 10 mins. The reaction mixture was stirred at RT 
overnight. The reaction was stopped by an addition of water (50 ml). The 
precipitate was collected, dried and purified by column chromatography 
(DCM) to give a white solid, 9-(2-chloropyridin-4-yl)-2,7-bis(hexyloxy)-9H-carbazole 98 (2.83 g, 
75%) as a white solid; m.pt. 176.1-177.5 oC; δH (400 MHz; CDCl3; Me4Si) 8.61 (1H, dd, J 5.4, 0.6), 
7.86 (2H, d, J 8.5), 7.61 (1H, dd, J 1.9, 0.6), 7.51 (1H, dd, J 5.4, 1.8), 6.87-7.00 (4H, m), 4.00 (4H, t, J 
6.5), 1.81 (4H, dq, J 8.0, 6.6), 1.55 (3H, s), 1.28-1.42 (9H, m), 0.91 (6H, m); δC (176 MHz; CDCl3; 
Me4Si)  158.08, 153.18, 151.27, 147.86, 140.56, 120.73, 120.32, 119.22, 118.19, 109.64, 95.59, 
68.66, 31.59, 29.30, 25.74, 22.57, 14.00; MS (ASAP+): m/z 478.2 (M+, 100%). 
2,4-Difluoro-3-cyanophenylboronic acid 104 
nBuLi (13.8 ml, 2.5 M in hexanes) was added dropwise to a stirred solution of DIPA (5.24 ml, 37.3 
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mmol) in THF (40 ml, dry) at 0 oC under argon. The solution was stirred at 0 oC  for 
30 min before the temperature was lowered to -78 oC. A solution of 2,6-
difluorobenzonitrile 103 (4.00 g, 28.8 mmol) in THF (15 ml, dry) was added 
dropwise via cannula and the mixture was stirred at -78 oC for 1 h. Triisopropyl 
borate (9.95 ml, 43.1 mmol) was slowly added, and the reaction mixture was stirred at-78 oC for 1 
h before being left to warm to RT overnight. Dilute HCl was added and the solution was extracted 
with EtOAc. The solvent was removed in vacuo to leave a sticky brown solid. The solids was 
redissolved in EtOAc and was extracted with aqueous KOH (150 ml). The aqueous layer was 
acidified to pH 5 with dilute HCl and extracted with EtOAc. The solvent was removed in vacuo to 
give a beige solid, 2,4-difluoro-3-cyanophenylboronic acid 104 (4.39 g, 84%); δH (400 MHz; 
acetone-d6; Me4Si) 8.13 (1H, dt, J 8.6 7.1), 7.71 (2H, s), 7.32 (1H, td, J 8.6 0.9); δF (376 MHz; 
acetone-d6; Me4Si) -98.62 (1F, d, J 6.6), -105.73 (1F, t, J 7.6); δB (400 MHz; acetone-d6; Me4Si) 
27.22 (1B, s); NMR data are consistent with the literature data.16 
2,6-Difluoro-3-(6-methyl-4,8-dioxo-1,3,6,2-dioxazaborocan-2-yl)benzonitrile 100 
A mixture of 104 (4.39 g, 24.0 mmol), methyliminodiacetic acid (MIDA) (4.24 g, 
28.8 mmol), DMSO (40 ml), and toluene (80 ml) was heated under reflux with a 
Dean Stark trap overnight. The mixture was cooled to room temperature, and 
water  (50 ml) was added. The precipitate was filtered off, washed with water 
and dried under vacuum to give 100 as an off-white solid (5.10 g, 72%); δH (400 
MHz; CDCl3; Me4Si) 7.82 (1H, q, J 7.5), 7.39 (1H, t, J 8.7), 4.40 (2H, d, J 17.3), 
4.08 (2H, d, J 17.3), 2.62 (3H, s); δF (376 MHz; DMSO-d6; Me4Si) -97.74 (d, J 7.6), -104.91 (ddt, J 
11.1, 6.6, 3.1); NMR data are consistent with the literature data.16 
9-(2',6'-Difluoro-[2,3'-bipyridin]-4-yl)-2,7-bis(hexyloxy)-9H-carbazole 101 
9-(2-Chloropyridin-4-yl)-2,7-bis(hexyloxy)-9H-carbazole 98 (0.80 g, 1.67 
mmol), MIDA ester 99 (0.68 g, 2.50 mmol) and SPhos (0.11 g, 0.13 mmol) 
were dissolved 1,4-dioxane (20 ml) and the reaction mixture was 
degassed by bubbling argon for 15 mins, before Pd(OAc)2 (30 mg, 0.13 
mmol) was added. A degassed aquesous solution of K3PO4 (1.28 g, mmol 
in 4 ml) was added and the reaction mixture was heated to 60 oC for 18h. 
The solution was cooled and the solvent was removed in vacuo. The  
crude material was dissolved in DCM, which was washed with water 
before the solvent was removed. The crude material was purified by column chromatography 
(DCM) to give 9-(2',6'-difluoro-[2,3'-bipyridin]-4-yl)-2,7-bis(hexyloxy)-9H-carbazole 101 (0.81 g, 
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87%) as a white solid; δH (400 MHz; CDCl3; Me4Si) 8.92 (1H, dd, J 5.2, 0.7), 8.78 (1H, dt, J 9.7, 8.1), 
8.10-8.16 (1H, m), 7.88 (2H, d, J 8.6), 7.60 (1H, dd, J 5.3, 2.0), 7.08 (2H, d, J 2.2), 7.05 (1H, dd, J 8.2, 
3.0, 0.8), 6.92 (2H, dd, J 8.6, 2.2), 4.01 (4H, t, J 6.5), 1.81 (4H, dt, J 14.3, 6.7), 1.42-1.54 (4H, m), 
1.22-1.40 (8H, m), 0.86-0.94 (6H, m); δF (376 MHz; CDCl3; Me4Si) -66.83 (ddd, J 10.5, 7.6, 3.0), -
69.87 (1F, t, J 10.0); δC (151 MHz; CDCl3; Me4Si) 161.45 (dd, J 249.6, 14.8), 158.52 (dd, J 248.4, 
14.2), 158.08, 152.50, 151.67, 146.45, 146.14, 140.65, 120.65 (d, J 10.3), 120.30, 119.46, 118.73 
(d, J 23.8), 118.12, 109.94, 107.20 (d, J 34.3), 95.27, 68.56, 31.58, 29.32, 25.75, 22.58, 14.00; MS 
(ASAP+): m/z 557.3 (M+, 100%). 
 
3-(4-(2,7-Bis(hexyloxy)-9H-carbazol-9-yl)pyridin-2-yl)-2,6-difluorobenzonitrile 102  
9-(2-Chloropyridin-4-yl)-2,7-bis(hexyloxy)-9H-carbazole 98 (1.00 g, 2.09 
mmol), MIDA ester  100 (0.92 g, 3.13 mmol) and SPhos (137 mg, 0.33 
mmol) were dissolved 1,4-dioxane (20 ml) and the reaction mixture was 
degassed by bubbling argon for 15 mins, before Pd(OAc)2 (37 mg, 0.16 
mmol) was added.. A degassed aquesous solution of K3PO4 (1.77 g, 8.34 
mmol in 4 ml) was added and the reaction mixture was heated to 60 oC 
for 72 h. The solution was cooled and the solvent was removed in vacuo. 
The  crude material was dissolved in DCM, which was washed with water 
before the solvent was removed. The crude material was purified by column chromatography 
(DCM) to give 3-(4-(2,7-bis(hexyloxy)-9H-carbazol-9-yl)pyridin-2-yl)-2,6-difluorobenzonitrile 102 
(1.01 g, 83%) as a white solid; m.pt. 126.1-127.9 oC; δH (400 MHz; CDCl3; Me4Si)  8.93 (1H, dd, J  
5.3, 0.7), 8.45 (1H, td, J 8.9, 6.4), 8.03-8.07 (1H, m), 7.88 (2H, d, J 8.5), 7.63 (1H, dd, J 5.3, 2.0), 
7.25 (1H, ddd, J 9.0, 7.7, 1.2), 7.07 (2H, d, J 2.1), 6.93 (2H, dd, J 8.5, 2.2), 4.02 (4H, t, J 6.6), 1.82 
(4H, dq, J 8.7, 6.6), 1.42-1.58 (4H, m), 1.27-1.42 (8H, m), 0.84-0.99 (6H, m); δF (376 MHz; CDCl3; 
Me4Si) -101.89 (1F, ddd, J 8.0, 6.4, 1.8), -108.04 (1F, dq, J 8.7, 1.9); δC (178 MHz; CDCl3; Me4Si ) 
163.51 (dd, J 265.0, 3.8), 160.7 (dd, J 263.8, 4.2), 158.27, 152.39 (d, J 1.8), 152.05, 146.65, 140.80, 
137.21 (dd, J 9.9, 4.8), 124.44 (dd , J 10.0, 3.9), 121.16 (d, J 9.2), 120.53, 119.94, 118.34, 113.05 
(dd, J 19.1, 4.0), 110.02, 109.06, 95.51, 93.30 (dd, J 20.5, 19.5), 68.78, 31.76, 29.50, 25.91, 22.75, 
14.19; HRMS (FTMS+ESI): calcd for [C36H37N3F2O2+H]
+: 582.2932. Found: 582.2931. 
Ir complex 90 
The reaction was conducted as described in the general procedure for synthesis of Iridium pic 
complexes, Method B. The following reagents were used in the stated quantities:  IrCl3.3H2O (150 
mg, 0.43 mmol), 101 (500 mg, 0.90 mmol), picolinic acid (184 mg, 1.49 mmol) and 2-
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ethoxyethanol (20 ml). The reaction was worked up 
as described in the general procedure, and the 
residue was purified by column chromatography (4% 
EtOAc in DCM) to leave 30 as a yellow solid (55 mg, 
9%); δH (400 MHz; CDCl3; Me4Si) 8.95 (1H, d, J 6.3), 
8.65 (2H, dt, J 23.4, 2.4), 8.50 (1H, dt, J 7.8, 1.1), 8.14 
(1H, td, J 7.7, 1.5), 7.99 (1H, dt, J 5.3, 1.2), 7.88 (2H, 
d, J 8.5), 7.87 (2H, d, J 8.5), 7.67 (2H, ddd, J 7.5, 3.9, 
2.2), 7.58 (1H, d, J 6.4), 7.45 (1H, dd, J 6.4, 2.4), 7.18 (2H, d, J 2.0), 7.15 (2H, d, J 2.0), 6.96 (4H, dd, 
J 8.5, 2.0), 6.11 (1H, t, J 1.9), 5.84 (1H, t, J 1.9), 4.04 (8H, td, J 6.5, 4.7), 1.82 (8H, dtd, J 15.8, 6.4, 
1.5), 1.41-1.58 (8H, m), 1.28-1.41 (16H, m), 0.82-0.96 (12H, m); δF (376 MHz; CDCl3; Me4Si) -67.83 
(1F, dt, J 9.1, 2.1), -68.29 (1F, dd, J 9.1, 2.4), -68.63 (1H, dt, J 9.2, 2.3), -68.96 (1F, dd, J 9.1, 2.4); 
HRMS (FTMS+ESI): calcd for [C74H76F4
191IrN7O6+H]: 1426.5477. Found: 1426.5470. 
Ir complex 105 
The reaction was conducted as described in the 
general procedure for synthesis of Iridium pic 
complexes, Method B. The following reagents were 
used in the stated quantities: IrCl3.3H2O (75 mg, 0.21 
mmol), 102 (260 mg, 0.45 mmol), picolinic acid (92 
mg, 0.75 mmol) and 2-ethoxyethanol (15 ml). The 
reaction was worked up as described in the general 
procedure, and the residue was purified by column 
chromatography (4% EtOAc in DCM) to leave 105 as a 
yellow solid (40 mg, 13%); δH (400 MHz; CDCl3; Me4Si) 8.91 (1H, d, J 6.4), 8.69 (1H, t, J 2.6), 8.64 
(1H, t, J 2.4), 8.49 (1H, d, J 7.8), 8.15 (1H, td, J 7.8, 1.6), 7.81-7.95 (5H, m), 7.63-7.74 (2H, m), 7.51-
7.58 (1H, m), 7.48 (1H, dd, J 6.4, 2.4), 7.17 (2H, d, J 2.1), 7.15 (2H, d, J 2.1), 6.97 (4H, dd, J 8.5, 2.1), 
6.26 (1H, d, J 8.1), 5.97 (1H, d, J 8.2), 4.05 (8H, td, J 6.6, 2.4), 1.78-1.90 (8H, m), 1.48-1.56 (8H, m) , 
1.28-1.37 (16H, m), 0.80-0.98 (12H, m); δF (376 MHz; CDCl3; Me4Si) -101.18 (1F, dd, J 8.2, 4.2), -
101.91 (1F, dd, J 8.2, 3.9), -105.62 (1F, d, J 4.3), -106.62 (1F, t, J 4.0);  HRMS (FTMS+ESI): calcd for 
[C78H76F4
191IrN7O6]
+: 1473.5399. Found: 1473.5367. 
Bis(4-methoxyphenyl)amine 108 
The reaction was conducted according to the literature method. p-Anisidine 107 (2.00 g, 16.24 
mmol), p-bromoanisole 91 (1.76 ml, 14.00 mmol), Pd2(dba)3 (0.64 g, 0.70 mmol), dppf (0.78 g, 
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1.41mmol) and NaOtBu (1.90 g, 19.77 mmol) were combined in 
toluene (20 ml, dry) and the solution was heated to 90 oC 
overnight under an argon atmosphere. The solution was cooled 
and water was added. The organic layer was separated, dried over MgSO4 and the solvent 
removed. The residue was purified by column chromatography (1:4 EtOAc in hexanes) to give a 
white solid, bis(4-methoxyphenyl)amine 108 (2.00 g, 62%); δH (400 MHz; acetone-d6; Me4Si) 6.92-
7.01 (4H, m), 6.76-6.88 (4H, m), 3.73 (6H, s). NMR data are consistent with the literature data.17 
3,7-Dimethoxyphenothiazine  109 
Sulfur (245 mg, 7.64 mmol) and iodine (194 mg, 0.76 mmol) were 
added to a stirred solution of bis(4-methoxyphenyl)amine (875 
mg, 3.82 mmol) in 1,2-dichlorobenzene (10 ml). The solution was 
heated to reflux for 30 min under an argon atmosphere before being cooled to RT. The solution 
was applied directly to a silica column (gradient elution 0-20% EtOAc in hexane) to remove the 
solvent and purify the product. The product was obtained as an off white crystalline solid, 3,7-
dimethoxyphenothiazine (300 mg, 30%); δH (400 MHz; acetone-d6; Me4Si) 7.42 (1H, br s), 6.69-
6.62 (2H, m), 6.62-6.55 (4H, m), 3.70 (6H, s). NMR data are consistent with the literature data.18 
10-(2-Chloropyridin-4-yl)-3,7-dimethoxy-10H-phenothiazine 110 
A solution of 3,7-dimethoxyphenothiazine 109 (0.78 g, 3.00 mmol) and 
4-iodo-2-chloropyridine 21 (0.72 g, 3.00 mmol) in DMF (10ml, dry) was 
degassed with bubbling argon for 15 min. CuI (166 mg, 0.87 mmol), 
1,10-phenanthroline (309 mg, 1.71 mmol) and K2CO3 (0.83 g, 6.02 
mmol) were added and the solution was heated to 120 oC for 18 h 
under an atmosphere of argon. The solution was cooled and water was 
added, resulting in formation of a dark precipitate. The precipitate was filtered off and purified by 
column chromatography (1% NEt3 in DCM) to give a white solid, 10-(2-chloropyridin-4-yl)-3,7-
dimethoxy-10H-phenothiazine 110 (0.58 g, 52%); δH (400 MHz; CD3OD; Me4Si) 7.91 (1H, d, J 6.1), 
7.48 (2H, d, J9.0), 7.16 (2H, d, J 2.4), 7.05 (2H, dt, J 8.8, 1.9), 6.80 – 6.72 (1H, dd, J 6.1, 2.3), 6.70 
(1H, d, J 2.3), 3.87 (6H, s); δC (176 MHz; CD3OD; Me4Si) 159.94, 157.50, 152.82, 150.12, 137.70, 
133.85, 129.45, 114.79, 114.75, 108.69, 108.25, 56.29; HRMS (FTMS+ESI): calcd for 
[C19H15N2O2SCl+H]
+: 371.0621. Found: 371.0611. 
10-(2-Chloropyridin-4-yl)-10H-phenothiazine-3,7-diol 111 
BBr3 (0.58 ml, 6.15 mmol) was added cautiously to a stirred solution of 10-(2-chloropyridin-4-yl)-
3,7-dimethoxy-10H-phenothiazine 110 (380 mg, 1.02 mmol) in DCM (10 ml, dry) cooled over an 
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ice bath and under an argon atmosphere. The mixture was stirred at 0 oC 
for 1 h before water was added to quench the reaction. The precipitate 
was filtered and washed with water. The bulk of the material was used 
for the next step without further purification (350 mg, 100%); a small 
sample was recrystallised from methanol to give analytically pure 10-(2-
chloropyridin-4-yl)-10H-phenothiazine-3,7-diol 111; δH (400 MHz; 
CD3OD; Me4Si) 9.70 (1H, d, J 7.2), 9.08 (2H, d, J 8.6), 8.71 (1H, dd, J 7.3, 2.6), 8.67 (1H, d, J 2.5), 
8.60 (2H, d, J 2.6), 8.49 (2H, dd, J 8.6, 2.7); δC (101 MHz; CD3OD; Me4Si) 160.15, 158.72, 144.54, 
142.56,  136.79, 130.73, 128.15, 116.51, 116.27, 109.31; HRMS (FTMS+ESI): calcd for 
[C17H11N2O2SCl+H]
+: 343.0308. Found: 343.0310. 
 
10-(2-Chloropyridin-4-yl)-3,7-bis(hexyloxy)-10H-phenothiazine 112 
10-(2-Chloropyridin-4-yl)-10H-phenothiazine-3,7-diol 111 (443 mg, 
1.29 mmol) was dissolved in DMSO (20 ml) and K2CO3 (540 mg, 3.91 
mmol) was added. The solution was stirred for 2 h at RT before 1-
bromohexane (0.54 ml, 3.88 mmol) was added. The solution was left 
to stir at RT overnight. Ethyl acetate was added and the organic phase 
was washed with brine to remove the DMSO. The solvent was 
removed in vacuo and the residue was purified by column chromatography (1% NEt3 in DCM) to 
give an oily solid, 10-(2-chloropyridin-4-yl)-3,7-bis(hexyloxy)-10H-phenothiazine 112 (500 mg, 
76%); δH (400 MHz; acetone-d6; Me4Si) 7.95 (1H, d, J 5.9), 7.53 (2H, d, J 8.7), 7.16 (2H, d, J 2.7), 
7.05 (2H, dd, J 8.7, 2.8), 6.71 (1H, dd, J 5.9, 2.3), 6.67 (1H, d, J 2.3), 4.07 (4H, t, J 6.5), 1.85 – 1.73 
(4H, m), 1.55 – 1.42 (4H, m), 1.42 – 1.22 (8H, m), 0.98 – 0.81 (6H, m); δC (176 MHz; acetone-d6; 
Me4Si) 158.78, 156.45, 152.83, 150.52, 137.01, 133.47, 129.43, 115.17, 114.94, 108.37, 107.70, 
69.26, 32.39, 29.87, 26.40, 23.28, 14.30; HRMS (FTMS+ESI): calcd for [C29H35N2O2SCl+H]
+: 
511.2186. Found: 511.2174. 
2-Fluoro-3-pyridylboronic acid 115 
The reaction was conducted according to the literature procedure.19 nBuLi (12.36 
ml, 2.5 M) was added dropwise to a stirred solution of DIPA (4.69 ml, 33.50 mmol) 
in THF (40 ml, dry) at 0 oC under an atmosphere of argon. The solution was stirred 
for 30 min at 0 oC before the temperature was lowered to -78 oC. 2-Fluoropyridine 114 (2.22 ml, 
25.75 mmol) was added dropwise and the solution was stirred at -78 oC for 1 h. B(OiPr)3 (8.90 ml, 
38.60 mmol) was then added dropwise and the reaction was left to warm to RT overnight. Dilute 
NaOH was added and the aqueous layer was separated and acidified to pH 6 with conc HCl. The 
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aqueous layer was then extracted with EtOAc, and the solvent removed to give a product 
assumed to be crude 2-fluoro-3-pyridylboronic acid 115. The material was used for the next step 
without further purification. 
2-Fluoro-3-pyridylboronic MIDA ester 112 
The crude boronic acid 115 (estimated 3.37 g, 23.9 mmol) and MIDA (4.22 g, 
28.7 mmol) were dissolved in DMSO (40 ml) and toluene (80 ml) and the 
solution was heated to reflux (170 oC) overnight in a Dean-Stark apparatus. The 
solution was cooled and water (100 ml) was added. The precipitate was 
filtered and dried to give an off-white solid, 2-fluoro-3-pyridylboronic MIDA 
ester 112 (3.33 g, 51% for two steps); δH (400 MHz; DMSO-d6; Me4Si) 8.26 (1H, 
ddd, J 4.9, 2.1, 0.9), 8.00 (1H, ddd, J 9.4, 7.1, 2.1), 7.36 (1H, ddd, J 7.1, 4.9, 3.0), 4.43 (2H, dd, J 
17.2, 1.0), 4.14 (2H, d, J 17.3), 2.65 (3H, s); δF (376 MHz; DMSO-d6; Me4Si) -60.50 (1F, dd, J 9.7, 
2.9); δB (128 MHz; DMSO-d6; Me4Si) 10.65 (1B, s); δC (101 MHz; DMSO-d6; Me4Si) 168.87, 165.55 
(d, J 235.0), 148.81 (d, J 15.0), 146.78 (d, J 8.4), 121.85 (d, J 4.07), 62.45, 47.49; HRMS 
(FTMS+ASAP): calcd for [C10H10N2O4F
10B+H]+: 252.0832. Found: 252.0821. 
 
10-(2'-Fluoro-[2,3'-bipyridin]-4-yl)-3,7-bis(hexyloxy)-10H-phenothiazine 113 
Method 1: A solution of 10-(2-chloropyridin-4-yl)-3,7-bis(hexyloxy)-
10H-phenothiazine 111 (500 mg, 0.98 mmol), 2-fluoro-3-
pyridylboronic MIDA ester  112 (370 mg, 1.47 mmol) and SPhos (64 
mg, 0.16 mmol) in dioxane (20 ml) was degassed with bubbling argon 
for 15 min. Pd(OAc)2 (18 mg, 0.08 mmol) was added, followed by a 
degassed solution of K3PO4 (1.50 g, 7.07 mmol in 4 ml) and the 
mixture was heated to 65 oC under an argon atmosphere overnight. 
The solution was cooled and the solvent removed in vacuo. The crude material was analysed by 
NMR and showed no sign of product. The 10-(2-chloropyridin-4-yl)-3,7-bis(hexyloxy)-10H-
phenothiazine was reclaimed. 
Method 2: A solution of 10-(2-chloropyridin-4-yl)-3,7-bis(hexyloxy)-10H-phenothiazine 111 (500 
mg, 0.98 mmol), 2-fluoro-3-pyridylboronic MIDA ester 112 (370 mg, 1.47 mmol) and PPh3 (62 mg, 
0.24 mmol) in DME (20 ml) was degassed with bubbling argon for 15 min. Pd(OAc)2 (13 mg, 0.06 
mmol) was added, followed by a degassed solution of Na2CO3 (423 mg, 4.00 mmol in 4 ml) and the 
mixture was heated to reflux under an argon atmosphere overnight. The solution was cooled and 
the solvent removed in vacuo. The residue was purified by column chromatography (10-20% 
EtOAc in DCM) to give 10-(2'-fluoro-[2,3'-bipyridin]-4-yl)-3,7-bis(hexyloxy)-10H-phenothiazine 113 
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(450 mg, 81%) as a viscous oil; δH (400 MHz; acetone-d6; Me4Si) 8.52 (1H, ddd, J 9.9, 7.5, 2.0), 8.31 
(1H, dd, J 5.9, 0.6), 8.21 (1H, ddd, J 4.8, 2.0, 1.3), 7.56 (2H, d, J 8.7), 7.42 (1H, ddd, J 7.6, 4.8, 2.0), 
7.39 – 7.36 (1H, m), 7.16 (2H, d, J 2.8), 7.07 (2H, dd, J 8.7, 2.8), 6.77 (1H, dd, J 5.9, 2.5), 4.07 (4H, t, 
J6.6), 1.79 (4H, dq, J 7.9, 6.6), 1.55 – 1.43 (4H, m), 1.43 – 1.28 (8H, m), 0.98 – 0.86 (6H, m); δF (376 
MHz; acetone-d6; Me4Si) -70.74 (1F, d, J 10.0); δC (176 MHz; acetone-d6; Me4Si) 161.37 (d, J 238.1), 
158.64, 154.78, 152.55 (d, J 6.8), 151.12, 148.30 (d, J 15.8), 142.37 (d, J 3.6), 137.04, 133.90, 
129.60, 123.45 (d, J 26.1), 123.01 (d, J 4.25), 115.05, 114.86, 109.00 (d, J 10.85), 108.20, 69.24, 
32.30, 29.89, 26.41, 23.29, 14.30; HRMS (FTMS+ESI): calcd for [C34H38N3O2SF]
+: 571.2669. Found: 
571.2685. 
 
Iridium complex 116 
10-(2'-Fluoro-[2,3'-bipyridin]-4-yl)-3,7-bis(hexyloxy)-
10H-phenothiazine 113 (450 mg, 0.79 mmol) was 
dissolved in toluene (10 ml, dry) and IrCl3.3H2O (132 
mg, mmol) was added. The mixture was heated to 
reflux overnight under an atmosphere of argon. 
Picolinic acid (92 mg, 0.75 mmol) was added and the 
solution was heated for a further 8 h before being 
cooled to RT. NMR analysis showed mostly the intermediate μ-dimer with little sign of complex or 
free ligand. The residue was redissolved in 2-ethoxyethanol (5 ml) and Na2CO3 (50 mg, 0.47 mmol) 
and picolinic acid (20 mg, 0.16 mmol) were added. The mixture was heated to 130 oC for 6 h 
before being cooled to RT. The solvent was removed in vacuo and the residue was purified by 
column chromatography (20% EtOAc in DCM) to give a yellow solid, iridium complex 116 (50 mg, 
9%); Anal. Calc. for C74H78F2IrN7O6S2: C, 61.05; H, 5.40; N, 6.73. Found: C, 60.57; H, 5.38; N, 6.48; 
δH (400 MHz; acetone-d6; Me4Si) 8.20 (1H, d, J 6.9), 8.14 (1H, ddd, J 7.8, 1.6, 0.8), 8.07 (1H, td, J 
7.6, 1.5), 7.86 (1H, t, J 3.2), 7.84 – 7.74 (2H, m), 7.65 (2H, d, J 8.7), 7.63 (2H, d, J 8.7), 7.57 (1H, 
ddd, J 7.2, 5.3, 1.6), 7.35 (1H, dd, J 5.1, 1.1), 7.32 (1H, dd, J 5.1, 1.1), 7.24 (1H, d, J 6.9), 7.18 (4H, 
dd, J 2.7, 0.8), 7.08 (2H, dd, J 8.7, 2.8), 7.07 (2H, dd, J 8.7, 2.8), 6.91 (1H, dd, J 6.9, 2.8), 6.66 (1H, 
dd, J 6.9, 2.9), 6.35 (1H, dd, J 5.1, 3.1), 6.16 (1H, dd, J 5.0, 3.2), 4.07 (8H, td, J 6.5, 3.1), 1.85 – 1.72 
(8H, m), 1.52-1.42 (8H, m), 1.41 – 1.25 (16H, m), 0.95 – 0.80 (12H, m);  MS (MALDI+): m/z = 1455.5 
(M+, 100%). 
Attempt 2: The above reaction was repeated using 10-(2'-fluoro-[2,3'-bipyridin]-4-yl)-3,7-
bis(hexyloxy)-10H-phenothiazine 113 (250 mg, 0.44 mmol), IrCl3.3H2O (73 mg, 0.21 mmol), 
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picolinic acid (51 mg, 0.41 mmol) and Na2CO3 (50 mg, 0.47 mmol) in diglyme (6 ml, dry). The 
reaction was worked up as previously described to give complex 116 (82 mg, 26%). 
Iridium complex 117 
IrCl3.3H2O (87 mg, 0.25 mmol) was added to a 
stirred solution of the 102 (300 mg, 0.52 
mmol) in diglyme (6 ml). The mixture was 
heated to 130 oC under an atmosphere of 
argon overnight. The mixture was then left to 
cool and the solvent was removed in vacuo. 
The yellow solid, presumed to be the 
intermediate bis(μ-Cl)dimer complex, was  
then suspended in a DCM/MeOH mixture 
(1:1), and 2,2’-bipyridine (42 mg, 0.27 mmol), NH4PF6 (400 mg, 2.46 mmol) and AgPF6 (30 mg, 0.12 
mmol) and the solution was stirred at RT overnight. The precipitated AgCl was removed by 
filtration over Celite, and the solvent removed in vacuo. The residue was then purified by column 
chromatography (DCM/MeOH 1:1), and the resultant solid was washed with cold methanol to 
give 117 (96 mg, 24%); Anal. Calc. for C82H80F10IrN8O4P: C, 59.52; H, 4.87; N, 6.77. Found: C, 59.41; 
H, 4.79; N, 6.68; δH (400 MHz; CDCl3; Me4Si) 8.65 (2H, t, J 2.5), 8.13-8.10 (2H, m), 7.98 (2H, d, J 
5.1), 7.95 (2H, d, J 8.6), 7.88 (4H, d, J 8.5), 7.65 (2H, d, J 6.4), 7.60 (2H, t, J 6.7), 7.52 (2H, dd, J 6.5, 
2.5), 7.13 (4H, d, J 2.1), 6.97 (4H, dd, J 8.6, 2.1), 6.01 (2H, d, J 7.9), 4.04 (8H, t, J 6.5), 1.81 (8H, p, J 
6.6), 1.48 (8H, q, J 7.2), 1.38–1.32 (16H, m), 0.91 (12H, q, J 4.3, 3.8); δF (376 MHz; CDCl3; Me4Si) -
72.40 (6F, J 713.9), -99.62 (2F), -104.92 (2F); HRMS (FTMS+ESI): calcd for [C82H80F4N8O4
191Ir]+: 
1507.5845. Found: 1507.5798. 
Experimental details for chapter 5: New ancillary ligands 
Part 1: 
4-Chloro-2-cyanopyridine-N-oxide 135 20 
4-Nitro-α-picoline N-oxide 134 (25.00 g, 0.16 mol) was added slowly to stirred acetyl 
chloride (120 ml) which was cooled by an ice bath. The mixture was stirred at RT for 
1.5 h then heated to 60 oC for 5 h. The solution was left to cool over the weekend. 
The acetyl chloride was evapourated in vacuo to give an oily residue which was 
taken up in water (100 ml) and neutralised with solid sodium carbonate.  The precipitate was 
collected, washed with cold toluene and air dried. The aqueous filtrate was extracted with 
chloroform, and the residue from the extract was dissolved in the minimum amount of boiling 
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toluene, filtered and cooled (freezer) to give a second crop of the expected product. The solid 
obtained was recrystallised from toluene to give 4-chloro-2-cyanopyridine-N-oxide 135 (6.00 g, 
23%); δH (400 MHz; CDCl3; Me4Si) 8.18 (1H, dd, J 7.2, 0.6), 7.63 (1H, dd, J 2.9, 0.6), 7.43 (1H, dd, J 
7.1, 3.0). NMR data are consistent with the literature data.20 
4-Chloro-2-cyanopyridine 136 20 
A solution of 4-chloro-2-cyanopyridine-N-oxide 135 (6.00 g, 38.82 mmol) in 
chloroform (50 ml) was treated with phosphorus trichloride (6.00 ml, 68.75 mmol) 
at RT for 2 h and then at reflux overnight. The mixture was poured into cold water 
(100 ml) and neutralised with solid sodium carbonate. The organic layer was separated, and the 
aqueous layer was further extracted with chloroform. The solvent was removed in vacuo and the 
residue was recrystallised from hexanes to give clear crystals of 4-chloro-2-cyanopyridine 136 
(3.96 g, 73%); δH (400 MHz; CDCl3; Me4Si) 8.64 (1H, dd, J 5.3, 0.7), 7.73 (1H, dd, J 2.0, 0.7), 7.57 
(1H, dd, J 5.4, 2.0). NMR data are consistent with the literature data.20 
2-Acetyl-4-chloropyridine 137 
A solution of methylmagnesium chloride (12.6 ml, 3.0 M in THF) was added to a 
stirred solution of 4-chloro-2-cyanopyridine 136 (3.96 g, 28.6 mmol) in ether (300 
ml, dry) dropwise over an ice bath. The resultant mixture was stirred at RT for 2.5 h 
and poured into aqueous 1 M ammonium chloride solution (300 ml). After 
acidification to pH 1 with conc.  HCl the mixture was stirred for 1 h, neutralised with Na2CO3. DCM 
was added and the organic layer was separated. The aqueous layer was extracted with further 
DCM. The solvent was removed in vacuo and the product was distilled (b.pt. 50oC at 0.6 mbar) 
giving a colourless oil which crystallised on standing, 2-acetyl-4-chloropyridine 137 (4.10 g, 92%); 
δH (400 MHz; CDCl3; Me4Si) 8.52 (1H, dd, J 5.2, 0.7), 8.04 (1H, dd, J 2.1, 0.6), 7.47 (1H, dd, J 5.2, 
2.1), 2.72 (3H, s); NMR data are consistent with the literature data.21 
 
1-(4-Mesitylpyridin-2-yl)ethanone 138 
2-Acetyl-4-chloropyridine 137 (1.5 g, 9.68 mmol), 2,4,6-trimethylphenylboronic 
acid 22 (1.75 g, 10.67 mmol) and PPh3 (657 mg, 2.50 mmol) were dissolved in 
DME (70 ml) and the solution was degassed for 20 min by bubbling with argon. 
Separately, an aqueous solution of Na2CO3 (4.18 g, 39.43 mmol in 17 ml) was 
degassed. The solutions were combined and Pd(OAc)2 (130 mg, 0.58 mmol) was 
added. The mixture was heated to reflux overnight under an atmosphere of 
argon. The solution was then cooled to RT, and the majority of the solvent was removed in vacuo. 
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DCM and water were added, and the organic layer separated. The aqueous layer was extracted 
with further DCM, and the extracts combined and the solvent removed in vacuo. The crude 
residue was purified by column chromatography (DCM), followed by recrystallisation from hexane 
to give 1-(4-mesitylpyridin-2-yl)ethanone 138 (1.2 g, 52%); m.pt. 118.9-119.9 oC; δH (400 MHz; 
CDCl3; Me4Si) 8.74 (1H, dd, J 4.9, 0.8), 7.88 (1H, dd, J 1.7, 0.8), 7.31 (1H, dd, J 4.9, 1.7), 6.95 –6.94 
(2H, m), 2.79 (3H, s), 2.33 (3H, s), 1.97 (6H, s); δC (101 MHz; CDCl3; Me4Si ) 200.07, 153.73, 151.14, 
149.18, 138.05, 135.64, 135.08, 128.61, 128.41, 123.06, 26.19, 21.19, 20.72; HRMS (FTMS+ESI): 
calcd for [C16H17NO+H]
+: 240.1388. Found: 240.1388.  
4-Mesityl-2-(3-(trifluoromethyl)-1H-pyrazol-5-yl)pyridine 133 
A solution of 4-mesityl-2-acetylpyridine 138 (1.20 g, 5.01 mmol) in THF 
(15 ml) was added dropwise to a stirred suspension of KOtBu (0.68 g, 
6.06 mmol) in dry THF solution (30 ml), which was cooled in an ice bath. 
After 5 min ethyl trifluoroacetate (0.65 ml, 5.51 mmol) was added 
slowly. The solution was allowed to stir at 0 oC for 15 mins before being 
removed from the ice bath. The mixture was heated to reflux overnight 
before being cooled, and the solvent was removed under reduced pressure. Water (30 ml) was 
added to the resulting solid and the resulting suspension was neutralised with conc. HCl. The 
solution was then extracted with DCM. The organic phase was dried over MgSO4 and the solvent 
removed to give the presumed 1,3-dione intermediate 139 (not characterised). This was dissolved 
in ethanol (30 ml) and hydrazine hydrate (0.34 ml, 95%) was added. The solution was heated to 
reflux overnight before the solvent was removed in vacuo. The residue was dissolved in DCM and 
washed with water to remove unreacted hydrazine hydrate. The solvent was removed, and the 
oily residue was redissolved in ethanol and conc. HCl (0.5 ml) was added (to prompt complete 
dehydration). The solution was heated to reflux for 5 h, before being cooled and the solvent 
removed. The crude solid was dissolved in DCM and washed with water, before being dried over 
MgSO4 and concentrated in vacuo. The crude solid was purified by column chromatography (1:3 
EtOAc:DCM) followed by  recrystallisation from hot hexane to give an off-white solid, 4-mesityl-2-
(3-(trifluoromethyl)-1H-pyrazol-5-yl)pyridine 133 (277 mg, 20%); m.pt. 171.1-172.9 oC; δH (400 
MHz; CDCl3; Me4Si) 11.95 (1H, br s), 8.70 (1H, dd, J 5.0, 0.9), 7.47 (1H, dd, J 1.5, 0.9), 7.15 (1H, dd, 
J 5.0, 1.5), 6.96-7.00 (2H, m), 6.91 (1H, s), 2.35 (3H, s), 2.02 (6H, s); δF (376 MHz; CDCl3; Me4Si) -
62.34 (3F, s); δC (101 MHz; CDCl3; Me4Si) 151.57, 149.86, 146.91, 144.61, 144.23, 143.10, 138.08, 
135.43, 134.97, 128.52, 125.07, 122.48, 121.40, 119.81, 101.34, 21.06, 20.57; HRMS (FTMS+ESI): 
calcd for [C18H16N3F3+H]
+: 332.1375. Found: 332.1379. 
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Iridium complex 140 
IrCl3.3H2O (66 mg, 0.19 mmol) was added to a 
stirred solution of 2-(2-fluoro-4-methoxy-3-
tosylphenyl)-4-mesitylpyridine 66 (169 mg, 0.38 
mmol) in 2-ethoxyethanol (5 ml). The solution was 
heated to 130 oC under an argon atmosphere 
overnight, during which a bright yellow precipitate 
formed, presumed to be the dichloro bridged 
dimer. The solvent was removed in vacuoand the precipitate was redissolved in DCM/ethanol (20 
ml, 3:1). 4-mesityl-2-(3-(trifluoromethyl)-1H-pyrazol-5-yl)pyridine 133 (77 mg, 0.28 mmol) was 
added and the solution was heated at 60oC overnight under an argon atmosphere. The solution 
was cooled and the solvent was removed in vacuo. The residue was purified by column 
chromatography (EtOAc in DCM, 2.5% increased to 4%) to give a yellow solid, iridium complex 140 
(190 mg, 70%); Anal. Calc. for C74H65F5IrN5O6S2: C, 60.39; H, 4.45; N, 4.76. Found: C, 59.44; H, 4.42; 
N, 4.62; δH (400 MHz; CDCl3; Me4Si) 8.12-8.17 (1H, m), 8.03-8.08 (1H, m), 7.89 (2H, d, J 8.2), 7.88 
(2H, d, J 8.2), 7.67 (1H, d, J 5.9), 7.64 (1H, d, J 5.9), 7.59 (1H, dd, J 1.7, 0.8), 7.57 (1H, d, J 5.9), 7.27 
(4H, t, J 8.7 Hz), 7.02 – 6.89 (8H, s), 6.78 (2H, td, J 6.1, 1.8),  5.79 (1H, s), 5.74 (1H, s), 3.47 (3H, s), 
3.44 (3H,s)  2.39 (3H, s), 2.38 (3H, s),  2.34 (3H, s), 2.33 (6H, s),  2.09 (3H, s), 2.01 (3H, s), 1.98 (3H, 
s), 1.97 (3H, s), 1.86 (6H, s); %); δF (376 MHz; CDCl3; Me4Si)-59.87 (3F, s), -110.50 (1F, s), -111.36 
(1F, s); HRMS (FTMS+ESI): calcd for [C74H65N5F5O6S2
191Ir+H]+: 1470.3981. Found: 1470.3995. 
Iridium complex 141 
[Ir(COD)Cl]2 (90 mg, 0.13 mmol) was added to a 
stirred solution of 2-(2,4-dimethoxy-3-
(methylsulfonyl)phenyl)-4-mesitylpyridine 79 (226 
mg, 0.55 mmol) in 2-ethoxyethanol (5 ml). The 
solution was heated to 130 oC under an argon 
atmosphere overnight before being cooled to RT. 
Water was added and a yellow precipitate formed 
which was filtered, washed with further water and dried. The precipitate, presumed to be the 
intermediate dichloro bridged dimer, was dissolved in DCM/ethanol (40 ml, 3:1) and 4-mesityl-2-
(3-(trifluoromethyl)-1H-pyrazol-5-yl)pyridine 133 (90 mg, 0.27 mmol) was added and the solution 
was heated at 55 oC overnight under an argon atmosphere. The solution was cooled and the 
solvent was removed in vacuo. The residue was purified by column chromatography (EtOAc in 
DCM gradient elution from 0% to 15%) to give a yellow solid, iridium complex 141 (98 mg, 27%); 
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δH (400 MHz; CD2Cl2; Me4Si) 8.47 (1H, d, J 1.4), 8.38 (1H, d, J 1.4), 7.80 – 7.74 (3H, m), 7.65 (1H, dd, 
J 1.8, 0.8), 6.98 (6H, s), 6.95 (3H, s), 6.91 (1H, dd, J 5.7, 1.8), 6.84 (1H, dd, J 5.9, 1.9), 6.81 (1H, dd, J 
5.9, 1.9), 6.03 (1H, s), 6.01 (1H, s), 3.88 (3H, s), 3.85 (3H, s), 3.61 (3H, s), 3.60 (3H, s), 3.22 (3H, s), 
3.19 (3H, s), 2.33 (3H, s), 2.32 (3H, s), 2.31 (3H, s), 2.09 (3H, s), 2.06 (3H, s), 2.05 (3H, s), 2.01 (3H, 
s), 1.88 (3H, s), 1.85 (3H, s); δF (376 MHz; CDCl3; Me4Si) -58.48 (3F, s); HRMS (FTMS+ESI): calcd for 
[C64H63F3N5O8S2
191Ir+H]+: 1342.3754. Found: 1342.3802. 
Part 2: 
2-Hydroxy-N-(2’-hydroxyethyl)benzamide 155 22 
The reaction was conducted as described in the literature.22 Methyl salicylate 
153 (4.26 g, 28.00 mmol) and 2-aminoethanol 154 (1.62 ml, 26.85 mmol) were 
combined and heated to reflux (~170 oC) for 2 h before the solution was cooled 
to RT and the methanol produced was removed by vacuum distillation.  The 
crude residue was purified by column chromatography (30:70 EtOAc:DCM to 
remove impurities, increased to 5:25:70 MeOH:EtOAc:DCM to elute the product) to give a 
crystalline white solid, 2-hydroxy-N-(2’-hydroxyethyl)benzamide 155 (3.98 g, 82%); δH (400 MHz; 
CD2Cl2; Me4Si) 12.27 (1H, br s), 7.47 – 7.36 (2H, m), 6.98 – 6.91 (1H, dd, J 8.4, 1.1), 6.87 (1H, ddd, J 
7.9, 7.3, 1.2), 6.85 (1H, br s), 3.81 (2H, dd, J 5.7, 4.6), 3.60 (2H, td, J 5.7, 4.6), 2.13 (1H, br s). NMR 
data is consistent with  
 
2-(2’-Hydroxyphenyl)-2-oxazoline 152 
2-Hydroxy-N-(2’-hydroxyethyl)benzamide 155 (3.98 g, 21.98 mmol) was suspended 
in DCM (100 ml) and SOCl2 (3.19 ml, 43.96 mmol) was added with caution. The 
solution was stirred under an atmosphere of argon overnight before the HCl salt of 
the desired product was filtered off and neutralised with a saturated NaHCO3 
solution. The aqueous solution was extracted with diethyl ether (3 x 100 ml) and the solvent 
removed to leave a pale pink oil which solidified on standing. 2-(2’-Hydroxyphenyl)-2-oxazoline 
152 (3.39 g, 94%); δH (400 MHz; CDCl3; Me4Si) 12.18 (1H, br s),  7.65 (1H, dd, J 7.8, 1.8), 7.37 (1H, 
ddd, J 8.4, 7.3, 1.8), 7.02 (1H, dd, J 8.4, 0.9), 6.87 (1H, ddd, J 7.8, 7.3, 0.9), 4.49 – 4.40 (2H, m), 4.16 
– 4.07 (2H, m). NMR data are consistent with the literature data.22 
Iridium complex 145 
IrCl3.3H2O (209 mg, 0.59 mmol) was added to a stirred solution of 2-(2,4-difluorophenyl)pyridine 
13 (250 mg, 1.31 mmol) in 2-ethoxyethanol (6 ml) under argon. The solution was heated to 135 oC 
for 6 h, before 2-(2’-hydroxyphenyl)-2-oxazoline 152 (121 mg, 0.74 mmol) and Na2CO3 (315 mg, 
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2.97 mmol) were added and the solution was heated to 135 oC 
overnight. Water was added and the yellow precipitate was 
collected by filtration. The residue was purified by column 
chromatography (hexane:EtOAc 4:1) to give complex 145 as a 
yellow solid (310 mg, 79%); Anal. Calc. for C31H20F4IrN3O2: C, 50.68; 
H, 2.74; N, 5.72. Found: C, 50.43; H, 3.07; N, 5.47; δH (400 MHz; 
CD2Cl2; Me4Si) 8.78 (1H, d, J 5.2), 8.39 (1H, d, J 5.8), 8.26 (2H, t, J 8.9), 7.87 – 7.75 (2H, m), 7.61 
(1H, d, J 8.1), 7.21 (1H, t, J 6.6), 7.14 (2H, t, J 7.0), 6.60 (1H, d, J 8.7), 6.45 – 6.32 (3H, m), 5.79 (1H, 
dd, J 8.9, 2.3), 5.62 (1H, dd, J 8.9, 2.4), 4.36 (1H, q, J 9.3), 4.23 (1H, q, J 8.5), 3.64 – 3.47 (1H, m), 
3.14 – 3.00 (1H, m); δF (376 MHz CD2Cl2; Me4Si) -109.30 (1F, q, J 9.1), -109.34 (1F, q, J 9.3), -110.90 
(1F, ddd, J 12.4, 10.1, 1.6), -110.95 (1F, ddd, J 12.5, 10.1, 2.5); HRMS (FTMS+ESI): calcd for 
[C31H20F4N3O2
191Ir+H]+: 734.1176. Found: 734.1186. Crystals for X-ray analysis were grown by slow 
evaporation of a DCM/Methanol solution of 145. 
3,6-Di-tert-butyl-9H-carbazole 
ZnCl2 (4.84 g, 35.50 mmol) was added to a degassed solution of 
carbazole (2.00 g, 11.96 mmol) in CH3NO2 (60 ml) under argon. 
tBuCl (2.6 
ml, 23.92 mmol) was added dropwise and the solution was stirred at RT 
for 2 h. Water (50 ml) was added and the organic layer was separated 
and washed with further water (2 x 50 ml) before the solvent was removed in vacuo. The product 
was recrystallised from hexane to give a white solid (0.65 g, 19%); δH (400 MHz; CDCl3; Me4Si) 8.07 
(2H, d, J 1.9), 7.87 (1H, br s), 7.46 (2H, dd, J 8.5, 1.9), 7.34 (2H, dd, J 8.6, 0.7), 1.45 (18H, s); NMR 
data are consistent with the literature data.23 
 
3,6-Di-tert-butyl-9-(2-chloropyridin-4-yl)-9H-carbazole 149 
3,6-Di-tert-butyl-9H-carbazole 148 (0.65 g, 2.32 mmol), 2-chloro-4-
iodopyridine 21 (0.56 g, 2.32 mmol) and 1,10-phenanthroline (0.24 g, 
1.33 mmol) were dissolved in DMF (10 ml, dry) and the solution was 
degassed for 15 min. CuI (0.13 g, 0.67 mmol) and K2CO3 (0.64 g, 4.65 
mmol) were added and the solution was heated to 120 oC overnight 
under an argon atmosphere. The solution was cooled to RT and brine 
(50 ml) and DCM (50 ml) were added. The phases were separated and the aqueous phase was 
extracted with further DCM (50 ml). The organic phases were combined and the solvent removed 
in vacuo. The residue was purified by column chromatography (hexane: EtOAc 6:1) to give a white 
solid, 3,6-di-tert-butyl-9-(2-chloropyridin-4-yl)-9H-carbazole 149 (0.72 g, 79%); m.pt. 175.1-177.2 
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oC; δH (700 MHz; CDCl3; Me4Si) 8.57 (1H, d, J 5.3), 8.11 (2H, dd, J 1.9, 0.8), 7.64 (1H, d, J 1.8), 7.55 – 
7.49 (5H, m), 1.47 (18H, s); δC (176 MHz; CDCl3; Me4Si) 153.18, 151.21, 148.37, 144.94, 137.60, 
124.73, 124.39, 120.11, 118.72, 116.79, 109.53, 34.97, 32.04; HRMS (FTMS+ESI): calcd for 
[C25H27N2Cl+H]
+: 391.1941. Found: 391.1943. 
 
3,6-Di-tert-butyl-9-(2-phenylpyridin-4-yl)-9H-carbazole 151 
3,6-Di-tert-butyl-9-(2-chloropyridin-4-yl)-9H-carbazole 149 (400 mg, 
1.02 mmol) and phenylboronic acid 150 (187 mg, 1.53 mmol) were 
dissolved in a mixture of toluene (7 ml), EtOH (1.5 ml) and water (7 
ml) and the solution was degassed with bubbling argon for 10 min. 
Pd(PPh3)4 (71 mg,  1.02 mmol) and Na2CO3 (400 mg, 4.17 mmol) were 
added and the solution was heated to reflux overnight before being 
cooled to RT. The organic phase was separated and the aqueous layer 
was extracted with EtOAc (2 x 50 ml). The organic phases were 
combined, dried over MgSO4 and the solvent was removed in vacuo. The residue was purified by 
column chromatography (hexane:EtOAc 6:1) to give an off-white solid,  151 (460 mg, 58%); m.pt. 
176.3-177.0 oC; δH (700 MHz; CDCl3; Me4Si) 8.89 (1H, d, J 5.3), 8.15 (2H, d, J 1.9), 8.09 – 8.05 (2H, 
m), 8.02 (1H, d, J 2.0), 7.57 (2H, d, J 8.6), 7.55 – 7.50 (5H, m), 7.50 – 7.45 (1H, m), 1.48 (18 H, s); δC 
(176 MHz; CDCl3; Me4Si) 147.16, 144.45, 137.99, 129.10, 127.25, 124.52, 124.25, 120.88, 118.58, 
117.09, 116.74, 115.44, 109.59, 96.05, 34.97, 32.09; HRMS (FTMS+ESI): calcd for [C31H32N2+H]
+: 
433.2644. Found: 433.2616. 
 
Iridium complex 146 
IrCl3.3H2O (170 mg, 0.48 mmol) was added to a 
stirred solution of 3,6-di-tert-butyl-9-(2-
phenylpyridin-4-yl)-9H-carbazole 151 (460 mg, 1.06 
mmol) and the solution was heated to 135 oC 
overnight. 2-(2’-hydroxyphenyl)-2-oxazoline 152 
(99 mg, 0.61 mmol) and Na2CO3 (256 mg, 2.41 
mmol) were added and the solution was heated to 
135 oC for 8 h before being cooled to RT. Water (5 
ml) was added and the precipitate was filtered off and dried. The precipitate was purified by 
column chromatography (hexane:EtOAc 7:1). The product from the column was stirred in hot 
MeOH, allowed to cool, and filtered. This was repeated to remove soluble impurities. The product 
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146 was obtained as an orange-yellow solid (109 mg, 19%); δH (400 MHz; CDCl3; Me4Si) 9.09 (1H, 
d, J 6.3), 8.58 (1H, d, J 6.3), 8.24 – 8.13 (6H, m), 7.79 – 7.72 (3H, m), 7.72 – 7.65 (2H, m), 7.65 – 
7.54 (6H, m), 7.52 (1H, dd, J 6.3, 2.3), 7.38 (1H, dd, J 6.3, 2.3), 7.23 (1H, ddd, J 8.8, 6.7, 2.0), 6.97 – 
6.78 (5H, m), 6.60 (1H, dd, J 7.5, 1.3), 6.50 (1H, dd, J 6.6, 1.9), 6.46 (1H, ddd, J 8.1, 6.8, 1.2), 4.42 
(1H, q, J 9.3), 4.35 (1H, dt, J 10.4, 8.2), 3.71 (1H, ddd, J 14.0, 10.2, 7.6), 3.21 (1H, dt, J 14.0, 10.1), 
1.56 (3H, d, J 3.3); HRMS (FTMS+ASAP): calcd for [C71H70N5O2
191Ir]+: 1215.5136. Found: 1215.5104. 
 
2-(Oxazol-2-yl)phenol 156 
MnO2 (5.00 g, 57.52 mmol) was added to a stirred solution of 2-(2’-hydroxyphenyl)-
2-oxazoline 152 (500 mg, 3.06 mmol) in toluene (20 ml) and the mixture was 
heated to reflux for 5 h. The mixture was cooled to RT and filtered through a celite 
plug (DCM) and the solvent was removed in vacuo. The residue was purified by 
column chromatography (DCM) to give a white solid, 2-(oxazol-2-yl)phenol 156 (140 mg, 28%); δH 
(700 MHz; CDCl3; Me4Si) 11.20 (1H, s), 7.84 (1H, dd, J 7.8, 1.7), 7.69 (1H, t, J 0.9), 7.39 – 7.34 (1H, 
m), 7.24 (1H, d, J 1.0), 7.08 (1H, dd, J 8.3, 1.2), 6.95 (1H, td, J 7.5, 1.0); δC (176 MHz; CDCl3; Me4Si) 
161.78, 157.35, 137.49, 132.47, 126.51, 126.08, 119.52, 117.31, 111.25; HRMS (FTMS+ESI): calcd 
for [C9H7NO2+H]
+: 162.0555. Found: 162.0542. 
 
N-(2,2-diethoxyethyl)-2-methoxybenzamide 159 
Methyl-2-methoxybenzoate 157 (5.00 g, 28.93 mmol) and 
aminoacetaldehyde diethylacetal 158 (2.78 g, 17.25 mmol) were combined 
and the mixture was heated to 160 oC for 4 h before being cooled to RT. A 
crude NMR showed the reaction had not gone to completion, more 
aminoacetaldehyde diethylacetal 158 (1.00 g, 6.20 mmol) was added and 
the reaction was heated to 160 oC overnight before being cooled to RT. Any methanol produced 
was removed by rotary evaporation and the oily residue was purified by column chromatography 
(hexane:EtOAc 1:1) to give an oil, N-(2,2-diethoxyethyl)-2-methoxybenzamide 159 (2.80 g, 36%); 
δH (400 MHz; CDCl3; Me4Si) 8.21 (1H, dd, J 7.8, 1.9), 8.15 (1H, br t, J 5.5), 7.45 (1H, ddd, J 8.3, 7.3, 
1.8), 7.08 (1H, ddd, J 7.8, 7.3 1.0), 6.98 (1H, dd, J 8.4, 1.0), 4.63 (1H, t, J 5.6), 3.97 (3H, s), 3.76 (dq, 
J 9.4, 7.0), 3.67 – 3.54 (4H, m), 1.25 (6H, t, J 7.0); HRMS (FTMS+ESI): calcd for [C14H21NO4+Na]
+: 
290.1368. Found: 290.1368. The carbon NMR could not be obtained as 159 hydrolysed to the 
aldehyde in the NMR solvent; δH (600 MHz; CDCl3; Me4Si) 9.76 (1H, d, J 0.6), 8.64 (1H, br s), 8.21 
(1H, dd, J 7.7, 1.9), 7.51 – 7.45 (1H, m), 7.09 (1H, t, J 7.6), 7.01 (1H, d, J 8.4), 4.41 (2H, dd, J 4.8, 
0.7), 4.03 (3H, d, J 0.6); δC (151 MHz; CDCl3; Me4Si) 196.97, 165.69, 157.96, 133.45, 132.52, 
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121.48, 120.70, 111.55, 56.20, 51.15.   
 
2-(2-Methoxyphenyl)oxazole  160 and 2-(2-methoxy-5-(methylsulfonyl)phenyl)oxazole 161 
Methanesulfonic acid (35 ml) was added cautiously to N-(2,2-
diethoxyethyl)-2-methoxybenzamide 159 (2.80 g, 11.70 mmol) 
with stirring. P4O10 (4.50 g, 15.85 mmol) was added with 
caution and the mixture was heated to 180 oC overnight. The 
mixture was cooled to RT and added dropwise to aq. NaHCO3 
solution (300 ml) with stirring. The aqueous phase (pH 8) was extracted with DCM (3 x 400 ml) 
and the solvent was removed in vacuo to leave a thick oil. The residue was purified by column 
chromatography (10-20% EtOAc in DCM) to give the product as a yellow oil 160 (400 mg, 19%); δH 
(400 MHz; CDCl3; Me4Si) 7.98 (1H, dd, J 8.1, 1.8), 7.76 (1H, d, J 0.8), 7.46 (1H, ddd, J 8.3, 7.4, 1.8), 
7.31 (1H, d, J 0.8), 7.04- 7.11 (2H, m), 4.00 (3H, s); δC (151 MHz; CDCl3; Me4Si) 160.44, 157.67, 
138.31, 138.27, 131.90, 130.41, 128.28, 120.79, 116.61, 112.10, 56.20; HRMS (FTMS+ESI): calcd 
for [C10H9NO2+H]
+: 176.0712. Found: 176.0740. 
Also isolated as a second fraction was 2-(2-methoxy-5-(methylsulfonyl)phenyl)oxazole 161 (538 
mg, 18%); δH (400 MHz; CDCl3; Me4Si) 8.54 (1H, dd, J 2.4, 0.8), 8.01 (1H, ddd, J 8.8, 2.4, 0.8), 7.78 
(1H, d, J 0.8), 7.33 (1H, s), 7.18 (1H, d, J 8.8), 4.07 (3H, s), 3.09 (3H, s); δC (151 MHz; CDCl3; Me4Si) 
161.29 , 139.10 , 131.21 , 130.18 , 128.69 , 112.49 , 56.85 , 44.94 . HRMS (FTMS+ESI): calcd for 
[C11H11NO4S+H]
+: 254.0487. Found: 254.0471. 
 
2-(Oxazol-2-yl)phenol 156 
BBr3 (0.65 ml, 6.87 mmol) was added dropwise to a stirred solution of 2-(2-
methoxyphenyl)oxazole 160 (400 mg, 2.28 mmol) in DCM (10 ml, dry) over an ice bath. The 
suspension was stirred at RT overnight before the reaction was quenched with water (CAUTION). 
The solid formed, presumed to be (2-(2-hydroxyphenyl)oxazol-3-ium bromide) was filtered off and 
suspended in DCM. This was then washed with aq. Na2CO3 to neutralise the salt. The organic 
phase was collected and the aqueous phase was washed with further DCM (3 x 50 ml). The 
organic phases were combined, dried over MgSO4 and filtered. The solvent was removed in vacuo 




BBr3 (0.61 ml, 6.37 mmol) was added dropwise to a stirred solution of 2-(2-methoxy-5-
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(methylsulfonyl)phenyl)oxazole 161  (538 mg, mmol) in DCM (10 ml, dry) over an 
ice bath. The suspension was stirred at RT overnight before the reaction was 
quenched with water (caution!). The solid formed, presumed to be 2-(2-hydroxy-
5-(methylsulfonyl)phenyl)oxazol-3-ium bromide, was filtered off and suspended 
in DCM. This was then washed with aq. Na2CO3 to neutralise the salt. The organic phase was 
collected and the aqueous phase was washed with further DCM (3 x 50 ml). The organic phases 
were combined, dried over MgSO4 and filtered. TLC revealed a mixture of starting material and 
product; the crude mixture was redissolved in DCM and extracted with aq. NaOH solution (3 x 50 
ml, 1 M). The aqueous phases were combined, acidified to pH 6 with conc. HCl and re-extracted 
with DCM (4 x 100 ml). The organic phase was dried over MgSO4, the solvent was removed and 
the residue was purified by silica plug (EtOAc) to give a white solid, 4-(methylsulfonyl)-2-(oxazol-2-
yl)phenol 162 (200 mg, 39%). A small sample was recrystallised from methanol to give an 
analytically pure sample; δH (400 MHz; CDCl3; Me4Si) 11.91 (1H, s), 8.47 (1H, d, J 2.4), 7.91 (1H, dd, 
J 8.8, 2.4), 7.79 (1H, d, J 0.9), 7.32 (1H, d, J 0.9), 7.23 (1H, d, 8.8), 3.10 (3H, s); δC (101 MHz; CDCl3; 
Me4Si) 161.39, 160.21, 138.54, 131.68, 131.30, 126.78, 126.56, 118.56, 111.65, 45.01; HRMS 
(FTMS+ESI): calcd for [C10H9NO4S]
+: 240.0331. Found: 240.0335. 
 
Iridium complex 164 
IrCl3.3H2O (123 mg, 0.35 mmol) was added to a stirred solution 
of 2-phenylpyridine 163 (0.11 ml, 0.77 mmol) in 2-
ethoxyethanol (10 ml). The solution was heated to reflux (135 
oC) overnight. Na2CO3 (300 mg, 2.83 mmol) and 2-(oxazol-2-
yl)phenol 156 (62 mg, 0.38 mmol) and the solution was heated 
to reflux overnight before being cooled to RT. Water was added 
and the precipitate was filtered to give a yellow solid. The 
crude product was filtered and washed with more water to 
remove water soluble impurities. The product was dried, then washed with hexane and cold 
diethyl ether to remove traces of ppy 163 ligand. The product was obtained as a yellow solid, 164 
(200 mg, 87%); δH (700 MHz; CDCl3; Me4Si) 8.88 (1H, d, J 5.7, HA6), 7.99 (1H, d, J 5.8, HC6), 7.85 (1H, 
d, J 8.2, HC3), 7.80 (1H, d, J 8.2, HA3), 7.72 (1H, dd, J 8.2, 1.9, HF3), 7.67 (1H, td, J 8.1, 1.5, HA4), 7.65 
(1H, td, J 8.1, 1.5, HC4), 7.59 (1H, dd, J 7.9, 1.1, HD3), 7.56 (1H, dd, J 7.6, 1.1, HB3), 7.38 (1H, d, J 1.0, 
HE2), 7.12 (1H, ddd, J 8.7, 7.0, 1.9, HF5), 7.07 (1H, ddd, J 7.4, 6.0, 1.4, HA5), 6.92 (1H, ddd, J 8.1, 5.9, 
1.4, HC5), 6.87 (1H, td, J  7.5, 1.2, HD4), 6.86 (1H, td, J 7.4, 1.2, HB4), 6.80 – 6.75 (2H, m, HF6+D5), 6.73 
(1H, dt, J 7.3, 1.1, HB5), 6.42 (1H, ddd, J 7.9, 6.9, 1.1, HF4), 6.36 (1H, d, J 7.6, HB6), 6.28 (1H, d, J 7.6, 
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HD6), 6.20 (1H, d, J 1.0, HE1); δC (151 MHz; CDCl3; Me4Si) 169.22 (CC2), 168.10 (CA2), 167.20 (CF1), 
158.67 (CE3), 152.67 (CD1), 149.07 (CA6) 148. 72 (CB1), 148.67 (CC6), 144.87 (CB2), 144.83 (CD2), 137.49 
(CE2), 136.91 (CA4), 136.74 (CC4),  133.20 (CB6), 132.56 (CF5), 132.48 (CD6), 129.69 (CB5), 129.58 (CD5), 
127.39 (CF3), 126.64 (CE1), 125.53 (CF6), 124.18 (CB3), 124.10 (CD3), 122.07 (CA5) 121.80 (CC5), 120.79 
(CD4), 119.02 (CB4), 118.73 (CC3), 118.25 (CA3), 113.34 (CF4), 110.94 (CF2); HRMS (FTMS+ESI): calcd 
for [C31H22N3O4
191Ir+H]+: 660.1396. Found: 660.1406 
 
Iridium complex 165 
IrCl3.3H2O (236 mg, 0.67 mmol) was added to a stirred 
solution of 2-phenylpyridine 163 (0.21 ml, 1.47 mmol) in 2-
ethoxyethanol (10 ml). The solution was heated to reflux (135 
oC) overnight. Na2CO3 (354 mg, 3.34 mmol) and 4-
(methylsulfonyl)-2-(oxazol-2-yl)phenol 162 (200 mg, 0.84 
mmol) and the solution was heated to reflux overnight before being cooled to RT. Water was 
added and the precipitate was filtered to give a yellow solid. The crude material was purified by 
column chromatography (10% EtOAc in DCM) to give the product as a yellow solid. Fractions 
containing product 165 contaminated with unreacted ppy were combined, the solvent was then 
removed and the solid was washed with hexane to give further product 165 (combined yield: 281 
mg, 57%); δH (400 MHz; CDCl3; Me4Si) 8.75 (1H, ddd, J 5.8, 1.5, 0.7), 8.38 (1H, d, J 2.6), 7.96 (1H, d, 
J 5.7, 1.5, 0.7), 7.91 (1H, d, J 8.1), 7.87 (1H, d, J 8.1), 7.75 (1H, td, J 7.6, 1.7), 7.73 (1H, td, J 7.5, 
1.6), 7.60 (1H, td, J 8.4, 1.1), 7.57 (1H, dd, J 9.2, 2.6), 7.49 (1H, d, J 1.0), 7.14 (1H, ddd, J 7.3, 5.7, 
1.4), 7.01 (1H, ddd, J 7.4, 5.8, 1.5), 6.93 (1H, td, J 7.5, 1.2), 6.92 (1H, td, J 7.5, 1.2), 6.82 (1H, d, J 
9.2), 6.79 (1H, td, J 6.16, 1.2), 6.76 (1H, td, J 7.4, 1.4), 6.83 – 6.77 (1H, m), 6.79 – 6.74 (m, 1H), 6.38 
(1H, dd, J 7.7, 1.0), 6.29 (1H, dd, J 7.6, 1.0), 6.27 (1H, d, J 1.0), 3.04 (s, 3H); HRMS (FTMS+ESI): 
calcd for [C32H24N3O4S
191Ir]+: 737.1094. Found: 737.1118. 
Experimental details for chapter 6: ‘Cage complexes’ for enhanced stability 
Tris(2-chloroethyl)amine hydrochloride 176 24 
The reaction was conducted as described in the literature. Triethanolamine 
175 (2.81 g, 18.84 mmol) was dissolved in chloroform (10 ml) and added 
dropwise with caution to a stirred solution of thionyl chloride (6.84 ml, 94.14 
mmol) in chloroform (10 ml). After the addition was complete, the reaction 
mixture was stirred for another 2 h at RT before the solvent and excess thionyl chloride were 
removed in vacuo. The remaining product was recrystallised from acetone to give a white solid, 
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tris(2-chloroethyl)amine hydrochloride 176 (4.33 g, 95%); δH (400 MHz; CDCl3; Me4Si) 4.10 (1H, t, J 
6.3), 3.66 (1H, t, J 6.4). NMR data are consistent with the literature data.24 
Tris(2-(4-bromophenoxy)ethyl)amine 177 
The reaction was conducted as described in the literature. NaOH 
(0.72 g, 17.98 mmol) was added to a solution of 4-bromophenol (2.28 
g, 13.17 mmol) in methanol (50 ml, dry) and stirred at RT for 1 h. 
Tris(2-chloroethyl)amine hydrochloride 176 (0.96 g, 3.99 mmol) was added and the solution was 
heated to reflux (100 oC) overnight before being cooled to RT. The solvent was removed in vacuo 
and water (50 ml) and chloroform (50 ml) were added. The layers were separated and the 
aqueous layer was extracted with additional chloroform (50 ml). The organic phases were 
combined, dried over MgSO4 and the solvent removed. The residue was purified by column 
chromatography (EtOAc:hexane 1:2) to give a brown oil, tris(2-(4-bromophenoxy)ethyl)amine 177 
(1.21 g, 49%); δH (400 MHz; CDCl3; Me4Si) 7.37 – 7.30 (6H, m), 6.76 – 6.69 (6H, m), 4.04 (6H, t, J 
5.6), 3.12 (6H, t, J 5.6). NMR data are consistent with the literature data.25 
Also isolated was N,N-bis(4-bromophenethyl)-2-chloroethan-1-amine (460 mg, 24%); δH (400 
MHz; CDCl3; Me4Si) 7.40 – 7.30 (4H, m), 6.80 – 6.71 (4H, m), 4.03 (4H, t, J 5.9), 3.50 (2H, t, J 5.7), 
3.07 (4H, t, J 5.9), 2.89 (2H, t, J 5.6).  
Tris(2-(4-(1H-imidazol-1-yl)phenoxy)ethyl)amine 178 
Tris(2-(4-bromophenoxy)ethyl)amine 177 (1.21 g, 1.97 mmol), 
imidazole (0.53 g, 7.79 mmol) and 1,10-phenanthroline (212 mg, 
1.18 mmol) were dissolved in DMSO (6 ml, dry). CuI (112 mg, 
0.59 mmol) and Cs2CO3 (3.84 g, 11.79 mmol) were added and the 
solution was heated to 165 oC under argon for 40 h before being cooled to RT. DCM (50 ml) and 
brine (50 ml) were added and the layers were separated. The aqueous layer was extracted with 
further DCM before the organic layers were combined, dried over MgSO4, filtered and the solvent 
removed. The residue was purified by crystallisation from a mixture of toluene and acetone to 
give tris(2-(4-(1H-imidazol-1-yl)phenoxy)ethyl)amine 178 (0.52 g, 46%); δH (400 MHz; CD2Cl2; 
Me4Si) 7.76 (3H, br s), 7.35 – 7.22 (6H, m), 7.25 (3H, br s), 7.15 (3H, br s), 7.02 – 6.95 (6H, m), 4.14 
(6H, t, J 5.7), 3.18 (6H, t, J 5.7); δC (176 MHz; CD2Cl2; Me4Si) 158.68, 131.48, 130.49, 123.56, 
116.02, 68.09, 55.06; HRMS (FTMS+ESI): calcd for [C33H33N7O3+H]
+: 576.2723. Found: 576.2722. 
 
Imidazolium ion 179 
Tris(2-(4-(1H-imidazol-1-yl)phenoxy)ethyl)amine 178 (520 mg, 0.90 mmol) was suspended in 
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acetonitrile (25 ml) and CH3I (0.16 ml, 2.61 mmol) was 
added. The solution was heated to reflux for 4h, during 
which time a precipitate formed. The solution was cooled 
and the acetonitrile was decanted. The product was 
recrystallized by addition of acetone to a solution of the product in methanol. The product was 
obtained as a brown solid 179 (446 mg, 50%); δH (700 MHz; DMSO-d6; Me4Si) 9.72 – 9.68 (1H, m), 
8.23 (1H, dt, J 3.8, 1.8), 7.95 (1H, t, J 1.8), 7.79 – 7.74 (2H, m), 7.32 (2H, dd, J 9.2, 2.5), 4.71 – 4.67 
(2H, m), 4.15 (2H, m), 3.95 (3H, s), 3.42 (1H, d, J 5.3); δC (176 MHz; DMSO-d6; Me4Si) 232.80, 
232.79, 158.02, 135.70, 128.54, 124.31, 123.33, 121.17, 121.16, 116.09, 62.01, 61.36, 49.94, 
36.14. 
 
4-(2-Pyridyl)phenol 182 26 
The reaction was conducted according to the literature method. 2-Bromopyridine 11 
(1.21 ml, 12.66 mmol), 4-hydroxyphenylboronic acid 181 (2.62 g, 19.00 mmol), Pd(OAc)2 
(14 mg, 0.06 mmol) were combined in ethylene glycol (40 ml) and the mixture was 
heated to 80 oC for 2 h before being cooled to RT. Water (50 ml), brine (50 ml) and DCM 
(100 ml) were added and the layers were separated. The aqueous layer was extracted 
with further DCM (3 x 100 ml) and the extracts were combined and the solvent was removed in 
vacuo. The residue was purified by column chromatography (3:2 to 1:1 hexane: EtOAc) to give a 
white solid, 4-(2-pyridyl)phenol 182 (1.81 g, 84%); δH (400 MHz; CDCl3; Me4Si) 8.64 (1H, ddd, J 4.9, 
1.8, 1.0), 7.90 – 7.81 (2H, m), 7.74 (1H, ddd, J 8.0, 7.4, 1.8), 7.66 (1H, dt, J 8.1, 1.1), 7.20 (1H, ddd, J 




NaOH (0.57 g, 14.34 mmol) was added to a stirred solution of 4-
(2-pyridyl)phenol 182 (1.81 g, 10.57 mmol) in MeOH (40 ml, dry) 
and the solution was stirred at RT for 1 h. Tris(2-
chloroethyl)amine hydrochloride (0.77 g, 3.20 mmol) was added 
and the solution was heated to reflux overnight before being cooled to RT. The solvent was 
removed in vacuo and DCM (50 ml) and water (50 ml) were added. The organic layer was 
separated and the aqueous phase was extracted with further DCM (2 x 100 ml). The organic 
phases were combined and the solvent removed in vacuo. The residue was purified by using the 
Biotage® Isolera One ™ purification system (Reverse phase C18 column, H2O/MeOH gradient 
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elution) to give a white solid, tris(2-(4-(pyridin-2-yl)phenoxy)ethyl)amine 183 (0.75 g, 40%); δH 
(400 MHz; CDCl3; Me4Si)  8.64 (3H, ddd, J 4.9, 1.8, 1.0), 7.96 – 7.88 (6H, m), 7.69 (3H, ddd, J 8.0, 
7.2, 1.8), 7.64 (3H, dt, J 8.1, 1.3), 7.16 (3H, ddd, J 7.2, 4.8, 1.3), 7.03 – 6.94 (2H, m), 4.19 (6H, br t, J 
4.8), 3.22 (6H, t, J 4.8); δC (176 MHz; CDCl3; Me4Si) 159.76, 157.23, 149.66, 136.77, 132.28, 128.32, 





KOH (0.93 g, 16.57 mmol) was added to a stirred solution of 4-(2-
pyridyl)phenol 182 (1.42 g, 8.29 mmol) in acetonitrile (30 ml) and the 
mixture was heated to reflux for 2 h. KI (1.38 g, 8.31 mmol) and 2-(2-
chloroethoxy)ethanol (1.75 ml, 16.62 mmol) were added and the mixture 
was heated to reflux for 40 h before being cooled to RT. The solvent was 
removed in vacuo and DCM (50 ml) and water (50 ml) were added. The 
organic phase was separated and the aqueous phase was extracted with 
further DCM (2 x 50 ml). The organic phases were combined, dried over 
MgSO4, and the solvent removed. The residue was purified by column chromatography (EtOAc) to 
give an oil which solidified on standing, 2-(2-(4-(pyridin-2-yl)phenoxy)ethoxy)ethan-1-ol 185 (1.88 
g, 87%); δH (400 MHz; CDCl3; Me4Si) 8.65 (1H, ddd, J 4.7, 1.8, 1.0), 8.02 – 7.85 (2H, m), 7.77 – 7.68 
(1H, m), 7.68 – 7.61 (1H, m), 7.23 – 7.10 (1H, m), 7.10 – 6.96 (2H, m), 4.20 (2H, ddd, J 4.7, 3.8, 1.4), 
3.99 – 3.82 (2H, m), 3.82 – 3.73 (2H, m), 3.69 (2H, ddd, J 5.5, 3.3, 1.4);  δC (101 MHz; CDCl3; Me4Si) 
159.66, 157.17, 149.67, 136.83, 132.49, 128.33, 121.62, 120.01, 114.92, 90.77, 72.76, 69.80, 
67.61, 61.94; HRMS (FTMS+ASAP): calcd for [C15H17NO3+H]
+: 260.1287. Found: 260.1290. 
 
Tris(2-iodoethyl)amine 27 
KI (1.38 g, 8.31 mmol) was added to a stirred solution of tris(2-
chloroethyl)aminehydrochloride 176 (490 mg, 2.03 mmol) in acetonitrile and the 
solution was heated to reflux for 3 h before being cooled to RT. The KCl formed 
was removed by filtration and the filtrate was reduced in vacuo to give a yellow 
solid which was washed with sodium bisulfite solution (1 ml), dried, and used in the next step 
without further purification. 
 
2-(4-(2-(2-Iodoethoxy)ethoxy)phenyl)pyridine 188 
I2 (896 mg, 3.53 mmol) was added to a stirred solution of PPh3 (997 mg, 3.80 mmol) and imidazole 
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(259 mg, 3.80 mmol) in DCM (10 ml, dry) at 0 oC under argon. The resulting 
suspension was stirred at 0 oC for 30 mins before a solution of 2-(2-(4-
(pyridin-2-yl)phenoxy)ethoxy)ethan-1-ol 185 (657 mg, 2.53 mmol) in DCM 
(10 ml, dry) was added. The mixture was stirred at RT overnight before the 
reaction was quenched by aq. NH4Cl solution. The organic phase was 
separated and the aqueous layer was extracted with further DCM (2 x 70 
ml). The organic phases were combined, concentrated in vacuo and the 
residue obtained was purified by column chromatography (20-50% EtOAc in 
DCM) to give an oil that solidified to a white solid, 2-(4-(2-(2-iodoethoxy)ethoxy)phenyl)pyridine 
188 (764 mg, 82%); δH (400 MHz; CDCl3; Me4Si) 8.66 (1H, ddd, J 4.9, 1.8, 1.0), 7.91-7.99 (2H, m), 
7.77 – 7.70 (1H, m), 7.70 – 7.65 (1H, m), 7.22 – 7.16 (1H, m), 7.06 – 6.98 (2H, m), 4.24 – 4.18 (2H, 
m), 3.92 – 3.88 (2H, m), 3.85 (2H, t, J 7.2), 3.30 (2H, t, J 7.2); δC (151 MHz; CDCl3; Me4Si) 159.79, 
156.79, 137.11, 132.28, 128.39, 127.56, 121.65, 114.99, 69.47, 68.85, 67.68, 2.81; HRMS 
(FTMS+ESI): calcd for [C15H16
127INO2+H]
+: 370.0304. Found: 370.0295. 
 
2-(2-((Tetrahydro-2H-pyran-2-yl)oxy)ethoxy)ethanol 19128 
The reaction was conducted as described in the literature. p-
Toluenesulfonic acid (20 mg, 0.12 mmol) was added to diethylene 
glycol 190 (9 ml) and the solution was cooled to -10 oC and stirred. 3,4-Dihydro-2H-pyran (1.08 ml, 
11.89 mmol) was added dropwise over 15 min. The solution was stirred at -10 oC for 1 h and then 
at RT for 2 h before aq. NaOH (0.5 M, 60 ml). This was extracted with DCM (4 x 60 ml) and the 
organic phases were combined and dried over MgSO4, filtered and the solvent was removed in 
vacuo. The crude product was purified by vacuum distillation (Kugelrohr, ~120 oC at 1 mbar) to 
give a colourless oil, 2-(2-((tetrahydro-2H-pyran-2-yl)oxy)ethoxy)ethanol 191 (2.10 g, 93%); δH 
(400 MHz; CDCl3; Me4Si) 4.64 (1H, dd, J 4.4, 2.9), 3.96 – 3.85 (2H, m), 3.82 – 3.71 (4H, m), 3.68 – 
3.64 (3H, m), 3.57 –3.51 (1H, m), 1.91 – 1.68 (2H, m), 1.68 – 1.47 (4H, m). NMR data are consistent 
with the literature data.28 
 
Tris(2-(2-(2-((tetrahydro-2H-pyran-2-yl)oxy)ethoxy)ethoxy)ethyl)amine 192 
NaOH (210 mg, 5.25 mmol, ground) was added to a 
stirred solution of THP-protected ethylene glycol 191 
(1.00 g, 5.25 mmol) and tetrabutylammonium 
hydrogensulfate (71 mg, 0.21 mmol) in THF (10 ml, dry) and the solution was heated to reflux for 
2 h. The solution was cooled and tris(2-chloroethyl)amine hydrochloride 176 (317 mg, 1.31 mmol) 
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was added. The solution was heated to reflux over the weekend before being cooled to RT. The 
solution was filtered to remove any NaCl formed, and the solid was washed with DCM. The 
solvent was removed in vacuo and the residue was purified by column chromatography (EtOAc, 
stained with KMnO4) to give a yellow oil, tris(2-(2-(2-((tetrahydro-2H-pyran-2-
yl)oxy)ethoxy)ethoxy)ethyl)amine 192 (550 mg, 63%); δH (400 MHz; CDCl3; Me4Si) 4.67 (3H, dd, J 
4.4, 2.9), 3.96 – 3.83 (6H, m), 3.81 – 3.70 (13H, m), 3.70 – 3.60 (9H, m), 3.60 – 3.50 (3H, m), 2.56 
(3H, t, J 5.0), 1.94 – 1.72 (7H, m), 1.69 – 1.48 (19H, m).  
 
Tris(2-(2-(2-hydroxy)ethoxy)ethyl)amine 193 
Sodium (1.00 g, 43.48 mmol) was added to a stirred diethylene 
glycol 190 (25 ml) and the mixture  
was heated with stirring until the sodium had fully dissolved. Trichloroethylamine (1.78 g, 8.70 
mmol, prepared by washing the salt 176 with aq. Na2CO3 and extracting) was added and the 
solution was heated to 130 oC overnight before being cooled to RT. The majority of the excess 
diethylene glycol was removed by vacuum distillation (2 mbar, 108-110 oC), with the rest being 
removed via distillation in the Kugelrohr. The residue was dissolved in DCM and the solution was 
filtered to remove and NaCl. The solution was then concentrated to give the product 193 (3.55 g, 
99%), δH (400 MHz; CDCl3; Me4Si) 3.80 – 3.56 (m, 36H); HRMS (FTMS+ESI): calcd for 
[C18H39NO9+H]
+: 414.2703. Found: 414.2700.  
 
Tris(2-(2-(2-methanesulfonate-ethoxy)ethoxy)ethyl)amine 195  
MsCl (2.91 ml, 37.53 mmol) was added dropwise (caution, 
exothermic) to a stirred solution of tris(2-(2-(2-
hydroxy)ethoxy)ethyl)amine 193 (2.22 g, 5.36 mmol) and NEt3 (20 ml) in DCM (50 ml, dry) over an 
ice bath under an atmosphere of argon. The solution was left to warm to RT overnight before aq. 
NaHCO3 (20 ml) was added. The organic layer was separated and the aqueous layer was extracted 
with further DCM (4 x 100 ml, spiked with iPrOH due to water soluble products). The solvent was 
removed in vacuo and the residue was purified by using the Biotage® Isolera One ™ purification 
system (Reverse phase C18 column, H2O/MeOH gradient elution) to give a brown oil containing 
tris(2-(2-(2-methanesulfonate-ethoxy)ethoxy)ethyl)amine 195; δH (400 MHz;CDCl3;Me4Si) 4.41 
(6H, m), 3.85 – 3.61 (30H, m), 3.09 (9H, s); HRMS (FTMS+ESI): calcd for [C21H45NO15S3+H]
+: 
648.2030. Found: 648.2020. 
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Tris(2-(2-(2-iodoethoxy)ethoxy)ethyl)amine 196 
NaI (14.50 g, 96.73 mmol) was added to a solution of tris(2-(2-(2-
methanesulfonate-ethoxy)ethoxy)ethyl)amine 195 (1.49 g, 2.30 
mmol) in acetonitrile (20 ml) and the solution was heated to reflux overnight before being cooled 
to RT. The solvent was removed in vacuo, and water (20 ml) and chloroform (50 ml) were added. 
The layers were separated, and the aqueous phase was extracted with further chloroform (3 x 40 
ml). The organic phases were combined, dried over MgSO4, and the solvent was removed in 
vacuo. The residue was purified using the Biotage® Isolera One ™ purification system (Reverse 
phase C18 column, H2O/MeOH gradient elution) to give a brown oil containing tris(2-(2-(2-
iodoethoxy)ethoxy)ethyl)amine 196; δH (400 MHz;CDCl3;Me4Si) 3.81 –3.75 (m), 3.75 – 3.71 (12H, 
m), 3.70 – 3.66 12H, m); δC (101 MHz; CDCl3; Me4Si) 95.79, 72.11, 70.26, 67.05, 31.08, 2.86; HRMS 
(FTMS+ESI): calcd for [C18H36NO6
127I3+H]
+: 743.9755. Found: 743.9760. 
 
1,3,5-Benzenetrimethanol 198 29 
A solution of 1,3,5-trimethylbenzene carboxylate 197 (4.00 g, 15.86 mmol) 
in THF (40 ml, dry) was added dropwise to a suspension of LiAlH4 (1.80 g, 
47.43 mmol, crushed to a powder) in THF (60 ml, dry) over an ice bath, 
under an argon atmosphere. Once addition was complete the suspension 
was heated to reflux overnight. The reaction was quenched by slow pouring onto ice (caution, gas 
evolution). The precipitate formed was filtered through celite and washed with CHCl3 (100 ml). 
The solvents were then removed in vacuo to leave a white solid, 1,3,5-benzenetrimethanol 198 
(2.67 g, quant); δH (400 MHz; CD3OH; Me4Si) 7.26 (3H, p, 0.6), 4.61 (6H, q, 0.6); NMR data is 
consistent with the literature data.29 
 
1,3,5-Tris(bromomethyl)benzene 199 30 
PBr3 (7.52 ml, 79.17 mmol) was added dropwise to a stirred suspension of 
1,3,5-benzenetrimethanol 198 (3.33 g, 19.80 mmol) in diethyl ether (60 ml, 
dry) over an ice bath under an atmosphere of argon. The solution was stirred 
at 0 oC for 2 h and then at RT for 6 h. The solution was poured over ice and 
the layers were separated. The aqueous layer was extracted with further diethyl ether (3 x 40 ml) 
and the organic phases were combined, dried over MgSO4, filtered and the solvent removed in 
vacuo. The residue was purified by column chromatography (3:1 hexane:EtOAc) to give the 
product as a white crystalline solid, 1,3,5-tris(bromomethyl)benzene (5.15 g, 74%); δH (400 MHz; 
CDCl3; Me4Si) 7.36 (3H, s), 4.46  
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(2H, s); NMR data is consistent with the literature data.30 
 
1,3,5-Tris((2-(2-((tetrahydro-2H-pyran-2-yl)oxy)ethoxy)ethoxy)methyl)benzene 200 
NaOH (1.05 g, 26.25 mmol) was added to a solution of PEG-THP 
191 (5.00 g, 26.29 mmol) and TBAHSO4 (357 mg,  1.05 mmol). 
The mixture was heated to reflux for 2 h before 1,3,5-
tris(bromomethyl)benzene 199 (2.32 g, 6.56 mmol) was added. 
The solution was heated to reflux overnight before being cooled 
to RT. The mixture was filtered to remove the white precipitate and the solvent was removed in 
vacuo. The residue was purified by column chromatography (50-0% hexane in EtOAc) to give the 
product as a colourless oil, 200 (1.10 g, 24%); δH (400 MHz; CDCl3; Me4Si) 7.24 (3H, s), 4.64 (6H, q, 
J 4.4), 4.56 (6H, s), 3.90-3.82 (6H, m), 3.78 – 3.59 (7 H, m), 3.59 – 3.46 (1 H, m), 2.05 (1 H, s), 1.83 
(1 H, d, J 10.1), 1.80 – 1.66 (1 H, m), 1.66 – 1.51 (5 H, m), 1.26 (1 H, t, J 7.1); NMR data is 
consistent with the literature data.31 
 
1,3,5-Tris((2-(2-hydroxyethoxy)ethoxy)methyl)benzene 201 
The THP-protected alcohol 200 (1.10 g, 1.61 mmol) was dissolved 
in DCM/Methanol (1:1, 20 ml) and a drop of conc. HCl (37%) was 
added. The solution was stirred at RT overnight. Solid NaHCO3 was 
added and the solvent removed in vacuo. The residue was 
suspended in EtOAc and filtered. The solvent was removed to give 
the product as a colourless oil, 201 (500 mg, 71%); δH (400 MHz; 




Sodium (1.67 g, 72.61 mmol) was added to stirred diethylene glycol (30 ml) and the mixture was 
heated to 80 oC for 3 h (until the sodium dissolved). The mixture was cooled and 1,3,5-
tris(bromomethyl)benzene 199 (5.15 g , 14.56 mmol) was added and the solution was heated to 
100 oC overnight before being cooled to RT. The remaining diethylene glycol was removed by 
vacuum distillation using the Kugelrohr apparatus to leave a mixture of the crude product 201 and 
diethylene glycol sodium salts.  
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1,3,5-Tris((2-(2-mesyl-ethoxy)ethoxy)methyl)benzene 202 
Mesyl chloride (15 ml, 0.19 mol) was added cautiously to a stirred 
solution of the crude mixture containing 201 (~10 g) and NEt3 (30 
ml) in DCM (50 ml, dry) at 0 oC under argon. The solution was left 
to stir at 0 oC for 1 h, then allowed to warm to RT overnight. 
Water (200 ml) was added, and the layers were separated. The 
aqueous layer was extracted with further DCM (3 x 100 ml) and the organic phases were 
combined, dried over MgSO4, and the solvent removed to give an oil containing diethylene glycol 
dimesylate and the product 202; δH (400 MHz; CDCl3; Me4Si) 7.23 (3H, s), 4.54 (6H, s), 4.39 – 4.37 




NaI (44.00 g, 0.29 mol) was added to a stirred solution of the crude 
mixture containing 202 (~26 g) in acetonitrile (120 ml). The mixture 
was heated to reflux overnight before being cooled to RT. The 
mixture was cooled and the solvent removed in vacuo. DCM and 
water were added. The organic phase was separated and the 
aqueous phase was extracted with further DCM. The organic phases were combined, dried over 
MgSO4, filtered and the solvent removed. The residue was purified by an alumina column 
(hexane:EtOAc 1:1) followed by a Kugelrohr distillation to remove bis(2-iodoethyl) ether (b.pt. 
110-120 oC at 0.66 mbar32). The product 203 was obtained as an orange oil (5.94 g, 54% over 
three steps); δH (400 MHz; CDCl3; Me4Si) 7.27 (3H, s), 4.58 (6H, s), 3.78 (6H, t, J 6.9), 3.71 – 3.68 
(6H, m), 3.66 – 3.63 (6H, m), 3.27 (6H, t, J 6.9); NMR data is consistent with the literature data.31 
 
1,3,5-Tris((2-(2-(4-(pyridin-2-yl)phenoxy)ethoxy)ethoxy)methyl)benzene 223 
NaOH (93 mg, 2.33 mmol) was added to a stirred solution of 
4-(2-pyridyl)phenol 182 (500 mg, 2.92 mmol) in THF (20 ml, 
dry). The mixture was heated to reflux under argon for 3 h 
before being cooled to RT. A solution of 1,3,5-tris((2-(2-
iodoethoxy)ethoxy)methyl)benzene 203 (445 mg, 0.58 mmol) 
in THF (5 ml, dry) and the solution was heated to reflux 
overnight. The solution was then cooled to RT and the solvent 
was removed in vacuo. The residue was purified by column chromatography (EtOAc) to give the 
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product as a clear oil, 1,3,5-tris((2-(2-(4-(pyridin-2-yl)phenoxy)ethoxy)ethoxy)methyl)benzene 223 
(345 mg, 66%); δH (400 MHz; CDCl3; Me4Si) 8.63 (3H, d, J 4.3), 7.95 – 7.88 (6H, m), 7.71 – 7.61 (6H, 
m), 7.26 (3H, s), 7.15 (3H, ddd, J7.1, 4.9, 1.5), 7.03 – 6.96 (6H, m), 4.55 (6H, s), 4.17 – 4.15 (6H, m), 
3.91 – 3.82 (6H, m), 3.79 – 3.69 (6H, m), 3.69 – 3.59 (6H, m); δC (101 MHz; CDCl3; Me4Si) 159.75, 
157.11, 149.58, 138.69, 136.72, 132.22, 128.19, 126.41, 121.49, 119.86, 114.88, 73.19, 70.97, 
69.80, 69.67, 67.59; HRMS (FTMS+ESI): calcd for [C54H57N3O9+H]
+: 892.4173. Found: 892.4181. 
 
Iridium complex 228 
Reaction 1: Ligand 223 (64 mg, 0.07 mmol) was suspended in ethylene 
glycol (300 ml) and the solution was degassed with bubbling argon. The 
solution was heated to 140 oC before Ir(acac)3 (21 mg, 0.07 mmol) was 
added. The solution was heated to 160 oC for 24 h under argon before 
being cooled. The solvent was removed via trap-to-trap distillation and 
DCM (20 ml) and water (20 ml) were added. The organic phase was 
separated and the aqueous phase was extracted with further DCM (2 x 
20 ml). The organic phases were combined, dried over MgSO4, and the 
solvent removed in vacuo. TLC analysis showed only unreacted ligand 
223. The ligand and unreacted Ir(acac)3 were reclaimed via column 
chromatography (DCM to EtOAc).  
Reaction 2: Ligand 223 (64 mg, 0.07 mmol) was suspended in ethylene glycol (150 ml) and the 
solution was degassed with bubbling argon. The solution was heated to 140 oC before Ir(acac)3 (21 
mg, 0.07 mmol) was added. The solution was heated to reflux for 24 h under argon before being 
cooled. The solvent was removed via trap-to-trap distillation and DCM (20 ml) and water (20 ml) 
were added. The organic phase was separated and the aqueous phase was extracted with further 
DCM (2 x 20 ml). The organic phases were combined, dried over MgSO4, and the solvent removed 
in vacuo. The residue was purified by column chromatography (DCM:EtOAc 1:1) to give the 
product 228 as a yellow solid (25 mg, 32%); δH (700 MHz; CD2Cl2; Me4Si) 7.77 (3H, dt, J 8.4, 1.1, 
HA3), 7.58 (3H, d, J, HB3), 7.56 (3H, ddd, J, HA4), 7.44 (3H, ddd, J 5.4, 1.6, 0.8, HA6), 7.25 (3H, s, HC2), 
6.79 (3H, ddd, J 7.0, 5.5, 1.3, HA5), 6.43 (3H, dd, J 8.6, 2.7, HB4), 6.25 (3H, d, J 2.7, HB6),  4.50 (6H, m, 
H5), 3.87 – 3.78 (6H, m, H1), 3.65 (12H, ddt, J 7.2, 5.4, 3.9, H2/3), 3.60 (6H, t, J 5.1, H4); δC (176 MHz; 
CD2Cl2; Me4Si) 166.64 (CA2), 163.82 (CB1), 160.62 (CB5), 147.50 (CA6), 138.98 (CC1), 137.49 (CB2), 
136.44 (CA4), 128.64 (CC2), 125.76 (CB3), 122.36 (CB6), 121.25 (CA5), 118.63 (CA3), 106.22 (CB4), 73.82 
(C5), 71.02 (C3), 70.45 (C2), 69.79 (C4), 67.21 (C1); HRMS (FTMS+ESI): calcd for [C54H54IrN3O9]
+: 
1079.3466. Found: 1079.3489.  
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4-Imidazol-1-ylphenol 33 
CuI (440 mg, 2.31 mmol) and Cs2CO3 (7.53 g, 23.11 mmol) were added to a stirred 
solution of 4-bromophenol 207 (2.00 g, 11.56 mmol) and imidazole (1.10 g, 16.16 mmol) 
in DMF (8 ml, dry) under an atmosphere of argon. The mixture was heated to 120 oC for 
48 h before being cooled to RT. EtOAc was added and the suspension was passed through 
a column of silica to remove any copper salts (eluent: EtOAc/ethanol). The residue 
obtained was purified by column chromatography (1-5% ethanol in EtOAc) to give the product as 
a white solid, 4-imidazol-1-ylphenol 204 (250 mg, 14%); δH (400 MHz; CD3OD; Me4Si) 7.96 (1H, t, J 
1.2), 7.43 (1H, t, J 1.4), 7.39 – 7.30 (2 H, m), 7.12 (1H, t, J 1.2), 6.98 – 6.85 (2H, m). NMR data is 
consistent with the literature.33 
 
2-(4-Bromophenoxy)tetrahydro-2H-pyran 208 
3,4-Dihydro-2H-pyrane (1.05 ml, 11.53 mmol) was added dropwise to a stirred 
solution of 4-bromophenol 207 (2.00 g, 11.56 mmol) and p-toluenesulfonic acid (20 
mg, 0.12 mmol) in DCM (20 ml). The solution was stirred at RT for 2 h before dilute 
aq. NaOH (50 ml) was added. Diethyl ether (50 ml) was added and the layers were 
separated. The aqueous layer was extracted with further diethyl ether (2 x 50 ml), 
the organic phases were then combined, dried over MgSO4 and the solvent removed to give an 
oil. The product was run through a short silica column (eluent: hexane) to give the product as a 
white crystalline solid, 2-(4-bromophenoxy)tetrahydro-2H-pyran 208 (1.10 g, 37%); δH (400 MHz; 
CDCl3; Me4Si) 7.41 – 7.32 (2H, m), 6.99 – 6.89 (2H, m), 5.37 (1H, t, J 3.2), 3.87 (1H, ddd, J 11.5, 9.6, 
3.2), 3.60 (1H, dtd, J 11.4, 4.1, 1.5), 2.07 – 1.83 (2H, m), 1.81 – 1.64 (2H, m), 1.64 – 1.49 (2H, m). 
NMR data is consistent with the literature data.34 
 
2-(4-Imidazol-1-yl-phenoxy)tetrahydro-2H-pyran 209 
A solution of 2-(4-bromophenoxy)tetrahydro-2H-pyran 208 (962 mg, 3.74 mmol), 
imidazole (382 mg, 5.61 mmol) and 1,10-phenanthroline (405 mg, 2.25 mmol) in 
DMSO (5 ml, dry) was degassed with bubbling argon for 10 mins. Cs2CO3 (7.33 mg, 
22.50 mmol) and CuI (214 mg, 1.12 mmol) were added and the solution was heated 
to 165 oC overnight under argon before being cooled to RT. Brine (30 ml) and DCM 
(30 ml) were added, the organic phase was separated and aqueous phase was 
extracted with further DCM (2 x 30 ml). The organic phases were combined, dried over MgSO4, 
and the solvent was removed in vacuo. The residue was purified by column chromatography 
(EtOAc) to give an off-white solid, 2-(4-imidazol-1-yl-phenoxy)tetrahydro-2H-pyran 209 (630 mg, 
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69%); δH (400 MHz; CDCl3; Me4Si) 7.80 (1H, s), 7.34 – 7.25 (2H, m), 7.22 (1H, s), 7.20 (1H, s), 7.17 – 
7.10 (2H, m), 5.45 (1H, t, J 3.2), 3.90 (1H, ddd, J 11.4, 9.6, 3.1), 3.63 (1H, dtd, J 11.3, 4.1, 1.4), 2.12 
– 1.91 (2H, m), 1.91 – 1.85 (2H, m), 1.78 – 1.58 (2H, m). 
 
4-Imidazol-1-ylphenol 
Conc. HCl (1 ml, 37%) was added to a stirred solution of 2-(4-imidazol-1-yl-phenoxy)tetrahydro-
2H-pyran 209 (765 mg, mmol) in MeOH (10 ml). The mixture was stirred at RT overnight before 
NaHCO3 was added. The solvent was removed in vacuo and the mixture was redissolved in EtOAc 
(20 ml) and filtered. The solvent was removed to give an off-white solid, 4-imidazol-1-ylphenol 
204 (500 mg, quant.). The NMR data was consistent with that obtained previously. 
 
6-(2-Thienyl)-3-pyridinol 205 
2-Thienylboronic acid 211 (0.88 g, 6.88 mmol) and 2-bromo-5-hydroxypyridine 210 (1.00 
g, 5.75 mmol) were combined in DME/water (20/9 ml) and the solution was degassed 
for 20 min with bubbling argon. PdCl2(PPh3)2 (20 mg, 0.03 mmol) and K2CO3 (2.22 g, 
16.06 mmol) were added and the solution was heated to reflux overnight before being 
cooled to RT. The solvent was removed in vacuo and DCM (50 ml) and water (50 ml) 
were added. The aqueous layer was acidified to pH 7 with dilute HCl (2.0 M) and the layers were 
separated. The aqueous layer was extracted with additional DCM (3 x 50 ml) and the organic 
phases were combined, dried over MgSO4, filtered and the solvent removed to give an off-white 
solid. NMR revealed a mixture of starting material and product that did not separate on TLC. The 
starting material removed by sublimation (150 oC, 0.1 mbar) using a Kugelrohr apparatus to leave 
the product as a white solid, 6-(2-thienyl)-3-pyridinol 205 (690 mg, 68%); δH (400 MHz; CDCl3; 
Me4Si) 8.27 (1H, dd, J 2.9, 0.7), 7.58 (1H, dd, J 8.6, 0.7), 7.50 (1H, dd, J 3.7, 1.1), 7.34 (1H, dd, J 5.1, 
1.1), 7.25 (1H, dd, J 8.6, 2.9), 7.09 (1H, dd, J 5.1, 3.7); δC (151 MHz; CDCl3; Me4Si) 151.76, 145.40, 
143.71, 136.86, 128.21, 126.75, 124.60, 123.96, 120.39; HRMS (FTMS+ESI): calcd for 
[C9H7NOS+H]
+: 178.0327. Found: 178.0324.  
 
1,3,5-Tris((2-(2-((6-(thiophen-2-yl)pyridin-3-yl)oxy)ethoxy)ethoxy)methyl)benzene 226 
NaOH (69 mg, 1.73 mmol) was added to a stirred solution of 6-(2-thienyl)- 3-pyridinol 205 (332 
mg, 1.87 mmol) in THF (20 ml, dry). The mixture was heated to reflux under argon for 3 h before 
being cooled to RT. 1,3,5-Tris((2-(2-iodoethoxy)ethoxy)methyl)benzene 103 (210 mg, 0.28 mmol) 
was added and the solution was heated to reflux overnight. The solution was then cooled to RT 
and the solvent was removed in vacuo. The residue was purified by column chromatography 
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(EtOAc:hexane 3:1) to give intermediate 225 (200 mg, 
80%); δH (400 MHz; CDCl3; Me4Si) 8.26 (2H, dd, J 2.9, 
0.7), 7.55 (2H, dd, J 8.7, 0.7), 7.42 (2H, dd, J 3.7, 1.2), 
7.30 (2H, dd, J 5.1, 1.1), 7.24 (3H, s), 7.21 (2H, dd, J 
8.7, 3.0), 7.05 (2H, dd, J 5.1, 3.6), 4.54 (4H, s), 4.53 
(2H, s), 4.19 – 4.16 (4H, m), 3.90 – 3.82 (4H, m), 3.79 
– 3.72 (6H, m), 3.72 – 3.56 (8H, m), 3.28 – 3.19 (2H, 
m); HRMS (FTMS+ESI): calcd for [C39H45N2O8S2I+H]
+: 861.1760. Found: 861.1735. 
NaOH (28 mg, 0.70 mmol) was added to a stirred solution of 6-(2-thienyl)-3-pyridinol 205 (165 
mg, 0.93 mmol) in THF (20 ml, dry) and the mixture was heated to reflux for 4 h under an argon 
atmosphere before being cooled to RT. The intermediate 225 (200 mg, 0.23 mmol) was added and 
the mixture was heated to reflux overnight before being cooled to RT. The solvent was removed 
in vacuo and the residue was purified by column chromatograpy (hexane:EtOAc 3:1) to give the 
product as an oil, 226 (105 mg, 50%); δH (600 MHz; CDCl3; Me4Si) 8.26 (3H, d, J 2.9, HB6), 7.55 (3H, 
d, J 8.7, HB3), 7.44 (3H, d, J 3.6, HA5), 7.31 (3H, dd, J 5.1, 1.1, HA3), 7.24 (3H, s, HC1), 7.23 (3H, dd, J, 
8.7, 2.9, HB4), 7.06 (3H, dd, J 5.1, 3.6, HA4), 4.53 (6H, s, H5), 4.20 – 4.15 (4H, m, H1), 3.88 – 3.83 (6H, 
m, H2), 3.74 – 3.69 (6H, m, H3), 3.66 – 3.61 (6H, m, H4). δC (151 MHz; CDCl3; Me4Si) 154.10 (CB5), 
145.71 (CB2), 144.34 (CA2), 138.74 (CC2), 137.19 (CB6), 128.12 (CA4), 126.63 (CA3), 126.50 (CC1), 123.57 
(CA5), 122.77 (CB4), 119.56 (CB3), 73.29 (C5), 71.09 (C3), 69.77 (C2/4), 69.76 (C2/4), 68.25 (C1); HRMS 
(FTMS+ESI): calcd for [C48H51N3O9S3+H]
+: 910.2866. Found: 910.2867. 
 
Iridium complex 229 
Ligand 226 (105 mg, 0.12 mmol) was suspended in ethylene glycol (150 
ml) and the solution was degassed with bubbling argon. The solution was 
heated to 140 oC before Ir(acac)3 (34 mg, 0.12 mmol) was added. The 
solution was heated to reflux for 24 h under argon before being cooled. 
The solvent was removed via trap-to-trap distillation and DCM (20 ml) and 
water (20 ml) were added. The organic phase was separated and the 
aqueous phase was extracted with further DCM (2 x 20 ml). The organic 
phases were combined, dried over MgSO4, and the solvent removed in 
vacuo. The residue was purified by column chromatography (DCM:EtOAc 
1:1) to give the product as a yellow solid 229 (9 mg, 8%); δH (700 MHz; 
CD2Cl2; Me4Si) 7.38 (3H, dd, J 8.9, 0.7, HB3), 7.32 (3H, dd, J 2.8, 0.7, HB6), 
7.29 (3H, s, HC2), 7.14 (3H, dd, J 8.9, 2.7, HB4), 7.07 (3 H, d, J 4.6, HA5), 6.20 (3 H, d, J 4.6, HA4), 4.50 
Chapter 8: Experimental data  
 
  229 
(3 H, d, J 10.9, H5a), 4.46 (3 H, d, J 10.9, H5b), 3.97 (3 H, ddd, J 9.5, 6.0, 3.1, H1a), 3.83 (3 H, ddd, J 
10.1, 4.8, 2.8, H1a), 3.69 (6 H, dt, J 4.9, 2.7, H2), 3.67 – 3.61 (12 H, m, H3/4); δC (176 MHz; CD2Cl2; 
Me4Si) 156.06 (CB2), 155.41 (CA3), 153.29 (CB5), 139.00 (CC1), 137.26 (CB6), 135.69 (CA4), 134.94 (CA2), 
128.77 (CC2), 126.00 (CA5), 122.51 (CB4), 117.78 (CB3), 73.94 (C5), 71.13 (C3), 70.32(C4), 70.13 (C2), 
68.69 (C1); HRMS (FTMS+ESI): calcd for [C48H48
191IrN3O9S3]
+: 1097.2159. Found: 1097.2152. 
 
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole 35 
B2pin2 (1.87 g, 7.36 mmol), [Ir(COD)Cl]2 (122 mg, 0.18 mmol) and 3,4,7,8-
tetramethyl-1,10-phenanthroline (87 mg, 0.37 mmol) were added to degassed 
THF (20 ml, dry) and the solution was heated to reflux for 1 h. 3-
(Trifluoromethyl)pyrazole 213 (1.00 g, 7.35 mmol) was added and the solution was heated to 
reflux overnight under an atmosphere of argon before being cooled to RT. The reaction was 
quenched with water and the solvent was removed. DCM and water were added and the organic 
phase was separated. The aqueous phase was extracted with further DCM; the organic phases 
were combined, dried over MgSO4, filtered and the solvent removed. The residue was purified by 
column chromatography (hexane:EtOAc 4:1) to give the product as a white solid, 5-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole 212 (1.40 g, 73%); δH (400 
MHz; CDCl3; Me4Si) 6.99 (1H, d, J 0.7), 1.35 (13 H, s); δF (376 MHz; CDCl3; Me4Si) -61.81 (1F, s); δB 
(128 MHz; CDCl3; Me4Si) 27.28 (br s); NMR data is consistent with the literature data.
35 
 
1-(Tetrahydro-2H-pyran-2-yl)-3-(trifluoromethyl)- 1H-pyrazole 215 36 
Trifluroroacetic acid (0.16 ml, 2.02 mmol) was added to a stirred solution of 3-
(trifluoromethyl)pyrazole 213 (1.85 g, 13.59 mmol) and 3,4-dihydro-2H-pyran (1.30 ml, 
14.27 mmol) in toluene (15 ml) and the mixture was heated to 80 oC overnight before 
being cooled to RT. The toluene was removed in vacuo and EtOAc (40 ml) and water 
(40 ml) were added. The organic phase was separated, and the aqueous phase was 
extracted with further EtOAc (3 x 40 ml). The organic phases were combined, washed with brine 
then dried over MgSO4 and filtered. The solvent was removed and the residue was purified by 
column chromatography (hexane:EtOAc 3:1), product visualised with KMnO4 stain) to give the 
product as a yellow oil, 1-(tetrahydro-2H-pyran-2-yl)-3-(trifluoromethyl)- 1H-pyrazole 215 (2.84 g, 
95%); δH (400 MHz; CDCl3; Me4Si) 7.66 (1H, dq, J 1.9, 0.9), 6.56 (1H, d, J 2.5), 5.44 (1H, dd, J 8.6, 
3.5), 4.16 – 4.02 (1H, m), 3.78 – 3.63 (1H, m), 2.16 – 1.95 (3H, m), 1.78 – 1.58 (3H, m); δF (376 
MHz; CDCl3; Me4Si) -62.01 (3F, s). 
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1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-
(trifluoromethyl)- 1H-pyrazole 214 
Trifluroroacetic acid (0.017 ml, 0.23 mmol) was added to a stirred solution of 5-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)- 1H-pyrazole 
212 (400 mg, 1.53 mmol) and 3,4-dihydro-2H-pyran (0.146 ml, 1.62 mmol) in 
toluene (10 ml) and the mixture was heated to 80 oC overnight before being 
cooled to RT. The toluene was removed in vacuo and EtOAc (40 ml) and water 
(40 ml) were added. The organic phase was separated, and the aqueous phase was extracted with 
further EtOAc (3 x 40 ml). The organic phases were combined, washed with brine then dried over 
MgSO4 and filtered. The solvent was removed and the residue was purified by column 
chromatography (hexane:EtOAc 3:1, product visualised with KMnO4 stain) to give the product as 
an orange oil, 1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-
(trifluoromethyl)- 1H-pyrazole 214 (126 mg, 24%); δH (400 MHz; CDCl3; Me4Si) 6.96 (1H, s), 5.85 
(1H, dd, J 10.0, 2.5), 4.04 (1H, dt, J 11.6, 2.0), 3.67 (1 H, td, J 11.3, 2.7), 2.49 –2.37 (1H, m), 2.16 – 
2.03 (1H, m), 1.98 (1H, ddd, J 13.0, 3.9, 2.4), 1.82 – 1.63 (2H, m), 1.63 – 1.52 (1 H, m), 1.34 (12H, 




nBuLi (7.76 ml, 2.5 M) was added dropwise to a stirred solution of 1-(tetrahydro-
2H-pyran-2-yl)-3-(trifluoromethyl)-1H-pyrazole 212 (3.56 g, 16.17 mmol) in THF 
(20 ml, dry) under argon at -78 oC. The mixture was stirred at LT for 1 h before 
iPrOBpin (4.29 ml, 21.01 mmol) was added dropwise and the mixture was stirred 
at LT for 1 h before being allowed to rise to RT overnight. The reaction was 
quenched with water (20 ml) and DCM (40 ml) was added. The organic phase was separated and 
the aqueous phase was extracted with further DCM (3 x 40 ml). The organic phases were then 
combined, dried over MgSO4, filtered and the solvent removed. The residue was purified by 
column chromatography on alumina (hexane:EtOAc 3:1, product visualised with KMnO4 stain) to 
give the product as a yellow oil, 1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole 214 (2.30 g, 41%). The NMR data was 
consistent with that obtained previously. 
 
2-Cyano-5-hydroxy pyridine 218 37 
A solution of NaNO2 (1.90 g, 27.54 mmol) in water (17 ml) was added dropwise to a stirred 
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solution of 5-amino-2-cyano pyridine 217 (3.00 g, 25.10 mmol) in conc. H2SO4/water 
(13/45 ml). The temperature was monitored and maintained below 2 oC. After addition 
was complete the solution was stirred at 0 oC for 30 min. The mixture was then poured 
into a boiling mixture of water (33 ml) and conc. H2SO4 (3 ml). The mixture was stirred 
for 30 min at boiling before being cooled to RT and extracted with EtOAc (4 x 100 ml). The organic 
layers were combined, dried over MgSO4 and filtered. The solvent was removed in vacuo to give 
the product as an orange solid, 2-cyano-5-hydroxy pyridine 218 (3.01 g, 100%), which was used 
without further purification; δH (400 MHz; CDCl3; Me4Si) 8.34 (6 H, dd, J 2.8, 0.6), 7.58 (6 H, dt, J 
8.6, 0.7), 7.25 (1H, dd, J 8.6, 2.8). 
 
2-Cyano-5-methoxypyridine 219 
MeI (2.34 ml, 37.62 mmol) was added dropwise to a stirred suspension of K2CO3 (3.81 g, 
27.57 mmol) and 2-cyano-5-hydroxy pyridine 218 (3.01 g, 25.06 mmol) in acetonitrile 
(100 ml). The mixture was stirred at RT overnight before the solvent was removed. 
EtOAc and water were added and the organic phase was separated. The aqueous phase 
was extracted with further EtOAc. The organic layers were combined, dried over MgSO4, filtered 
and the solvent was removed in vacuo. The residue was purified by column chromatography 
(hexane:EtOAc 4:1) to give the product as an off-white solid 219 (975 mg, 29%); δH (400 MHz, 
CDCl3; Me4Si) 8.38 (1 H, dd, J 2.9, 0.6), 7.65 (1 H, dd, J 8.6, 0.7), 7.24 (1 H, dd, J 8.6, 2.9), 3.93 (3 H, 
s); δC (101 MHz; CDCl3; Me4Si) 157.99, 140.24, 129.66, 125.50, 119.89, 117.60, 56.09; NMR data is 
consistent with the literature data.38 
1-(5-Methoxy-2-pyridinyl)-ethanone 220  
A solution of MeMgBr (3.15 ml, 3.0 M) was added dropwise to a stirred solution of 2-
cyano-5-methoxypyridine 219 (0.98 g, 7.27 mmol) in THF (40 ml, dry) at 0 oC. The 
mixture was stirred at LT for 2 h, then allowed to warm overnight. The solution was 
poured into aq. NH4Cl (100 ml, 1M) solution and acidified to pH 1 with conc. HCl. The 
mixture was stirred at RT for 1 h before being neutralised with solid NaHCO3. DCM was 
added, and the layers were separated. The aqueous layer was extracted with further DCM and the 
organic phases were combined, dried over MgSO4, filtered and the solvent was removed in vacuo. 
The residue was purified by column chromatography (hexane:EtOAc 1:2) to give the product as a 
clear oil that solidifies on standing, 220 (0.62 g, 56%); δH (400 MHz, CDCl3; Me4Si) 8.33 (1 H, dd, J 
2.9, 0.6), 8.05 (1 H, dd, J 8.8, 0.6), 7.26 (3 H, dd, J 8.7, 2.9), 3.93 (3 H, s), 2.69 (3 H, s); NMR data is 
consistent with the literature data.39  
Chapter 8: Experimental data  
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